1	be	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	0	_	_	_	_	_	aware.a	Awareness	O
3	that	_	that	_	IN	0	_	_	_	_	_	_	_	O
4	,	_	,	_	,	0	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	0	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	0	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	0	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
12	,	_	,	_	,	0	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	0	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	0	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	0	_	_	_	_	_	_	_	O
20	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	0	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	0	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	0	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	0	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	0	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	0	_	_	_	_	_	_	_	O
4	,	_	,	_	,	0	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	0	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	0	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	0	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
12	,	_	,	_	,	0	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	0	_	_	_	_	_	_	_	S-Entity
14	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	0	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	0	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	0	_	_	_	_	_	effective.a	Usefulness	O
18	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	0	_	_	_	_	_	_	_	O
20	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	0	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	0	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	0	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	0	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	0	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	0	_	_	_	_	_	_	_	O
4	,	_	,	_	,	0	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	0	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	0	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	0	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
12	,	_	,	_	,	0	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	0	_	_	_	_	_	_	_	S-Goods
14	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	0	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	0	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	0	_	_	_	_	_	cost.n	Expensiveness	O
20	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	0	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	0	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	0	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	0	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	0	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	0	_	_	_	_	_	_	_	O
4	,	_	,	_	,	0	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	0	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	0	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	0	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
12	,	_	,	_	,	0	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	0	_	_	_	_	_	_	_	S-Entity
14	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	0	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	0	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	0	_	_	_	_	_	_	_	O
20	effective	_	effective	_	JJ	0	_	_	_	_	_	effective.a	Usefulness	O
21	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	0	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	0	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	0	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	0	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	0	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	0	_	_	_	_	_	_	_	O
4	,	_	,	_	,	0	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	0	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	0	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	0	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
12	,	_	,	_	,	0	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	0	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	0	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	0	_	_	_	_	_	_	_	O
20	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	0	_	_	_	_	_	adult.n	People_by_age	S-Person
23	with	_	with	_	IN	0	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	0	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	0	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	0	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	0	_	_	_	_	_	_	_	O
4	,	_	,	_	,	0	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	0	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	0	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	0	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
12	,	_	,	_	,	0	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	0	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	0	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	0	_	_	_	_	_	_	_	O
20	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	0	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	0	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	0	_	_	_	_	_	type.n	Type	S-Subtype
25	2	_	2	_	CD	0	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	1	_	_	_	_	_	_	_	O
2	,	_	,	_	,	1	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	1	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	1	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	1	_	_	_	_	_	person.n	People	S-Person
7	for	_	for	_	IN	1	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	1	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	1	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	1	_	_	_	_	_	_	_	O
13	,	_	,	_	,	1	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	1	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	1	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	1	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
20	combination	_	combination	_	NN	1	_	_	_	_	_	_	_	O
21	containing	_	contain	_	VBG	1	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
23	that	_	that	_	WDT	1	_	_	_	_	_	_	_	O
24	can	_	can	_	MD	1	_	_	_	_	_	_	_	O
25	be	_	be	_	VB	1	_	_	_	_	_	_	_	O
26	offered	_	offer	_	VBN	1	_	_	_	_	_	_	_	O
27	at	_	at	_	IN	1	_	_	_	_	_	_	_	O
28	first	_	first	_	JJ	1	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
30	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	1	_	_	_	_	_	_	_	O
2	,	_	,	_	,	1	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	1	_	_	_	_	_	_	_	B-Item
4	with	_	with	_	IN	1	_	_	_	_	_	_	_	I-Item
5	any	_	any	_	DT	1	_	_	_	_	_	_	_	I-Item
6	person	_	person	_	NN	1	_	_	_	_	_	_	_	I-Item
7	for	_	for	_	IN	1	_	_	_	_	_	_	_	I-Item
8	whom	_	whom	_	WP	1	_	_	_	_	_	_	_	I-Item
9	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	I-Item
10	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	1	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	1	_	_	_	_	_	consider.v	Categorization	O
13	,	_	,	_	,	1	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	1	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	1	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	1	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
20	combination	_	combination	_	NN	1	_	_	_	_	_	_	_	O
21	containing	_	contain	_	VBG	1	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
23	that	_	that	_	WDT	1	_	_	_	_	_	_	_	O
24	can	_	can	_	MD	1	_	_	_	_	_	_	_	O
25	be	_	be	_	VB	1	_	_	_	_	_	_	_	O
26	offered	_	offer	_	VBN	1	_	_	_	_	_	_	_	O
27	at	_	at	_	IN	1	_	_	_	_	_	_	_	O
28	first	_	first	_	JJ	1	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
30	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	1	_	_	_	_	_	_	_	O
2	,	_	,	_	,	1	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	1	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	1	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	1	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	1	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	1	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	1	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	1	_	_	_	_	_	_	_	O
13	,	_	,	_	,	1	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	1	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	1	_	_	_	_	_	there.adv	Locative_relation	S-Ground
16	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	1	_	_	_	_	_	_	_	B-Ground
18	licensed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	I-Ground
19	unk	_	UNK	_	JJ	1	_	_	_	_	_	_	_	I-Ground
20	combination	_	combination	_	NN	1	_	_	_	_	_	_	_	I-Ground
21	containing	_	contain	_	VBG	1	_	_	_	_	_	_	_	I-Ground
22	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	I-Ground
23	that	_	that	_	WDT	1	_	_	_	_	_	_	_	I-Ground
24	can	_	can	_	MD	1	_	_	_	_	_	_	_	I-Ground
25	be	_	be	_	VB	1	_	_	_	_	_	_	_	I-Ground
26	offered	_	offer	_	VBN	1	_	_	_	_	_	_	_	I-Ground
27	at	_	at	_	IN	1	_	_	_	_	_	_	_	I-Ground
28	first	_	first	_	JJ	1	_	_	_	_	_	_	_	I-Ground
29	intensification	_	UNK	_	NN	1	_	_	_	_	_	_	_	I-Ground
30	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	1	_	_	_	_	_	_	_	O
2	,	_	,	_	,	1	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	1	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	1	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	1	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	1	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	1	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	1	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	1	_	_	_	_	_	_	_	O
13	,	_	,	_	,	1	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	1	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	1	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	1	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	B-Aggregate_property
19	unk	_	UNK	_	JJ	1	_	_	_	_	_	_	_	I-Aggregate_property
20	combination	_	combination	_	NN	1	_	_	_	_	_	combination.n	Aggregate	S-Aggregate
21	containing	_	contain	_	VBG	1	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
23	that	_	that	_	WDT	1	_	_	_	_	_	_	_	O
24	can	_	can	_	MD	1	_	_	_	_	_	_	_	O
25	be	_	be	_	VB	1	_	_	_	_	_	_	_	O
26	offered	_	offer	_	VBN	1	_	_	_	_	_	_	_	O
27	at	_	at	_	IN	1	_	_	_	_	_	_	_	O
28	first	_	first	_	JJ	1	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
30	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	1	_	_	_	_	_	_	_	O
2	,	_	,	_	,	1	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	1	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	1	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	1	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	1	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	1	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	1	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	1	_	_	_	_	_	_	_	O
13	,	_	,	_	,	1	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	1	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	1	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	1	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
20	combination	_	combination	_	NN	1	_	_	_	_	_	_	_	O
21	containing	_	contain	_	VBG	1	_	_	_	_	_	contain.v	Containing	O
22	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	B-Contents
23	that	_	that	_	WDT	1	_	_	_	_	_	_	_	I-Contents
24	can	_	can	_	MD	1	_	_	_	_	_	_	_	I-Contents
25	be	_	be	_	VB	1	_	_	_	_	_	_	_	I-Contents
26	offered	_	offer	_	VBN	1	_	_	_	_	_	_	_	I-Contents
27	at	_	at	_	IN	1	_	_	_	_	_	_	_	I-Contents
28	first	_	first	_	JJ	1	_	_	_	_	_	_	_	I-Contents
29	intensification	_	UNK	_	NN	1	_	_	_	_	_	_	_	I-Contents
30	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	1	_	_	_	_	_	_	_	O
2	,	_	,	_	,	1	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	1	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	1	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	1	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	1	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	1	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	1	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	1	_	_	_	_	_	_	_	O
13	,	_	,	_	,	1	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	1	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	1	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	1	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
20	combination	_	combination	_	NN	1	_	_	_	_	_	_	_	O
21	containing	_	contain	_	VBG	1	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	B-Entity
23	that	_	that	_	WDT	1	_	_	_	_	_	_	_	I-Entity
24	can	_	can	_	MD	1	_	_	_	_	_	can.v	Capability	O
25	be	_	be	_	VB	1	_	_	_	_	_	_	_	B-Event
26	offered	_	offer	_	VBN	1	_	_	_	_	_	_	_	I-Event
27	at	_	at	_	IN	1	_	_	_	_	_	_	_	I-Event
28	first	_	first	_	JJ	1	_	_	_	_	_	_	_	I-Event
29	intensification	_	UNK	_	NN	1	_	_	_	_	_	_	_	I-Event
30	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	1	_	_	_	_	_	_	_	O
2	,	_	,	_	,	1	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	1	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	1	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	1	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	1	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	1	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	1	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	1	_	_	_	_	_	_	_	O
13	,	_	,	_	,	1	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	1	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	1	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	1	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
20	combination	_	combination	_	NN	1	_	_	_	_	_	_	_	O
21	containing	_	contain	_	VBG	1	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
23	that	_	that	_	WDT	1	_	_	_	_	_	_	_	O
24	can	_	can	_	MD	1	_	_	_	_	_	_	_	O
25	be	_	be	_	VB	1	_	_	_	_	_	_	_	O
26	offered	_	offer	_	VBN	1	_	_	_	_	_	_	_	O
27	at	_	at	_	IN	1	_	_	_	_	_	_	_	O
28	first	_	first	_	JJ	1	_	_	_	_	_	first.a	Ordinal_numbers	O
29	intensification	_	UNK	_	NN	1	_	_	_	_	_	_	_	S-Type
30	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	2	_	_	_	_	_	risk.n	Run_risk	O
3	factors	_	factor	_	NNS	2	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
6	conditions	_	condition	_	NNS	2	_	_	_	_	_	_	_	O
7	,	_	,	_	,	2	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	2	_	_	_	_	_	_	_	O
9	increased	_	increase	_	VBN	2	_	_	_	_	_	_	_	O
10	age	_	age	_	NN	2	_	_	_	_	_	_	_	O
11	,	_	,	_	,	2	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	2	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	2	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	2	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	2	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	2	_	_	_	_	_	_	_	O
18	:	_	:	_	:	2	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	2	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	2	_	_	_	_	_	_	_	O
22	'	_	'	_	POS	2	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	2	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	2	_	_	_	_	_	_	_	O
26	characteristics	_	characteristic	_	NNS	2	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	2	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	2	_	_	_	_	_	_	_	O
3	factors	_	factor	_	NNS	2	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	2	_	_	_	_	_	_	_	B-Total
6	conditions	_	condition	_	NNS	2	_	_	_	_	_	_	_	I-Total
7	,	_	,	_	,	2	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	2	_	_	_	_	_	include.v	Inclusion	O
9	increased	_	increase	_	VBN	2	_	_	_	_	_	_	_	B-Part
10	age	_	age	_	NN	2	_	_	_	_	_	_	_	I-Part
11	,	_	,	_	,	2	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	2	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	2	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	2	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	2	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	2	_	_	_	_	_	_	_	O
18	:	_	:	_	:	2	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	2	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	2	_	_	_	_	_	_	_	O
22	'	_	'	_	POS	2	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	2	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	2	_	_	_	_	_	_	_	O
26	characteristics	_	characteristic	_	NNS	2	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	2	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	2	_	_	_	_	_	_	_	O
3	factors	_	factor	_	NNS	2	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
6	conditions	_	condition	_	NNS	2	_	_	_	_	_	_	_	O
7	,	_	,	_	,	2	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	2	_	_	_	_	_	_	_	O
9	increased	_	increase	_	VBN	2	_	_	_	_	_	increase.v	Change_position_on_a_scale	O
10	age	_	age	_	NN	2	_	_	_	_	_	_	_	S-Item
11	,	_	,	_	,	2	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	2	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	2	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	2	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	2	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	2	_	_	_	_	_	_	_	O
18	:	_	:	_	:	2	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	2	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	2	_	_	_	_	_	_	_	O
22	'	_	'	_	POS	2	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	2	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	2	_	_	_	_	_	_	_	O
26	characteristics	_	characteristic	_	NNS	2	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	2	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	2	_	_	_	_	_	_	_	O
3	factors	_	factor	_	NNS	2	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
6	conditions	_	condition	_	NNS	2	_	_	_	_	_	_	_	O
7	,	_	,	_	,	2	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	2	_	_	_	_	_	_	_	O
9	increased	_	increase	_	VBN	2	_	_	_	_	_	_	_	S-Relative_time
10	age	_	age	_	NN	2	_	_	_	_	_	age.n	Calendric_unit	S-Unit
11	,	_	,	_	,	2	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	2	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	2	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	2	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	2	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	2	_	_	_	_	_	_	_	O
18	:	_	:	_	:	2	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	2	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	2	_	_	_	_	_	_	_	O
22	'	_	'	_	POS	2	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	2	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	2	_	_	_	_	_	_	_	O
26	characteristics	_	characteristic	_	NNS	2	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	2	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	2	_	_	_	_	_	_	_	O
3	factors	_	factor	_	NNS	2	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
6	conditions	_	condition	_	NNS	2	_	_	_	_	_	_	_	O
7	,	_	,	_	,	2	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	2	_	_	_	_	_	_	_	O
9	increased	_	increase	_	VBN	2	_	_	_	_	_	_	_	O
10	age	_	age	_	NN	2	_	_	_	_	_	_	_	O
11	,	_	,	_	,	2	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	2	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	2	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	2	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	2	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	2	_	_	_	_	_	_	_	O
18	:	_	:	_	:	2	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	2	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	2	_	_	_	_	_	manufacturer.n	Manufacturing	S-Producer
22	'	_	'	_	POS	2	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	2	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	2	_	_	_	_	_	_	_	O
26	characteristics	_	characteristic	_	NNS	2	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	2	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	2	_	_	_	_	_	_	_	O
3	factors	_	factor	_	NNS	2	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
6	conditions	_	condition	_	NNS	2	_	_	_	_	_	_	_	O
7	,	_	,	_	,	2	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	2	_	_	_	_	_	_	_	O
9	increased	_	increase	_	VBN	2	_	_	_	_	_	_	_	O
10	age	_	age	_	NN	2	_	_	_	_	_	_	_	O
11	,	_	,	_	,	2	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	2	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	2	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	2	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	2	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	2	_	_	_	_	_	_	_	O
18	:	_	:	_	:	2	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	2	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	2	_	_	_	_	_	_	_	O
22	'	_	'	_	POS	2	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	2	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	2	_	_	_	_	_	_	_	S-Entity
26	characteristics	_	characteristic	_	NNS	2	_	_	_	_	_	characteristic.n	Distinctiveness	O
27	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	2	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	3	_	_	_	_	_	_	_	B-Speaker
2	and	_	and	_	CC	3	_	_	_	_	_	_	_	I-Speaker
3	healthcare	_	UNK	_	NNP	3	_	_	_	_	_	_	_	I-Speaker
4	products	_	product	_	NNS	3	_	_	_	_	_	_	_	I-Speaker
5	regulatory	_	Regulatory	_	NNP	3	_	_	_	_	_	_	_	I-Speaker
6	agency	_	Agency	_	NNP	3	_	_	_	_	_	_	_	I-Speaker
7	(	_	(	_	(	3	_	_	_	_	_	_	_	I-Speaker
8	mhra	_	UNK	_	NNP	3	_	_	_	_	_	_	_	I-Speaker
9	)	_	)	_	)	3	_	_	_	_	_	_	_	I-Speaker
10	guidance	_	guidance	_	NN	3	_	_	_	_	_	_	_	I-Speaker
11	(	_	(	_	(	3	_	_	_	_	_	_	_	I-Speaker
12	2011	_	2011	_	CD	3	_	_	_	_	_	_	_	I-Speaker
13	)	_	)	_	)	3	_	_	_	_	_	_	_	I-Speaker
14	advises	_	advise	_	VBZ	3	_	_	_	_	_	advise.v	Telling	O
15	that	_	that	_	IN	3	_	_	_	_	_	_	_	B-Message
16	unk	_	UNK	_	NNS	3	_	_	_	_	_	_	_	I-Message
17	should	_	should	_	MD	3	_	_	_	_	_	_	_	I-Message
18	review	_	review	_	VB	3	_	_	_	_	_	_	_	I-Message
19	the	_	the	_	DT	3	_	_	_	_	_	_	_	I-Message
20	safety	_	safety	_	NN	3	_	_	_	_	_	_	_	I-Message
21	and	_	and	_	CC	3	_	_	_	_	_	_	_	I-Message
22	efficacy	_	UNK	_	NN	3	_	_	_	_	_	_	_	I-Message
23	of	_	of	_	IN	3	_	_	_	_	_	_	_	I-Message
24	pioglitazone	_	UNK	_	NN	3	_	_	_	_	_	_	_	I-Message
25	in	_	in	_	IN	3	_	_	_	_	_	_	_	I-Message
26	individuals	_	individual	_	NNS	3	_	_	_	_	_	_	_	I-Message
27	after	_	after	_	IN	3	_	_	_	_	_	_	_	I-Message
28	unk	_	UNK	_	CD	3	_	_	_	_	_	_	_	I-Message
29	months	_	month	_	NNS	3	_	_	_	_	_	_	_	I-Message
30	of	_	of	_	IN	3	_	_	_	_	_	_	_	I-Message
31	treatment	_	treatment	_	NN	3	_	_	_	_	_	_	_	I-Message
32	to	_	to	_	TO	3	_	_	_	_	_	_	_	I-Message
33	ensure	_	ensure	_	VB	3	_	_	_	_	_	_	_	I-Message
34	that	_	that	_	IN	3	_	_	_	_	_	_	_	I-Message
35	only	_	only	_	JJ	3	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	3	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	3	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	3	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	3	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	3	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	3	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	3	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	3	_	_	_	_	_	_	_	O
45	'	_	'	_	POS	3	_	_	_	_	_	_	_	O
46	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	3	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	3	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	3	_	_	_	_	_	_	_	O
7	(	_	(	_	(	3	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
9	)	_	)	_	)	3	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	3	_	_	_	_	_	_	_	O
11	(	_	(	_	(	3	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	3	_	_	_	_	_	_	_	O
13	)	_	)	_	)	3	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	3	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	3	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	3	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	3	_	_	_	_	_	safety.n	Being_at_risk	O
21	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	3	_	_	_	_	_	_	_	O
27	after	_	after	_	IN	3	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	3	_	_	_	_	_	_	_	O
29	months	_	month	_	NNS	3	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	3	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	3	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	3	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	3	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	3	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	3	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	3	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	3	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	3	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	3	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	3	_	_	_	_	_	_	_	O
45	'	_	'	_	POS	3	_	_	_	_	_	_	_	O
46	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	3	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	3	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	3	_	_	_	_	_	_	_	O
7	(	_	(	_	(	3	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
9	)	_	)	_	)	3	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	3	_	_	_	_	_	_	_	O
11	(	_	(	_	(	3	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	3	_	_	_	_	_	_	_	O
13	)	_	)	_	)	3	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	3	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	3	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	3	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	3	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	3	_	_	_	_	_	individual.n	People	S-Person
27	after	_	after	_	IN	3	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	3	_	_	_	_	_	_	_	O
29	months	_	month	_	NNS	3	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	3	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	3	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	3	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	3	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	3	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	3	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	3	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	3	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	3	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	3	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	3	_	_	_	_	_	_	_	O
45	'	_	'	_	POS	3	_	_	_	_	_	_	_	O
46	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	3	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	3	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	3	_	_	_	_	_	_	_	O
7	(	_	(	_	(	3	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
9	)	_	)	_	)	3	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	3	_	_	_	_	_	_	_	O
11	(	_	(	_	(	3	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	3	_	_	_	_	_	_	_	O
13	)	_	)	_	)	3	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	3	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	3	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	3	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	3	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	3	_	_	_	_	_	_	_	O
27	after	_	after	_	IN	3	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	3	_	_	_	_	_	_	_	S-Count
29	months	_	month	_	NNS	3	_	_	_	_	_	month.n	Calendric_unit	S-Unit
30	of	_	of	_	IN	3	_	_	_	_	_	_	_	B-Whole
31	treatment	_	treatment	_	NN	3	_	_	_	_	_	_	_	I-Whole
32	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	3	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	3	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	3	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	3	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	3	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	3	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	3	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	3	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	3	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	3	_	_	_	_	_	_	_	O
45	'	_	'	_	POS	3	_	_	_	_	_	_	_	O
46	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	3	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	3	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	3	_	_	_	_	_	_	_	O
7	(	_	(	_	(	3	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
9	)	_	)	_	)	3	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	3	_	_	_	_	_	_	_	O
11	(	_	(	_	(	3	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	3	_	_	_	_	_	_	_	O
13	)	_	)	_	)	3	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	3	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	3	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	3	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	3	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	3	_	_	_	_	_	_	_	O
27	after	_	after	_	IN	3	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	3	_	_	_	_	_	_	_	O
29	months	_	month	_	NNS	3	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	3	_	_	_	_	_	treatment.n	Cure	S-Patient
32	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	3	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	3	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	3	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	3	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	3	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	3	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	3	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	3	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	3	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	3	_	_	_	_	_	_	_	O
45	'	_	'	_	POS	3	_	_	_	_	_	_	_	O
46	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	3	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	3	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	3	_	_	_	_	_	_	_	O
7	(	_	(	_	(	3	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
9	)	_	)	_	)	3	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	3	_	_	_	_	_	_	_	O
11	(	_	(	_	(	3	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	3	_	_	_	_	_	_	_	O
13	)	_	)	_	)	3	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	3	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	3	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	3	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	3	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	3	_	_	_	_	_	_	_	O
27	after	_	after	_	IN	3	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	3	_	_	_	_	_	_	_	O
29	months	_	month	_	NNS	3	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	3	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	3	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	3	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	3	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	3	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	3	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	3	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	3	_	_	_	_	_	_	_	S-Manner
41	continue	_	continue	_	NN	3	_	_	_	_	_	continue.v	Process_continue	O
42	to	_	to	_	TO	3	_	_	_	_	_	_	_	B-Event
43	be	_	be	_	VB	3	_	_	_	_	_	_	_	I-Event
44	treated	_	treat	_	VBN	3	_	_	_	_	_	_	_	I-Event
45	'	_	'	_	POS	3	_	_	_	_	_	_	_	I-Event
46	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	3	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	3	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	3	_	_	_	_	_	_	_	O
7	(	_	(	_	(	3	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
9	)	_	)	_	)	3	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	3	_	_	_	_	_	_	_	O
11	(	_	(	_	(	3	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	3	_	_	_	_	_	_	_	O
13	)	_	)	_	)	3	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	3	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	3	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	3	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	3	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	3	_	_	_	_	_	_	_	O
27	after	_	after	_	IN	3	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	3	_	_	_	_	_	_	_	O
29	months	_	month	_	NNS	3	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	3	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	3	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	3	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	3	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	3	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	3	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	3	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	3	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	3	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	3	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	3	_	_	_	_	_	treat.v	Medical_intervention	O
45	'	_	'	_	POS	3	_	_	_	_	_	_	_	S-Patient
46	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	4	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	4	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	4	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	4	_	_	_	_	_	_	_	O
6	:	_	:	_	:	4	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	4	_	_	_	_	_	_	_	O
8	(	_	(	_	(	4	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	4	_	_	_	_	_	_	_	O
10	)	_	)	_	)	4	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	4	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	4	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
14	)	_	)	_	)	4	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	4	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	4	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	4	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	4	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	4	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	4	_	_	_	_	_	_	_	O
8	(	_	(	_	(	4	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	4	_	_	_	_	_	_	_	O
10	)	_	)	_	)	4	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	4	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	4	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
14	)	_	)	_	)	4	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	5	_	_	_	_	_	last.a	Relative_time	O
2	updated	_	update	_	VBD	5	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	5	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	5	_	_	_	_	_	_	_	O
5	1	_	1	_	CD	5	_	_	_	_	_	_	_	O
6	recommendations	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	6	_	_	_	_	_	_	_	B-Instrument
2	wording	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Instrument
3	used	_	use	_	VBN	6	_	_	_	_	_	use.v	Using	O
4	in	_	in	_	IN	6	_	_	_	_	_	_	_	B-Purpose
5	the	_	the	_	DT	6	_	_	_	_	_	_	_	I-Purpose
6	recommendations	_	UNK	_	NNS	6	_	_	_	_	_	_	_	I-Purpose
7	in	_	in	_	IN	6	_	_	_	_	_	_	_	I-Purpose
8	this	_	this	_	DT	6	_	_	_	_	_	_	_	I-Purpose
9	guideline	_	guideline	_	NN	6	_	_	_	_	_	_	_	I-Purpose
10	(	_	(	_	(	6	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	6	_	_	_	_	_	_	_	O
12	example	_	example	_	NN	6	_	_	_	_	_	_	_	O
13	,	_	,	_	,	6	_	_	_	_	_	_	_	O
14	words	_	word	_	NNS	6	_	_	_	_	_	_	_	O
15	such	_	such	_	JJ	6	_	_	_	_	_	_	_	O
16	as	_	a	_	IN	6	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
18	'	_	'	_	''	6	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	NNP	6	_	_	_	_	_	_	_	O
21	'	_	'	_	POS	6	_	_	_	_	_	_	_	O
22	)	_	)	_	)	6	_	_	_	_	_	_	_	O
23	denotes	_	UNK	_	VBZ	6	_	_	_	_	_	_	_	O
24	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
25	certainty	_	certainty	_	NN	6	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	6	_	_	_	_	_	_	_	O
27	which	_	which	_	WDT	6	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
29	recommendation	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	6	_	_	_	_	_	_	_	O
31	made	_	make	_	VBN	6	_	_	_	_	_	_	_	O
32	(	_	(	_	(	6	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
34	strength	_	strength	_	NN	6	_	_	_	_	_	_	_	O
35	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
37	recommendation	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
38	)	_	)	_	)	6	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	6	_	_	_	_	_	_	_	O
2	wording	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
3	used	_	use	_	VBN	6	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	6	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
6	recommendations	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	6	_	_	_	_	_	_	_	O
8	this	_	this	_	DT	6	_	_	_	_	_	_	_	O
9	guideline	_	guideline	_	NN	6	_	_	_	_	_	_	_	O
10	(	_	(	_	(	6	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	6	_	_	_	_	_	_	_	O
12	example	_	example	_	NN	6	_	_	_	_	_	example.n	Instance	S-Instance
13	,	_	,	_	,	6	_	_	_	_	_	_	_	O
14	words	_	word	_	NNS	6	_	_	_	_	_	_	_	O
15	such	_	such	_	JJ	6	_	_	_	_	_	_	_	O
16	as	_	a	_	IN	6	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
18	'	_	'	_	''	6	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	NNP	6	_	_	_	_	_	_	_	O
21	'	_	'	_	POS	6	_	_	_	_	_	_	_	O
22	)	_	)	_	)	6	_	_	_	_	_	_	_	O
23	denotes	_	UNK	_	VBZ	6	_	_	_	_	_	_	_	O
24	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
25	certainty	_	certainty	_	NN	6	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	6	_	_	_	_	_	_	_	O
27	which	_	which	_	WDT	6	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
29	recommendation	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	6	_	_	_	_	_	_	_	O
31	made	_	make	_	VBN	6	_	_	_	_	_	_	_	O
32	(	_	(	_	(	6	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
34	strength	_	strength	_	NN	6	_	_	_	_	_	_	_	O
35	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
37	recommendation	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
38	)	_	)	_	)	6	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	6	_	_	_	_	_	_	_	O
2	wording	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
3	used	_	use	_	VBN	6	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	6	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
6	recommendations	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	6	_	_	_	_	_	_	_	O
8	this	_	this	_	DT	6	_	_	_	_	_	_	_	O
9	guideline	_	guideline	_	NN	6	_	_	_	_	_	_	_	O
10	(	_	(	_	(	6	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	6	_	_	_	_	_	_	_	O
12	example	_	example	_	NN	6	_	_	_	_	_	_	_	O
13	,	_	,	_	,	6	_	_	_	_	_	_	_	O
14	words	_	word	_	NNS	6	_	_	_	_	_	_	_	O
15	such	_	such	_	JJ	6	_	_	_	_	_	_	_	O
16	as	_	a	_	IN	6	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
18	'	_	'	_	''	6	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	NNP	6	_	_	_	_	_	_	_	O
21	'	_	'	_	POS	6	_	_	_	_	_	_	_	O
22	)	_	)	_	)	6	_	_	_	_	_	_	_	O
23	denotes	_	UNK	_	VBZ	6	_	_	_	_	_	_	_	O
24	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
25	certainty	_	certainty	_	NN	6	_	_	_	_	_	certainty.n	Certainty	O
26	with	_	with	_	IN	6	_	_	_	_	_	_	_	B-Content
27	which	_	which	_	WDT	6	_	_	_	_	_	_	_	I-Content
28	the	_	the	_	DT	6	_	_	_	_	_	_	_	I-Content
29	recommendation	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Content
30	is	_	be	_	VBZ	6	_	_	_	_	_	_	_	I-Content
31	made	_	make	_	VBN	6	_	_	_	_	_	_	_	I-Content
32	(	_	(	_	(	6	_	_	_	_	_	_	_	I-Content
33	the	_	the	_	DT	6	_	_	_	_	_	_	_	I-Content
34	strength	_	strength	_	NN	6	_	_	_	_	_	_	_	I-Content
35	of	_	of	_	IN	6	_	_	_	_	_	_	_	I-Content
36	the	_	the	_	DT	6	_	_	_	_	_	_	_	I-Content
37	recommendation	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Content
38	)	_	)	_	)	6	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	7	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	7	_	_	_	_	_	_	_	S-Descriptor
4	approach	_	approach	_	NN	7	_	_	_	_	_	approach.n	Means	O
5	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	7	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	7	_	_	_	_	_	_	_	O
9	is	_	be	_	VBZ	7	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	7	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
13	needs	_	need	_	NNS	7	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
15	circumstances	_	circumstance	_	NNS	7	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	7	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	7	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	7	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
22	,	_	,	_	,	7	_	_	_	_	_	_	_	O
23	taking	_	take	_	VBG	7	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	7	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	7	_	_	_	_	_	_	_	O
26	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
27	personal	_	personal	_	JJ	7	_	_	_	_	_	_	_	O
28	preferences	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
29	,	_	,	_	,	7	_	_	_	_	_	_	_	O
30	comorbidities	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
31	,	_	,	_	,	7	_	_	_	_	_	_	_	O
32	risks	_	risk	_	NNS	7	_	_	_	_	_	_	_	O
33	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
34	polypharmacy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
35	,	_	,	_	,	7	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
37	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
38	ability	_	ability	_	NN	7	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	VB	7	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
42	long-term	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
43	interventions	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
44	because	_	because	_	IN	7	_	_	_	_	_	_	_	O
45	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
46	reduced	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
47	life	_	life	_	NN	7	_	_	_	_	_	_	_	O
48	expectancy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
49	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	7	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
4	approach	_	approach	_	NN	7	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	7	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	7	_	_	_	_	_	_	_	S-Person
9	is	_	be	_	VBZ	7	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	7	_	_	_	_	_	tailor.n	People_by_vocation	O
11	to	_	to	_	TO	7	_	_	_	_	_	_	_	B-Person
12	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Person
13	needs	_	need	_	NNS	7	_	_	_	_	_	_	_	I-Person
14	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Person
15	circumstances	_	circumstance	_	NNS	7	_	_	_	_	_	_	_	I-Person
16	of	_	of	_	IN	7	_	_	_	_	_	_	_	I-Person
17	adults	_	adult	_	NNS	7	_	_	_	_	_	_	_	I-Person
18	with	_	with	_	IN	7	_	_	_	_	_	_	_	I-Person
19	type	_	type	_	JJ	7	_	_	_	_	_	_	_	I-Person
20	2	_	2	_	CD	7	_	_	_	_	_	_	_	I-Person
21	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Person
22	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Person
23	taking	_	take	_	VBG	7	_	_	_	_	_	_	_	I-Person
24	into	_	into	_	IN	7	_	_	_	_	_	_	_	I-Person
25	account	_	account	_	NN	7	_	_	_	_	_	_	_	I-Person
26	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	I-Person
27	personal	_	personal	_	JJ	7	_	_	_	_	_	_	_	I-Person
28	preferences	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Person
29	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Person
30	comorbidities	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Person
31	,	_	,	_	,	7	_	_	_	_	_	_	_	O
32	risks	_	risk	_	NNS	7	_	_	_	_	_	_	_	O
33	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
34	polypharmacy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
35	,	_	,	_	,	7	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
37	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
38	ability	_	ability	_	NN	7	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	VB	7	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
42	long-term	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
43	interventions	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
44	because	_	because	_	IN	7	_	_	_	_	_	_	_	O
45	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
46	reduced	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
47	life	_	life	_	NN	7	_	_	_	_	_	_	_	O
48	expectancy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
49	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	7	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
4	approach	_	approach	_	NN	7	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	7	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	7	_	_	_	_	_	_	_	O
9	is	_	be	_	VBZ	7	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	7	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
13	needs	_	need	_	NNS	7	_	_	_	_	_	need.n	Needing	S-Requirement
14	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
15	circumstances	_	circumstance	_	NNS	7	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	7	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	7	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	7	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
22	,	_	,	_	,	7	_	_	_	_	_	_	_	O
23	taking	_	take	_	VBG	7	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	7	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	7	_	_	_	_	_	_	_	O
26	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
27	personal	_	personal	_	JJ	7	_	_	_	_	_	_	_	O
28	preferences	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
29	,	_	,	_	,	7	_	_	_	_	_	_	_	O
30	comorbidities	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
31	,	_	,	_	,	7	_	_	_	_	_	_	_	O
32	risks	_	risk	_	NNS	7	_	_	_	_	_	_	_	O
33	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
34	polypharmacy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
35	,	_	,	_	,	7	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
37	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
38	ability	_	ability	_	NN	7	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	VB	7	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
42	long-term	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
43	interventions	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
44	because	_	because	_	IN	7	_	_	_	_	_	_	_	O
45	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
46	reduced	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
47	life	_	life	_	NN	7	_	_	_	_	_	_	_	O
48	expectancy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
49	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	7	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
4	approach	_	approach	_	NN	7	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	7	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	7	_	_	_	_	_	_	_	O
9	is	_	be	_	VBZ	7	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	7	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
13	needs	_	need	_	NNS	7	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
15	circumstances	_	circumstance	_	NNS	7	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	7	_	_	_	_	_	adult.n	People_by_age	S-Person
18	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	7	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	7	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
22	,	_	,	_	,	7	_	_	_	_	_	_	_	O
23	taking	_	take	_	VBG	7	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	7	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	7	_	_	_	_	_	_	_	O
26	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
27	personal	_	personal	_	JJ	7	_	_	_	_	_	_	_	O
28	preferences	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
29	,	_	,	_	,	7	_	_	_	_	_	_	_	O
30	comorbidities	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
31	,	_	,	_	,	7	_	_	_	_	_	_	_	O
32	risks	_	risk	_	NNS	7	_	_	_	_	_	_	_	O
33	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
34	polypharmacy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
35	,	_	,	_	,	7	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
37	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
38	ability	_	ability	_	NN	7	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	VB	7	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
42	long-term	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
43	interventions	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
44	because	_	because	_	IN	7	_	_	_	_	_	_	_	O
45	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
46	reduced	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
47	life	_	life	_	NN	7	_	_	_	_	_	_	_	O
48	expectancy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
49	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	7	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
4	approach	_	approach	_	NN	7	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	7	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	7	_	_	_	_	_	_	_	O
9	is	_	be	_	VBZ	7	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	7	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
13	needs	_	need	_	NNS	7	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
15	circumstances	_	circumstance	_	NNS	7	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	7	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	7	_	_	_	_	_	type.n	Type	S-Subtype
20	2	_	2	_	CD	7	_	_	_	_	_	_	_	B-Category
21	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Category
22	,	_	,	_	,	7	_	_	_	_	_	_	_	O
23	taking	_	take	_	VBG	7	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	7	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	7	_	_	_	_	_	_	_	O
26	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
27	personal	_	personal	_	JJ	7	_	_	_	_	_	_	_	O
28	preferences	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
29	,	_	,	_	,	7	_	_	_	_	_	_	_	O
30	comorbidities	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
31	,	_	,	_	,	7	_	_	_	_	_	_	_	O
32	risks	_	risk	_	NNS	7	_	_	_	_	_	_	_	O
33	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
34	polypharmacy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
35	,	_	,	_	,	7	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
37	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
38	ability	_	ability	_	NN	7	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	VB	7	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
42	long-term	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
43	interventions	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
44	because	_	because	_	IN	7	_	_	_	_	_	_	_	O
45	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
46	reduced	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
47	life	_	life	_	NN	7	_	_	_	_	_	_	_	O
48	expectancy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
49	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	7	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
4	approach	_	approach	_	NN	7	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	7	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	7	_	_	_	_	_	_	_	O
9	is	_	be	_	VBZ	7	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	7	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
13	needs	_	need	_	NNS	7	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
15	circumstances	_	circumstance	_	NNS	7	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	7	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	7	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	7	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
22	,	_	,	_	,	7	_	_	_	_	_	_	_	O
23	taking	_	take	_	VBG	7	_	_	_	_	_	take.v	Taking	O
24	into	_	into	_	IN	7	_	_	_	_	_	_	_	B-Theme
25	account	_	account	_	NN	7	_	_	_	_	_	_	_	I-Theme
26	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	I-Theme
27	personal	_	personal	_	JJ	7	_	_	_	_	_	_	_	I-Theme
28	preferences	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Theme
29	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Theme
30	comorbidities	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Theme
31	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Theme
32	risks	_	risk	_	NNS	7	_	_	_	_	_	_	_	I-Theme
33	from	_	from	_	IN	7	_	_	_	_	_	_	_	I-Theme
34	polypharmacy	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Theme
35	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Theme
36	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Theme
37	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	I-Theme
38	ability	_	ability	_	NN	7	_	_	_	_	_	_	_	I-Theme
39	to	_	to	_	TO	7	_	_	_	_	_	_	_	I-Theme
40	benefit	_	benefit	_	VB	7	_	_	_	_	_	_	_	I-Theme
41	from	_	from	_	IN	7	_	_	_	_	_	_	_	I-Theme
42	long-term	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Theme
43	interventions	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Theme
44	because	_	because	_	IN	7	_	_	_	_	_	_	_	O
45	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
46	reduced	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
47	life	_	life	_	NN	7	_	_	_	_	_	_	_	O
48	expectancy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
49	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	7	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
4	approach	_	approach	_	NN	7	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	7	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	7	_	_	_	_	_	_	_	O
9	is	_	be	_	VBZ	7	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	7	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
13	needs	_	need	_	NNS	7	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
15	circumstances	_	circumstance	_	NNS	7	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	7	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	7	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	7	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
22	,	_	,	_	,	7	_	_	_	_	_	_	_	O
23	taking	_	take	_	VBG	7	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	7	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	7	_	_	_	_	_	account.n	Text	O
26	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
27	personal	_	personal	_	JJ	7	_	_	_	_	_	_	_	O
28	preferences	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
29	,	_	,	_	,	7	_	_	_	_	_	_	_	O
30	comorbidities	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
31	,	_	,	_	,	7	_	_	_	_	_	_	_	O
32	risks	_	risk	_	NNS	7	_	_	_	_	_	_	_	O
33	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
34	polypharmacy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
35	,	_	,	_	,	7	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
37	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
38	ability	_	ability	_	NN	7	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	VB	7	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
42	long-term	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
43	interventions	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
44	because	_	because	_	IN	7	_	_	_	_	_	_	_	O
45	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
46	reduced	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
47	life	_	life	_	NN	7	_	_	_	_	_	_	_	O
48	expectancy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
49	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	7	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
4	approach	_	approach	_	NN	7	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	7	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	7	_	_	_	_	_	_	_	O
9	is	_	be	_	VBZ	7	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	7	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
13	needs	_	need	_	NNS	7	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
15	circumstances	_	circumstance	_	NNS	7	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	7	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	7	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	7	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
22	,	_	,	_	,	7	_	_	_	_	_	_	_	O
23	taking	_	take	_	VBG	7	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	7	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	7	_	_	_	_	_	_	_	O
26	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
27	personal	_	personal	_	JJ	7	_	_	_	_	_	_	_	O
28	preferences	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
29	,	_	,	_	,	7	_	_	_	_	_	_	_	O
30	comorbidities	_	UNK	_	NNS	7	_	_	_	_	_	_	_	S-Protagonist
31	,	_	,	_	,	7	_	_	_	_	_	_	_	O
32	risks	_	risk	_	NNS	7	_	_	_	_	_	risk.n	Run_risk	O
33	from	_	from	_	IN	7	_	_	_	_	_	_	_	B-Action
34	polypharmacy	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Action
35	,	_	,	_	,	7	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
37	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
38	ability	_	ability	_	NN	7	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	VB	7	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
42	long-term	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
43	interventions	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
44	because	_	because	_	IN	7	_	_	_	_	_	_	_	O
45	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
46	reduced	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
47	life	_	life	_	NN	7	_	_	_	_	_	_	_	O
48	expectancy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
49	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	7	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
4	approach	_	approach	_	NN	7	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	7	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	7	_	_	_	_	_	_	_	O
9	is	_	be	_	VBZ	7	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	7	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
13	needs	_	need	_	NNS	7	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
15	circumstances	_	circumstance	_	NNS	7	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	7	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	7	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	7	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
22	,	_	,	_	,	7	_	_	_	_	_	_	_	O
23	taking	_	take	_	VBG	7	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	7	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	7	_	_	_	_	_	_	_	O
26	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
27	personal	_	personal	_	JJ	7	_	_	_	_	_	_	_	O
28	preferences	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
29	,	_	,	_	,	7	_	_	_	_	_	_	_	O
30	comorbidities	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
31	,	_	,	_	,	7	_	_	_	_	_	_	_	O
32	risks	_	risk	_	NNS	7	_	_	_	_	_	_	_	O
33	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
34	polypharmacy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
35	,	_	,	_	,	7	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
37	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	S-Entity
38	ability	_	ability	_	NN	7	_	_	_	_	_	ability.n	Capability	O
39	to	_	to	_	TO	7	_	_	_	_	_	_	_	B-Event
40	benefit	_	benefit	_	VB	7	_	_	_	_	_	_	_	I-Event
41	from	_	from	_	IN	7	_	_	_	_	_	_	_	I-Event
42	long-term	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Event
43	interventions	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Event
44	because	_	because	_	IN	7	_	_	_	_	_	_	_	O
45	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
46	reduced	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
47	life	_	life	_	NN	7	_	_	_	_	_	_	_	O
48	expectancy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
49	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	7	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
4	approach	_	approach	_	NN	7	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	7	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	7	_	_	_	_	_	_	_	O
9	is	_	be	_	VBZ	7	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	7	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
13	needs	_	need	_	NNS	7	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
15	circumstances	_	circumstance	_	NNS	7	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	7	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	7	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	7	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
22	,	_	,	_	,	7	_	_	_	_	_	_	_	O
23	taking	_	take	_	VBG	7	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	7	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	7	_	_	_	_	_	_	_	O
26	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
27	personal	_	personal	_	JJ	7	_	_	_	_	_	_	_	O
28	preferences	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
29	,	_	,	_	,	7	_	_	_	_	_	_	_	O
30	comorbidities	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
31	,	_	,	_	,	7	_	_	_	_	_	_	_	O
32	risks	_	risk	_	NNS	7	_	_	_	_	_	_	_	O
33	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
34	polypharmacy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
35	,	_	,	_	,	7	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
37	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
38	ability	_	ability	_	NN	7	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	VB	7	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	7	_	_	_	_	_	_	_	B-Cause
42	long-term	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Cause
43	interventions	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Cause
44	because	_	because	_	IN	7	_	_	_	_	_	because.c	Causation	O
45	of	_	of	_	IN	7	_	_	_	_	_	_	_	B-Cause
46	reduced	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Cause
47	life	_	life	_	NN	7	_	_	_	_	_	_	_	I-Cause
48	expectancy	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Cause
49	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	reassess	_	UNK	_	VB	8	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
3	person	_	person	_	NN	8	_	_	_	_	_	person.n	People	S-Person
4	's	_	's	_	POS	8	_	_	_	_	_	_	_	O
5	needs	_	need	_	NNS	8	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
7	circumstances	_	circumstance	_	NNS	8	_	_	_	_	_	_	_	O
8	at	_	at	_	IN	8	_	_	_	_	_	_	_	O
9	each	_	each	_	DT	8	_	_	_	_	_	_	_	O
10	review	_	review	_	NN	8	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
12	think	_	think	_	VB	8	_	_	_	_	_	_	_	O
13	about	_	about	_	IN	8	_	_	_	_	_	_	_	O
14	whether	_	whether	_	IN	8	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	8	_	_	_	_	_	_	_	O
16	stop	_	stop	_	VB	8	_	_	_	_	_	_	_	O
17	any	_	any	_	DT	8	_	_	_	_	_	_	_	O
18	medicines	_	medicine	_	NNS	8	_	_	_	_	_	_	_	O
19	that	_	that	_	WDT	8	_	_	_	_	_	_	_	O
20	are	_	be	_	VBP	8	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	8	_	_	_	_	_	_	_	O
22	effective	_	effective	_	JJ	8	_	_	_	_	_	_	_	O
23	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	reassess	_	UNK	_	VB	8	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
3	person	_	person	_	NN	8	_	_	_	_	_	_	_	B-Cognizer
4	's	_	's	_	POS	8	_	_	_	_	_	_	_	I-Cognizer
5	needs	_	need	_	NNS	8	_	_	_	_	_	need.n	Needing	S-Requirement
6	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
7	circumstances	_	circumstance	_	NNS	8	_	_	_	_	_	_	_	O
8	at	_	at	_	IN	8	_	_	_	_	_	_	_	O
9	each	_	each	_	DT	8	_	_	_	_	_	_	_	O
10	review	_	review	_	NN	8	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
12	think	_	think	_	VB	8	_	_	_	_	_	_	_	O
13	about	_	about	_	IN	8	_	_	_	_	_	_	_	O
14	whether	_	whether	_	IN	8	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	8	_	_	_	_	_	_	_	O
16	stop	_	stop	_	VB	8	_	_	_	_	_	_	_	O
17	any	_	any	_	DT	8	_	_	_	_	_	_	_	O
18	medicines	_	medicine	_	NNS	8	_	_	_	_	_	_	_	O
19	that	_	that	_	WDT	8	_	_	_	_	_	_	_	O
20	are	_	be	_	VBP	8	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	8	_	_	_	_	_	_	_	O
22	effective	_	effective	_	JJ	8	_	_	_	_	_	_	_	O
23	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	reassess	_	UNK	_	VB	8	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
3	person	_	person	_	NN	8	_	_	_	_	_	_	_	O
4	's	_	's	_	POS	8	_	_	_	_	_	_	_	O
5	needs	_	need	_	NNS	8	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
7	circumstances	_	circumstance	_	NNS	8	_	_	_	_	_	_	_	O
8	at	_	at	_	IN	8	_	_	_	_	_	_	_	O
9	each	_	each	_	DT	8	_	_	_	_	_	_	_	O
10	review	_	review	_	NN	8	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
12	think	_	think	_	VB	8	_	_	_	_	_	think.v	Opinion	O
13	about	_	about	_	IN	8	_	_	_	_	_	_	_	B-Opinion
14	whether	_	whether	_	IN	8	_	_	_	_	_	_	_	I-Opinion
15	to	_	to	_	TO	8	_	_	_	_	_	_	_	I-Opinion
16	stop	_	stop	_	VB	8	_	_	_	_	_	_	_	I-Opinion
17	any	_	any	_	DT	8	_	_	_	_	_	_	_	I-Opinion
18	medicines	_	medicine	_	NNS	8	_	_	_	_	_	_	_	I-Opinion
19	that	_	that	_	WDT	8	_	_	_	_	_	_	_	I-Opinion
20	are	_	be	_	VBP	8	_	_	_	_	_	_	_	I-Opinion
21	not	_	not	_	RB	8	_	_	_	_	_	_	_	I-Opinion
22	effective	_	effective	_	JJ	8	_	_	_	_	_	_	_	I-Opinion
23	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	reassess	_	UNK	_	VB	8	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
3	person	_	person	_	NN	8	_	_	_	_	_	_	_	O
4	's	_	's	_	POS	8	_	_	_	_	_	_	_	O
5	needs	_	need	_	NNS	8	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
7	circumstances	_	circumstance	_	NNS	8	_	_	_	_	_	_	_	O
8	at	_	at	_	IN	8	_	_	_	_	_	_	_	O
9	each	_	each	_	DT	8	_	_	_	_	_	_	_	O
10	review	_	review	_	NN	8	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
12	think	_	think	_	VB	8	_	_	_	_	_	_	_	O
13	about	_	about	_	IN	8	_	_	_	_	_	_	_	O
14	whether	_	whether	_	IN	8	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	8	_	_	_	_	_	_	_	O
16	stop	_	stop	_	VB	8	_	_	_	_	_	stop.v	Preventing_or_letting	O
17	any	_	any	_	DT	8	_	_	_	_	_	_	_	B-Event
18	medicines	_	medicine	_	NNS	8	_	_	_	_	_	_	_	I-Event
19	that	_	that	_	WDT	8	_	_	_	_	_	_	_	I-Event
20	are	_	be	_	VBP	8	_	_	_	_	_	_	_	I-Event
21	not	_	not	_	RB	8	_	_	_	_	_	_	_	I-Event
22	effective	_	effective	_	JJ	8	_	_	_	_	_	_	_	I-Event
23	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	reassess	_	UNK	_	VB	8	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
3	person	_	person	_	NN	8	_	_	_	_	_	_	_	O
4	's	_	's	_	POS	8	_	_	_	_	_	_	_	O
5	needs	_	need	_	NNS	8	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
7	circumstances	_	circumstance	_	NNS	8	_	_	_	_	_	_	_	O
8	at	_	at	_	IN	8	_	_	_	_	_	_	_	O
9	each	_	each	_	DT	8	_	_	_	_	_	_	_	O
10	review	_	review	_	NN	8	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
12	think	_	think	_	VB	8	_	_	_	_	_	_	_	O
13	about	_	about	_	IN	8	_	_	_	_	_	_	_	O
14	whether	_	whether	_	IN	8	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	8	_	_	_	_	_	_	_	O
16	stop	_	stop	_	VB	8	_	_	_	_	_	_	_	O
17	any	_	any	_	DT	8	_	_	_	_	_	_	_	B-Entity
18	medicines	_	medicine	_	NNS	8	_	_	_	_	_	_	_	I-Entity
19	that	_	that	_	WDT	8	_	_	_	_	_	_	_	I-Entity
20	are	_	be	_	VBP	8	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	8	_	_	_	_	_	_	_	O
22	effective	_	effective	_	JJ	8	_	_	_	_	_	effective.a	Usefulness	O
23	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	take	_	UNK	_	VB	9	_	_	_	_	_	_	_	O
2	into	_	into	_	IN	9	_	_	_	_	_	_	_	O
3	account	_	account	_	NN	9	_	_	_	_	_	account.n	Text	O
4	any	_	any	_	DT	9	_	_	_	_	_	_	_	B-Text
5	disabilities	_	disability	_	NNS	9	_	_	_	_	_	_	_	I-Text
6	,	_	,	_	,	9	_	_	_	_	_	_	_	O
7	including	_	include	_	VBG	9	_	_	_	_	_	_	_	O
8	visual	_	visual	_	JJ	9	_	_	_	_	_	_	_	O
9	impairment	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
10	,	_	,	_	,	9	_	_	_	_	_	_	_	O
11	when	_	when	_	WRB	9	_	_	_	_	_	_	_	O
12	planning	_	planning	_	NN	9	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	9	_	_	_	_	_	_	_	O
14	delivering	_	deliver	_	VBG	9	_	_	_	_	_	_	_	O
15	care	_	care	_	NN	9	_	_	_	_	_	_	_	O
16	for	_	for	_	IN	9	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	9	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	9	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	9	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	9	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
22	.	_	.	_	.	9	_	_	_	_	_	_	_	O

1	take	_	UNK	_	VB	9	_	_	_	_	_	_	_	O
2	into	_	into	_	IN	9	_	_	_	_	_	_	_	O
3	account	_	account	_	NN	9	_	_	_	_	_	_	_	O
4	any	_	any	_	DT	9	_	_	_	_	_	_	_	B-Total
5	disabilities	_	disability	_	NNS	9	_	_	_	_	_	_	_	I-Total
6	,	_	,	_	,	9	_	_	_	_	_	_	_	O
7	including	_	include	_	VBG	9	_	_	_	_	_	include.v	Inclusion	O
8	visual	_	visual	_	JJ	9	_	_	_	_	_	_	_	B-Part
9	impairment	_	UNK	_	NN	9	_	_	_	_	_	_	_	I-Part
10	,	_	,	_	,	9	_	_	_	_	_	_	_	O
11	when	_	when	_	WRB	9	_	_	_	_	_	_	_	O
12	planning	_	planning	_	NN	9	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	9	_	_	_	_	_	_	_	O
14	delivering	_	deliver	_	VBG	9	_	_	_	_	_	_	_	O
15	care	_	care	_	NN	9	_	_	_	_	_	_	_	O
16	for	_	for	_	IN	9	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	9	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	9	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	9	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	9	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
22	.	_	.	_	.	9	_	_	_	_	_	_	_	O

1	take	_	UNK	_	VB	9	_	_	_	_	_	_	_	O
2	into	_	into	_	IN	9	_	_	_	_	_	_	_	O
3	account	_	account	_	NN	9	_	_	_	_	_	_	_	O
4	any	_	any	_	DT	9	_	_	_	_	_	_	_	O
5	disabilities	_	disability	_	NNS	9	_	_	_	_	_	_	_	O
6	,	_	,	_	,	9	_	_	_	_	_	_	_	O
7	including	_	include	_	VBG	9	_	_	_	_	_	_	_	O
8	visual	_	visual	_	JJ	9	_	_	_	_	_	_	_	O
9	impairment	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
10	,	_	,	_	,	9	_	_	_	_	_	_	_	O
11	when	_	when	_	WRB	9	_	_	_	_	_	_	_	O
12	planning	_	planning	_	NN	9	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	9	_	_	_	_	_	_	_	O
14	delivering	_	deliver	_	VBG	9	_	_	_	_	_	deliver.v	Delivery	O
15	care	_	care	_	NN	9	_	_	_	_	_	_	_	S-Theme
16	for	_	for	_	IN	9	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	9	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	9	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	9	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	9	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
22	.	_	.	_	.	9	_	_	_	_	_	_	_	O

1	take	_	UNK	_	VB	9	_	_	_	_	_	_	_	O
2	into	_	into	_	IN	9	_	_	_	_	_	_	_	O
3	account	_	account	_	NN	9	_	_	_	_	_	_	_	O
4	any	_	any	_	DT	9	_	_	_	_	_	_	_	O
5	disabilities	_	disability	_	NNS	9	_	_	_	_	_	_	_	O
6	,	_	,	_	,	9	_	_	_	_	_	_	_	O
7	including	_	include	_	VBG	9	_	_	_	_	_	_	_	O
8	visual	_	visual	_	JJ	9	_	_	_	_	_	_	_	O
9	impairment	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
10	,	_	,	_	,	9	_	_	_	_	_	_	_	O
11	when	_	when	_	WRB	9	_	_	_	_	_	_	_	O
12	planning	_	planning	_	NN	9	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	9	_	_	_	_	_	_	_	O
14	delivering	_	deliver	_	VBG	9	_	_	_	_	_	_	_	O
15	care	_	care	_	NN	9	_	_	_	_	_	_	_	O
16	for	_	for	_	IN	9	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	9	_	_	_	_	_	adult.n	People_by_age	S-Person
18	with	_	with	_	IN	9	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	9	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	9	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
22	.	_	.	_	.	9	_	_	_	_	_	_	_	O

1	take	_	UNK	_	VB	9	_	_	_	_	_	_	_	O
2	into	_	into	_	IN	9	_	_	_	_	_	_	_	O
3	account	_	account	_	NN	9	_	_	_	_	_	_	_	O
4	any	_	any	_	DT	9	_	_	_	_	_	_	_	O
5	disabilities	_	disability	_	NNS	9	_	_	_	_	_	_	_	O
6	,	_	,	_	,	9	_	_	_	_	_	_	_	O
7	including	_	include	_	VBG	9	_	_	_	_	_	_	_	O
8	visual	_	visual	_	JJ	9	_	_	_	_	_	_	_	O
9	impairment	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
10	,	_	,	_	,	9	_	_	_	_	_	_	_	O
11	when	_	when	_	WRB	9	_	_	_	_	_	_	_	O
12	planning	_	planning	_	NN	9	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	9	_	_	_	_	_	_	_	O
14	delivering	_	deliver	_	VBG	9	_	_	_	_	_	_	_	O
15	care	_	care	_	NN	9	_	_	_	_	_	_	_	O
16	for	_	for	_	IN	9	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	9	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	9	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	9	_	_	_	_	_	type.n	Type	S-Subtype
20	2	_	2	_	CD	9	_	_	_	_	_	_	_	B-Category
21	diabetes	_	UNK	_	NNS	9	_	_	_	_	_	_	_	I-Category
22	.	_	.	_	.	9	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
2	structured	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
3	education	_	education	_	NN	10	_	_	_	_	_	education.n	Education_teaching	O
4	to	_	to	_	TO	10	_	_	_	_	_	_	_	O
5	adults	_	UNK	_	VB	10	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	10	_	_	_	_	_	_	_	O
7	type	_	type	_	JJ	10	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	10	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
10	and/or	_	and/or	_	VBP	10	_	_	_	_	_	_	_	O
11	their	_	their	_	PRP$	10	_	_	_	_	_	_	_	O
12	family	_	family	_	NN	10	_	_	_	_	_	_	_	O
13	members	_	member	_	NNS	10	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	10	_	_	_	_	_	_	_	O
15	carers	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
16	(	_	(	_	(	10	_	_	_	_	_	_	_	O
17	as	_	a	_	IN	10	_	_	_	_	_	_	_	O
18	appropriate	_	appropriate	_	NN	10	_	_	_	_	_	_	_	O
19	)	_	)	_	)	10	_	_	_	_	_	_	_	O
20	at	_	at	_	IN	10	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	10	_	_	_	_	_	_	_	O
22	around	_	around	_	IN	10	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
24	time	_	time	_	NN	10	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
26	diagnosis	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
27	,	_	,	_	,	10	_	_	_	_	_	_	_	O
28	with	_	with	_	IN	10	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
2	structured	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
3	education	_	education	_	NN	10	_	_	_	_	_	_	_	O
4	to	_	to	_	TO	10	_	_	_	_	_	_	_	O
5	adults	_	UNK	_	VB	10	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	10	_	_	_	_	_	_	_	O
7	type	_	type	_	JJ	10	_	_	_	_	_	type.n	Type	S-Subtype
8	2	_	2	_	CD	10	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
10	and/or	_	and/or	_	VBP	10	_	_	_	_	_	_	_	O
11	their	_	their	_	PRP$	10	_	_	_	_	_	_	_	O
12	family	_	family	_	NN	10	_	_	_	_	_	_	_	O
13	members	_	member	_	NNS	10	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	10	_	_	_	_	_	_	_	O
15	carers	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
16	(	_	(	_	(	10	_	_	_	_	_	_	_	O
17	as	_	a	_	IN	10	_	_	_	_	_	_	_	O
18	appropriate	_	appropriate	_	NN	10	_	_	_	_	_	_	_	O
19	)	_	)	_	)	10	_	_	_	_	_	_	_	O
20	at	_	at	_	IN	10	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	10	_	_	_	_	_	_	_	O
22	around	_	around	_	IN	10	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
24	time	_	time	_	NN	10	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
26	diagnosis	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
27	,	_	,	_	,	10	_	_	_	_	_	_	_	O
28	with	_	with	_	IN	10	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
2	structured	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
3	education	_	education	_	NN	10	_	_	_	_	_	_	_	O
4	to	_	to	_	TO	10	_	_	_	_	_	_	_	O
5	adults	_	UNK	_	VB	10	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	10	_	_	_	_	_	_	_	O
7	type	_	type	_	JJ	10	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	10	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
10	and/or	_	and/or	_	VBP	10	_	_	_	_	_	_	_	O
11	their	_	their	_	PRP$	10	_	_	_	_	_	_	_	O
12	family	_	family	_	NN	10	_	_	_	_	_	family.n	Kinship	S-Relatives
13	members	_	member	_	NNS	10	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	10	_	_	_	_	_	_	_	O
15	carers	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
16	(	_	(	_	(	10	_	_	_	_	_	_	_	O
17	as	_	a	_	IN	10	_	_	_	_	_	_	_	O
18	appropriate	_	appropriate	_	NN	10	_	_	_	_	_	_	_	O
19	)	_	)	_	)	10	_	_	_	_	_	_	_	O
20	at	_	at	_	IN	10	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	10	_	_	_	_	_	_	_	O
22	around	_	around	_	IN	10	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
24	time	_	time	_	NN	10	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
26	diagnosis	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
27	,	_	,	_	,	10	_	_	_	_	_	_	_	O
28	with	_	with	_	IN	10	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
2	structured	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
3	education	_	education	_	NN	10	_	_	_	_	_	_	_	O
4	to	_	to	_	TO	10	_	_	_	_	_	_	_	O
5	adults	_	UNK	_	VB	10	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	10	_	_	_	_	_	_	_	O
7	type	_	type	_	JJ	10	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	10	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
10	and/or	_	and/or	_	VBP	10	_	_	_	_	_	_	_	O
11	their	_	their	_	PRP$	10	_	_	_	_	_	_	_	S-Member
12	family	_	family	_	NN	10	_	_	_	_	_	_	_	S-Group
13	members	_	member	_	NNS	10	_	_	_	_	_	member.n	Membership	S-Member
14	or	_	or	_	CC	10	_	_	_	_	_	_	_	O
15	carers	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
16	(	_	(	_	(	10	_	_	_	_	_	_	_	O
17	as	_	a	_	IN	10	_	_	_	_	_	_	_	O
18	appropriate	_	appropriate	_	NN	10	_	_	_	_	_	_	_	O
19	)	_	)	_	)	10	_	_	_	_	_	_	_	O
20	at	_	at	_	IN	10	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	10	_	_	_	_	_	_	_	O
22	around	_	around	_	IN	10	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
24	time	_	time	_	NN	10	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
26	diagnosis	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
27	,	_	,	_	,	10	_	_	_	_	_	_	_	O
28	with	_	with	_	IN	10	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
2	structured	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
3	education	_	education	_	NN	10	_	_	_	_	_	_	_	O
4	to	_	to	_	TO	10	_	_	_	_	_	_	_	O
5	adults	_	UNK	_	VB	10	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	10	_	_	_	_	_	_	_	O
7	type	_	type	_	JJ	10	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	10	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
10	and/or	_	and/or	_	VBP	10	_	_	_	_	_	_	_	O
11	their	_	their	_	PRP$	10	_	_	_	_	_	_	_	O
12	family	_	family	_	NN	10	_	_	_	_	_	_	_	O
13	members	_	member	_	NNS	10	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	10	_	_	_	_	_	_	_	O
15	carers	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
16	(	_	(	_	(	10	_	_	_	_	_	_	_	O
17	as	_	a	_	IN	10	_	_	_	_	_	_	_	O
18	appropriate	_	appropriate	_	NN	10	_	_	_	_	_	appropriate.a	Suitability	O
19	)	_	)	_	)	10	_	_	_	_	_	_	_	O
20	at	_	at	_	IN	10	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	10	_	_	_	_	_	_	_	O
22	around	_	around	_	IN	10	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
24	time	_	time	_	NN	10	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
26	diagnosis	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
27	,	_	,	_	,	10	_	_	_	_	_	_	_	O
28	with	_	with	_	IN	10	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	11	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	11	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	11	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	11	_	_	_	_	_	_	_	O
6	:	_	:	_	:	11	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	11	_	_	_	_	_	_	_	O
8	(	_	(	_	(	11	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	11	_	_	_	_	_	_	_	O
10	)	_	)	_	)	11	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	11	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	11	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
14	)	_	)	_	)	11	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	11	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	11	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	11	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	11	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	11	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	11	_	_	_	_	_	_	_	O
8	(	_	(	_	(	11	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	11	_	_	_	_	_	_	_	O
10	)	_	)	_	)	11	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	11	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	11	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
14	)	_	)	_	)	11	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	12	_	_	_	_	_	last.a	Relative_time	O
2	updated	_	update	_	VBD	12	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	12	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	12	_	_	_	_	_	_	_	O
5	annual	_	annual	_	JJ	12	_	_	_	_	_	_	_	O
6	reinforcement	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
7	and	_	and	_	CC	12	_	_	_	_	_	_	_	O
8	review	_	review	_	NN	12	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	12	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	12	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	12	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	12	_	_	_	_	_	_	_	O
5	annual	_	annual	_	JJ	12	_	_	_	_	_	annual.a	Frequency	S-Interval
6	reinforcement	_	UNK	_	NN	12	_	_	_	_	_	_	_	S-Event
7	and	_	and	_	CC	12	_	_	_	_	_	_	_	O
8	review	_	review	_	NN	12	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	13	_	_	_	_	_	_	_	O
3	any	_	any	_	DT	13	_	_	_	_	_	_	_	O
4	structured	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
5	education	_	education	_	NN	13	_	_	_	_	_	education.n	Education_teaching	O
6	programme	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	13	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	13	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	13	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	13	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	13	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
13	includes	_	include	_	VBZ	13	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	13	_	_	_	_	_	_	_	O
15	following	_	following	_	JJ	13	_	_	_	_	_	_	_	O
16	components	_	component	_	NNS	13	_	_	_	_	_	_	_	O
17	:	_	:	_	:	13	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	13	_	_	_	_	_	_	_	O
3	any	_	any	_	DT	13	_	_	_	_	_	_	_	O
4	structured	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
5	education	_	education	_	NN	13	_	_	_	_	_	_	_	O
6	programme	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	13	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	13	_	_	_	_	_	adult.n	People_by_age	S-Person
9	with	_	with	_	IN	13	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	13	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	13	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
13	includes	_	include	_	VBZ	13	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	13	_	_	_	_	_	_	_	O
15	following	_	following	_	JJ	13	_	_	_	_	_	_	_	O
16	components	_	component	_	NNS	13	_	_	_	_	_	_	_	O
17	:	_	:	_	:	13	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	13	_	_	_	_	_	_	_	O
3	any	_	any	_	DT	13	_	_	_	_	_	_	_	O
4	structured	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
5	education	_	education	_	NN	13	_	_	_	_	_	_	_	O
6	programme	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	13	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	13	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	13	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	13	_	_	_	_	_	type.n	Type	S-Subtype
11	2	_	2	_	CD	13	_	_	_	_	_	_	_	B-Category
12	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	I-Category
13	includes	_	include	_	VBZ	13	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	13	_	_	_	_	_	_	_	O
15	following	_	following	_	JJ	13	_	_	_	_	_	_	_	O
16	components	_	component	_	NNS	13	_	_	_	_	_	_	_	O
17	:	_	:	_	:	13	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	13	_	_	_	_	_	_	_	O
3	any	_	any	_	DT	13	_	_	_	_	_	_	_	B-Total
4	structured	_	UNK	_	JJ	13	_	_	_	_	_	_	_	I-Total
5	education	_	education	_	NN	13	_	_	_	_	_	_	_	I-Total
6	programme	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Total
7	for	_	for	_	IN	13	_	_	_	_	_	_	_	I-Total
8	adults	_	adult	_	NNS	13	_	_	_	_	_	_	_	I-Total
9	with	_	with	_	IN	13	_	_	_	_	_	_	_	I-Total
10	type	_	type	_	JJ	13	_	_	_	_	_	_	_	I-Total
11	2	_	2	_	CD	13	_	_	_	_	_	_	_	I-Total
12	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	I-Total
13	includes	_	include	_	VBZ	13	_	_	_	_	_	include.v	Inclusion	O
14	the	_	the	_	DT	13	_	_	_	_	_	_	_	B-Part
15	following	_	following	_	JJ	13	_	_	_	_	_	_	_	I-Part
16	components	_	component	_	NNS	13	_	_	_	_	_	_	_	I-Part
17	:	_	:	_	:	13	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	13	_	_	_	_	_	_	_	O
3	any	_	any	_	DT	13	_	_	_	_	_	_	_	O
4	structured	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
5	education	_	education	_	NN	13	_	_	_	_	_	_	_	O
6	programme	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	13	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	13	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	13	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	13	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	13	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
13	includes	_	include	_	VBZ	13	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	13	_	_	_	_	_	_	_	O
15	following	_	following	_	JJ	13	_	_	_	_	_	_	_	O
16	components	_	component	_	NNS	13	_	_	_	_	_	component.n	Ingredients	S-Material
17	:	_	:	_	:	13	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	14	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	14	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	14	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	14	_	_	_	_	_	aim.n	Purpose	S-Goal
5	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	14	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	14	_	_	_	_	_	_	_	S-Goal
8	,	_	,	_	,	14	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	14	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	14	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	14	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	14	_	_	_	_	_	_	_	O
15	family	_	family	_	NN	14	_	_	_	_	_	_	_	O
16	members	_	member	_	NNS	14	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	14	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	14	_	_	_	_	_	_	_	O
21	attitudes	_	attitude	_	NNS	14	_	_	_	_	_	_	_	O
22	,	_	,	_	,	14	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	14	_	_	_	_	_	_	_	O
24	,	_	,	_	,	14	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	14	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	14	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	14	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	14	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
31	.	_	.	_	.	14	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	14	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	14	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	14	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	14	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	14	_	_	_	_	_	learn.v	Becoming_aware	O
7	objectives	_	objective	_	NNS	14	_	_	_	_	_	_	_	S-Phenomenon
8	,	_	,	_	,	14	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	14	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	14	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	14	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	14	_	_	_	_	_	_	_	O
15	family	_	family	_	NN	14	_	_	_	_	_	_	_	O
16	members	_	member	_	NNS	14	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	14	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	14	_	_	_	_	_	_	_	O
21	attitudes	_	attitude	_	NNS	14	_	_	_	_	_	_	_	O
22	,	_	,	_	,	14	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	14	_	_	_	_	_	_	_	O
24	,	_	,	_	,	14	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	14	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	14	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	14	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	14	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
31	.	_	.	_	.	14	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	14	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	14	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	14	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	14	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	14	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	14	_	_	_	_	_	objective.n	Purpose	S-Goal
8	,	_	,	_	,	14	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	14	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	14	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	14	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	14	_	_	_	_	_	_	_	O
15	family	_	family	_	NN	14	_	_	_	_	_	_	_	O
16	members	_	member	_	NNS	14	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	14	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	14	_	_	_	_	_	_	_	O
21	attitudes	_	attitude	_	NNS	14	_	_	_	_	_	_	_	O
22	,	_	,	_	,	14	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	14	_	_	_	_	_	_	_	O
24	,	_	,	_	,	14	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	14	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	14	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	14	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	14	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
31	.	_	.	_	.	14	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	14	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	14	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	14	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	14	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	14	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	14	_	_	_	_	_	_	_	O
8	,	_	,	_	,	14	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	14	_	_	_	_	_	support.v	Taking_sides	O
11	the	_	the	_	DT	14	_	_	_	_	_	_	_	B-Side
12	person	_	person	_	NN	14	_	_	_	_	_	_	_	I-Side
13	and	_	and	_	CC	14	_	_	_	_	_	_	_	I-Side
14	their	_	their	_	PRP$	14	_	_	_	_	_	_	_	I-Side
15	family	_	family	_	NN	14	_	_	_	_	_	_	_	I-Side
16	members	_	member	_	NNS	14	_	_	_	_	_	_	_	I-Side
17	and	_	and	_	CC	14	_	_	_	_	_	_	_	I-Side
18	carers	_	UNK	_	NNS	14	_	_	_	_	_	_	_	I-Side
19	in	_	in	_	IN	14	_	_	_	_	_	_	_	I-Side
20	developing	_	develop	_	VBG	14	_	_	_	_	_	_	_	I-Side
21	attitudes	_	attitude	_	NNS	14	_	_	_	_	_	_	_	I-Side
22	,	_	,	_	,	14	_	_	_	_	_	_	_	I-Side
23	beliefs	_	belief	_	NNS	14	_	_	_	_	_	_	_	I-Side
24	,	_	,	_	,	14	_	_	_	_	_	_	_	I-Side
25	knowledge	_	knowledge	_	NN	14	_	_	_	_	_	_	_	I-Side
26	and	_	and	_	CC	14	_	_	_	_	_	_	_	I-Side
27	skills	_	skill	_	NNS	14	_	_	_	_	_	_	_	I-Side
28	to	_	to	_	TO	14	_	_	_	_	_	_	_	I-Side
29	unk	_	UNK	_	NN	14	_	_	_	_	_	_	_	I-Side
30	diabetes	_	UNK	_	NNS	14	_	_	_	_	_	_	_	I-Side
31	.	_	.	_	.	14	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	14	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	14	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	14	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	14	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	14	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	14	_	_	_	_	_	_	_	O
8	,	_	,	_	,	14	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	14	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	14	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	14	_	_	_	_	_	person.n	People	S-Person
13	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	14	_	_	_	_	_	_	_	O
15	family	_	family	_	NN	14	_	_	_	_	_	_	_	O
16	members	_	member	_	NNS	14	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	14	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	14	_	_	_	_	_	_	_	O
21	attitudes	_	attitude	_	NNS	14	_	_	_	_	_	_	_	O
22	,	_	,	_	,	14	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	14	_	_	_	_	_	_	_	O
24	,	_	,	_	,	14	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	14	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	14	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	14	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	14	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
31	.	_	.	_	.	14	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	14	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	14	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	14	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	14	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	14	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	14	_	_	_	_	_	_	_	O
8	,	_	,	_	,	14	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	14	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	14	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	14	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	14	_	_	_	_	_	_	_	O
15	family	_	family	_	NN	14	_	_	_	_	_	family.n	Kinship	S-Relatives
16	members	_	member	_	NNS	14	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	14	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	14	_	_	_	_	_	_	_	O
21	attitudes	_	attitude	_	NNS	14	_	_	_	_	_	_	_	O
22	,	_	,	_	,	14	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	14	_	_	_	_	_	_	_	O
24	,	_	,	_	,	14	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	14	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	14	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	14	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	14	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
31	.	_	.	_	.	14	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	14	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	14	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	14	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	14	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	14	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	14	_	_	_	_	_	_	_	O
8	,	_	,	_	,	14	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	14	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	14	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	14	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	14	_	_	_	_	_	_	_	S-Member
15	family	_	family	_	NN	14	_	_	_	_	_	_	_	S-Group
16	members	_	member	_	NNS	14	_	_	_	_	_	member.n	Membership	S-Member
17	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	14	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	14	_	_	_	_	_	_	_	O
21	attitudes	_	attitude	_	NNS	14	_	_	_	_	_	_	_	O
22	,	_	,	_	,	14	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	14	_	_	_	_	_	_	_	O
24	,	_	,	_	,	14	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	14	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	14	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	14	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	14	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
31	.	_	.	_	.	14	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	14	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	14	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	14	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	14	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	14	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	14	_	_	_	_	_	_	_	O
8	,	_	,	_	,	14	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	14	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	14	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	14	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	14	_	_	_	_	_	_	_	O
15	family	_	family	_	NN	14	_	_	_	_	_	_	_	O
16	members	_	member	_	NNS	14	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	14	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	14	_	_	_	_	_	develop.v	Cause_to_make_progress	O
21	attitudes	_	attitude	_	NNS	14	_	_	_	_	_	_	_	S-Project
22	,	_	,	_	,	14	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	14	_	_	_	_	_	_	_	O
24	,	_	,	_	,	14	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	14	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	14	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	14	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	14	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
31	.	_	.	_	.	14	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	14	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	14	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	14	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	14	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	14	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	14	_	_	_	_	_	_	_	O
8	,	_	,	_	,	14	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	14	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	14	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	14	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	14	_	_	_	_	_	_	_	O
15	family	_	family	_	NN	14	_	_	_	_	_	_	_	O
16	members	_	member	_	NNS	14	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	14	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	14	_	_	_	_	_	_	_	O
21	attitudes	_	attitude	_	NNS	14	_	_	_	_	_	_	_	O
22	,	_	,	_	,	14	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	14	_	_	_	_	_	belief.n	Opinion	O
24	,	_	,	_	,	14	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	14	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	14	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	14	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	14	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
31	.	_	.	_	.	14	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	14	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	14	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	14	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	14	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	14	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	14	_	_	_	_	_	_	_	O
8	,	_	,	_	,	14	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	14	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	14	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	14	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	14	_	_	_	_	_	_	_	O
15	family	_	family	_	NN	14	_	_	_	_	_	_	_	O
16	members	_	member	_	NNS	14	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	14	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	14	_	_	_	_	_	_	_	O
21	attitudes	_	attitude	_	NNS	14	_	_	_	_	_	_	_	O
22	,	_	,	_	,	14	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	14	_	_	_	_	_	_	_	S-Cognizer
24	,	_	,	_	,	14	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	14	_	_	_	_	_	knowledge.n	Awareness	O
26	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	14	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	14	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	14	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
31	.	_	.	_	.	14	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	14	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	14	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	14	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	14	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	14	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	14	_	_	_	_	_	_	_	O
8	,	_	,	_	,	14	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	14	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	14	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	14	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	14	_	_	_	_	_	_	_	O
15	family	_	family	_	NN	14	_	_	_	_	_	_	_	O
16	members	_	member	_	NNS	14	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	14	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	14	_	_	_	_	_	_	_	O
21	attitudes	_	attitude	_	NNS	14	_	_	_	_	_	_	_	O
22	,	_	,	_	,	14	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	14	_	_	_	_	_	_	_	O
24	,	_	,	_	,	14	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	14	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	14	_	_	_	_	_	skill.n	Expertise	S-Protagonist
28	to	_	to	_	TO	14	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	14	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
31	.	_	.	_	.	14	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	15	_	_	_	_	_	_	_	S-Speaker
2	is	_	be	_	VBZ	15	_	_	_	_	_	_	_	O
3	quality	_	quality	_	JJ	15	_	_	_	_	_	_	_	O
4	assured	_	assure	_	VBN	15	_	_	_	_	_	assure.v	Telling	O
5	,	_	,	_	,	15	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	15	_	_	_	_	_	_	_	O
7	reviewed	_	review	_	VBN	15	_	_	_	_	_	_	_	O
8	by	_	by	_	IN	15	_	_	_	_	_	_	_	O
9	trained	_	trained	_	JJ	15	_	_	_	_	_	_	_	O
10	,	_	,	_	,	15	_	_	_	_	_	_	_	O
11	competent	_	competent	_	JJ	15	_	_	_	_	_	_	_	O
12	,	_	,	_	,	15	_	_	_	_	_	_	_	O
13	independent	_	independent	_	JJ	15	_	_	_	_	_	_	_	O
14	assessors	_	UNK	_	NNS	15	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	15	_	_	_	_	_	_	_	O
16	measure	_	measure	_	VBP	15	_	_	_	_	_	_	_	O
17	it	_	it	_	PRP	15	_	_	_	_	_	_	_	O
18	against	_	against	_	IN	15	_	_	_	_	_	_	_	O
19	criteria	_	UNK	_	NNS	15	_	_	_	_	_	_	_	O
20	that	_	that	_	IN	15	_	_	_	_	_	_	_	O
21	ensure	_	ensure	_	VB	15	_	_	_	_	_	_	_	O
22	consistency	_	UNK	_	NN	15	_	_	_	_	_	_	_	O
23	.	_	.	_	.	15	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	15	_	_	_	_	_	_	_	O
2	is	_	be	_	VBZ	15	_	_	_	_	_	_	_	O
3	quality	_	quality	_	JJ	15	_	_	_	_	_	_	_	O
4	assured	_	assure	_	VBN	15	_	_	_	_	_	_	_	O
5	,	_	,	_	,	15	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	15	_	_	_	_	_	_	_	O
7	reviewed	_	review	_	VBN	15	_	_	_	_	_	_	_	O
8	by	_	by	_	IN	15	_	_	_	_	_	_	_	O
9	trained	_	trained	_	JJ	15	_	_	_	_	_	_	_	O
10	,	_	,	_	,	15	_	_	_	_	_	_	_	O
11	competent	_	competent	_	JJ	15	_	_	_	_	_	competent.a	Expertise	O
12	,	_	,	_	,	15	_	_	_	_	_	_	_	O
13	independent	_	independent	_	JJ	15	_	_	_	_	_	_	_	O
14	assessors	_	UNK	_	NNS	15	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	15	_	_	_	_	_	_	_	O
16	measure	_	measure	_	VBP	15	_	_	_	_	_	_	_	O
17	it	_	it	_	PRP	15	_	_	_	_	_	_	_	O
18	against	_	against	_	IN	15	_	_	_	_	_	_	_	O
19	criteria	_	UNK	_	NNS	15	_	_	_	_	_	_	_	O
20	that	_	that	_	IN	15	_	_	_	_	_	_	_	O
21	ensure	_	ensure	_	VB	15	_	_	_	_	_	_	_	O
22	consistency	_	UNK	_	NN	15	_	_	_	_	_	_	_	O
23	.	_	.	_	.	15	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	15	_	_	_	_	_	_	_	O
2	is	_	be	_	VBZ	15	_	_	_	_	_	_	_	O
3	quality	_	quality	_	JJ	15	_	_	_	_	_	_	_	O
4	assured	_	assure	_	VBN	15	_	_	_	_	_	_	_	O
5	,	_	,	_	,	15	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	15	_	_	_	_	_	_	_	O
7	reviewed	_	review	_	VBN	15	_	_	_	_	_	_	_	O
8	by	_	by	_	IN	15	_	_	_	_	_	_	_	O
9	trained	_	trained	_	JJ	15	_	_	_	_	_	_	_	O
10	,	_	,	_	,	15	_	_	_	_	_	_	_	O
11	competent	_	competent	_	JJ	15	_	_	_	_	_	_	_	O
12	,	_	,	_	,	15	_	_	_	_	_	_	_	O
13	independent	_	independent	_	JJ	15	_	_	_	_	_	_	_	B-Object
14	assessors	_	UNK	_	NNS	15	_	_	_	_	_	_	_	I-Object
15	who	_	who	_	WP	15	_	_	_	_	_	_	_	I-Object
16	measure	_	measure	_	VBP	15	_	_	_	_	_	measure.v	Dimension	S-Dimension
17	it	_	it	_	PRP	15	_	_	_	_	_	_	_	S-Object
18	against	_	against	_	IN	15	_	_	_	_	_	_	_	O
19	criteria	_	UNK	_	NNS	15	_	_	_	_	_	_	_	O
20	that	_	that	_	IN	15	_	_	_	_	_	_	_	O
21	ensure	_	ensure	_	VB	15	_	_	_	_	_	_	_	O
22	consistency	_	UNK	_	NN	15	_	_	_	_	_	_	_	O
23	.	_	.	_	.	15	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	VB	16	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	16	_	_	_	_	_	_	_	B-Supplier
3	unk	_	UNK	_	NN	16	_	_	_	_	_	_	_	I-Supplier
4	programme	_	UNK	_	NN	16	_	_	_	_	_	_	_	I-Supplier
5	provides	_	provide	_	VBZ	16	_	_	_	_	_	provide.v	Supply	O
6	the	_	the	_	DT	16	_	_	_	_	_	_	_	B-Theme
7	necessary	_	necessary	_	JJ	16	_	_	_	_	_	_	_	I-Theme
8	resources	_	resource	_	NNS	16	_	_	_	_	_	_	_	I-Theme
9	to	_	to	_	TO	16	_	_	_	_	_	_	_	I-Theme
10	support	_	support	_	VB	16	_	_	_	_	_	_	_	I-Theme
11	the	_	the	_	DT	16	_	_	_	_	_	_	_	I-Theme
12	educators	_	UNK	_	NNS	16	_	_	_	_	_	_	_	I-Theme
13	,	_	,	_	,	16	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	16	_	_	_	_	_	_	_	O
16	educators	_	UNK	_	NNS	16	_	_	_	_	_	_	_	O
17	are	_	be	_	VBP	16	_	_	_	_	_	_	_	O
18	properly	_	UNK	_	RB	16	_	_	_	_	_	_	_	O
19	trained	_	train	_	VBN	16	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
21	given	_	give	_	VBN	16	_	_	_	_	_	_	_	O
22	time	_	time	_	NN	16	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	16	_	_	_	_	_	_	_	O
24	develop	_	develop	_	VB	16	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
26	maintain	_	maintain	_	VB	16	_	_	_	_	_	_	_	O
27	their	_	their	_	PRP$	16	_	_	_	_	_	_	_	O
28	skills	_	skill	_	NNS	16	_	_	_	_	_	_	_	O
29	.	_	.	_	.	16	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	VB	16	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
4	programme	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
5	provides	_	provide	_	VBZ	16	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
7	necessary	_	necessary	_	JJ	16	_	_	_	_	_	necessary.a	Being_necessary	O
8	resources	_	resource	_	NNS	16	_	_	_	_	_	_	_	S-Requirement
9	to	_	to	_	TO	16	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	16	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
12	educators	_	UNK	_	NNS	16	_	_	_	_	_	_	_	O
13	,	_	,	_	,	16	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	16	_	_	_	_	_	_	_	O
16	educators	_	UNK	_	NNS	16	_	_	_	_	_	_	_	O
17	are	_	be	_	VBP	16	_	_	_	_	_	_	_	O
18	properly	_	UNK	_	RB	16	_	_	_	_	_	_	_	O
19	trained	_	train	_	VBN	16	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
21	given	_	give	_	VBN	16	_	_	_	_	_	_	_	O
22	time	_	time	_	NN	16	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	16	_	_	_	_	_	_	_	O
24	develop	_	develop	_	VB	16	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
26	maintain	_	maintain	_	VB	16	_	_	_	_	_	_	_	O
27	their	_	their	_	PRP$	16	_	_	_	_	_	_	_	O
28	skills	_	skill	_	NNS	16	_	_	_	_	_	_	_	O
29	.	_	.	_	.	16	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	VB	16	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
4	programme	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
5	provides	_	provide	_	VBZ	16	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
7	necessary	_	necessary	_	JJ	16	_	_	_	_	_	_	_	O
8	resources	_	resource	_	NNS	16	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	16	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	16	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
12	educators	_	UNK	_	NNS	16	_	_	_	_	_	_	_	O
13	,	_	,	_	,	16	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	16	_	_	_	_	_	_	_	O
16	educators	_	UNK	_	NNS	16	_	_	_	_	_	_	_	S-Student
17	are	_	be	_	VBP	16	_	_	_	_	_	_	_	O
18	properly	_	UNK	_	RB	16	_	_	_	_	_	_	_	S-Manner
19	trained	_	train	_	VBN	16	_	_	_	_	_	train.v	Education_teaching	O
20	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
21	given	_	give	_	VBN	16	_	_	_	_	_	_	_	O
22	time	_	time	_	NN	16	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	16	_	_	_	_	_	_	_	O
24	develop	_	develop	_	VB	16	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
26	maintain	_	maintain	_	VB	16	_	_	_	_	_	_	_	O
27	their	_	their	_	PRP$	16	_	_	_	_	_	_	_	O
28	skills	_	skill	_	NNS	16	_	_	_	_	_	_	_	O
29	.	_	.	_	.	16	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	VB	16	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
4	programme	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
5	provides	_	provide	_	VBZ	16	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
7	necessary	_	necessary	_	JJ	16	_	_	_	_	_	_	_	O
8	resources	_	resource	_	NNS	16	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	16	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	16	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
12	educators	_	UNK	_	NNS	16	_	_	_	_	_	_	_	O
13	,	_	,	_	,	16	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	16	_	_	_	_	_	_	_	O
16	educators	_	UNK	_	NNS	16	_	_	_	_	_	_	_	S-Agent
17	are	_	be	_	VBP	16	_	_	_	_	_	_	_	O
18	properly	_	UNK	_	RB	16	_	_	_	_	_	_	_	O
19	trained	_	train	_	VBN	16	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
21	given	_	give	_	VBN	16	_	_	_	_	_	_	_	O
22	time	_	time	_	NN	16	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	16	_	_	_	_	_	_	_	O
24	develop	_	develop	_	VB	16	_	_	_	_	_	develop.v	Cause_to_make_progress	O
25	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
26	maintain	_	maintain	_	VB	16	_	_	_	_	_	_	_	O
27	their	_	their	_	PRP$	16	_	_	_	_	_	_	_	B-Project
28	skills	_	skill	_	NNS	16	_	_	_	_	_	_	_	I-Project
29	.	_	.	_	.	16	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	VB	16	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
4	programme	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
5	provides	_	provide	_	VBZ	16	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
7	necessary	_	necessary	_	JJ	16	_	_	_	_	_	_	_	O
8	resources	_	resource	_	NNS	16	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	16	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	16	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
12	educators	_	UNK	_	NNS	16	_	_	_	_	_	_	_	O
13	,	_	,	_	,	16	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	16	_	_	_	_	_	_	_	O
16	educators	_	UNK	_	NNS	16	_	_	_	_	_	_	_	S-Agent
17	are	_	be	_	VBP	16	_	_	_	_	_	_	_	O
18	properly	_	UNK	_	RB	16	_	_	_	_	_	_	_	O
19	trained	_	train	_	VBN	16	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
21	given	_	give	_	VBN	16	_	_	_	_	_	_	_	O
22	time	_	time	_	NN	16	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	16	_	_	_	_	_	_	_	O
24	develop	_	develop	_	VB	16	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
26	maintain	_	maintain	_	VB	16	_	_	_	_	_	maintain.v	Activity_ongoing	O
27	their	_	their	_	PRP$	16	_	_	_	_	_	_	_	B-Activity
28	skills	_	skill	_	NNS	16	_	_	_	_	_	_	_	I-Activity
29	.	_	.	_	.	16	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	VB	16	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
4	programme	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
5	provides	_	provide	_	VBZ	16	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
7	necessary	_	necessary	_	JJ	16	_	_	_	_	_	_	_	O
8	resources	_	resource	_	NNS	16	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	16	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	16	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
12	educators	_	UNK	_	NNS	16	_	_	_	_	_	_	_	O
13	,	_	,	_	,	16	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	16	_	_	_	_	_	_	_	O
16	educators	_	UNK	_	NNS	16	_	_	_	_	_	_	_	O
17	are	_	be	_	VBP	16	_	_	_	_	_	_	_	O
18	properly	_	UNK	_	RB	16	_	_	_	_	_	_	_	O
19	trained	_	train	_	VBN	16	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
21	given	_	give	_	VBN	16	_	_	_	_	_	_	_	O
22	time	_	time	_	NN	16	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	16	_	_	_	_	_	_	_	O
24	develop	_	develop	_	VB	16	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
26	maintain	_	maintain	_	VB	16	_	_	_	_	_	_	_	O
27	their	_	their	_	PRP$	16	_	_	_	_	_	_	_	O
28	skills	_	skill	_	NNS	16	_	_	_	_	_	skill.n	Expertise	S-Protagonist
29	.	_	.	_	.	16	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	17	_	_	_	_	_	_	_	O
4	members	_	member	_	NNS	17	_	_	_	_	_	member.n	Membership	S-Member
5	of	_	of	_	IN	17	_	_	_	_	_	_	_	B-Group
6	the	_	the	_	DT	17	_	_	_	_	_	_	_	I-Group
7	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	I-Group
8	healthcare	_	healthcare	_	VBP	17	_	_	_	_	_	_	_	O
9	team	_	team	_	NN	17	_	_	_	_	_	_	_	O
10	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	17	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
15	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
16	available	_	available	_	JJ	17	_	_	_	_	_	_	_	O
17	locally	_	locally	_	RB	17	_	_	_	_	_	_	_	O
18	,	_	,	_	,	17	_	_	_	_	_	_	_	O
19	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
20	these	_	these	_	DT	17	_	_	_	_	_	_	_	O
21	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
22	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
23	integrated	_	UNK	_	VBN	17	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
26	rest	_	rest	_	NN	17	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
29	care	_	care	_	NN	17	_	_	_	_	_	_	_	O
30	pathway	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
31	,	_	,	_	,	17	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	17	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	17	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	17	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
39	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	17	_	_	_	_	_	_	_	O
41	family	_	family	_	NN	17	_	_	_	_	_	_	_	O
42	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	17	_	_	_	_	_	_	_	O
44	carers	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
45	(	_	(	_	(	17	_	_	_	_	_	_	_	O
46	as	_	a	_	IN	17	_	_	_	_	_	_	_	O
47	appropriate	_	appropriate	_	NN	17	_	_	_	_	_	_	_	O
48	)	_	)	_	)	17	_	_	_	_	_	_	_	O
49	have	_	have	_	VBP	17	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	17	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	17	_	_	_	_	_	_	_	O
54	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
55	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
56	design	_	design	_	NN	17	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
58	provision	_	provision	_	NN	17	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
60	local	_	local	_	JJ	17	_	_	_	_	_	_	_	O
61	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
62	.	_	.	_	.	17	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	17	_	_	_	_	_	_	_	O
4	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
8	healthcare	_	healthcare	_	VBP	17	_	_	_	_	_	_	_	O
9	team	_	team	_	NN	17	_	_	_	_	_	team.n	Aggregate	S-Aggregate
10	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	17	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
15	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
16	available	_	available	_	JJ	17	_	_	_	_	_	_	_	O
17	locally	_	locally	_	RB	17	_	_	_	_	_	_	_	O
18	,	_	,	_	,	17	_	_	_	_	_	_	_	O
19	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
20	these	_	these	_	DT	17	_	_	_	_	_	_	_	O
21	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
22	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
23	integrated	_	UNK	_	VBN	17	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
26	rest	_	rest	_	NN	17	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
29	care	_	care	_	NN	17	_	_	_	_	_	_	_	O
30	pathway	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
31	,	_	,	_	,	17	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	17	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	17	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	17	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
39	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	17	_	_	_	_	_	_	_	O
41	family	_	family	_	NN	17	_	_	_	_	_	_	_	O
42	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	17	_	_	_	_	_	_	_	O
44	carers	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
45	(	_	(	_	(	17	_	_	_	_	_	_	_	O
46	as	_	a	_	IN	17	_	_	_	_	_	_	_	O
47	appropriate	_	appropriate	_	NN	17	_	_	_	_	_	_	_	O
48	)	_	)	_	)	17	_	_	_	_	_	_	_	O
49	have	_	have	_	VBP	17	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	17	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	17	_	_	_	_	_	_	_	O
54	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
55	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
56	design	_	design	_	NN	17	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
58	provision	_	provision	_	NN	17	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
60	local	_	local	_	JJ	17	_	_	_	_	_	_	_	O
61	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
62	.	_	.	_	.	17	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	17	_	_	_	_	_	_	_	B-Protagonist
4	members	_	member	_	NNS	17	_	_	_	_	_	_	_	I-Protagonist
5	of	_	of	_	IN	17	_	_	_	_	_	_	_	I-Protagonist
6	the	_	the	_	DT	17	_	_	_	_	_	_	_	I-Protagonist
7	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	I-Protagonist
8	healthcare	_	healthcare	_	VBP	17	_	_	_	_	_	_	_	I-Protagonist
9	team	_	team	_	NN	17	_	_	_	_	_	_	_	I-Protagonist
10	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	17	_	_	_	_	_	familiar.a	Expertise	O
12	with	_	with	_	IN	17	_	_	_	_	_	_	_	B-Knowledge
13	the	_	the	_	DT	17	_	_	_	_	_	_	_	I-Knowledge
14	unk	_	UNK	_	NN	17	_	_	_	_	_	_	_	I-Knowledge
15	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	I-Knowledge
16	available	_	available	_	JJ	17	_	_	_	_	_	_	_	I-Knowledge
17	locally	_	locally	_	RB	17	_	_	_	_	_	_	_	I-Knowledge
18	,	_	,	_	,	17	_	_	_	_	_	_	_	I-Knowledge
19	that	_	that	_	IN	17	_	_	_	_	_	_	_	I-Knowledge
20	these	_	these	_	DT	17	_	_	_	_	_	_	_	I-Knowledge
21	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	I-Knowledge
22	are	_	be	_	VBP	17	_	_	_	_	_	_	_	I-Knowledge
23	integrated	_	UNK	_	VBN	17	_	_	_	_	_	_	_	I-Knowledge
24	with	_	with	_	IN	17	_	_	_	_	_	_	_	I-Knowledge
25	the	_	the	_	DT	17	_	_	_	_	_	_	_	I-Knowledge
26	rest	_	rest	_	NN	17	_	_	_	_	_	_	_	I-Knowledge
27	of	_	of	_	IN	17	_	_	_	_	_	_	_	I-Knowledge
28	the	_	the	_	DT	17	_	_	_	_	_	_	_	I-Knowledge
29	care	_	care	_	NN	17	_	_	_	_	_	_	_	I-Knowledge
30	pathway	_	UNK	_	NN	17	_	_	_	_	_	_	_	I-Knowledge
31	,	_	,	_	,	17	_	_	_	_	_	_	_	I-Knowledge
32	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	17	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	17	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	17	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
39	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	17	_	_	_	_	_	_	_	O
41	family	_	family	_	NN	17	_	_	_	_	_	_	_	O
42	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	17	_	_	_	_	_	_	_	O
44	carers	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
45	(	_	(	_	(	17	_	_	_	_	_	_	_	O
46	as	_	a	_	IN	17	_	_	_	_	_	_	_	O
47	appropriate	_	appropriate	_	NN	17	_	_	_	_	_	_	_	O
48	)	_	)	_	)	17	_	_	_	_	_	_	_	O
49	have	_	have	_	VBP	17	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	17	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	17	_	_	_	_	_	_	_	O
54	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
55	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
56	design	_	design	_	NN	17	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
58	provision	_	provision	_	NN	17	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
60	local	_	local	_	JJ	17	_	_	_	_	_	_	_	O
61	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
62	.	_	.	_	.	17	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	17	_	_	_	_	_	_	_	O
4	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
8	healthcare	_	healthcare	_	VBP	17	_	_	_	_	_	_	_	O
9	team	_	team	_	NN	17	_	_	_	_	_	_	_	O
10	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	17	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
15	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
16	available	_	available	_	JJ	17	_	_	_	_	_	_	_	O
17	locally	_	locally	_	RB	17	_	_	_	_	_	_	_	O
18	,	_	,	_	,	17	_	_	_	_	_	_	_	O
19	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
20	these	_	these	_	DT	17	_	_	_	_	_	_	_	O
21	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
22	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
23	integrated	_	UNK	_	VBN	17	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
26	rest	_	rest	_	NN	17	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
29	care	_	care	_	NN	17	_	_	_	_	_	_	_	O
30	pathway	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
31	,	_	,	_	,	17	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	17	_	_	_	_	_	adult.n	People_by_age	S-Person
35	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	17	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	17	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
39	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	17	_	_	_	_	_	_	_	O
41	family	_	family	_	NN	17	_	_	_	_	_	_	_	O
42	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	17	_	_	_	_	_	_	_	O
44	carers	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
45	(	_	(	_	(	17	_	_	_	_	_	_	_	O
46	as	_	a	_	IN	17	_	_	_	_	_	_	_	O
47	appropriate	_	appropriate	_	NN	17	_	_	_	_	_	_	_	O
48	)	_	)	_	)	17	_	_	_	_	_	_	_	O
49	have	_	have	_	VBP	17	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	17	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	17	_	_	_	_	_	_	_	O
54	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
55	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
56	design	_	design	_	NN	17	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
58	provision	_	provision	_	NN	17	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
60	local	_	local	_	JJ	17	_	_	_	_	_	_	_	O
61	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
62	.	_	.	_	.	17	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	17	_	_	_	_	_	_	_	O
4	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
8	healthcare	_	healthcare	_	VBP	17	_	_	_	_	_	_	_	O
9	team	_	team	_	NN	17	_	_	_	_	_	_	_	O
10	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	17	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
15	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
16	available	_	available	_	JJ	17	_	_	_	_	_	_	_	O
17	locally	_	locally	_	RB	17	_	_	_	_	_	_	_	O
18	,	_	,	_	,	17	_	_	_	_	_	_	_	O
19	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
20	these	_	these	_	DT	17	_	_	_	_	_	_	_	O
21	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
22	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
23	integrated	_	UNK	_	VBN	17	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
26	rest	_	rest	_	NN	17	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
29	care	_	care	_	NN	17	_	_	_	_	_	_	_	O
30	pathway	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
31	,	_	,	_	,	17	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	17	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	17	_	_	_	_	_	type.n	Type	S-Subtype
37	2	_	2	_	CD	17	_	_	_	_	_	_	_	B-Category
38	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	I-Category
39	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	17	_	_	_	_	_	_	_	O
41	family	_	family	_	NN	17	_	_	_	_	_	_	_	O
42	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	17	_	_	_	_	_	_	_	O
44	carers	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
45	(	_	(	_	(	17	_	_	_	_	_	_	_	O
46	as	_	a	_	IN	17	_	_	_	_	_	_	_	O
47	appropriate	_	appropriate	_	NN	17	_	_	_	_	_	_	_	O
48	)	_	)	_	)	17	_	_	_	_	_	_	_	O
49	have	_	have	_	VBP	17	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	17	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	17	_	_	_	_	_	_	_	O
54	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
55	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
56	design	_	design	_	NN	17	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
58	provision	_	provision	_	NN	17	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
60	local	_	local	_	JJ	17	_	_	_	_	_	_	_	O
61	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
62	.	_	.	_	.	17	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	17	_	_	_	_	_	_	_	O
4	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
8	healthcare	_	healthcare	_	VBP	17	_	_	_	_	_	_	_	O
9	team	_	team	_	NN	17	_	_	_	_	_	_	_	O
10	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	17	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
15	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
16	available	_	available	_	JJ	17	_	_	_	_	_	_	_	O
17	locally	_	locally	_	RB	17	_	_	_	_	_	_	_	O
18	,	_	,	_	,	17	_	_	_	_	_	_	_	O
19	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
20	these	_	these	_	DT	17	_	_	_	_	_	_	_	O
21	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
22	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
23	integrated	_	UNK	_	VBN	17	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
26	rest	_	rest	_	NN	17	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
29	care	_	care	_	NN	17	_	_	_	_	_	_	_	O
30	pathway	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
31	,	_	,	_	,	17	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	17	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	17	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	17	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
39	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	17	_	_	_	_	_	_	_	O
41	family	_	family	_	NN	17	_	_	_	_	_	family.n	Kinship	S-Relatives
42	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	17	_	_	_	_	_	_	_	O
44	carers	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
45	(	_	(	_	(	17	_	_	_	_	_	_	_	O
46	as	_	a	_	IN	17	_	_	_	_	_	_	_	O
47	appropriate	_	appropriate	_	NN	17	_	_	_	_	_	_	_	O
48	)	_	)	_	)	17	_	_	_	_	_	_	_	O
49	have	_	have	_	VBP	17	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	17	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	17	_	_	_	_	_	_	_	O
54	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
55	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
56	design	_	design	_	NN	17	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
58	provision	_	provision	_	NN	17	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
60	local	_	local	_	JJ	17	_	_	_	_	_	_	_	O
61	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
62	.	_	.	_	.	17	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	17	_	_	_	_	_	_	_	O
4	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
8	healthcare	_	healthcare	_	VBP	17	_	_	_	_	_	_	_	O
9	team	_	team	_	NN	17	_	_	_	_	_	_	_	O
10	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	17	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
15	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
16	available	_	available	_	JJ	17	_	_	_	_	_	_	_	O
17	locally	_	locally	_	RB	17	_	_	_	_	_	_	_	O
18	,	_	,	_	,	17	_	_	_	_	_	_	_	O
19	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
20	these	_	these	_	DT	17	_	_	_	_	_	_	_	O
21	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
22	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
23	integrated	_	UNK	_	VBN	17	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
26	rest	_	rest	_	NN	17	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
29	care	_	care	_	NN	17	_	_	_	_	_	_	_	O
30	pathway	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
31	,	_	,	_	,	17	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	17	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	17	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	17	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
39	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	17	_	_	_	_	_	_	_	S-Member
41	family	_	family	_	NN	17	_	_	_	_	_	_	_	S-Group
42	members	_	member	_	NNS	17	_	_	_	_	_	member.n	Membership	S-Member
43	or	_	or	_	CC	17	_	_	_	_	_	_	_	O
44	carers	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
45	(	_	(	_	(	17	_	_	_	_	_	_	_	O
46	as	_	a	_	IN	17	_	_	_	_	_	_	_	O
47	appropriate	_	appropriate	_	NN	17	_	_	_	_	_	_	_	O
48	)	_	)	_	)	17	_	_	_	_	_	_	_	O
49	have	_	have	_	VBP	17	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	17	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	17	_	_	_	_	_	_	_	O
54	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
55	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
56	design	_	design	_	NN	17	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
58	provision	_	provision	_	NN	17	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
60	local	_	local	_	JJ	17	_	_	_	_	_	_	_	O
61	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
62	.	_	.	_	.	17	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	17	_	_	_	_	_	_	_	O
4	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
8	healthcare	_	healthcare	_	VBP	17	_	_	_	_	_	_	_	O
9	team	_	team	_	NN	17	_	_	_	_	_	_	_	O
10	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	17	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
15	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
16	available	_	available	_	JJ	17	_	_	_	_	_	_	_	O
17	locally	_	locally	_	RB	17	_	_	_	_	_	_	_	O
18	,	_	,	_	,	17	_	_	_	_	_	_	_	O
19	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
20	these	_	these	_	DT	17	_	_	_	_	_	_	_	O
21	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
22	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
23	integrated	_	UNK	_	VBN	17	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
26	rest	_	rest	_	NN	17	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
29	care	_	care	_	NN	17	_	_	_	_	_	_	_	O
30	pathway	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
31	,	_	,	_	,	17	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	17	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	17	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	17	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
39	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	17	_	_	_	_	_	_	_	O
41	family	_	family	_	NN	17	_	_	_	_	_	_	_	B-Donor
42	members	_	member	_	NNS	17	_	_	_	_	_	_	_	I-Donor
43	or	_	or	_	CC	17	_	_	_	_	_	_	_	I-Donor
44	carers	_	UNK	_	NNS	17	_	_	_	_	_	_	_	I-Donor
45	(	_	(	_	(	17	_	_	_	_	_	_	_	I-Donor
46	as	_	a	_	IN	17	_	_	_	_	_	_	_	I-Donor
47	appropriate	_	appropriate	_	NN	17	_	_	_	_	_	_	_	I-Donor
48	)	_	)	_	)	17	_	_	_	_	_	_	_	I-Donor
49	have	_	have	_	VBP	17	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	17	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	17	_	_	_	_	_	contribute.v	Giving	O
54	to	_	to	_	TO	17	_	_	_	_	_	_	_	B-Theme
55	the	_	the	_	DT	17	_	_	_	_	_	_	_	I-Theme
56	design	_	design	_	NN	17	_	_	_	_	_	_	_	I-Theme
57	and	_	and	_	CC	17	_	_	_	_	_	_	_	I-Theme
58	provision	_	provision	_	NN	17	_	_	_	_	_	_	_	I-Theme
59	of	_	of	_	IN	17	_	_	_	_	_	_	_	I-Theme
60	local	_	local	_	JJ	17	_	_	_	_	_	_	_	I-Theme
61	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	I-Theme
62	.	_	.	_	.	17	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	17	_	_	_	_	_	_	_	O
4	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
8	healthcare	_	healthcare	_	VBP	17	_	_	_	_	_	_	_	O
9	team	_	team	_	NN	17	_	_	_	_	_	_	_	O
10	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	17	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
15	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
16	available	_	available	_	JJ	17	_	_	_	_	_	_	_	O
17	locally	_	locally	_	RB	17	_	_	_	_	_	_	_	O
18	,	_	,	_	,	17	_	_	_	_	_	_	_	O
19	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
20	these	_	these	_	DT	17	_	_	_	_	_	_	_	O
21	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
22	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
23	integrated	_	UNK	_	VBN	17	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
26	rest	_	rest	_	NN	17	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
29	care	_	care	_	NN	17	_	_	_	_	_	_	_	O
30	pathway	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
31	,	_	,	_	,	17	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	17	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	17	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	17	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
39	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	17	_	_	_	_	_	_	_	O
41	family	_	family	_	NN	17	_	_	_	_	_	_	_	O
42	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	17	_	_	_	_	_	_	_	O
44	carers	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
45	(	_	(	_	(	17	_	_	_	_	_	_	_	O
46	as	_	a	_	IN	17	_	_	_	_	_	_	_	O
47	appropriate	_	appropriate	_	NN	17	_	_	_	_	_	_	_	O
48	)	_	)	_	)	17	_	_	_	_	_	_	_	O
49	have	_	have	_	VBP	17	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	17	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	17	_	_	_	_	_	_	_	O
54	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
55	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
56	design	_	design	_	NN	17	_	_	_	_	_	design.n	Coming_up_with	O
57	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
58	provision	_	provision	_	NN	17	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	17	_	_	_	_	_	_	_	B-Idea
60	local	_	local	_	JJ	17	_	_	_	_	_	_	_	I-Idea
61	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	I-Idea
62	.	_	.	_	.	17	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	17	_	_	_	_	_	_	_	O
4	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
8	healthcare	_	healthcare	_	VBP	17	_	_	_	_	_	_	_	O
9	team	_	team	_	NN	17	_	_	_	_	_	_	_	O
10	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	17	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
15	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
16	available	_	available	_	JJ	17	_	_	_	_	_	_	_	O
17	locally	_	locally	_	RB	17	_	_	_	_	_	_	_	O
18	,	_	,	_	,	17	_	_	_	_	_	_	_	O
19	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
20	these	_	these	_	DT	17	_	_	_	_	_	_	_	O
21	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
22	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
23	integrated	_	UNK	_	VBN	17	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
26	rest	_	rest	_	NN	17	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
29	care	_	care	_	NN	17	_	_	_	_	_	_	_	O
30	pathway	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
31	,	_	,	_	,	17	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	17	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	17	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	17	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
39	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	17	_	_	_	_	_	_	_	O
41	family	_	family	_	NN	17	_	_	_	_	_	_	_	O
42	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	17	_	_	_	_	_	_	_	O
44	carers	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
45	(	_	(	_	(	17	_	_	_	_	_	_	_	O
46	as	_	a	_	IN	17	_	_	_	_	_	_	_	O
47	appropriate	_	appropriate	_	NN	17	_	_	_	_	_	_	_	O
48	)	_	)	_	)	17	_	_	_	_	_	_	_	O
49	have	_	have	_	VBP	17	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	17	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	17	_	_	_	_	_	_	_	O
54	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
55	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
56	design	_	design	_	NN	17	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
58	provision	_	provision	_	NN	17	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
60	local	_	local	_	JJ	17	_	_	_	_	_	local.a	Political_locales	S-Locale
61	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
62	.	_	.	_	.	17	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	18	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	18	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	18	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	18	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	18	_	_	_	_	_	_	_	O
6	:	_	:	_	:	18	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	18	_	_	_	_	_	_	_	O
8	(	_	(	_	(	18	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	18	_	_	_	_	_	_	_	O
10	)	_	)	_	)	18	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	18	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	18	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	18	_	_	_	_	_	_	_	O
14	)	_	)	_	)	18	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	18	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	18	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	18	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	18	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	18	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	18	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	18	_	_	_	_	_	_	_	O
8	(	_	(	_	(	18	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	18	_	_	_	_	_	_	_	O
10	)	_	)	_	)	18	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	18	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	18	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	18	_	_	_	_	_	_	_	O
14	)	_	)	_	)	18	_	_	_	_	_	_	_	O

1	emphasise	_	UNK	_	NNP	19	_	_	_	_	_	_	_	O
2	advice	_	advice	_	NN	19	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	19	_	_	_	_	_	_	_	O
4	healthy	_	healthy	_	JJ	19	_	_	_	_	_	_	_	O
5	balanced	_	balance	_	VBN	19	_	_	_	_	_	_	_	O
6	eating	_	UNK	_	NN	19	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	19	_	_	_	_	_	_	_	O
8	is	_	be	_	VBZ	19	_	_	_	_	_	_	_	O
9	applicable	_	applicable	_	JJ	19	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	19	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	19	_	_	_	_	_	_	_	O
12	general	_	general	_	JJ	19	_	_	_	_	_	_	_	S-Aggregate_property
13	population	_	population	_	NN	19	_	_	_	_	_	population.n	Aggregate	S-Aggregate
14	when	_	when	_	WRB	19	_	_	_	_	_	_	_	O
15	providing	_	provide	_	VBG	19	_	_	_	_	_	_	_	O
16	advice	_	advice	_	NN	19	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	19	_	_	_	_	_	_	_	O
18	adults	_	adult	_	NNS	19	_	_	_	_	_	_	_	O
19	with	_	with	_	IN	19	_	_	_	_	_	_	_	O
20	type	_	type	_	JJ	19	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	19	_	_	_	_	_	_	_	O
22	diabetes	_	UNK	_	NNS	19	_	_	_	_	_	_	_	O

1	emphasise	_	UNK	_	NNP	19	_	_	_	_	_	_	_	B-Supplier
2	advice	_	advice	_	NN	19	_	_	_	_	_	_	_	I-Supplier
3	on	_	on	_	IN	19	_	_	_	_	_	_	_	I-Supplier
4	healthy	_	healthy	_	JJ	19	_	_	_	_	_	_	_	I-Supplier
5	balanced	_	balance	_	VBN	19	_	_	_	_	_	_	_	I-Supplier
6	eating	_	UNK	_	NN	19	_	_	_	_	_	_	_	I-Supplier
7	that	_	that	_	WDT	19	_	_	_	_	_	_	_	I-Supplier
8	is	_	be	_	VBZ	19	_	_	_	_	_	_	_	I-Supplier
9	applicable	_	applicable	_	JJ	19	_	_	_	_	_	_	_	I-Supplier
10	to	_	to	_	TO	19	_	_	_	_	_	_	_	I-Supplier
11	the	_	the	_	DT	19	_	_	_	_	_	_	_	I-Supplier
12	general	_	general	_	JJ	19	_	_	_	_	_	_	_	I-Supplier
13	population	_	population	_	NN	19	_	_	_	_	_	_	_	I-Supplier
14	when	_	when	_	WRB	19	_	_	_	_	_	_	_	O
15	providing	_	provide	_	VBG	19	_	_	_	_	_	provide.v	Supply	O
16	advice	_	advice	_	NN	19	_	_	_	_	_	_	_	S-Theme
17	to	_	to	_	TO	19	_	_	_	_	_	_	_	O
18	adults	_	adult	_	NNS	19	_	_	_	_	_	_	_	O
19	with	_	with	_	IN	19	_	_	_	_	_	_	_	O
20	type	_	type	_	JJ	19	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	19	_	_	_	_	_	_	_	O
22	diabetes	_	UNK	_	NNS	19	_	_	_	_	_	_	_	O

1	emphasise	_	UNK	_	NNP	19	_	_	_	_	_	_	_	O
2	advice	_	advice	_	NN	19	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	19	_	_	_	_	_	_	_	O
4	healthy	_	healthy	_	JJ	19	_	_	_	_	_	_	_	O
5	balanced	_	balance	_	VBN	19	_	_	_	_	_	_	_	O
6	eating	_	UNK	_	NN	19	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	19	_	_	_	_	_	_	_	O
8	is	_	be	_	VBZ	19	_	_	_	_	_	_	_	O
9	applicable	_	applicable	_	JJ	19	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	19	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	19	_	_	_	_	_	_	_	O
12	general	_	general	_	JJ	19	_	_	_	_	_	_	_	O
13	population	_	population	_	NN	19	_	_	_	_	_	_	_	O
14	when	_	when	_	WRB	19	_	_	_	_	_	_	_	O
15	providing	_	provide	_	VBG	19	_	_	_	_	_	_	_	O
16	advice	_	advice	_	NN	19	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	19	_	_	_	_	_	_	_	O
18	adults	_	adult	_	NNS	19	_	_	_	_	_	adult.n	People_by_age	S-Person
19	with	_	with	_	IN	19	_	_	_	_	_	_	_	O
20	type	_	type	_	JJ	19	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	19	_	_	_	_	_	_	_	O
22	diabetes	_	UNK	_	NNS	19	_	_	_	_	_	_	_	O

1	emphasise	_	UNK	_	NNP	19	_	_	_	_	_	_	_	O
2	advice	_	advice	_	NN	19	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	19	_	_	_	_	_	_	_	O
4	healthy	_	healthy	_	JJ	19	_	_	_	_	_	_	_	O
5	balanced	_	balance	_	VBN	19	_	_	_	_	_	_	_	O
6	eating	_	UNK	_	NN	19	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	19	_	_	_	_	_	_	_	O
8	is	_	be	_	VBZ	19	_	_	_	_	_	_	_	O
9	applicable	_	applicable	_	JJ	19	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	19	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	19	_	_	_	_	_	_	_	O
12	general	_	general	_	JJ	19	_	_	_	_	_	_	_	O
13	population	_	population	_	NN	19	_	_	_	_	_	_	_	O
14	when	_	when	_	WRB	19	_	_	_	_	_	_	_	O
15	providing	_	provide	_	VBG	19	_	_	_	_	_	_	_	O
16	advice	_	advice	_	NN	19	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	19	_	_	_	_	_	_	_	O
18	adults	_	adult	_	NNS	19	_	_	_	_	_	_	_	O
19	with	_	with	_	IN	19	_	_	_	_	_	_	_	O
20	type	_	type	_	JJ	19	_	_	_	_	_	type.n	Type	S-Subtype
21	2	_	2	_	CD	19	_	_	_	_	_	_	_	O
22	diabetes	_	UNK	_	NNS	19	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	20	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	20	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	20	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	20	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	20	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	20	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	20	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	20	_	_	_	_	_	_	_	O
9	overweight	_	UNK	_	JJ	20	_	_	_	_	_	_	_	O
10	,	_	,	_	,	20	_	_	_	_	_	_	_	O
11	set	_	set	_	VBD	20	_	_	_	_	_	_	_	O
12	an	_	an	_	DT	20	_	_	_	_	_	_	_	O
13	initial	_	initial	_	JJ	20	_	_	_	_	_	_	_	O
14	body	_	body	_	NN	20	_	_	_	_	_	_	_	O
15	weight	_	weight	_	JJ	20	_	_	_	_	_	_	_	O
16	loss	_	loss	_	NN	20	_	_	_	_	_	_	_	O
17	target	_	target	_	NN	20	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	20	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	CD	20	_	_	_	_	_	_	_	O
20	%	_	%	_	NN	20	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	20	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	20	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	20	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	20	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	20	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	20	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	20	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	20	_	_	_	_	_	_	_	O
9	overweight	_	UNK	_	JJ	20	_	_	_	_	_	_	_	O
10	,	_	,	_	,	20	_	_	_	_	_	_	_	O
11	set	_	set	_	VBD	20	_	_	_	_	_	_	_	O
12	an	_	an	_	DT	20	_	_	_	_	_	_	_	O
13	initial	_	initial	_	JJ	20	_	_	_	_	_	_	_	O
14	body	_	body	_	NN	20	_	_	_	_	_	_	_	O
15	weight	_	weight	_	JJ	20	_	_	_	_	_	_	_	O
16	loss	_	loss	_	NN	20	_	_	_	_	_	_	_	O
17	target	_	target	_	NN	20	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	20	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	CD	20	_	_	_	_	_	_	_	O
20	%	_	%	_	NN	20	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	20	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	20	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	20	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	20	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	20	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	20	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	20	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	20	_	_	_	_	_	_	_	O
9	overweight	_	UNK	_	JJ	20	_	_	_	_	_	_	_	O
10	,	_	,	_	,	20	_	_	_	_	_	_	_	O
11	set	_	set	_	VBD	20	_	_	_	_	_	_	_	O
12	an	_	an	_	DT	20	_	_	_	_	_	_	_	O
13	initial	_	initial	_	JJ	20	_	_	_	_	_	_	_	S-Descriptor
14	body	_	body	_	NN	20	_	_	_	_	_	body.n	Body_parts	S-Body_part
15	weight	_	weight	_	JJ	20	_	_	_	_	_	_	_	O
16	loss	_	loss	_	NN	20	_	_	_	_	_	_	_	O
17	target	_	target	_	NN	20	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	20	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	CD	20	_	_	_	_	_	_	_	O
20	%	_	%	_	NN	20	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	20	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	20	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	20	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	20	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	20	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	20	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	20	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	20	_	_	_	_	_	_	_	O
9	overweight	_	UNK	_	JJ	20	_	_	_	_	_	_	_	O
10	,	_	,	_	,	20	_	_	_	_	_	_	_	O
11	set	_	set	_	VBD	20	_	_	_	_	_	_	_	O
12	an	_	an	_	DT	20	_	_	_	_	_	_	_	O
13	initial	_	initial	_	JJ	20	_	_	_	_	_	_	_	O
14	body	_	body	_	NN	20	_	_	_	_	_	_	_	S-Object
15	weight	_	weight	_	JJ	20	_	_	_	_	_	weight.n	Dimension	S-Dimension
16	loss	_	loss	_	NN	20	_	_	_	_	_	_	_	O
17	target	_	target	_	NN	20	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	20	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	CD	20	_	_	_	_	_	_	_	O
20	%	_	%	_	NN	20	_	_	_	_	_	_	_	O

1	unk	_	UNK	_	NNP	21	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	21	_	_	_	_	_	_	_	O
3	for	_	for	_	IN	21	_	_	_	_	_	_	_	O
4	carbohydrate	_	UNK	_	NN	21	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
6	alcohol	_	alcohol	_	NN	21	_	_	_	_	_	alcohol.n	Intoxicants	S-Intoxicant
7	intake	_	UNK	_	NN	21	_	_	_	_	_	_	_	O
8	,	_	,	_	,	21	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
10	meal	_	meal	_	NN	21	_	_	_	_	_	_	_	O
11	patterns	_	pattern	_	NNS	21	_	_	_	_	_	_	_	O

1	unk	_	UNK	_	NNP	21	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	21	_	_	_	_	_	_	_	O
3	for	_	for	_	IN	21	_	_	_	_	_	_	_	O
4	carbohydrate	_	UNK	_	NN	21	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
6	alcohol	_	alcohol	_	NN	21	_	_	_	_	_	_	_	O
7	intake	_	UNK	_	NN	21	_	_	_	_	_	_	_	O
8	,	_	,	_	,	21	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
10	meal	_	meal	_	NN	21	_	_	_	_	_	_	_	S-Entities
11	patterns	_	pattern	_	NNS	21	_	_	_	_	_	pattern.n	Pattern	O

1	reducing	_	UNK	_	VBG	22	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	22	_	_	_	_	_	_	_	O
3	risk	_	risk	_	NN	22	_	_	_	_	_	risk.n	Run_risk	O
4	of	_	of	_	IN	22	_	_	_	_	_	_	_	B-Asset
5	unk	_	UNK	_	NN	22	_	_	_	_	_	_	_	I-Asset
6	should	_	should	_	MD	22	_	_	_	_	_	_	_	O
7	be	_	be	_	VB	22	_	_	_	_	_	_	_	O
8	a	_	a	_	DT	22	_	_	_	_	_	_	_	O
9	particular	_	particular	_	JJ	22	_	_	_	_	_	_	_	O
10	aim	_	aim	_	NN	22	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	22	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	22	_	_	_	_	_	_	_	O
13	person	_	person	_	NN	22	_	_	_	_	_	_	_	O
14	using	_	use	_	VBG	22	_	_	_	_	_	_	_	O
15	insulin	_	UNK	_	NN	22	_	_	_	_	_	_	_	O
16	or	_	or	_	CC	22	_	_	_	_	_	_	_	O
17	an	_	an	_	DT	22	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	JJ	22	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NN	22	_	_	_	_	_	_	_	O
20	.	_	.	_	.	22	_	_	_	_	_	_	_	O

1	reducing	_	UNK	_	VBG	22	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	22	_	_	_	_	_	_	_	O
3	risk	_	risk	_	NN	22	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	22	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	NN	22	_	_	_	_	_	_	_	O
6	should	_	should	_	MD	22	_	_	_	_	_	_	_	O
7	be	_	be	_	VB	22	_	_	_	_	_	_	_	O
8	a	_	a	_	DT	22	_	_	_	_	_	_	_	O
9	particular	_	particular	_	JJ	22	_	_	_	_	_	_	_	O
10	aim	_	aim	_	NN	22	_	_	_	_	_	aim.n	Purpose	O
11	for	_	for	_	IN	22	_	_	_	_	_	_	_	B-Goal
12	a	_	a	_	DT	22	_	_	_	_	_	_	_	I-Goal
13	person	_	person	_	NN	22	_	_	_	_	_	_	_	I-Goal
14	using	_	use	_	VBG	22	_	_	_	_	_	_	_	I-Goal
15	insulin	_	UNK	_	NN	22	_	_	_	_	_	_	_	I-Goal
16	or	_	or	_	CC	22	_	_	_	_	_	_	_	I-Goal
17	an	_	an	_	DT	22	_	_	_	_	_	_	_	I-Goal
18	insulin	_	UNK	_	JJ	22	_	_	_	_	_	_	_	I-Goal
19	unk	_	UNK	_	NN	22	_	_	_	_	_	_	_	I-Goal
20	.	_	.	_	.	22	_	_	_	_	_	_	_	O

1	reducing	_	UNK	_	VBG	22	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	22	_	_	_	_	_	_	_	O
3	risk	_	risk	_	NN	22	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	22	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	NN	22	_	_	_	_	_	_	_	O
6	should	_	should	_	MD	22	_	_	_	_	_	_	_	O
7	be	_	be	_	VB	22	_	_	_	_	_	_	_	O
8	a	_	a	_	DT	22	_	_	_	_	_	_	_	O
9	particular	_	particular	_	JJ	22	_	_	_	_	_	_	_	O
10	aim	_	aim	_	NN	22	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	22	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	22	_	_	_	_	_	_	_	O
13	person	_	person	_	NN	22	_	_	_	_	_	person.n	People	S-Person
14	using	_	use	_	VBG	22	_	_	_	_	_	_	_	O
15	insulin	_	UNK	_	NN	22	_	_	_	_	_	_	_	O
16	or	_	or	_	CC	22	_	_	_	_	_	_	_	O
17	an	_	an	_	DT	22	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	JJ	22	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NN	22	_	_	_	_	_	_	_	O
20	.	_	.	_	.	22	_	_	_	_	_	_	_	O

1	reducing	_	UNK	_	VBG	22	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	22	_	_	_	_	_	_	_	O
3	risk	_	risk	_	NN	22	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	22	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	NN	22	_	_	_	_	_	_	_	O
6	should	_	should	_	MD	22	_	_	_	_	_	_	_	O
7	be	_	be	_	VB	22	_	_	_	_	_	_	_	O
8	a	_	a	_	DT	22	_	_	_	_	_	_	_	O
9	particular	_	particular	_	JJ	22	_	_	_	_	_	_	_	O
10	aim	_	aim	_	NN	22	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	22	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	22	_	_	_	_	_	_	_	B-Agent
13	person	_	person	_	NN	22	_	_	_	_	_	_	_	I-Agent
14	using	_	use	_	VBG	22	_	_	_	_	_	use.v	Using	O
15	insulin	_	UNK	_	NN	22	_	_	_	_	_	_	_	B-Instrument
16	or	_	or	_	CC	22	_	_	_	_	_	_	_	I-Instrument
17	an	_	an	_	DT	22	_	_	_	_	_	_	_	I-Instrument
18	insulin	_	UNK	_	JJ	22	_	_	_	_	_	_	_	I-Instrument
19	unk	_	UNK	_	NN	22	_	_	_	_	_	_	_	I-Instrument
20	.	_	.	_	.	22	_	_	_	_	_	_	_	O

1	advise	_	UNK	_	NNP	23	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	23	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	23	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	23	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	23	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	23	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	23	_	_	_	_	_	_	_	O
8	limited	_	limit	_	VBD	23	_	_	_	_	_	_	_	O
9	substitution	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
10	of	_	of	_	IN	23	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	23	_	_	_	_	_	_	_	O
12	foods	_	food	_	NNS	23	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	23	_	_	_	_	_	_	_	O
14	other	_	other	_	JJ	23	_	_	_	_	_	_	_	O
15	carbohydrate	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
16	in	_	in	_	IN	23	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	23	_	_	_	_	_	_	_	O
18	meal	_	meal	_	NN	23	_	_	_	_	_	_	_	O
19	plan	_	plan	_	NN	23	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	23	_	_	_	_	_	_	_	O
21	allowable	_	UNK	_	JJ	23	_	_	_	_	_	_	_	O
22	,	_	,	_	,	23	_	_	_	_	_	_	_	O
23	but	_	but	_	CC	23	_	_	_	_	_	_	_	O
24	that	_	that	_	IN	23	_	_	_	_	_	_	_	O
25	they	_	they	_	PRP	23	_	_	_	_	_	_	_	O
26	should	_	should	_	MD	23	_	_	_	_	_	_	_	O
27	take	_	take	_	VB	23	_	_	_	_	_	_	_	O
28	care	_	care	_	NN	23	_	_	_	_	_	_	_	O
29	to	_	to	_	TO	23	_	_	_	_	_	_	_	O
30	avoid	_	avoid	_	VB	23	_	_	_	_	_	_	_	O
31	excess	_	excess	_	JJ	23	_	_	_	_	_	_	_	O
32	energy	_	energy	_	NN	23	_	_	_	_	_	_	_	O
33	intake	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
34	.	_	.	_	.	23	_	_	_	_	_	_	_	O

1	advise	_	UNK	_	NNP	23	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	23	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	23	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	23	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	23	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	23	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	23	_	_	_	_	_	_	_	O
8	limited	_	limit	_	VBD	23	_	_	_	_	_	_	_	O
9	substitution	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
10	of	_	of	_	IN	23	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	23	_	_	_	_	_	_	_	O
12	foods	_	food	_	NNS	23	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	23	_	_	_	_	_	_	_	O
14	other	_	other	_	JJ	23	_	_	_	_	_	_	_	O
15	carbohydrate	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
16	in	_	in	_	IN	23	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	23	_	_	_	_	_	_	_	O
18	meal	_	meal	_	NN	23	_	_	_	_	_	_	_	O
19	plan	_	plan	_	NN	23	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	23	_	_	_	_	_	_	_	O
21	allowable	_	UNK	_	JJ	23	_	_	_	_	_	_	_	O
22	,	_	,	_	,	23	_	_	_	_	_	_	_	O
23	but	_	but	_	CC	23	_	_	_	_	_	_	_	O
24	that	_	that	_	IN	23	_	_	_	_	_	_	_	O
25	they	_	they	_	PRP	23	_	_	_	_	_	_	_	O
26	should	_	should	_	MD	23	_	_	_	_	_	_	_	O
27	take	_	take	_	VB	23	_	_	_	_	_	_	_	O
28	care	_	care	_	NN	23	_	_	_	_	_	_	_	O
29	to	_	to	_	TO	23	_	_	_	_	_	_	_	O
30	avoid	_	avoid	_	VB	23	_	_	_	_	_	_	_	O
31	excess	_	excess	_	JJ	23	_	_	_	_	_	_	_	O
32	energy	_	energy	_	NN	23	_	_	_	_	_	_	_	O
33	intake	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
34	.	_	.	_	.	23	_	_	_	_	_	_	_	O

1	advise	_	UNK	_	NNP	23	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	23	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	23	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	23	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	23	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	23	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	23	_	_	_	_	_	_	_	O
8	limited	_	limit	_	VBD	23	_	_	_	_	_	_	_	O
9	substitution	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
10	of	_	of	_	IN	23	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	23	_	_	_	_	_	_	_	S-Type
12	foods	_	food	_	NNS	23	_	_	_	_	_	food.n	Food	S-Food
13	for	_	for	_	IN	23	_	_	_	_	_	_	_	O
14	other	_	other	_	JJ	23	_	_	_	_	_	_	_	O
15	carbohydrate	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
16	in	_	in	_	IN	23	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	23	_	_	_	_	_	_	_	O
18	meal	_	meal	_	NN	23	_	_	_	_	_	_	_	O
19	plan	_	plan	_	NN	23	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	23	_	_	_	_	_	_	_	O
21	allowable	_	UNK	_	JJ	23	_	_	_	_	_	_	_	O
22	,	_	,	_	,	23	_	_	_	_	_	_	_	O
23	but	_	but	_	CC	23	_	_	_	_	_	_	_	O
24	that	_	that	_	IN	23	_	_	_	_	_	_	_	O
25	they	_	they	_	PRP	23	_	_	_	_	_	_	_	O
26	should	_	should	_	MD	23	_	_	_	_	_	_	_	O
27	take	_	take	_	VB	23	_	_	_	_	_	_	_	O
28	care	_	care	_	NN	23	_	_	_	_	_	_	_	O
29	to	_	to	_	TO	23	_	_	_	_	_	_	_	O
30	avoid	_	avoid	_	VB	23	_	_	_	_	_	_	_	O
31	excess	_	excess	_	JJ	23	_	_	_	_	_	_	_	O
32	energy	_	energy	_	NN	23	_	_	_	_	_	_	_	O
33	intake	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
34	.	_	.	_	.	23	_	_	_	_	_	_	_	O

1	advise	_	UNK	_	NNP	23	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	23	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	23	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	23	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	23	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	23	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	23	_	_	_	_	_	_	_	O
8	limited	_	limit	_	VBD	23	_	_	_	_	_	_	_	O
9	substitution	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
10	of	_	of	_	IN	23	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	23	_	_	_	_	_	_	_	O
12	foods	_	food	_	NNS	23	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	23	_	_	_	_	_	_	_	O
14	other	_	other	_	JJ	23	_	_	_	_	_	other.a	Increment	O
15	carbohydrate	_	UNK	_	NN	23	_	_	_	_	_	_	_	S-Class
16	in	_	in	_	IN	23	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	23	_	_	_	_	_	_	_	O
18	meal	_	meal	_	NN	23	_	_	_	_	_	_	_	O
19	plan	_	plan	_	NN	23	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	23	_	_	_	_	_	_	_	O
21	allowable	_	UNK	_	JJ	23	_	_	_	_	_	_	_	O
22	,	_	,	_	,	23	_	_	_	_	_	_	_	O
23	but	_	but	_	CC	23	_	_	_	_	_	_	_	O
24	that	_	that	_	IN	23	_	_	_	_	_	_	_	O
25	they	_	they	_	PRP	23	_	_	_	_	_	_	_	O
26	should	_	should	_	MD	23	_	_	_	_	_	_	_	O
27	take	_	take	_	VB	23	_	_	_	_	_	_	_	O
28	care	_	care	_	NN	23	_	_	_	_	_	_	_	O
29	to	_	to	_	TO	23	_	_	_	_	_	_	_	O
30	avoid	_	avoid	_	VB	23	_	_	_	_	_	_	_	O
31	excess	_	excess	_	JJ	23	_	_	_	_	_	_	_	O
32	energy	_	energy	_	NN	23	_	_	_	_	_	_	_	O
33	intake	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
34	.	_	.	_	.	23	_	_	_	_	_	_	_	O

1	advise	_	UNK	_	NNP	23	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	23	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	23	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	23	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	23	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	23	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	23	_	_	_	_	_	_	_	O
8	limited	_	limit	_	VBD	23	_	_	_	_	_	_	_	O
9	substitution	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
10	of	_	of	_	IN	23	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	23	_	_	_	_	_	_	_	O
12	foods	_	food	_	NNS	23	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	23	_	_	_	_	_	_	_	O
14	other	_	other	_	JJ	23	_	_	_	_	_	_	_	O
15	carbohydrate	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
16	in	_	in	_	IN	23	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	23	_	_	_	_	_	_	_	O
18	meal	_	meal	_	NN	23	_	_	_	_	_	_	_	S-Goal
19	plan	_	plan	_	NN	23	_	_	_	_	_	plan.n	Purpose	S-Value
20	is	_	be	_	VBZ	23	_	_	_	_	_	_	_	O
21	allowable	_	UNK	_	JJ	23	_	_	_	_	_	_	_	O
22	,	_	,	_	,	23	_	_	_	_	_	_	_	O
23	but	_	but	_	CC	23	_	_	_	_	_	_	_	O
24	that	_	that	_	IN	23	_	_	_	_	_	_	_	O
25	they	_	they	_	PRP	23	_	_	_	_	_	_	_	O
26	should	_	should	_	MD	23	_	_	_	_	_	_	_	O
27	take	_	take	_	VB	23	_	_	_	_	_	_	_	O
28	care	_	care	_	NN	23	_	_	_	_	_	_	_	O
29	to	_	to	_	TO	23	_	_	_	_	_	_	_	O
30	avoid	_	avoid	_	VB	23	_	_	_	_	_	_	_	O
31	excess	_	excess	_	JJ	23	_	_	_	_	_	_	_	O
32	energy	_	energy	_	NN	23	_	_	_	_	_	_	_	O
33	intake	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
34	.	_	.	_	.	23	_	_	_	_	_	_	_	O

1	advise	_	UNK	_	NNP	23	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	23	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	23	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	23	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	23	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	23	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	23	_	_	_	_	_	_	_	O
8	limited	_	limit	_	VBD	23	_	_	_	_	_	_	_	O
9	substitution	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
10	of	_	of	_	IN	23	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	23	_	_	_	_	_	_	_	O
12	foods	_	food	_	NNS	23	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	23	_	_	_	_	_	_	_	O
14	other	_	other	_	JJ	23	_	_	_	_	_	_	_	O
15	carbohydrate	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
16	in	_	in	_	IN	23	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	23	_	_	_	_	_	_	_	O
18	meal	_	meal	_	NN	23	_	_	_	_	_	_	_	O
19	plan	_	plan	_	NN	23	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	23	_	_	_	_	_	_	_	O
21	allowable	_	UNK	_	JJ	23	_	_	_	_	_	_	_	O
22	,	_	,	_	,	23	_	_	_	_	_	_	_	O
23	but	_	but	_	CC	23	_	_	_	_	_	_	_	O
24	that	_	that	_	IN	23	_	_	_	_	_	_	_	O
25	they	_	they	_	PRP	23	_	_	_	_	_	_	_	S-State_of_affairs
26	should	_	should	_	MD	23	_	_	_	_	_	should.v	Desirable_event	O
27	take	_	take	_	VB	23	_	_	_	_	_	_	_	B-State_of_affairs
28	care	_	care	_	NN	23	_	_	_	_	_	_	_	I-State_of_affairs
29	to	_	to	_	TO	23	_	_	_	_	_	_	_	I-State_of_affairs
30	avoid	_	avoid	_	VB	23	_	_	_	_	_	_	_	I-State_of_affairs
31	excess	_	excess	_	JJ	23	_	_	_	_	_	_	_	I-State_of_affairs
32	energy	_	energy	_	NN	23	_	_	_	_	_	_	_	I-State_of_affairs
33	intake	_	UNK	_	NN	23	_	_	_	_	_	_	_	I-State_of_affairs
34	.	_	.	_	.	23	_	_	_	_	_	_	_	O

1	advise	_	UNK	_	NNP	23	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	23	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	23	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	23	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	23	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	23	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	23	_	_	_	_	_	_	_	O
8	limited	_	limit	_	VBD	23	_	_	_	_	_	_	_	O
9	substitution	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
10	of	_	of	_	IN	23	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	23	_	_	_	_	_	_	_	O
12	foods	_	food	_	NNS	23	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	23	_	_	_	_	_	_	_	O
14	other	_	other	_	JJ	23	_	_	_	_	_	_	_	O
15	carbohydrate	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
16	in	_	in	_	IN	23	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	23	_	_	_	_	_	_	_	O
18	meal	_	meal	_	NN	23	_	_	_	_	_	_	_	O
19	plan	_	plan	_	NN	23	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	23	_	_	_	_	_	_	_	O
21	allowable	_	UNK	_	JJ	23	_	_	_	_	_	_	_	O
22	,	_	,	_	,	23	_	_	_	_	_	_	_	O
23	but	_	but	_	CC	23	_	_	_	_	_	_	_	O
24	that	_	that	_	IN	23	_	_	_	_	_	_	_	O
25	they	_	they	_	PRP	23	_	_	_	_	_	_	_	S-Agent
26	should	_	should	_	MD	23	_	_	_	_	_	_	_	O
27	take	_	take	_	VB	23	_	_	_	_	_	_	_	O
28	care	_	care	_	NN	23	_	_	_	_	_	_	_	O
29	to	_	to	_	TO	23	_	_	_	_	_	_	_	O
30	avoid	_	avoid	_	VB	23	_	_	_	_	_	avoid.v	Avoiding	O
31	excess	_	excess	_	JJ	23	_	_	_	_	_	_	_	B-Undesirable_situation
32	energy	_	energy	_	NN	23	_	_	_	_	_	_	_	I-Undesirable_situation
33	intake	_	UNK	_	NN	23	_	_	_	_	_	_	_	I-Undesirable_situation
34	.	_	.	_	.	23	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	24	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	24	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	24	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	24	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	24	_	_	_	_	_	_	_	O
6	:	_	:	_	:	24	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	24	_	_	_	_	_	_	_	O
8	(	_	(	_	(	24	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	24	_	_	_	_	_	_	_	O
10	)	_	)	_	)	24	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	24	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	24	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	24	_	_	_	_	_	_	_	O
14	)	_	)	_	)	24	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	24	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	24	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	24	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	24	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	24	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	24	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	24	_	_	_	_	_	_	_	O
8	(	_	(	_	(	24	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	24	_	_	_	_	_	_	_	O
10	)	_	)	_	)	24	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	24	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	24	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	24	_	_	_	_	_	_	_	O
14	)	_	)	_	)	24	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	O
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	O
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	O
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	I-Category
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	O
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	O
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	O
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	B-Information
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	I-Information
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	I-Information
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	I-Information
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	I-Information
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	admit.v	Reveal_secret	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	B-Information
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	I-Information
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	I-Information
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	I-Information
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	I-Information
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	I-Information
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	I-Information
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	I-Information
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	I-Information
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	I-Information
19	,	_	,	_	,	25	_	_	_	_	_	_	_	I-Information
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	I-Information
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	I-Information
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	I-Information
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	I-Information
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	I-Information
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	I-Information
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	I-Information
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	I-Information
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	I-Information
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	hospital.n	Buildings	S-Building
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	O
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	O
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	O
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	other.a	Increment	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	S-Class
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	O
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	O
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	O
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	implement.v	Execute_plan	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	B-Plan
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	I-Plan
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	I-Plan
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	I-Plan
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	I-Plan
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	I-Plan
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	I-Plan
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	I-Plan
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	I-Plan
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	I-Plan
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	I-Plan
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	I-Plan
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	I-Plan
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	I-Plan
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	I-Plan
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	S-Component_entities
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	S-Function
24	system	_	system	_	NN	25	_	_	_	_	_	system.n	System	S-Complex
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	B-Supplier
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	I-Supplier
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	I-Supplier
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	I-Supplier
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	I-Supplier
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	provide.v	Supply	O
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	B-Theme
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	I-Theme
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	I-Theme
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	I-Theme
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	I-Theme
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	I-Theme
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	I-Theme
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	I-Theme
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	I-Theme
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	26	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	26	_	_	_	_	_	_	_	O
4	lifestyle	_	lifestyle	_	JJ	26	_	_	_	_	_	_	_	O
5	advice	_	advice	_	NN	26	_	_	_	_	_	_	_	O
6	,	_	,	_	,	26	_	_	_	_	_	_	_	O
7	see	_	see	_	VBP	26	_	_	_	_	_	see.v	Perception_experience	O
8	the	_	the	_	DT	26	_	_	_	_	_	_	_	B-Phenomenon
9	nice	_	UNK	_	NNP	26	_	_	_	_	_	_	_	I-Phenomenon
10	guidelines	_	guideline	_	NNS	26	_	_	_	_	_	_	_	I-Phenomenon
11	on	_	on	_	IN	26	_	_	_	_	_	_	_	I-Phenomenon
12	:	_	:	_	:	26	_	_	_	_	_	_	_	O
13	preventing	_	UNK	_	NN	26	_	_	_	_	_	_	_	O
14	excess	_	excess	_	JJ	26	_	_	_	_	_	_	_	O
15	weight	_	weight	_	NN	26	_	_	_	_	_	_	_	O
16	gain	_	gain	_	NN	26	_	_	_	_	_	_	_	O
17	,	_	,	_	,	26	_	_	_	_	_	_	_	O
18	weight	_	weight	_	JJ	26	_	_	_	_	_	_	_	O
19	management	_	management	_	NN	26	_	_	_	_	_	_	_	O
20	,	_	,	_	,	26	_	_	_	_	_	_	_	O
21	obesity	_	obesity	_	NN	26	_	_	_	_	_	_	_	O
22	,	_	,	_	,	26	_	_	_	_	_	_	_	O
23	physical	_	physical	_	JJ	26	_	_	_	_	_	_	_	O
24	activity	_	activity	_	NN	26	_	_	_	_	_	_	_	O
25	,	_	,	_	,	26	_	_	_	_	_	_	_	O
26	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
27	:	_	:	_	:	26	_	_	_	_	_	_	_	O
28	brief	_	brief	_	JJ	26	_	_	_	_	_	_	_	O
29	interventions	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
30	and	_	and	_	CC	26	_	_	_	_	_	_	_	O
31	referrals	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
32	,	_	,	_	,	26	_	_	_	_	_	_	_	O
33	stop	_	stop	_	VB	26	_	_	_	_	_	_	_	O
34	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
35	services	_	service	_	NNS	26	_	_	_	_	_	_	_	O
36	,	_	,	_	,	26	_	_	_	_	_	_	_	O
37	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
38	:	_	:	_	:	26	_	_	_	_	_	_	_	O
39	harm	_	harm	_	NN	26	_	_	_	_	_	_	_	O
40	reduction	_	reduction	_	NN	26	_	_	_	_	_	_	_	O
41	,	_	,	_	,	26	_	_	_	_	_	_	_	O
42	and	_	and	_	CC	26	_	_	_	_	_	_	_	O
43	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
44	:	_	:	_	:	26	_	_	_	_	_	_	_	O
45	acute	_	acute	_	NN	26	_	_	_	_	_	_	_	O
46	,	_	,	_	,	26	_	_	_	_	_	_	_	O
47	maternity	_	UNK	_	NN	26	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	26	_	_	_	_	_	_	_	O
49	mental	_	mental	_	JJ	26	_	_	_	_	_	_	_	O
50	health	_	health	_	NN	26	_	_	_	_	_	_	_	O
51	services	_	service	_	NNS	26	_	_	_	_	_	_	_	O
52	.	_	.	_	.	26	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	26	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	26	_	_	_	_	_	_	_	O
4	lifestyle	_	lifestyle	_	JJ	26	_	_	_	_	_	_	_	O
5	advice	_	advice	_	NN	26	_	_	_	_	_	_	_	O
6	,	_	,	_	,	26	_	_	_	_	_	_	_	O
7	see	_	see	_	VBP	26	_	_	_	_	_	_	_	O
8	the	_	the	_	DT	26	_	_	_	_	_	_	_	O
9	nice	_	UNK	_	NNP	26	_	_	_	_	_	_	_	O
10	guidelines	_	guideline	_	NNS	26	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	26	_	_	_	_	_	_	_	O
12	:	_	:	_	:	26	_	_	_	_	_	_	_	O
13	preventing	_	UNK	_	NN	26	_	_	_	_	_	_	_	O
14	excess	_	excess	_	JJ	26	_	_	_	_	_	_	_	O
15	weight	_	weight	_	NN	26	_	_	_	_	_	weight.n	Dimension	S-Dimension
16	gain	_	gain	_	NN	26	_	_	_	_	_	_	_	O
17	,	_	,	_	,	26	_	_	_	_	_	_	_	O
18	weight	_	weight	_	JJ	26	_	_	_	_	_	_	_	O
19	management	_	management	_	NN	26	_	_	_	_	_	_	_	O
20	,	_	,	_	,	26	_	_	_	_	_	_	_	O
21	obesity	_	obesity	_	NN	26	_	_	_	_	_	_	_	O
22	,	_	,	_	,	26	_	_	_	_	_	_	_	O
23	physical	_	physical	_	JJ	26	_	_	_	_	_	_	_	O
24	activity	_	activity	_	NN	26	_	_	_	_	_	_	_	O
25	,	_	,	_	,	26	_	_	_	_	_	_	_	O
26	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
27	:	_	:	_	:	26	_	_	_	_	_	_	_	O
28	brief	_	brief	_	JJ	26	_	_	_	_	_	_	_	O
29	interventions	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
30	and	_	and	_	CC	26	_	_	_	_	_	_	_	O
31	referrals	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
32	,	_	,	_	,	26	_	_	_	_	_	_	_	O
33	stop	_	stop	_	VB	26	_	_	_	_	_	_	_	O
34	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
35	services	_	service	_	NNS	26	_	_	_	_	_	_	_	O
36	,	_	,	_	,	26	_	_	_	_	_	_	_	O
37	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
38	:	_	:	_	:	26	_	_	_	_	_	_	_	O
39	harm	_	harm	_	NN	26	_	_	_	_	_	_	_	O
40	reduction	_	reduction	_	NN	26	_	_	_	_	_	_	_	O
41	,	_	,	_	,	26	_	_	_	_	_	_	_	O
42	and	_	and	_	CC	26	_	_	_	_	_	_	_	O
43	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
44	:	_	:	_	:	26	_	_	_	_	_	_	_	O
45	acute	_	acute	_	NN	26	_	_	_	_	_	_	_	O
46	,	_	,	_	,	26	_	_	_	_	_	_	_	O
47	maternity	_	UNK	_	NN	26	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	26	_	_	_	_	_	_	_	O
49	mental	_	mental	_	JJ	26	_	_	_	_	_	_	_	O
50	health	_	health	_	NN	26	_	_	_	_	_	_	_	O
51	services	_	service	_	NNS	26	_	_	_	_	_	_	_	O
52	.	_	.	_	.	26	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	26	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	26	_	_	_	_	_	_	_	O
4	lifestyle	_	lifestyle	_	JJ	26	_	_	_	_	_	_	_	O
5	advice	_	advice	_	NN	26	_	_	_	_	_	_	_	O
6	,	_	,	_	,	26	_	_	_	_	_	_	_	O
7	see	_	see	_	VBP	26	_	_	_	_	_	_	_	O
8	the	_	the	_	DT	26	_	_	_	_	_	_	_	O
9	nice	_	UNK	_	NNP	26	_	_	_	_	_	_	_	O
10	guidelines	_	guideline	_	NNS	26	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	26	_	_	_	_	_	_	_	O
12	:	_	:	_	:	26	_	_	_	_	_	_	_	O
13	preventing	_	UNK	_	NN	26	_	_	_	_	_	_	_	O
14	excess	_	excess	_	JJ	26	_	_	_	_	_	_	_	S-Place
15	weight	_	weight	_	NN	26	_	_	_	_	_	_	_	S-Theme
16	gain	_	gain	_	NN	26	_	_	_	_	_	gain.n	Getting	O
17	,	_	,	_	,	26	_	_	_	_	_	_	_	O
18	weight	_	weight	_	JJ	26	_	_	_	_	_	_	_	O
19	management	_	management	_	NN	26	_	_	_	_	_	_	_	O
20	,	_	,	_	,	26	_	_	_	_	_	_	_	O
21	obesity	_	obesity	_	NN	26	_	_	_	_	_	_	_	O
22	,	_	,	_	,	26	_	_	_	_	_	_	_	O
23	physical	_	physical	_	JJ	26	_	_	_	_	_	_	_	O
24	activity	_	activity	_	NN	26	_	_	_	_	_	_	_	O
25	,	_	,	_	,	26	_	_	_	_	_	_	_	O
26	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
27	:	_	:	_	:	26	_	_	_	_	_	_	_	O
28	brief	_	brief	_	JJ	26	_	_	_	_	_	_	_	O
29	interventions	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
30	and	_	and	_	CC	26	_	_	_	_	_	_	_	O
31	referrals	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
32	,	_	,	_	,	26	_	_	_	_	_	_	_	O
33	stop	_	stop	_	VB	26	_	_	_	_	_	_	_	O
34	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
35	services	_	service	_	NNS	26	_	_	_	_	_	_	_	O
36	,	_	,	_	,	26	_	_	_	_	_	_	_	O
37	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
38	:	_	:	_	:	26	_	_	_	_	_	_	_	O
39	harm	_	harm	_	NN	26	_	_	_	_	_	_	_	O
40	reduction	_	reduction	_	NN	26	_	_	_	_	_	_	_	O
41	,	_	,	_	,	26	_	_	_	_	_	_	_	O
42	and	_	and	_	CC	26	_	_	_	_	_	_	_	O
43	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
44	:	_	:	_	:	26	_	_	_	_	_	_	_	O
45	acute	_	acute	_	NN	26	_	_	_	_	_	_	_	O
46	,	_	,	_	,	26	_	_	_	_	_	_	_	O
47	maternity	_	UNK	_	NN	26	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	26	_	_	_	_	_	_	_	O
49	mental	_	mental	_	JJ	26	_	_	_	_	_	_	_	O
50	health	_	health	_	NN	26	_	_	_	_	_	_	_	O
51	services	_	service	_	NNS	26	_	_	_	_	_	_	_	O
52	.	_	.	_	.	26	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	26	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	26	_	_	_	_	_	_	_	O
4	lifestyle	_	lifestyle	_	JJ	26	_	_	_	_	_	_	_	O
5	advice	_	advice	_	NN	26	_	_	_	_	_	_	_	O
6	,	_	,	_	,	26	_	_	_	_	_	_	_	O
7	see	_	see	_	VBP	26	_	_	_	_	_	_	_	O
8	the	_	the	_	DT	26	_	_	_	_	_	_	_	O
9	nice	_	UNK	_	NNP	26	_	_	_	_	_	_	_	O
10	guidelines	_	guideline	_	NNS	26	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	26	_	_	_	_	_	_	_	O
12	:	_	:	_	:	26	_	_	_	_	_	_	_	O
13	preventing	_	UNK	_	NN	26	_	_	_	_	_	_	_	O
14	excess	_	excess	_	JJ	26	_	_	_	_	_	_	_	O
15	weight	_	weight	_	NN	26	_	_	_	_	_	_	_	O
16	gain	_	gain	_	NN	26	_	_	_	_	_	_	_	O
17	,	_	,	_	,	26	_	_	_	_	_	_	_	O
18	weight	_	weight	_	JJ	26	_	_	_	_	_	weight.n	Dimension	S-Dimension
19	management	_	management	_	NN	26	_	_	_	_	_	_	_	S-Object
20	,	_	,	_	,	26	_	_	_	_	_	_	_	O
21	obesity	_	obesity	_	NN	26	_	_	_	_	_	_	_	O
22	,	_	,	_	,	26	_	_	_	_	_	_	_	O
23	physical	_	physical	_	JJ	26	_	_	_	_	_	_	_	O
24	activity	_	activity	_	NN	26	_	_	_	_	_	_	_	O
25	,	_	,	_	,	26	_	_	_	_	_	_	_	O
26	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
27	:	_	:	_	:	26	_	_	_	_	_	_	_	O
28	brief	_	brief	_	JJ	26	_	_	_	_	_	_	_	O
29	interventions	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
30	and	_	and	_	CC	26	_	_	_	_	_	_	_	O
31	referrals	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
32	,	_	,	_	,	26	_	_	_	_	_	_	_	O
33	stop	_	stop	_	VB	26	_	_	_	_	_	_	_	O
34	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
35	services	_	service	_	NNS	26	_	_	_	_	_	_	_	O
36	,	_	,	_	,	26	_	_	_	_	_	_	_	O
37	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
38	:	_	:	_	:	26	_	_	_	_	_	_	_	O
39	harm	_	harm	_	NN	26	_	_	_	_	_	_	_	O
40	reduction	_	reduction	_	NN	26	_	_	_	_	_	_	_	O
41	,	_	,	_	,	26	_	_	_	_	_	_	_	O
42	and	_	and	_	CC	26	_	_	_	_	_	_	_	O
43	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
44	:	_	:	_	:	26	_	_	_	_	_	_	_	O
45	acute	_	acute	_	NN	26	_	_	_	_	_	_	_	O
46	,	_	,	_	,	26	_	_	_	_	_	_	_	O
47	maternity	_	UNK	_	NN	26	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	26	_	_	_	_	_	_	_	O
49	mental	_	mental	_	JJ	26	_	_	_	_	_	_	_	O
50	health	_	health	_	NN	26	_	_	_	_	_	_	_	O
51	services	_	service	_	NNS	26	_	_	_	_	_	_	_	O
52	.	_	.	_	.	26	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	26	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	26	_	_	_	_	_	_	_	O
4	lifestyle	_	lifestyle	_	JJ	26	_	_	_	_	_	_	_	O
5	advice	_	advice	_	NN	26	_	_	_	_	_	_	_	O
6	,	_	,	_	,	26	_	_	_	_	_	_	_	O
7	see	_	see	_	VBP	26	_	_	_	_	_	_	_	O
8	the	_	the	_	DT	26	_	_	_	_	_	_	_	O
9	nice	_	UNK	_	NNP	26	_	_	_	_	_	_	_	O
10	guidelines	_	guideline	_	NNS	26	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	26	_	_	_	_	_	_	_	O
12	:	_	:	_	:	26	_	_	_	_	_	_	_	O
13	preventing	_	UNK	_	NN	26	_	_	_	_	_	_	_	O
14	excess	_	excess	_	JJ	26	_	_	_	_	_	_	_	O
15	weight	_	weight	_	NN	26	_	_	_	_	_	_	_	O
16	gain	_	gain	_	NN	26	_	_	_	_	_	_	_	O
17	,	_	,	_	,	26	_	_	_	_	_	_	_	O
18	weight	_	weight	_	JJ	26	_	_	_	_	_	_	_	O
19	management	_	management	_	NN	26	_	_	_	_	_	_	_	O
20	,	_	,	_	,	26	_	_	_	_	_	_	_	O
21	obesity	_	obesity	_	NN	26	_	_	_	_	_	_	_	O
22	,	_	,	_	,	26	_	_	_	_	_	_	_	O
23	physical	_	physical	_	JJ	26	_	_	_	_	_	_	_	S-Domain
24	activity	_	activity	_	NN	26	_	_	_	_	_	activity.n	Intentionally_act	O
25	,	_	,	_	,	26	_	_	_	_	_	_	_	O
26	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
27	:	_	:	_	:	26	_	_	_	_	_	_	_	O
28	brief	_	brief	_	JJ	26	_	_	_	_	_	_	_	O
29	interventions	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
30	and	_	and	_	CC	26	_	_	_	_	_	_	_	O
31	referrals	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
32	,	_	,	_	,	26	_	_	_	_	_	_	_	O
33	stop	_	stop	_	VB	26	_	_	_	_	_	_	_	O
34	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
35	services	_	service	_	NNS	26	_	_	_	_	_	_	_	O
36	,	_	,	_	,	26	_	_	_	_	_	_	_	O
37	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
38	:	_	:	_	:	26	_	_	_	_	_	_	_	O
39	harm	_	harm	_	NN	26	_	_	_	_	_	_	_	O
40	reduction	_	reduction	_	NN	26	_	_	_	_	_	_	_	O
41	,	_	,	_	,	26	_	_	_	_	_	_	_	O
42	and	_	and	_	CC	26	_	_	_	_	_	_	_	O
43	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
44	:	_	:	_	:	26	_	_	_	_	_	_	_	O
45	acute	_	acute	_	NN	26	_	_	_	_	_	_	_	O
46	,	_	,	_	,	26	_	_	_	_	_	_	_	O
47	maternity	_	UNK	_	NN	26	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	26	_	_	_	_	_	_	_	O
49	mental	_	mental	_	JJ	26	_	_	_	_	_	_	_	O
50	health	_	health	_	NN	26	_	_	_	_	_	_	_	O
51	services	_	service	_	NNS	26	_	_	_	_	_	_	_	O
52	.	_	.	_	.	26	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	26	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	26	_	_	_	_	_	_	_	O
4	lifestyle	_	lifestyle	_	JJ	26	_	_	_	_	_	_	_	O
5	advice	_	advice	_	NN	26	_	_	_	_	_	_	_	O
6	,	_	,	_	,	26	_	_	_	_	_	_	_	O
7	see	_	see	_	VBP	26	_	_	_	_	_	_	_	O
8	the	_	the	_	DT	26	_	_	_	_	_	_	_	O
9	nice	_	UNK	_	NNP	26	_	_	_	_	_	_	_	O
10	guidelines	_	guideline	_	NNS	26	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	26	_	_	_	_	_	_	_	O
12	:	_	:	_	:	26	_	_	_	_	_	_	_	O
13	preventing	_	UNK	_	NN	26	_	_	_	_	_	_	_	O
14	excess	_	excess	_	JJ	26	_	_	_	_	_	_	_	O
15	weight	_	weight	_	NN	26	_	_	_	_	_	_	_	O
16	gain	_	gain	_	NN	26	_	_	_	_	_	_	_	O
17	,	_	,	_	,	26	_	_	_	_	_	_	_	O
18	weight	_	weight	_	JJ	26	_	_	_	_	_	_	_	O
19	management	_	management	_	NN	26	_	_	_	_	_	_	_	O
20	,	_	,	_	,	26	_	_	_	_	_	_	_	O
21	obesity	_	obesity	_	NN	26	_	_	_	_	_	_	_	O
22	,	_	,	_	,	26	_	_	_	_	_	_	_	O
23	physical	_	physical	_	JJ	26	_	_	_	_	_	_	_	O
24	activity	_	activity	_	NN	26	_	_	_	_	_	_	_	O
25	,	_	,	_	,	26	_	_	_	_	_	_	_	O
26	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
27	:	_	:	_	:	26	_	_	_	_	_	_	_	O
28	brief	_	brief	_	JJ	26	_	_	_	_	_	brief.a	Duration_description	O
29	interventions	_	UNK	_	NNS	26	_	_	_	_	_	_	_	B-Eventuality
30	and	_	and	_	CC	26	_	_	_	_	_	_	_	I-Eventuality
31	referrals	_	UNK	_	NNS	26	_	_	_	_	_	_	_	I-Eventuality
32	,	_	,	_	,	26	_	_	_	_	_	_	_	O
33	stop	_	stop	_	VB	26	_	_	_	_	_	_	_	O
34	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
35	services	_	service	_	NNS	26	_	_	_	_	_	_	_	O
36	,	_	,	_	,	26	_	_	_	_	_	_	_	O
37	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
38	:	_	:	_	:	26	_	_	_	_	_	_	_	O
39	harm	_	harm	_	NN	26	_	_	_	_	_	_	_	O
40	reduction	_	reduction	_	NN	26	_	_	_	_	_	_	_	O
41	,	_	,	_	,	26	_	_	_	_	_	_	_	O
42	and	_	and	_	CC	26	_	_	_	_	_	_	_	O
43	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
44	:	_	:	_	:	26	_	_	_	_	_	_	_	O
45	acute	_	acute	_	NN	26	_	_	_	_	_	_	_	O
46	,	_	,	_	,	26	_	_	_	_	_	_	_	O
47	maternity	_	UNK	_	NN	26	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	26	_	_	_	_	_	_	_	O
49	mental	_	mental	_	JJ	26	_	_	_	_	_	_	_	O
50	health	_	health	_	NN	26	_	_	_	_	_	_	_	O
51	services	_	service	_	NNS	26	_	_	_	_	_	_	_	O
52	.	_	.	_	.	26	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	26	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	26	_	_	_	_	_	_	_	O
4	lifestyle	_	lifestyle	_	JJ	26	_	_	_	_	_	_	_	O
5	advice	_	advice	_	NN	26	_	_	_	_	_	_	_	O
6	,	_	,	_	,	26	_	_	_	_	_	_	_	O
7	see	_	see	_	VBP	26	_	_	_	_	_	_	_	O
8	the	_	the	_	DT	26	_	_	_	_	_	_	_	O
9	nice	_	UNK	_	NNP	26	_	_	_	_	_	_	_	O
10	guidelines	_	guideline	_	NNS	26	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	26	_	_	_	_	_	_	_	O
12	:	_	:	_	:	26	_	_	_	_	_	_	_	O
13	preventing	_	UNK	_	NN	26	_	_	_	_	_	_	_	O
14	excess	_	excess	_	JJ	26	_	_	_	_	_	_	_	O
15	weight	_	weight	_	NN	26	_	_	_	_	_	_	_	O
16	gain	_	gain	_	NN	26	_	_	_	_	_	_	_	O
17	,	_	,	_	,	26	_	_	_	_	_	_	_	O
18	weight	_	weight	_	JJ	26	_	_	_	_	_	_	_	O
19	management	_	management	_	NN	26	_	_	_	_	_	_	_	O
20	,	_	,	_	,	26	_	_	_	_	_	_	_	O
21	obesity	_	obesity	_	NN	26	_	_	_	_	_	_	_	B-Process
22	,	_	,	_	,	26	_	_	_	_	_	_	_	I-Process
23	physical	_	physical	_	JJ	26	_	_	_	_	_	_	_	I-Process
24	activity	_	activity	_	NN	26	_	_	_	_	_	_	_	I-Process
25	,	_	,	_	,	26	_	_	_	_	_	_	_	I-Process
26	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	I-Process
27	:	_	:	_	:	26	_	_	_	_	_	_	_	I-Process
28	brief	_	brief	_	JJ	26	_	_	_	_	_	_	_	I-Process
29	interventions	_	UNK	_	NNS	26	_	_	_	_	_	_	_	I-Process
30	and	_	and	_	CC	26	_	_	_	_	_	_	_	I-Process
31	referrals	_	UNK	_	NNS	26	_	_	_	_	_	_	_	I-Process
32	,	_	,	_	,	26	_	_	_	_	_	_	_	O
33	stop	_	stop	_	VB	26	_	_	_	_	_	stop.v	Process_stop	O
34	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	B-Process
35	services	_	service	_	NNS	26	_	_	_	_	_	_	_	I-Process
36	,	_	,	_	,	26	_	_	_	_	_	_	_	I-Process
37	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	I-Process
38	:	_	:	_	:	26	_	_	_	_	_	_	_	I-Process
39	harm	_	harm	_	NN	26	_	_	_	_	_	_	_	I-Process
40	reduction	_	reduction	_	NN	26	_	_	_	_	_	_	_	I-Process
41	,	_	,	_	,	26	_	_	_	_	_	_	_	I-Process
42	and	_	and	_	CC	26	_	_	_	_	_	_	_	I-Process
43	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	I-Process
44	:	_	:	_	:	26	_	_	_	_	_	_	_	O
45	acute	_	acute	_	NN	26	_	_	_	_	_	_	_	O
46	,	_	,	_	,	26	_	_	_	_	_	_	_	O
47	maternity	_	UNK	_	NN	26	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	26	_	_	_	_	_	_	_	O
49	mental	_	mental	_	JJ	26	_	_	_	_	_	_	_	O
50	health	_	health	_	NN	26	_	_	_	_	_	_	_	O
51	services	_	service	_	NNS	26	_	_	_	_	_	_	_	O
52	.	_	.	_	.	26	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	26	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	26	_	_	_	_	_	_	_	O
4	lifestyle	_	lifestyle	_	JJ	26	_	_	_	_	_	_	_	O
5	advice	_	advice	_	NN	26	_	_	_	_	_	_	_	O
6	,	_	,	_	,	26	_	_	_	_	_	_	_	O
7	see	_	see	_	VBP	26	_	_	_	_	_	_	_	O
8	the	_	the	_	DT	26	_	_	_	_	_	_	_	O
9	nice	_	UNK	_	NNP	26	_	_	_	_	_	_	_	O
10	guidelines	_	guideline	_	NNS	26	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	26	_	_	_	_	_	_	_	O
12	:	_	:	_	:	26	_	_	_	_	_	_	_	O
13	preventing	_	UNK	_	NN	26	_	_	_	_	_	_	_	O
14	excess	_	excess	_	JJ	26	_	_	_	_	_	_	_	O
15	weight	_	weight	_	NN	26	_	_	_	_	_	_	_	O
16	gain	_	gain	_	NN	26	_	_	_	_	_	_	_	O
17	,	_	,	_	,	26	_	_	_	_	_	_	_	O
18	weight	_	weight	_	JJ	26	_	_	_	_	_	_	_	O
19	management	_	management	_	NN	26	_	_	_	_	_	_	_	O
20	,	_	,	_	,	26	_	_	_	_	_	_	_	O
21	obesity	_	obesity	_	NN	26	_	_	_	_	_	_	_	O
22	,	_	,	_	,	26	_	_	_	_	_	_	_	O
23	physical	_	physical	_	JJ	26	_	_	_	_	_	_	_	O
24	activity	_	activity	_	NN	26	_	_	_	_	_	_	_	O
25	,	_	,	_	,	26	_	_	_	_	_	_	_	O
26	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
27	:	_	:	_	:	26	_	_	_	_	_	_	_	O
28	brief	_	brief	_	JJ	26	_	_	_	_	_	_	_	O
29	interventions	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
30	and	_	and	_	CC	26	_	_	_	_	_	_	_	O
31	referrals	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
32	,	_	,	_	,	26	_	_	_	_	_	_	_	O
33	stop	_	stop	_	VB	26	_	_	_	_	_	_	_	O
34	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	S-Domain
35	services	_	service	_	NNS	26	_	_	_	_	_	service.n	Public_services	S-Institution
36	,	_	,	_	,	26	_	_	_	_	_	_	_	O
37	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
38	:	_	:	_	:	26	_	_	_	_	_	_	_	O
39	harm	_	harm	_	NN	26	_	_	_	_	_	_	_	O
40	reduction	_	reduction	_	NN	26	_	_	_	_	_	_	_	O
41	,	_	,	_	,	26	_	_	_	_	_	_	_	O
42	and	_	and	_	CC	26	_	_	_	_	_	_	_	O
43	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
44	:	_	:	_	:	26	_	_	_	_	_	_	_	O
45	acute	_	acute	_	NN	26	_	_	_	_	_	_	_	O
46	,	_	,	_	,	26	_	_	_	_	_	_	_	O
47	maternity	_	UNK	_	NN	26	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	26	_	_	_	_	_	_	_	O
49	mental	_	mental	_	JJ	26	_	_	_	_	_	_	_	O
50	health	_	health	_	NN	26	_	_	_	_	_	_	_	O
51	services	_	service	_	NNS	26	_	_	_	_	_	_	_	O
52	.	_	.	_	.	26	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	26	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	26	_	_	_	_	_	_	_	O
4	lifestyle	_	lifestyle	_	JJ	26	_	_	_	_	_	_	_	O
5	advice	_	advice	_	NN	26	_	_	_	_	_	_	_	O
6	,	_	,	_	,	26	_	_	_	_	_	_	_	O
7	see	_	see	_	VBP	26	_	_	_	_	_	_	_	O
8	the	_	the	_	DT	26	_	_	_	_	_	_	_	O
9	nice	_	UNK	_	NNP	26	_	_	_	_	_	_	_	O
10	guidelines	_	guideline	_	NNS	26	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	26	_	_	_	_	_	_	_	O
12	:	_	:	_	:	26	_	_	_	_	_	_	_	O
13	preventing	_	UNK	_	NN	26	_	_	_	_	_	_	_	O
14	excess	_	excess	_	JJ	26	_	_	_	_	_	_	_	O
15	weight	_	weight	_	NN	26	_	_	_	_	_	_	_	O
16	gain	_	gain	_	NN	26	_	_	_	_	_	_	_	O
17	,	_	,	_	,	26	_	_	_	_	_	_	_	O
18	weight	_	weight	_	JJ	26	_	_	_	_	_	_	_	O
19	management	_	management	_	NN	26	_	_	_	_	_	_	_	O
20	,	_	,	_	,	26	_	_	_	_	_	_	_	O
21	obesity	_	obesity	_	NN	26	_	_	_	_	_	_	_	O
22	,	_	,	_	,	26	_	_	_	_	_	_	_	O
23	physical	_	physical	_	JJ	26	_	_	_	_	_	_	_	O
24	activity	_	activity	_	NN	26	_	_	_	_	_	_	_	O
25	,	_	,	_	,	26	_	_	_	_	_	_	_	O
26	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
27	:	_	:	_	:	26	_	_	_	_	_	_	_	O
28	brief	_	brief	_	JJ	26	_	_	_	_	_	_	_	O
29	interventions	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
30	and	_	and	_	CC	26	_	_	_	_	_	_	_	O
31	referrals	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
32	,	_	,	_	,	26	_	_	_	_	_	_	_	O
33	stop	_	stop	_	VB	26	_	_	_	_	_	_	_	O
34	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
35	services	_	service	_	NNS	26	_	_	_	_	_	_	_	O
36	,	_	,	_	,	26	_	_	_	_	_	_	_	O
37	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
38	:	_	:	_	:	26	_	_	_	_	_	_	_	O
39	harm	_	harm	_	NN	26	_	_	_	_	_	_	_	S-Item
40	reduction	_	reduction	_	NN	26	_	_	_	_	_	reduction.n	Cause_change_of_position_on_a_scale	O
41	,	_	,	_	,	26	_	_	_	_	_	_	_	O
42	and	_	and	_	CC	26	_	_	_	_	_	_	_	O
43	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
44	:	_	:	_	:	26	_	_	_	_	_	_	_	O
45	acute	_	acute	_	NN	26	_	_	_	_	_	_	_	O
46	,	_	,	_	,	26	_	_	_	_	_	_	_	O
47	maternity	_	UNK	_	NN	26	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	26	_	_	_	_	_	_	_	O
49	mental	_	mental	_	JJ	26	_	_	_	_	_	_	_	O
50	health	_	health	_	NN	26	_	_	_	_	_	_	_	O
51	services	_	service	_	NNS	26	_	_	_	_	_	_	_	O
52	.	_	.	_	.	26	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	26	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	26	_	_	_	_	_	_	_	O
4	lifestyle	_	lifestyle	_	JJ	26	_	_	_	_	_	_	_	O
5	advice	_	advice	_	NN	26	_	_	_	_	_	_	_	O
6	,	_	,	_	,	26	_	_	_	_	_	_	_	O
7	see	_	see	_	VBP	26	_	_	_	_	_	_	_	O
8	the	_	the	_	DT	26	_	_	_	_	_	_	_	O
9	nice	_	UNK	_	NNP	26	_	_	_	_	_	_	_	O
10	guidelines	_	guideline	_	NNS	26	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	26	_	_	_	_	_	_	_	O
12	:	_	:	_	:	26	_	_	_	_	_	_	_	O
13	preventing	_	UNK	_	NN	26	_	_	_	_	_	_	_	O
14	excess	_	excess	_	JJ	26	_	_	_	_	_	_	_	O
15	weight	_	weight	_	NN	26	_	_	_	_	_	_	_	O
16	gain	_	gain	_	NN	26	_	_	_	_	_	_	_	O
17	,	_	,	_	,	26	_	_	_	_	_	_	_	O
18	weight	_	weight	_	JJ	26	_	_	_	_	_	_	_	O
19	management	_	management	_	NN	26	_	_	_	_	_	_	_	O
20	,	_	,	_	,	26	_	_	_	_	_	_	_	O
21	obesity	_	obesity	_	NN	26	_	_	_	_	_	_	_	O
22	,	_	,	_	,	26	_	_	_	_	_	_	_	O
23	physical	_	physical	_	JJ	26	_	_	_	_	_	_	_	O
24	activity	_	activity	_	NN	26	_	_	_	_	_	_	_	O
25	,	_	,	_	,	26	_	_	_	_	_	_	_	O
26	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
27	:	_	:	_	:	26	_	_	_	_	_	_	_	O
28	brief	_	brief	_	JJ	26	_	_	_	_	_	_	_	O
29	interventions	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
30	and	_	and	_	CC	26	_	_	_	_	_	_	_	O
31	referrals	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
32	,	_	,	_	,	26	_	_	_	_	_	_	_	O
33	stop	_	stop	_	VB	26	_	_	_	_	_	_	_	O
34	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
35	services	_	service	_	NNS	26	_	_	_	_	_	_	_	O
36	,	_	,	_	,	26	_	_	_	_	_	_	_	O
37	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
38	:	_	:	_	:	26	_	_	_	_	_	_	_	O
39	harm	_	harm	_	NN	26	_	_	_	_	_	_	_	O
40	reduction	_	reduction	_	NN	26	_	_	_	_	_	_	_	O
41	,	_	,	_	,	26	_	_	_	_	_	_	_	O
42	and	_	and	_	CC	26	_	_	_	_	_	_	_	O
43	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
44	:	_	:	_	:	26	_	_	_	_	_	_	_	O
45	acute	_	acute	_	NN	26	_	_	_	_	_	acute.a	Importance	O
46	,	_	,	_	,	26	_	_	_	_	_	_	_	O
47	maternity	_	UNK	_	NN	26	_	_	_	_	_	_	_	B-Factor
48	and	_	and	_	CC	26	_	_	_	_	_	_	_	I-Factor
49	mental	_	mental	_	JJ	26	_	_	_	_	_	_	_	I-Factor
50	health	_	health	_	NN	26	_	_	_	_	_	_	_	I-Factor
51	services	_	service	_	NNS	26	_	_	_	_	_	_	_	I-Factor
52	.	_	.	_	.	26	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	26	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	26	_	_	_	_	_	_	_	O
4	lifestyle	_	lifestyle	_	JJ	26	_	_	_	_	_	_	_	O
5	advice	_	advice	_	NN	26	_	_	_	_	_	_	_	O
6	,	_	,	_	,	26	_	_	_	_	_	_	_	O
7	see	_	see	_	VBP	26	_	_	_	_	_	_	_	O
8	the	_	the	_	DT	26	_	_	_	_	_	_	_	O
9	nice	_	UNK	_	NNP	26	_	_	_	_	_	_	_	O
10	guidelines	_	guideline	_	NNS	26	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	26	_	_	_	_	_	_	_	O
12	:	_	:	_	:	26	_	_	_	_	_	_	_	O
13	preventing	_	UNK	_	NN	26	_	_	_	_	_	_	_	O
14	excess	_	excess	_	JJ	26	_	_	_	_	_	_	_	O
15	weight	_	weight	_	NN	26	_	_	_	_	_	_	_	O
16	gain	_	gain	_	NN	26	_	_	_	_	_	_	_	O
17	,	_	,	_	,	26	_	_	_	_	_	_	_	O
18	weight	_	weight	_	JJ	26	_	_	_	_	_	_	_	O
19	management	_	management	_	NN	26	_	_	_	_	_	_	_	O
20	,	_	,	_	,	26	_	_	_	_	_	_	_	O
21	obesity	_	obesity	_	NN	26	_	_	_	_	_	_	_	O
22	,	_	,	_	,	26	_	_	_	_	_	_	_	O
23	physical	_	physical	_	JJ	26	_	_	_	_	_	_	_	O
24	activity	_	activity	_	NN	26	_	_	_	_	_	_	_	O
25	,	_	,	_	,	26	_	_	_	_	_	_	_	O
26	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
27	:	_	:	_	:	26	_	_	_	_	_	_	_	O
28	brief	_	brief	_	JJ	26	_	_	_	_	_	_	_	O
29	interventions	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
30	and	_	and	_	CC	26	_	_	_	_	_	_	_	O
31	referrals	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
32	,	_	,	_	,	26	_	_	_	_	_	_	_	O
33	stop	_	stop	_	VB	26	_	_	_	_	_	_	_	O
34	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
35	services	_	service	_	NNS	26	_	_	_	_	_	_	_	O
36	,	_	,	_	,	26	_	_	_	_	_	_	_	O
37	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
38	:	_	:	_	:	26	_	_	_	_	_	_	_	O
39	harm	_	harm	_	NN	26	_	_	_	_	_	_	_	O
40	reduction	_	reduction	_	NN	26	_	_	_	_	_	_	_	O
41	,	_	,	_	,	26	_	_	_	_	_	_	_	O
42	and	_	and	_	CC	26	_	_	_	_	_	_	_	O
43	smoking	_	smoking	_	NN	26	_	_	_	_	_	_	_	O
44	:	_	:	_	:	26	_	_	_	_	_	_	_	O
45	acute	_	acute	_	NN	26	_	_	_	_	_	_	_	O
46	,	_	,	_	,	26	_	_	_	_	_	_	_	O
47	maternity	_	UNK	_	NN	26	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	26	_	_	_	_	_	_	_	O
49	mental	_	mental	_	JJ	26	_	_	_	_	_	_	_	B-Institution
50	health	_	health	_	NN	26	_	_	_	_	_	_	_	I-Institution
51	services	_	service	_	NNS	26	_	_	_	_	_	service.n	Public_services	O
52	.	_	.	_	.	26	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	27	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	27	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	27	_	_	_	_	_	_	_	O
4	bariatric	_	UNK	_	JJ	27	_	_	_	_	_	_	_	O
5	surgery	_	UNK	_	NN	27	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	27	_	_	_	_	_	_	_	O
7	people	_	people	_	NNS	27	_	_	_	_	_	people.n	People	S-Person
8	with	_	with	_	IN	27	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	JJ	27	_	_	_	_	_	_	_	O
10	type	_	type	_	NN	27	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	27	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	27	_	_	_	_	_	_	_	O
13	,	_	,	_	,	27	_	_	_	_	_	_	_	O
14	see	_	see	_	VBP	27	_	_	_	_	_	_	_	O
15	the	_	the	_	DT	27	_	_	_	_	_	_	_	O
16	section	_	section	_	NN	27	_	_	_	_	_	_	_	O
17	on	_	on	_	IN	27	_	_	_	_	_	_	_	O
18	bariatric	_	UNK	_	JJ	27	_	_	_	_	_	_	_	O
19	surgery	_	UNK	_	NN	27	_	_	_	_	_	_	_	O
20	for	_	for	_	IN	27	_	_	_	_	_	_	_	O
21	people	_	people	_	NNS	27	_	_	_	_	_	_	_	O
22	with	_	with	_	IN	27	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	JJ	27	_	_	_	_	_	_	_	O
24	type	_	type	_	NN	27	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	27	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	27	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	27	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	27	_	_	_	_	_	_	_	O
29	nice	_	UNK	_	NNP	27	_	_	_	_	_	_	_	O
30	guideline	_	guideline	_	NN	27	_	_	_	_	_	_	_	O
31	on	_	on	_	IN	27	_	_	_	_	_	_	_	O
32	obesity	_	obesity	_	NN	27	_	_	_	_	_	_	_	O
33	.	_	.	_	.	27	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	27	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	27	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	27	_	_	_	_	_	_	_	O
4	bariatric	_	UNK	_	JJ	27	_	_	_	_	_	_	_	O
5	surgery	_	UNK	_	NN	27	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	27	_	_	_	_	_	_	_	O
7	people	_	people	_	NNS	27	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	27	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	JJ	27	_	_	_	_	_	_	_	S-Type_property
10	type	_	type	_	NN	27	_	_	_	_	_	type.n	Type	S-Subtype
11	2	_	2	_	CD	27	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	27	_	_	_	_	_	_	_	O
13	,	_	,	_	,	27	_	_	_	_	_	_	_	O
14	see	_	see	_	VBP	27	_	_	_	_	_	_	_	O
15	the	_	the	_	DT	27	_	_	_	_	_	_	_	O
16	section	_	section	_	NN	27	_	_	_	_	_	_	_	O
17	on	_	on	_	IN	27	_	_	_	_	_	_	_	O
18	bariatric	_	UNK	_	JJ	27	_	_	_	_	_	_	_	O
19	surgery	_	UNK	_	NN	27	_	_	_	_	_	_	_	O
20	for	_	for	_	IN	27	_	_	_	_	_	_	_	O
21	people	_	people	_	NNS	27	_	_	_	_	_	_	_	O
22	with	_	with	_	IN	27	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	JJ	27	_	_	_	_	_	_	_	O
24	type	_	type	_	NN	27	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	27	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	27	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	27	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	27	_	_	_	_	_	_	_	O
29	nice	_	UNK	_	NNP	27	_	_	_	_	_	_	_	O
30	guideline	_	guideline	_	NN	27	_	_	_	_	_	_	_	O
31	on	_	on	_	IN	27	_	_	_	_	_	_	_	O
32	obesity	_	obesity	_	NN	27	_	_	_	_	_	_	_	O
33	.	_	.	_	.	27	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	27	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	27	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	27	_	_	_	_	_	_	_	O
4	bariatric	_	UNK	_	JJ	27	_	_	_	_	_	_	_	O
5	surgery	_	UNK	_	NN	27	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	27	_	_	_	_	_	_	_	O
7	people	_	people	_	NNS	27	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	27	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	JJ	27	_	_	_	_	_	_	_	O
10	type	_	type	_	NN	27	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	27	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	27	_	_	_	_	_	_	_	O
13	,	_	,	_	,	27	_	_	_	_	_	_	_	O
14	see	_	see	_	VBP	27	_	_	_	_	_	_	_	O
15	the	_	the	_	DT	27	_	_	_	_	_	_	_	O
16	section	_	section	_	NN	27	_	_	_	_	_	section.n	Part_whole	S-Part
17	on	_	on	_	IN	27	_	_	_	_	_	_	_	B-Whole
18	bariatric	_	UNK	_	JJ	27	_	_	_	_	_	_	_	I-Whole
19	surgery	_	UNK	_	NN	27	_	_	_	_	_	_	_	I-Whole
20	for	_	for	_	IN	27	_	_	_	_	_	_	_	O
21	people	_	people	_	NNS	27	_	_	_	_	_	_	_	O
22	with	_	with	_	IN	27	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	JJ	27	_	_	_	_	_	_	_	O
24	type	_	type	_	NN	27	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	27	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	27	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	27	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	27	_	_	_	_	_	_	_	O
29	nice	_	UNK	_	NNP	27	_	_	_	_	_	_	_	O
30	guideline	_	guideline	_	NN	27	_	_	_	_	_	_	_	O
31	on	_	on	_	IN	27	_	_	_	_	_	_	_	O
32	obesity	_	obesity	_	NN	27	_	_	_	_	_	_	_	O
33	.	_	.	_	.	27	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	27	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	27	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	27	_	_	_	_	_	_	_	O
4	bariatric	_	UNK	_	JJ	27	_	_	_	_	_	_	_	O
5	surgery	_	UNK	_	NN	27	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	27	_	_	_	_	_	_	_	O
7	people	_	people	_	NNS	27	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	27	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	JJ	27	_	_	_	_	_	_	_	O
10	type	_	type	_	NN	27	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	27	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	27	_	_	_	_	_	_	_	O
13	,	_	,	_	,	27	_	_	_	_	_	_	_	O
14	see	_	see	_	VBP	27	_	_	_	_	_	_	_	O
15	the	_	the	_	DT	27	_	_	_	_	_	_	_	O
16	section	_	section	_	NN	27	_	_	_	_	_	_	_	O
17	on	_	on	_	IN	27	_	_	_	_	_	_	_	O
18	bariatric	_	UNK	_	JJ	27	_	_	_	_	_	_	_	O
19	surgery	_	UNK	_	NN	27	_	_	_	_	_	_	_	O
20	for	_	for	_	IN	27	_	_	_	_	_	_	_	O
21	people	_	people	_	NNS	27	_	_	_	_	_	people.n	People	S-Person
22	with	_	with	_	IN	27	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	JJ	27	_	_	_	_	_	_	_	O
24	type	_	type	_	NN	27	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	27	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	27	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	27	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	27	_	_	_	_	_	_	_	O
29	nice	_	UNK	_	NNP	27	_	_	_	_	_	_	_	O
30	guideline	_	guideline	_	NN	27	_	_	_	_	_	_	_	O
31	on	_	on	_	IN	27	_	_	_	_	_	_	_	O
32	obesity	_	obesity	_	NN	27	_	_	_	_	_	_	_	O
33	.	_	.	_	.	27	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	27	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	27	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	27	_	_	_	_	_	_	_	O
4	bariatric	_	UNK	_	JJ	27	_	_	_	_	_	_	_	O
5	surgery	_	UNK	_	NN	27	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	27	_	_	_	_	_	_	_	O
7	people	_	people	_	NNS	27	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	27	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	JJ	27	_	_	_	_	_	_	_	O
10	type	_	type	_	NN	27	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	27	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	27	_	_	_	_	_	_	_	O
13	,	_	,	_	,	27	_	_	_	_	_	_	_	O
14	see	_	see	_	VBP	27	_	_	_	_	_	_	_	O
15	the	_	the	_	DT	27	_	_	_	_	_	_	_	O
16	section	_	section	_	NN	27	_	_	_	_	_	_	_	O
17	on	_	on	_	IN	27	_	_	_	_	_	_	_	O
18	bariatric	_	UNK	_	JJ	27	_	_	_	_	_	_	_	O
19	surgery	_	UNK	_	NN	27	_	_	_	_	_	_	_	O
20	for	_	for	_	IN	27	_	_	_	_	_	_	_	O
21	people	_	people	_	NNS	27	_	_	_	_	_	_	_	O
22	with	_	with	_	IN	27	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	JJ	27	_	_	_	_	_	_	_	S-Type_property
24	type	_	type	_	NN	27	_	_	_	_	_	type.n	Type	S-Subtype
25	2	_	2	_	CD	27	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	27	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	27	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	27	_	_	_	_	_	_	_	O
29	nice	_	UNK	_	NNP	27	_	_	_	_	_	_	_	O
30	guideline	_	guideline	_	NN	27	_	_	_	_	_	_	_	O
31	on	_	on	_	IN	27	_	_	_	_	_	_	_	O
32	obesity	_	obesity	_	NN	27	_	_	_	_	_	_	_	O
33	.	_	.	_	.	27	_	_	_	_	_	_	_	O

1	measure	_	UNK	_	NN	28	_	_	_	_	_	_	_	B-Speaker
2	blood	_	blood	_	NN	28	_	_	_	_	_	_	_	I-Speaker
3	pressure	_	pressure	_	NN	28	_	_	_	_	_	pressure.n	Attempt_suasion	O
4	at	_	at	_	IN	28	_	_	_	_	_	_	_	O
5	least	_	least	_	JJS	28	_	_	_	_	_	_	_	O
6	annually	_	annually	_	RB	28	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	28	_	_	_	_	_	_	_	O
8	an	_	an	_	DT	28	_	_	_	_	_	_	_	O
9	adult	_	adult	_	NN	28	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	28	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	28	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	28	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	28	_	_	_	_	_	_	_	O
14	without	_	without	_	IN	28	_	_	_	_	_	_	_	O
15	previously	_	previously	_	RB	28	_	_	_	_	_	_	_	O
16	diagnosed	_	UNK	_	VBN	28	_	_	_	_	_	_	_	O
17	hypertension	_	UNK	_	NN	28	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	28	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	28	_	_	_	_	_	_	_	O
20	disease	_	disease	_	NN	28	_	_	_	_	_	_	_	O

1	measure	_	UNK	_	NN	28	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	28	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	28	_	_	_	_	_	_	_	O
4	at	_	at	_	IN	28	_	_	_	_	_	_	_	O
5	least	_	least	_	JJS	28	_	_	_	_	_	_	_	O
6	annually	_	annually	_	RB	28	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	28	_	_	_	_	_	_	_	O
8	an	_	an	_	DT	28	_	_	_	_	_	_	_	O
9	adult	_	adult	_	NN	28	_	_	_	_	_	adult.n	People_by_age	S-Person
10	with	_	with	_	IN	28	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	28	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	28	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	28	_	_	_	_	_	_	_	O
14	without	_	without	_	IN	28	_	_	_	_	_	_	_	O
15	previously	_	previously	_	RB	28	_	_	_	_	_	_	_	O
16	diagnosed	_	UNK	_	VBN	28	_	_	_	_	_	_	_	O
17	hypertension	_	UNK	_	NN	28	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	28	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	28	_	_	_	_	_	_	_	O
20	disease	_	disease	_	NN	28	_	_	_	_	_	_	_	O

1	measure	_	UNK	_	NN	28	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	28	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	28	_	_	_	_	_	_	_	O
4	at	_	at	_	IN	28	_	_	_	_	_	_	_	O
5	least	_	least	_	JJS	28	_	_	_	_	_	_	_	O
6	annually	_	annually	_	RB	28	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	28	_	_	_	_	_	_	_	O
8	an	_	an	_	DT	28	_	_	_	_	_	_	_	O
9	adult	_	adult	_	NN	28	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	28	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	28	_	_	_	_	_	type.n	Type	S-Subtype
12	2	_	2	_	CD	28	_	_	_	_	_	_	_	B-Category
13	diabetes	_	UNK	_	NNS	28	_	_	_	_	_	_	_	I-Category
14	without	_	without	_	IN	28	_	_	_	_	_	_	_	O
15	previously	_	previously	_	RB	28	_	_	_	_	_	_	_	O
16	diagnosed	_	UNK	_	VBN	28	_	_	_	_	_	_	_	O
17	hypertension	_	UNK	_	NN	28	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	28	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	28	_	_	_	_	_	_	_	O
20	disease	_	disease	_	NN	28	_	_	_	_	_	_	_	O

1	measure	_	UNK	_	NN	28	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	28	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	28	_	_	_	_	_	_	_	O
4	at	_	at	_	IN	28	_	_	_	_	_	_	_	O
5	least	_	least	_	JJS	28	_	_	_	_	_	_	_	O
6	annually	_	annually	_	RB	28	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	28	_	_	_	_	_	_	_	O
8	an	_	an	_	DT	28	_	_	_	_	_	_	_	O
9	adult	_	adult	_	NN	28	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	28	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	28	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	28	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	28	_	_	_	_	_	_	_	O
14	without	_	without	_	IN	28	_	_	_	_	_	_	_	O
15	previously	_	previously	_	RB	28	_	_	_	_	_	_	_	O
16	diagnosed	_	UNK	_	VBN	28	_	_	_	_	_	_	_	O
17	hypertension	_	UNK	_	NN	28	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	28	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	28	_	_	_	_	_	_	_	O
20	disease	_	disease	_	NN	28	_	_	_	_	_	disease.n	Medical_conditions	S-Ailment

1	offer	_	UNK	_	NN	29	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	29	_	_	_	_	_	_	_	O
3	reinforce	_	reinforce	_	VB	29	_	_	_	_	_	reinforce.v	Cause_change_of_strength	O
4	preventive	_	UNK	_	JJ	29	_	_	_	_	_	_	_	B-Patient
5	lifestyle	_	lifestyle	_	JJ	29	_	_	_	_	_	_	_	I-Patient
6	advice	_	advice	_	NN	29	_	_	_	_	_	_	_	I-Patient
7	.	_	.	_	.	29	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	30	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	30	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	30	_	_	_	_	_	adult.n	People_by_age	S-Person
4	with	_	with	_	IN	30	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	30	_	_	_	_	_	_	_	O
6	2	_	2	_	CD	30	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	30	_	_	_	_	_	_	_	O
8	on	_	on	_	IN	30	_	_	_	_	_	_	_	O
9	antihypertensive	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	30	_	_	_	_	_	_	_	O
11	treatment	_	treatment	_	NN	30	_	_	_	_	_	_	_	O
12	when	_	when	_	WRB	30	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	VBZ	30	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	30	_	_	_	_	_	_	_	O
15	diagnosed	_	UNK	_	VBN	30	_	_	_	_	_	_	_	O
16	,	_	,	_	,	30	_	_	_	_	_	_	_	O
17	review	_	review	_	VB	30	_	_	_	_	_	_	_	O
18	blood	_	blood	_	NN	30	_	_	_	_	_	_	_	O
19	pressure	_	pressure	_	NN	30	_	_	_	_	_	_	_	O
20	control	_	control	_	NN	30	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
22	medications	_	medication	_	NNS	30	_	_	_	_	_	_	_	O
23	used	_	use	_	VBN	30	_	_	_	_	_	_	_	O
24	.	_	.	_	.	30	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	30	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	30	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	30	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	30	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	30	_	_	_	_	_	type.n	Type	S-Subtype
6	2	_	2	_	CD	30	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	30	_	_	_	_	_	_	_	O
8	on	_	on	_	IN	30	_	_	_	_	_	_	_	O
9	antihypertensive	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	30	_	_	_	_	_	_	_	O
11	treatment	_	treatment	_	NN	30	_	_	_	_	_	_	_	O
12	when	_	when	_	WRB	30	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	VBZ	30	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	30	_	_	_	_	_	_	_	O
15	diagnosed	_	UNK	_	VBN	30	_	_	_	_	_	_	_	O
16	,	_	,	_	,	30	_	_	_	_	_	_	_	O
17	review	_	review	_	VB	30	_	_	_	_	_	_	_	O
18	blood	_	blood	_	NN	30	_	_	_	_	_	_	_	O
19	pressure	_	pressure	_	NN	30	_	_	_	_	_	_	_	O
20	control	_	control	_	NN	30	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
22	medications	_	medication	_	NNS	30	_	_	_	_	_	_	_	O
23	used	_	use	_	VBN	30	_	_	_	_	_	_	_	O
24	.	_	.	_	.	30	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	30	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	30	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	30	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	30	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	30	_	_	_	_	_	_	_	O
6	2	_	2	_	CD	30	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	30	_	_	_	_	_	_	_	O
8	on	_	on	_	IN	30	_	_	_	_	_	_	_	O
9	antihypertensive	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	30	_	_	_	_	_	_	_	O
11	treatment	_	treatment	_	NN	30	_	_	_	_	_	_	_	O
12	when	_	when	_	WRB	30	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	VBZ	30	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	30	_	_	_	_	_	_	_	O
15	diagnosed	_	UNK	_	VBN	30	_	_	_	_	_	_	_	O
16	,	_	,	_	,	30	_	_	_	_	_	_	_	O
17	review	_	review	_	VB	30	_	_	_	_	_	_	_	O
18	blood	_	blood	_	NN	30	_	_	_	_	_	_	_	S-Speaker
19	pressure	_	pressure	_	NN	30	_	_	_	_	_	pressure.n	Attempt_suasion	O
20	control	_	control	_	NN	30	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
22	medications	_	medication	_	NNS	30	_	_	_	_	_	_	_	O
23	used	_	use	_	VBN	30	_	_	_	_	_	_	_	O
24	.	_	.	_	.	30	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	30	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	30	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	30	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	30	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	30	_	_	_	_	_	_	_	O
6	2	_	2	_	CD	30	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	30	_	_	_	_	_	_	_	O
8	on	_	on	_	IN	30	_	_	_	_	_	_	_	O
9	antihypertensive	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	30	_	_	_	_	_	_	_	O
11	treatment	_	treatment	_	NN	30	_	_	_	_	_	_	_	O
12	when	_	when	_	WRB	30	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	VBZ	30	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	30	_	_	_	_	_	_	_	O
15	diagnosed	_	UNK	_	VBN	30	_	_	_	_	_	_	_	O
16	,	_	,	_	,	30	_	_	_	_	_	_	_	O
17	review	_	review	_	VB	30	_	_	_	_	_	_	_	O
18	blood	_	blood	_	NN	30	_	_	_	_	_	_	_	B-Instrument
19	pressure	_	pressure	_	NN	30	_	_	_	_	_	_	_	I-Instrument
20	control	_	control	_	NN	30	_	_	_	_	_	_	_	I-Instrument
21	and	_	and	_	CC	30	_	_	_	_	_	_	_	I-Instrument
22	medications	_	medication	_	NNS	30	_	_	_	_	_	_	_	I-Instrument
23	used	_	use	_	VBN	30	_	_	_	_	_	use.v	Using	O
24	.	_	.	_	.	30	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	31	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	31	_	_	_	_	_	pressure.n	Attempt_suasion	O
4	measurements	_	measurement	_	NNS	31	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	31	_	_	_	_	_	_	_	O
6	:	_	:	_	:	31	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	31	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	31	_	_	_	_	_	_	_	O
9	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
11	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
16	mmhg	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	31	_	_	_	_	_	_	_	O
18	months	_	month	_	NNS	31	_	_	_	_	_	_	_	O
19	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
21	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
26	mmhg	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
27	2	_	2	_	CD	31	_	_	_	_	_	_	_	O
28	months	_	month	_	NNS	31	_	_	_	_	_	_	_	O
29	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
31	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
32	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	31	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	31	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	31	_	_	_	_	_	_	_	O
39	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
40	kidney	_	UNK	_	NN	31	_	_	_	_	_	_	_	O
41	,	_	,	_	,	31	_	_	_	_	_	_	_	O
42	eye	_	eye	_	NN	31	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	31	_	_	_	_	_	_	_	O
44	cerebrovascular	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
45	damage	_	damage	_	NN	31	_	_	_	_	_	_	_	O
46	.	_	.	_	.	31	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	31	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
4	measurements	_	measurement	_	NNS	31	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	31	_	_	_	_	_	_	_	O
6	:	_	:	_	:	31	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	31	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	31	_	_	_	_	_	month.n	Calendric_unit	S-Unit
9	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
11	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
16	mmhg	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	31	_	_	_	_	_	_	_	O
18	months	_	month	_	NNS	31	_	_	_	_	_	_	_	O
19	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
21	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
26	mmhg	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
27	2	_	2	_	CD	31	_	_	_	_	_	_	_	O
28	months	_	month	_	NNS	31	_	_	_	_	_	_	_	O
29	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
31	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
32	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	31	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	31	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	31	_	_	_	_	_	_	_	O
39	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
40	kidney	_	UNK	_	NN	31	_	_	_	_	_	_	_	O
41	,	_	,	_	,	31	_	_	_	_	_	_	_	O
42	eye	_	eye	_	NN	31	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	31	_	_	_	_	_	_	_	O
44	cerebrovascular	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
45	damage	_	damage	_	NN	31	_	_	_	_	_	_	_	O
46	.	_	.	_	.	31	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	31	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
4	measurements	_	measurement	_	NNS	31	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	31	_	_	_	_	_	_	_	O
6	:	_	:	_	:	31	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	31	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	31	_	_	_	_	_	_	_	O
9	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	S-Speaker
11	pressure	_	pressure	_	NN	31	_	_	_	_	_	pressure.n	Attempt_suasion	O
12	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
16	mmhg	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	31	_	_	_	_	_	_	_	O
18	months	_	month	_	NNS	31	_	_	_	_	_	_	_	O
19	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
21	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
26	mmhg	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
27	2	_	2	_	CD	31	_	_	_	_	_	_	_	O
28	months	_	month	_	NNS	31	_	_	_	_	_	_	_	O
29	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
31	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
32	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	31	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	31	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	31	_	_	_	_	_	_	_	O
39	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
40	kidney	_	UNK	_	NN	31	_	_	_	_	_	_	_	O
41	,	_	,	_	,	31	_	_	_	_	_	_	_	O
42	eye	_	eye	_	NN	31	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	31	_	_	_	_	_	_	_	O
44	cerebrovascular	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
45	damage	_	damage	_	NN	31	_	_	_	_	_	_	_	O
46	.	_	.	_	.	31	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	31	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
4	measurements	_	measurement	_	NNS	31	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	31	_	_	_	_	_	_	_	O
6	:	_	:	_	:	31	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	31	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	31	_	_	_	_	_	_	_	O
9	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
11	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	B-Relative_time
16	mmhg	_	UNK	_	JJ	31	_	_	_	_	_	_	_	I-Relative_time
17	2	_	2	_	CD	31	_	_	_	_	_	_	_	I-Relative_time
18	months	_	month	_	NNS	31	_	_	_	_	_	month.n	Calendric_unit	S-Unit
19	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
21	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
26	mmhg	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
27	2	_	2	_	CD	31	_	_	_	_	_	_	_	O
28	months	_	month	_	NNS	31	_	_	_	_	_	_	_	O
29	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
31	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
32	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	31	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	31	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	31	_	_	_	_	_	_	_	O
39	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
40	kidney	_	UNK	_	NN	31	_	_	_	_	_	_	_	O
41	,	_	,	_	,	31	_	_	_	_	_	_	_	O
42	eye	_	eye	_	NN	31	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	31	_	_	_	_	_	_	_	O
44	cerebrovascular	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
45	damage	_	damage	_	NN	31	_	_	_	_	_	_	_	O
46	.	_	.	_	.	31	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	31	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
4	measurements	_	measurement	_	NNS	31	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	31	_	_	_	_	_	_	_	O
6	:	_	:	_	:	31	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	31	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	31	_	_	_	_	_	_	_	O
9	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
11	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
16	mmhg	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	31	_	_	_	_	_	_	_	O
18	months	_	month	_	NNS	31	_	_	_	_	_	_	_	O
19	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	S-Speaker
21	pressure	_	pressure	_	NN	31	_	_	_	_	_	pressure.n	Attempt_suasion	O
22	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
26	mmhg	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
27	2	_	2	_	CD	31	_	_	_	_	_	_	_	O
28	months	_	month	_	NNS	31	_	_	_	_	_	_	_	O
29	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
31	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
32	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	31	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	31	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	31	_	_	_	_	_	_	_	O
39	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
40	kidney	_	UNK	_	NN	31	_	_	_	_	_	_	_	O
41	,	_	,	_	,	31	_	_	_	_	_	_	_	O
42	eye	_	eye	_	NN	31	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	31	_	_	_	_	_	_	_	O
44	cerebrovascular	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
45	damage	_	damage	_	NN	31	_	_	_	_	_	_	_	O
46	.	_	.	_	.	31	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	31	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
4	measurements	_	measurement	_	NNS	31	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	31	_	_	_	_	_	_	_	O
6	:	_	:	_	:	31	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	31	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	31	_	_	_	_	_	_	_	O
9	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
11	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
16	mmhg	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	31	_	_	_	_	_	_	_	O
18	months	_	month	_	NNS	31	_	_	_	_	_	_	_	O
19	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
21	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	B-Relative_time
26	mmhg	_	UNK	_	JJ	31	_	_	_	_	_	_	_	I-Relative_time
27	2	_	2	_	CD	31	_	_	_	_	_	_	_	I-Relative_time
28	months	_	month	_	NNS	31	_	_	_	_	_	month.n	Calendric_unit	S-Unit
29	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
31	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
32	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	31	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	31	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	31	_	_	_	_	_	_	_	O
39	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
40	kidney	_	UNK	_	NN	31	_	_	_	_	_	_	_	O
41	,	_	,	_	,	31	_	_	_	_	_	_	_	O
42	eye	_	eye	_	NN	31	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	31	_	_	_	_	_	_	_	O
44	cerebrovascular	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
45	damage	_	damage	_	NN	31	_	_	_	_	_	_	_	O
46	.	_	.	_	.	31	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	31	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
4	measurements	_	measurement	_	NNS	31	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	31	_	_	_	_	_	_	_	O
6	:	_	:	_	:	31	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	31	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	31	_	_	_	_	_	_	_	O
9	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
11	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
16	mmhg	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	31	_	_	_	_	_	_	_	O
18	months	_	month	_	NNS	31	_	_	_	_	_	_	_	O
19	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
21	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
26	mmhg	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
27	2	_	2	_	CD	31	_	_	_	_	_	_	_	O
28	months	_	month	_	NNS	31	_	_	_	_	_	_	_	O
29	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	S-Speaker
31	pressure	_	pressure	_	NN	31	_	_	_	_	_	pressure.n	Attempt_suasion	O
32	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	31	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	31	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	31	_	_	_	_	_	_	_	O
39	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
40	kidney	_	UNK	_	NN	31	_	_	_	_	_	_	_	O
41	,	_	,	_	,	31	_	_	_	_	_	_	_	O
42	eye	_	eye	_	NN	31	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	31	_	_	_	_	_	_	_	O
44	cerebrovascular	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
45	damage	_	damage	_	NN	31	_	_	_	_	_	_	_	O
46	.	_	.	_	.	31	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	31	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
4	measurements	_	measurement	_	NNS	31	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	31	_	_	_	_	_	_	_	O
6	:	_	:	_	:	31	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	31	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	31	_	_	_	_	_	_	_	O
9	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
11	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
16	mmhg	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	31	_	_	_	_	_	_	_	O
18	months	_	month	_	NNS	31	_	_	_	_	_	_	_	O
19	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
21	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
26	mmhg	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
27	2	_	2	_	CD	31	_	_	_	_	_	_	_	O
28	months	_	month	_	NNS	31	_	_	_	_	_	_	_	O
29	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
31	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
32	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	31	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	31	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	31	_	_	_	_	_	there.adv	Locative_relation	S-Figure
39	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	B-Ground
40	kidney	_	UNK	_	NN	31	_	_	_	_	_	_	_	I-Ground
41	,	_	,	_	,	31	_	_	_	_	_	_	_	I-Ground
42	eye	_	eye	_	NN	31	_	_	_	_	_	_	_	I-Ground
43	or	_	or	_	CC	31	_	_	_	_	_	_	_	I-Ground
44	cerebrovascular	_	UNK	_	JJ	31	_	_	_	_	_	_	_	I-Ground
45	damage	_	damage	_	NN	31	_	_	_	_	_	_	_	I-Ground
46	.	_	.	_	.	31	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	31	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
4	measurements	_	measurement	_	NNS	31	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	31	_	_	_	_	_	_	_	O
6	:	_	:	_	:	31	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	31	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	31	_	_	_	_	_	_	_	O
9	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
11	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
16	mmhg	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	31	_	_	_	_	_	_	_	O
18	months	_	month	_	NNS	31	_	_	_	_	_	_	_	O
19	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
21	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
26	mmhg	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
27	2	_	2	_	CD	31	_	_	_	_	_	_	_	O
28	months	_	month	_	NNS	31	_	_	_	_	_	_	_	O
29	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
31	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
32	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	31	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	31	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	31	_	_	_	_	_	_	_	O
39	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
40	kidney	_	UNK	_	NN	31	_	_	_	_	_	_	_	O
41	,	_	,	_	,	31	_	_	_	_	_	_	_	O
42	eye	_	eye	_	NN	31	_	_	_	_	_	eye.n	Body_parts	S-Body_part
43	or	_	or	_	CC	31	_	_	_	_	_	_	_	O
44	cerebrovascular	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
45	damage	_	damage	_	NN	31	_	_	_	_	_	_	_	O
46	.	_	.	_	.	31	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	31	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
4	measurements	_	measurement	_	NNS	31	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	31	_	_	_	_	_	_	_	O
6	:	_	:	_	:	31	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	31	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	31	_	_	_	_	_	_	_	O
9	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
11	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
16	mmhg	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	31	_	_	_	_	_	_	_	O
18	months	_	month	_	NNS	31	_	_	_	_	_	_	_	O
19	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
21	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
26	mmhg	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
27	2	_	2	_	CD	31	_	_	_	_	_	_	_	O
28	months	_	month	_	NNS	31	_	_	_	_	_	_	_	O
29	if	_	if	_	IN	31	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	31	_	_	_	_	_	_	_	O
31	pressure	_	pressure	_	NN	31	_	_	_	_	_	_	_	O
32	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	31	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	31	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	31	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	31	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	31	_	_	_	_	_	_	_	O
39	is	_	be	_	VBZ	31	_	_	_	_	_	_	_	O
40	kidney	_	UNK	_	NN	31	_	_	_	_	_	_	_	O
41	,	_	,	_	,	31	_	_	_	_	_	_	_	O
42	eye	_	eye	_	NN	31	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	31	_	_	_	_	_	_	_	O
44	cerebrovascular	_	UNK	_	JJ	31	_	_	_	_	_	_	_	S-Patient
45	damage	_	damage	_	NN	31	_	_	_	_	_	damage.n	Damaging	O
46	.	_	.	_	.	31	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	NNP	32	_	_	_	_	_	provide.v	Supply	O
2	lifestyle	_	lifestyle	_	JJ	32	_	_	_	_	_	_	_	B-Theme
3	advice	_	advice	_	NN	32	_	_	_	_	_	_	_	I-Theme
4	(	_	(	_	(	32	_	_	_	_	_	_	_	O
5	see	_	see	_	VB	32	_	_	_	_	_	_	_	O
6	section	_	section	_	NN	32	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	32	_	_	_	_	_	_	_	O
8	this	_	this	_	DT	32	_	_	_	_	_	_	_	O
9	guideline	_	guideline	_	NN	32	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	32	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	32	_	_	_	_	_	_	_	O
12	lifestyle	_	lifestyle	_	JJ	32	_	_	_	_	_	_	_	O
13	interventions	_	UNK	_	NNS	32	_	_	_	_	_	_	_	O
14	section	_	section	_	NN	32	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	32	_	_	_	_	_	_	_	O
16	hypertension	_	UNK	_	NN	32	_	_	_	_	_	_	_	O
17	in	_	in	_	IN	32	_	_	_	_	_	_	_	O
18	adults	_	adult	_	NNS	32	_	_	_	_	_	_	_	O
19	[	_	[	_	JJ	32	_	_	_	_	_	_	_	O
20	nice	_	UNK	_	NNP	32	_	_	_	_	_	_	_	O
21	guideline	_	guideline	_	NN	32	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NNP	32	_	_	_	_	_	_	_	O
23	]	_	]	_	NNP	32	_	_	_	_	_	_	_	O
24	)	_	)	_	)	32	_	_	_	_	_	_	_	O
25	if	_	if	_	IN	32	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	32	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	NNP	32	_	_	_	_	_	_	_	O
2	lifestyle	_	lifestyle	_	JJ	32	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	32	_	_	_	_	_	_	_	O
4	(	_	(	_	(	32	_	_	_	_	_	_	_	O
5	see	_	see	_	VB	32	_	_	_	_	_	_	_	O
6	section	_	section	_	NN	32	_	_	_	_	_	section.n	Part_whole	S-Part
7	in	_	in	_	IN	32	_	_	_	_	_	_	_	O
8	this	_	this	_	DT	32	_	_	_	_	_	_	_	O
9	guideline	_	guideline	_	NN	32	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	32	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	32	_	_	_	_	_	_	_	O
12	lifestyle	_	lifestyle	_	JJ	32	_	_	_	_	_	_	_	O
13	interventions	_	UNK	_	NNS	32	_	_	_	_	_	_	_	O
14	section	_	section	_	NN	32	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	32	_	_	_	_	_	_	_	O
16	hypertension	_	UNK	_	NN	32	_	_	_	_	_	_	_	O
17	in	_	in	_	IN	32	_	_	_	_	_	_	_	O
18	adults	_	adult	_	NNS	32	_	_	_	_	_	_	_	O
19	[	_	[	_	JJ	32	_	_	_	_	_	_	_	O
20	nice	_	UNK	_	NNP	32	_	_	_	_	_	_	_	O
21	guideline	_	guideline	_	NN	32	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NNP	32	_	_	_	_	_	_	_	O
23	]	_	]	_	NNP	32	_	_	_	_	_	_	_	O
24	)	_	)	_	)	32	_	_	_	_	_	_	_	O
25	if	_	if	_	IN	32	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	32	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	NNP	32	_	_	_	_	_	_	_	O
2	lifestyle	_	lifestyle	_	JJ	32	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	32	_	_	_	_	_	_	_	O
4	(	_	(	_	(	32	_	_	_	_	_	_	_	O
5	see	_	see	_	VB	32	_	_	_	_	_	_	_	O
6	section	_	section	_	NN	32	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	32	_	_	_	_	_	_	_	O
8	this	_	this	_	DT	32	_	_	_	_	_	_	_	O
9	guideline	_	guideline	_	NN	32	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	32	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	32	_	_	_	_	_	_	_	O
12	lifestyle	_	lifestyle	_	JJ	32	_	_	_	_	_	_	_	O
13	interventions	_	UNK	_	NNS	32	_	_	_	_	_	_	_	S-Whole
14	section	_	section	_	NN	32	_	_	_	_	_	section.n	Part_whole	S-Part
15	in	_	in	_	IN	32	_	_	_	_	_	_	_	O
16	hypertension	_	UNK	_	NN	32	_	_	_	_	_	_	_	O
17	in	_	in	_	IN	32	_	_	_	_	_	_	_	O
18	adults	_	adult	_	NNS	32	_	_	_	_	_	_	_	O
19	[	_	[	_	JJ	32	_	_	_	_	_	_	_	O
20	nice	_	UNK	_	NNP	32	_	_	_	_	_	_	_	O
21	guideline	_	guideline	_	NN	32	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NNP	32	_	_	_	_	_	_	_	O
23	]	_	]	_	NNP	32	_	_	_	_	_	_	_	O
24	)	_	)	_	)	32	_	_	_	_	_	_	_	O
25	if	_	if	_	IN	32	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	32	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	NNP	32	_	_	_	_	_	_	_	O
2	lifestyle	_	lifestyle	_	JJ	32	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	32	_	_	_	_	_	_	_	O
4	(	_	(	_	(	32	_	_	_	_	_	_	_	O
5	see	_	see	_	VB	32	_	_	_	_	_	_	_	O
6	section	_	section	_	NN	32	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	32	_	_	_	_	_	_	_	O
8	this	_	this	_	DT	32	_	_	_	_	_	_	_	O
9	guideline	_	guideline	_	NN	32	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	32	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	32	_	_	_	_	_	_	_	O
12	lifestyle	_	lifestyle	_	JJ	32	_	_	_	_	_	_	_	O
13	interventions	_	UNK	_	NNS	32	_	_	_	_	_	_	_	O
14	section	_	section	_	NN	32	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	32	_	_	_	_	_	_	_	O
16	hypertension	_	UNK	_	NN	32	_	_	_	_	_	_	_	O
17	in	_	in	_	IN	32	_	_	_	_	_	_	_	O
18	adults	_	adult	_	NNS	32	_	_	_	_	_	adult.n	People_by_age	S-Person
19	[	_	[	_	JJ	32	_	_	_	_	_	_	_	O
20	nice	_	UNK	_	NNP	32	_	_	_	_	_	_	_	O
21	guideline	_	guideline	_	NN	32	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NNP	32	_	_	_	_	_	_	_	O
23	]	_	]	_	NNP	32	_	_	_	_	_	_	_	O
24	)	_	)	_	)	32	_	_	_	_	_	_	_	O
25	if	_	if	_	IN	32	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	32	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	33	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	33	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	33	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	33	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	33	_	_	_	_	_	_	_	O
6	:	_	:	_	:	33	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	33	_	_	_	_	_	_	_	O
8	(	_	(	_	(	33	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	33	_	_	_	_	_	_	_	O
10	)	_	)	_	)	33	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	33	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	33	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	33	_	_	_	_	_	_	_	O
14	)	_	)	_	)	33	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	33	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	33	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	33	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	33	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	33	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	33	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	33	_	_	_	_	_	_	_	O
8	(	_	(	_	(	33	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	33	_	_	_	_	_	_	_	O
10	)	_	)	_	)	33	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	33	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	33	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	33	_	_	_	_	_	_	_	O
14	)	_	)	_	)	33	_	_	_	_	_	_	_	O

1	african	_	African	_	JJ	35	_	_	_	_	_	_	_	O
2	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
3	caribbean	_	Caribbean	_	JJ	35	_	_	_	_	_	_	_	O
4	family	_	family	_	NN	35	_	_	_	_	_	family.n	Kinship	S-Relatives
5	origin	_	origin	_	NN	35	_	_	_	_	_	_	_	O
6	,	_	,	_	,	35	_	_	_	_	_	_	_	O
7	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
8	women	_	woman	_	NNS	35	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
10	whom	_	whom	_	WP	35	_	_	_	_	_	_	_	O
11	there	_	there	_	EX	35	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
14	possibility	_	possibility	_	NN	35	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	35	_	_	_	_	_	_	_	O
16	becoming	_	become	_	VBG	35	_	_	_	_	_	_	_	O
17	pregnant	_	pregnant	_	NN	35	_	_	_	_	_	_	_	O
18	.	_	.	_	.	35	_	_	_	_	_	_	_	O

1	african	_	African	_	JJ	35	_	_	_	_	_	_	_	B-Origin
2	or	_	or	_	CC	35	_	_	_	_	_	_	_	I-Origin
3	caribbean	_	Caribbean	_	JJ	35	_	_	_	_	_	_	_	I-Origin
4	family	_	family	_	NN	35	_	_	_	_	_	_	_	I-Origin
5	origin	_	origin	_	NN	35	_	_	_	_	_	origin.n	Origin	I-Origin
6	,	_	,	_	,	35	_	_	_	_	_	_	_	O
7	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
8	women	_	woman	_	NNS	35	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
10	whom	_	whom	_	WP	35	_	_	_	_	_	_	_	O
11	there	_	there	_	EX	35	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
14	possibility	_	possibility	_	NN	35	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	35	_	_	_	_	_	_	_	O
16	becoming	_	become	_	VBG	35	_	_	_	_	_	_	_	O
17	pregnant	_	pregnant	_	NN	35	_	_	_	_	_	_	_	O
18	.	_	.	_	.	35	_	_	_	_	_	_	_	O

1	african	_	African	_	JJ	35	_	_	_	_	_	_	_	O
2	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
3	caribbean	_	Caribbean	_	JJ	35	_	_	_	_	_	_	_	O
4	family	_	family	_	NN	35	_	_	_	_	_	_	_	O
5	origin	_	origin	_	NN	35	_	_	_	_	_	_	_	O
6	,	_	,	_	,	35	_	_	_	_	_	_	_	O
7	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
8	women	_	woman	_	NNS	35	_	_	_	_	_	woman.n	People	S-Person
9	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
10	whom	_	whom	_	WP	35	_	_	_	_	_	_	_	O
11	there	_	there	_	EX	35	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
14	possibility	_	possibility	_	NN	35	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	35	_	_	_	_	_	_	_	O
16	becoming	_	become	_	VBG	35	_	_	_	_	_	_	_	O
17	pregnant	_	pregnant	_	NN	35	_	_	_	_	_	_	_	O
18	.	_	.	_	.	35	_	_	_	_	_	_	_	O

1	african	_	African	_	JJ	35	_	_	_	_	_	_	_	O
2	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
3	caribbean	_	Caribbean	_	JJ	35	_	_	_	_	_	_	_	O
4	family	_	family	_	NN	35	_	_	_	_	_	_	_	O
5	origin	_	origin	_	NN	35	_	_	_	_	_	_	_	O
6	,	_	,	_	,	35	_	_	_	_	_	_	_	O
7	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
8	women	_	woman	_	NNS	35	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
10	whom	_	whom	_	WP	35	_	_	_	_	_	_	_	O
11	there	_	there	_	EX	35	_	_	_	_	_	there.adv	Locative_relation	S-Ground
12	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
14	possibility	_	possibility	_	NN	35	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	35	_	_	_	_	_	_	_	O
16	becoming	_	become	_	VBG	35	_	_	_	_	_	_	_	O
17	pregnant	_	pregnant	_	NN	35	_	_	_	_	_	_	_	O
18	.	_	.	_	.	35	_	_	_	_	_	_	_	O

1	african	_	African	_	JJ	35	_	_	_	_	_	_	_	O
2	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
3	caribbean	_	Caribbean	_	JJ	35	_	_	_	_	_	_	_	O
4	family	_	family	_	NN	35	_	_	_	_	_	_	_	O
5	origin	_	origin	_	NN	35	_	_	_	_	_	_	_	O
6	,	_	,	_	,	35	_	_	_	_	_	_	_	O
7	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
8	women	_	woman	_	NNS	35	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
10	whom	_	whom	_	WP	35	_	_	_	_	_	_	_	O
11	there	_	there	_	EX	35	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
14	possibility	_	possibility	_	NN	35	_	_	_	_	_	possibility.n	Alternatives	O
15	of	_	of	_	IN	35	_	_	_	_	_	_	_	B-Salient_entity
16	becoming	_	become	_	VBG	35	_	_	_	_	_	_	_	I-Salient_entity
17	pregnant	_	pregnant	_	NN	35	_	_	_	_	_	_	_	I-Salient_entity
18	.	_	.	_	.	35	_	_	_	_	_	_	_	O

1	african	_	African	_	JJ	35	_	_	_	_	_	_	_	O
2	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
3	caribbean	_	Caribbean	_	JJ	35	_	_	_	_	_	_	_	O
4	family	_	family	_	NN	35	_	_	_	_	_	_	_	O
5	origin	_	origin	_	NN	35	_	_	_	_	_	_	_	O
6	,	_	,	_	,	35	_	_	_	_	_	_	_	O
7	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
8	women	_	woman	_	NNS	35	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
10	whom	_	whom	_	WP	35	_	_	_	_	_	_	_	O
11	there	_	there	_	EX	35	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
14	possibility	_	possibility	_	NN	35	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	35	_	_	_	_	_	_	_	O
16	becoming	_	become	_	VBG	35	_	_	_	_	_	become.v	Becoming	O
17	pregnant	_	pregnant	_	NN	35	_	_	_	_	_	_	_	S-Final_category
18	.	_	.	_	.	35	_	_	_	_	_	_	_	O

1	caribbean	_	Caribbean	_	NNP	36	_	_	_	_	_	_	_	O
2	family	_	family	_	NN	36	_	_	_	_	_	family.n	Kinship	S-Alter
3	origin	_	origin	_	NN	36	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	36	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	36	_	_	_	_	_	_	_	O
6	an	_	an	_	DT	36	_	_	_	_	_	_	_	O
7	ace	_	UNK	_	NNP	36	_	_	_	_	_	_	_	O
8	inhibitor	_	UNK	_	NN	36	_	_	_	_	_	_	_	O
9	plus	_	plus	_	CC	36	_	_	_	_	_	_	_	O
10	either	_	either	_	CC	36	_	_	_	_	_	_	_	O
11	a	_	a	_	DT	36	_	_	_	_	_	_	_	O
12	diuretic	_	UNK	_	JJ	36	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	36	_	_	_	_	_	_	_	O
14	a	_	a	_	DT	36	_	_	_	_	_	_	_	O
15	generic	_	UNK	_	JJ	36	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NN	36	_	_	_	_	_	_	_	O
17	blocker	_	UNK	_	NN	36	_	_	_	_	_	_	_	O
18	.	_	.	_	.	36	_	_	_	_	_	_	_	O

1	caribbean	_	Caribbean	_	NNP	36	_	_	_	_	_	_	_	B-Entity
2	family	_	family	_	NN	36	_	_	_	_	_	_	_	I-Entity
3	origin	_	origin	_	NN	36	_	_	_	_	_	origin.n	Origin	S-Origin
4	should	_	should	_	MD	36	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	36	_	_	_	_	_	_	_	O
6	an	_	an	_	DT	36	_	_	_	_	_	_	_	O
7	ace	_	UNK	_	NNP	36	_	_	_	_	_	_	_	O
8	inhibitor	_	UNK	_	NN	36	_	_	_	_	_	_	_	O
9	plus	_	plus	_	CC	36	_	_	_	_	_	_	_	O
10	either	_	either	_	CC	36	_	_	_	_	_	_	_	O
11	a	_	a	_	DT	36	_	_	_	_	_	_	_	O
12	diuretic	_	UNK	_	JJ	36	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	36	_	_	_	_	_	_	_	O
14	a	_	a	_	DT	36	_	_	_	_	_	_	_	O
15	generic	_	UNK	_	JJ	36	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NN	36	_	_	_	_	_	_	_	O
17	blocker	_	UNK	_	NN	36	_	_	_	_	_	_	_	O
18	.	_	.	_	.	36	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	37	_	_	_	_	_	_	_	B-State_of_affairs
2	unk	_	UNK	_	JJ	37	_	_	_	_	_	_	_	I-State_of_affairs
3	blocker	_	UNK	_	NN	37	_	_	_	_	_	_	_	I-State_of_affairs
4	should	_	should	_	MD	37	_	_	_	_	_	should.v	Desirable_event	O
5	be	_	be	_	VB	37	_	_	_	_	_	_	_	B-State_of_affairs
6	the	_	the	_	DT	37	_	_	_	_	_	_	_	I-State_of_affairs
7	first-line	_	UNK	_	JJ	37	_	_	_	_	_	_	_	I-State_of_affairs
8	antihypertensive	_	UNK	_	JJ	37	_	_	_	_	_	_	_	I-State_of_affairs
9	drug	_	drug	_	NN	37	_	_	_	_	_	_	_	I-State_of_affairs
10	treatment	_	treatment	_	NN	37	_	_	_	_	_	_	_	I-State_of_affairs
11	for	_	for	_	IN	37	_	_	_	_	_	_	_	I-State_of_affairs
12	a	_	a	_	DT	37	_	_	_	_	_	_	_	I-State_of_affairs
13	woman	_	woman	_	NN	37	_	_	_	_	_	_	_	I-State_of_affairs
14	for	_	for	_	IN	37	_	_	_	_	_	_	_	I-State_of_affairs
15	whom	_	whom	_	WP	37	_	_	_	_	_	_	_	I-State_of_affairs
16	,	_	,	_	,	37	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	37	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	37	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	37	_	_	_	_	_	_	_	O
21	,	_	,	_	,	37	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	37	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	37	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	37	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	37	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	37	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	37	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	37	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	37	_	_	_	_	_	_	_	O
30	her	_	her	_	PRP$	37	_	_	_	_	_	_	_	O
31	becoming	_	become	_	VBG	37	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	37	_	_	_	_	_	_	_	O
33	.	_	.	_	.	37	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	37	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	37	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	37	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	37	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	37	_	_	_	_	_	_	_	S-Patient
10	treatment	_	treatment	_	NN	37	_	_	_	_	_	treatment.n	Cure	O
11	for	_	for	_	IN	37	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	37	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	37	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	37	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	37	_	_	_	_	_	_	_	O
16	,	_	,	_	,	37	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	37	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	37	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	37	_	_	_	_	_	_	_	O
21	,	_	,	_	,	37	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	37	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	37	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	37	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	37	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	37	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	37	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	37	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	37	_	_	_	_	_	_	_	O
30	her	_	her	_	PRP$	37	_	_	_	_	_	_	_	O
31	becoming	_	become	_	VBG	37	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	37	_	_	_	_	_	_	_	O
33	.	_	.	_	.	37	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	37	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	37	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	37	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	37	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	37	_	_	_	_	_	_	_	O
10	treatment	_	treatment	_	NN	37	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	37	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	37	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	37	_	_	_	_	_	woman.n	People	S-Person
14	for	_	for	_	IN	37	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	37	_	_	_	_	_	_	_	O
16	,	_	,	_	,	37	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	37	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	37	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	37	_	_	_	_	_	_	_	O
21	,	_	,	_	,	37	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	37	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	37	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	37	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	37	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	37	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	37	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	37	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	37	_	_	_	_	_	_	_	O
30	her	_	her	_	PRP$	37	_	_	_	_	_	_	_	O
31	becoming	_	become	_	VBG	37	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	37	_	_	_	_	_	_	_	O
33	.	_	.	_	.	37	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	37	_	_	_	_	_	_	_	B-Event
2	unk	_	UNK	_	JJ	37	_	_	_	_	_	_	_	I-Event
3	blocker	_	UNK	_	NN	37	_	_	_	_	_	_	_	I-Event
4	should	_	should	_	MD	37	_	_	_	_	_	_	_	I-Event
5	be	_	be	_	VB	37	_	_	_	_	_	_	_	I-Event
6	the	_	the	_	DT	37	_	_	_	_	_	_	_	I-Event
7	first-line	_	UNK	_	JJ	37	_	_	_	_	_	_	_	I-Event
8	antihypertensive	_	UNK	_	JJ	37	_	_	_	_	_	_	_	I-Event
9	drug	_	drug	_	NN	37	_	_	_	_	_	_	_	I-Event
10	treatment	_	treatment	_	NN	37	_	_	_	_	_	_	_	I-Event
11	for	_	for	_	IN	37	_	_	_	_	_	_	_	I-Event
12	a	_	a	_	DT	37	_	_	_	_	_	_	_	I-Event
13	woman	_	woman	_	NN	37	_	_	_	_	_	_	_	I-Event
14	for	_	for	_	IN	37	_	_	_	_	_	_	_	I-Event
15	whom	_	whom	_	WP	37	_	_	_	_	_	_	_	I-Event
16	,	_	,	_	,	37	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	37	_	_	_	_	_	after.prep	Time_vector	O
18	an	_	an	_	DT	37	_	_	_	_	_	_	_	B-Landmark_event
19	informed	_	UNK	_	JJ	37	_	_	_	_	_	_	_	I-Landmark_event
20	discussion	_	discussion	_	NN	37	_	_	_	_	_	_	_	I-Landmark_event
21	,	_	,	_	,	37	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	37	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	37	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	37	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	37	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	37	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	37	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	37	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	37	_	_	_	_	_	_	_	O
30	her	_	her	_	PRP$	37	_	_	_	_	_	_	_	O
31	becoming	_	become	_	VBG	37	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	37	_	_	_	_	_	_	_	O
33	.	_	.	_	.	37	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	37	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	37	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	37	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	37	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	37	_	_	_	_	_	_	_	O
10	treatment	_	treatment	_	NN	37	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	37	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	37	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	37	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	37	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	37	_	_	_	_	_	_	_	O
16	,	_	,	_	,	37	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	37	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	37	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	37	_	_	_	_	_	_	_	S-Depictive
20	discussion	_	discussion	_	NN	37	_	_	_	_	_	discussion.n	Discussion	O
21	,	_	,	_	,	37	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	37	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	37	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	37	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	37	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	37	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	37	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	37	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	37	_	_	_	_	_	_	_	O
30	her	_	her	_	PRP$	37	_	_	_	_	_	_	_	O
31	becoming	_	become	_	VBG	37	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	37	_	_	_	_	_	_	_	O
33	.	_	.	_	.	37	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	37	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	37	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	37	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	37	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	37	_	_	_	_	_	_	_	O
10	treatment	_	treatment	_	NN	37	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	37	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	37	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	37	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	37	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	37	_	_	_	_	_	_	_	O
16	,	_	,	_	,	37	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	37	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	37	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	37	_	_	_	_	_	_	_	O
21	,	_	,	_	,	37	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	37	_	_	_	_	_	_	_	S-Party_1
23	is	_	be	_	VBZ	37	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	37	_	_	_	_	_	agree.v	Make_agreement_on_action	O
25	there	_	there	_	EX	37	_	_	_	_	_	_	_	B-Obligation
26	is	_	be	_	VBZ	37	_	_	_	_	_	_	_	I-Obligation
27	a	_	a	_	DT	37	_	_	_	_	_	_	_	I-Obligation
28	possibility	_	possibility	_	NN	37	_	_	_	_	_	_	_	I-Obligation
29	of	_	of	_	IN	37	_	_	_	_	_	_	_	I-Obligation
30	her	_	her	_	PRP$	37	_	_	_	_	_	_	_	I-Obligation
31	becoming	_	become	_	VBG	37	_	_	_	_	_	_	_	I-Obligation
32	pregnant	_	pregnant	_	JJ	37	_	_	_	_	_	_	_	I-Obligation
33	.	_	.	_	.	37	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	37	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	37	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	37	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	37	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	37	_	_	_	_	_	_	_	O
10	treatment	_	treatment	_	NN	37	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	37	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	37	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	37	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	37	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	37	_	_	_	_	_	_	_	O
16	,	_	,	_	,	37	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	37	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	37	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	37	_	_	_	_	_	_	_	O
21	,	_	,	_	,	37	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	37	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	37	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	37	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	37	_	_	_	_	_	there.adv	Locative_relation	S-Ground
26	is	_	be	_	VBZ	37	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	37	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	37	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	37	_	_	_	_	_	_	_	O
30	her	_	her	_	PRP$	37	_	_	_	_	_	_	_	O
31	becoming	_	become	_	VBG	37	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	37	_	_	_	_	_	_	_	O
33	.	_	.	_	.	37	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	37	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	37	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	37	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	37	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	37	_	_	_	_	_	_	_	O
10	treatment	_	treatment	_	NN	37	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	37	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	37	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	37	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	37	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	37	_	_	_	_	_	_	_	O
16	,	_	,	_	,	37	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	37	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	37	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	37	_	_	_	_	_	_	_	O
21	,	_	,	_	,	37	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	37	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	37	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	37	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	37	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	37	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	37	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	37	_	_	_	_	_	possibility.n	Alternatives	O
29	of	_	of	_	IN	37	_	_	_	_	_	_	_	B-Salient_entity
30	her	_	her	_	PRP$	37	_	_	_	_	_	_	_	I-Salient_entity
31	becoming	_	become	_	VBG	37	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	37	_	_	_	_	_	_	_	O
33	.	_	.	_	.	37	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	37	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	37	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	37	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	37	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	37	_	_	_	_	_	_	_	O
10	treatment	_	treatment	_	NN	37	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	37	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	37	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	37	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	37	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	37	_	_	_	_	_	_	_	O
16	,	_	,	_	,	37	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	37	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	37	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	37	_	_	_	_	_	_	_	O
21	,	_	,	_	,	37	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	37	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	37	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	37	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	37	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	37	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	37	_	_	_	_	_	_	_	B-Entity
28	possibility	_	possibility	_	NN	37	_	_	_	_	_	_	_	I-Entity
29	of	_	of	_	IN	37	_	_	_	_	_	_	_	I-Entity
30	her	_	her	_	PRP$	37	_	_	_	_	_	_	_	I-Entity
31	becoming	_	become	_	VBG	37	_	_	_	_	_	become.v	Becoming	O
32	pregnant	_	pregnant	_	JJ	37	_	_	_	_	_	_	_	O
33	.	_	.	_	.	37	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	38	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	38	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	38	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	38	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	38	_	_	_	_	_	_	_	O
6	:	_	:	_	:	38	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	38	_	_	_	_	_	_	_	O
8	(	_	(	_	(	38	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	38	_	_	_	_	_	_	_	O
10	)	_	)	_	)	38	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	38	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	38	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	38	_	_	_	_	_	_	_	O
14	)	_	)	_	)	38	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	38	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	38	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	38	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	38	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	38	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	38	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	38	_	_	_	_	_	_	_	O
8	(	_	(	_	(	38	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	38	_	_	_	_	_	_	_	O
10	)	_	)	_	)	38	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	38	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	38	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	38	_	_	_	_	_	_	_	O
14	)	_	)	_	)	38	_	_	_	_	_	_	_	O

1	do	_	Do	_	MD	39	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	39	_	_	_	_	_	_	_	O
3	offer	_	offer	_	VB	39	_	_	_	_	_	_	_	O
4	antiplatelet	_	UNK	_	NN	39	_	_	_	_	_	_	_	S-Type
5	therapy	_	therapy	_	NN	39	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
6	(	_	(	_	(	39	_	_	_	_	_	_	_	O
7	aspirin	_	UNK	_	JJ	39	_	_	_	_	_	_	_	O
8	or	_	or	_	CC	39	_	_	_	_	_	_	_	O
9	clopidogrel	_	UNK	_	NN	39	_	_	_	_	_	_	_	O
10	)	_	)	_	)	39	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	39	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	39	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	39	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	39	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	39	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	39	_	_	_	_	_	_	_	O
17	without	_	without	_	IN	39	_	_	_	_	_	_	_	O
18	cardiovascular	_	UNK	_	JJ	39	_	_	_	_	_	_	_	O
19	disease	_	disease	_	NN	39	_	_	_	_	_	_	_	O
20	.	_	.	_	.	39	_	_	_	_	_	_	_	O

1	do	_	Do	_	MD	39	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	39	_	_	_	_	_	_	_	O
3	offer	_	offer	_	VB	39	_	_	_	_	_	_	_	O
4	antiplatelet	_	UNK	_	NN	39	_	_	_	_	_	_	_	O
5	therapy	_	therapy	_	NN	39	_	_	_	_	_	_	_	O
6	(	_	(	_	(	39	_	_	_	_	_	_	_	O
7	aspirin	_	UNK	_	JJ	39	_	_	_	_	_	_	_	O
8	or	_	or	_	CC	39	_	_	_	_	_	_	_	O
9	clopidogrel	_	UNK	_	NN	39	_	_	_	_	_	_	_	O
10	)	_	)	_	)	39	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	39	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	39	_	_	_	_	_	adult.n	People_by_age	S-Person
13	with	_	with	_	IN	39	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	39	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	39	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	39	_	_	_	_	_	_	_	O
17	without	_	without	_	IN	39	_	_	_	_	_	_	_	O
18	cardiovascular	_	UNK	_	JJ	39	_	_	_	_	_	_	_	O
19	disease	_	disease	_	NN	39	_	_	_	_	_	_	_	O
20	.	_	.	_	.	39	_	_	_	_	_	_	_	O

1	do	_	Do	_	MD	39	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	39	_	_	_	_	_	_	_	O
3	offer	_	offer	_	VB	39	_	_	_	_	_	_	_	O
4	antiplatelet	_	UNK	_	NN	39	_	_	_	_	_	_	_	O
5	therapy	_	therapy	_	NN	39	_	_	_	_	_	_	_	O
6	(	_	(	_	(	39	_	_	_	_	_	_	_	O
7	aspirin	_	UNK	_	JJ	39	_	_	_	_	_	_	_	O
8	or	_	or	_	CC	39	_	_	_	_	_	_	_	O
9	clopidogrel	_	UNK	_	NN	39	_	_	_	_	_	_	_	O
10	)	_	)	_	)	39	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	39	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	39	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	39	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	39	_	_	_	_	_	type.n	Type	S-Subtype
15	2	_	2	_	CD	39	_	_	_	_	_	_	_	B-Category
16	diabetes	_	UNK	_	NNS	39	_	_	_	_	_	_	_	I-Category
17	without	_	without	_	IN	39	_	_	_	_	_	_	_	O
18	cardiovascular	_	UNK	_	JJ	39	_	_	_	_	_	_	_	O
19	disease	_	disease	_	NN	39	_	_	_	_	_	_	_	O
20	.	_	.	_	.	39	_	_	_	_	_	_	_	O

1	do	_	Do	_	MD	39	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	39	_	_	_	_	_	_	_	O
3	offer	_	offer	_	VB	39	_	_	_	_	_	_	_	O
4	antiplatelet	_	UNK	_	NN	39	_	_	_	_	_	_	_	O
5	therapy	_	therapy	_	NN	39	_	_	_	_	_	_	_	O
6	(	_	(	_	(	39	_	_	_	_	_	_	_	O
7	aspirin	_	UNK	_	JJ	39	_	_	_	_	_	_	_	O
8	or	_	or	_	CC	39	_	_	_	_	_	_	_	O
9	clopidogrel	_	UNK	_	NN	39	_	_	_	_	_	_	_	O
10	)	_	)	_	)	39	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	39	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	39	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	39	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	39	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	39	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	39	_	_	_	_	_	_	_	O
17	without	_	without	_	IN	39	_	_	_	_	_	_	_	O
18	cardiovascular	_	UNK	_	JJ	39	_	_	_	_	_	_	_	O
19	disease	_	disease	_	NN	39	_	_	_	_	_	disease.n	Medical_conditions	S-Ailment
20	.	_	.	_	.	39	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	40	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	40	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	40	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
5	primary	_	primary	_	JJ	40	_	_	_	_	_	primary.a	First_rank	O
6	and	_	and	_	CC	40	_	_	_	_	_	_	_	O
7	secondary	_	secondary	_	JJ	40	_	_	_	_	_	_	_	O
8	prevention	_	prevention	_	NN	40	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	40	_	_	_	_	_	_	_	B-Item
10	cardiovascular	_	UNK	_	JJ	40	_	_	_	_	_	_	_	I-Item
11	disease	_	disease	_	NN	40	_	_	_	_	_	_	_	I-Item
12	in	_	in	_	IN	40	_	_	_	_	_	_	_	I-Item
13	adults	_	adult	_	NNS	40	_	_	_	_	_	_	_	I-Item
14	with	_	with	_	IN	40	_	_	_	_	_	_	_	I-Item
15	type	_	type	_	JJ	40	_	_	_	_	_	_	_	I-Item
16	2	_	2	_	CD	40	_	_	_	_	_	_	_	I-Item
17	diabetes	_	UNK	_	NNS	40	_	_	_	_	_	_	_	I-Item
18	,	_	,	_	,	40	_	_	_	_	_	_	_	O
19	see	_	see	_	VBP	40	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
21	nice	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
22	guidelines	_	guideline	_	NNS	40	_	_	_	_	_	_	_	O
23	on	_	on	_	IN	40	_	_	_	_	_	_	_	O
24	cardiovascular	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
25	disease	_	disease	_	NN	40	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	40	_	_	_	_	_	_	_	O
27	myocardial	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
28	infarction	_	UNK	_	NN	40	_	_	_	_	_	_	_	O
29	.	_	.	_	.	40	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	40	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	40	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	40	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
5	primary	_	primary	_	JJ	40	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	40	_	_	_	_	_	_	_	O
7	secondary	_	secondary	_	JJ	40	_	_	_	_	_	_	_	S-Manner
8	prevention	_	prevention	_	NN	40	_	_	_	_	_	prevention.n	Preventing_or_letting	O
9	of	_	of	_	IN	40	_	_	_	_	_	_	_	B-Event
10	cardiovascular	_	UNK	_	JJ	40	_	_	_	_	_	_	_	I-Event
11	disease	_	disease	_	NN	40	_	_	_	_	_	_	_	I-Event
12	in	_	in	_	IN	40	_	_	_	_	_	_	_	I-Event
13	adults	_	adult	_	NNS	40	_	_	_	_	_	_	_	I-Event
14	with	_	with	_	IN	40	_	_	_	_	_	_	_	I-Event
15	type	_	type	_	JJ	40	_	_	_	_	_	_	_	I-Event
16	2	_	2	_	CD	40	_	_	_	_	_	_	_	I-Event
17	diabetes	_	UNK	_	NNS	40	_	_	_	_	_	_	_	I-Event
18	,	_	,	_	,	40	_	_	_	_	_	_	_	O
19	see	_	see	_	VBP	40	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
21	nice	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
22	guidelines	_	guideline	_	NNS	40	_	_	_	_	_	_	_	O
23	on	_	on	_	IN	40	_	_	_	_	_	_	_	O
24	cardiovascular	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
25	disease	_	disease	_	NN	40	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	40	_	_	_	_	_	_	_	O
27	myocardial	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
28	infarction	_	UNK	_	NN	40	_	_	_	_	_	_	_	O
29	.	_	.	_	.	40	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	40	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	40	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	40	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
5	primary	_	primary	_	JJ	40	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	40	_	_	_	_	_	_	_	O
7	secondary	_	secondary	_	JJ	40	_	_	_	_	_	_	_	O
8	prevention	_	prevention	_	NN	40	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	40	_	_	_	_	_	_	_	O
10	cardiovascular	_	UNK	_	JJ	40	_	_	_	_	_	_	_	S-Patient
11	disease	_	disease	_	NN	40	_	_	_	_	_	disease.n	Medical_conditions	S-Ailment
12	in	_	in	_	IN	40	_	_	_	_	_	_	_	O
13	adults	_	adult	_	NNS	40	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	40	_	_	_	_	_	_	_	O
15	type	_	type	_	JJ	40	_	_	_	_	_	_	_	O
16	2	_	2	_	CD	40	_	_	_	_	_	_	_	O
17	diabetes	_	UNK	_	NNS	40	_	_	_	_	_	_	_	O
18	,	_	,	_	,	40	_	_	_	_	_	_	_	O
19	see	_	see	_	VBP	40	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
21	nice	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
22	guidelines	_	guideline	_	NNS	40	_	_	_	_	_	_	_	O
23	on	_	on	_	IN	40	_	_	_	_	_	_	_	O
24	cardiovascular	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
25	disease	_	disease	_	NN	40	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	40	_	_	_	_	_	_	_	O
27	myocardial	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
28	infarction	_	UNK	_	NN	40	_	_	_	_	_	_	_	O
29	.	_	.	_	.	40	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	40	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	40	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	40	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
5	primary	_	primary	_	JJ	40	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	40	_	_	_	_	_	_	_	O
7	secondary	_	secondary	_	JJ	40	_	_	_	_	_	_	_	O
8	prevention	_	prevention	_	NN	40	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	40	_	_	_	_	_	_	_	O
10	cardiovascular	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
11	disease	_	disease	_	NN	40	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	40	_	_	_	_	_	_	_	O
13	adults	_	adult	_	NNS	40	_	_	_	_	_	adult.n	People_by_age	S-Person
14	with	_	with	_	IN	40	_	_	_	_	_	_	_	O
15	type	_	type	_	JJ	40	_	_	_	_	_	_	_	O
16	2	_	2	_	CD	40	_	_	_	_	_	_	_	O
17	diabetes	_	UNK	_	NNS	40	_	_	_	_	_	_	_	O
18	,	_	,	_	,	40	_	_	_	_	_	_	_	O
19	see	_	see	_	VBP	40	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
21	nice	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
22	guidelines	_	guideline	_	NNS	40	_	_	_	_	_	_	_	O
23	on	_	on	_	IN	40	_	_	_	_	_	_	_	O
24	cardiovascular	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
25	disease	_	disease	_	NN	40	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	40	_	_	_	_	_	_	_	O
27	myocardial	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
28	infarction	_	UNK	_	NN	40	_	_	_	_	_	_	_	O
29	.	_	.	_	.	40	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	40	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	40	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	40	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
5	primary	_	primary	_	JJ	40	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	40	_	_	_	_	_	_	_	O
7	secondary	_	secondary	_	JJ	40	_	_	_	_	_	_	_	O
8	prevention	_	prevention	_	NN	40	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	40	_	_	_	_	_	_	_	O
10	cardiovascular	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
11	disease	_	disease	_	NN	40	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	40	_	_	_	_	_	_	_	O
13	adults	_	adult	_	NNS	40	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	40	_	_	_	_	_	_	_	O
15	type	_	type	_	JJ	40	_	_	_	_	_	type.n	Type	S-Subtype
16	2	_	2	_	CD	40	_	_	_	_	_	_	_	B-Category
17	diabetes	_	UNK	_	NNS	40	_	_	_	_	_	_	_	I-Category
18	,	_	,	_	,	40	_	_	_	_	_	_	_	O
19	see	_	see	_	VBP	40	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
21	nice	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
22	guidelines	_	guideline	_	NNS	40	_	_	_	_	_	_	_	O
23	on	_	on	_	IN	40	_	_	_	_	_	_	_	O
24	cardiovascular	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
25	disease	_	disease	_	NN	40	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	40	_	_	_	_	_	_	_	O
27	myocardial	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
28	infarction	_	UNK	_	NN	40	_	_	_	_	_	_	_	O
29	.	_	.	_	.	40	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	40	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	40	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	40	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
5	primary	_	primary	_	JJ	40	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	40	_	_	_	_	_	_	_	O
7	secondary	_	secondary	_	JJ	40	_	_	_	_	_	_	_	O
8	prevention	_	prevention	_	NN	40	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	40	_	_	_	_	_	_	_	O
10	cardiovascular	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
11	disease	_	disease	_	NN	40	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	40	_	_	_	_	_	_	_	O
13	adults	_	adult	_	NNS	40	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	40	_	_	_	_	_	_	_	O
15	type	_	type	_	JJ	40	_	_	_	_	_	_	_	O
16	2	_	2	_	CD	40	_	_	_	_	_	_	_	O
17	diabetes	_	UNK	_	NNS	40	_	_	_	_	_	_	_	O
18	,	_	,	_	,	40	_	_	_	_	_	_	_	O
19	see	_	see	_	VBP	40	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
21	nice	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
22	guidelines	_	guideline	_	NNS	40	_	_	_	_	_	_	_	O
23	on	_	on	_	IN	40	_	_	_	_	_	_	_	O
24	cardiovascular	_	UNK	_	JJ	40	_	_	_	_	_	_	_	S-Patient
25	disease	_	disease	_	NN	40	_	_	_	_	_	disease.n	Medical_conditions	S-Ailment
26	and	_	and	_	CC	40	_	_	_	_	_	_	_	O
27	myocardial	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
28	infarction	_	UNK	_	NN	40	_	_	_	_	_	_	_	O
29	.	_	.	_	.	40	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	42	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	42	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	42	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	42	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	42	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	42	_	_	_	_	_	_	_	O
7	,	_	,	_	,	42	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	42	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	42	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	42	_	_	_	_	_	_	_	O
12	:	_	:	_	:	42	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
14	intervals	_	interval	_	NNS	42	_	_	_	_	_	_	_	O
15	(	_	(	_	(	42	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	42	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	42	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	42	_	_	_	_	_	_	_	O
19	needs	_	need	_	NNS	42	_	_	_	_	_	_	_	O
20	)	_	)	_	)	42	_	_	_	_	_	_	_	O
21	,	_	,	_	,	42	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	42	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	42	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	42	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	42	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	42	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	42	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	42	_	_	_	_	_	_	_	O
32	once	_	once	_	IN	42	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	42	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	42	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	42	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	42	_	_	_	_	_	_	_	O
38	glucose	_	UNK	_	NN	42	_	_	_	_	_	_	_	O
39	lowering	_	lower	_	VBG	42	_	_	_	_	_	_	_	O
40	therapy	_	therapy	_	NN	42	_	_	_	_	_	_	_	O
41	are	_	be	_	VBP	42	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	42	_	_	_	_	_	_	_	O
43	.	_	.	_	.	42	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	42	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	42	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	42	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	42	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	42	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	42	_	_	_	_	_	_	_	I-Category
7	,	_	,	_	,	42	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	42	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	42	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	42	_	_	_	_	_	_	_	O
12	:	_	:	_	:	42	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
14	intervals	_	interval	_	NNS	42	_	_	_	_	_	_	_	O
15	(	_	(	_	(	42	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	42	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	42	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	42	_	_	_	_	_	_	_	O
19	needs	_	need	_	NNS	42	_	_	_	_	_	_	_	O
20	)	_	)	_	)	42	_	_	_	_	_	_	_	O
21	,	_	,	_	,	42	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	42	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	42	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	42	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	42	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	42	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	42	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	42	_	_	_	_	_	_	_	O
32	once	_	once	_	IN	42	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	42	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	42	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	42	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	42	_	_	_	_	_	_	_	O
38	glucose	_	UNK	_	NN	42	_	_	_	_	_	_	_	O
39	lowering	_	lower	_	VBG	42	_	_	_	_	_	_	_	O
40	therapy	_	therapy	_	NN	42	_	_	_	_	_	_	_	O
41	are	_	be	_	VBP	42	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	42	_	_	_	_	_	_	_	O
43	.	_	.	_	.	42	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	42	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	42	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	42	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	42	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	42	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	42	_	_	_	_	_	_	_	O
7	,	_	,	_	,	42	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	42	_	_	_	_	_	_	_	S-Rank
9	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	S-Item
10	levels	_	level	_	NNS	42	_	_	_	_	_	level.n	Rank	O
11	at	_	at	_	IN	42	_	_	_	_	_	_	_	O
12	:	_	:	_	:	42	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
14	intervals	_	interval	_	NNS	42	_	_	_	_	_	_	_	O
15	(	_	(	_	(	42	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	42	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	42	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	42	_	_	_	_	_	_	_	O
19	needs	_	need	_	NNS	42	_	_	_	_	_	_	_	O
20	)	_	)	_	)	42	_	_	_	_	_	_	_	O
21	,	_	,	_	,	42	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	42	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	42	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	42	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	42	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	42	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	42	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	42	_	_	_	_	_	_	_	O
32	once	_	once	_	IN	42	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	42	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	42	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	42	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	42	_	_	_	_	_	_	_	O
38	glucose	_	UNK	_	NN	42	_	_	_	_	_	_	_	O
39	lowering	_	lower	_	VBG	42	_	_	_	_	_	_	_	O
40	therapy	_	therapy	_	NN	42	_	_	_	_	_	_	_	O
41	are	_	be	_	VBP	42	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	42	_	_	_	_	_	_	_	O
43	.	_	.	_	.	42	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	42	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	42	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	42	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	42	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	42	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	42	_	_	_	_	_	_	_	O
7	,	_	,	_	,	42	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	42	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	42	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	42	_	_	_	_	_	_	_	O
12	:	_	:	_	:	42	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	42	_	_	_	_	_	_	_	S-Time_span
14	intervals	_	interval	_	NNS	42	_	_	_	_	_	interval.n	Frequency	S-Interval
15	(	_	(	_	(	42	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	42	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	42	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	42	_	_	_	_	_	_	_	O
19	needs	_	need	_	NNS	42	_	_	_	_	_	_	_	O
20	)	_	)	_	)	42	_	_	_	_	_	_	_	O
21	,	_	,	_	,	42	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	42	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	42	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	42	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	42	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	42	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	42	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	42	_	_	_	_	_	_	_	O
32	once	_	once	_	IN	42	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	42	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	42	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	42	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	42	_	_	_	_	_	_	_	O
38	glucose	_	UNK	_	NN	42	_	_	_	_	_	_	_	O
39	lowering	_	lower	_	VBG	42	_	_	_	_	_	_	_	O
40	therapy	_	therapy	_	NN	42	_	_	_	_	_	_	_	O
41	are	_	be	_	VBP	42	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	42	_	_	_	_	_	_	_	O
43	.	_	.	_	.	42	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	42	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	42	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	42	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	42	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	42	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	42	_	_	_	_	_	_	_	O
7	,	_	,	_	,	42	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	42	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	42	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	42	_	_	_	_	_	_	_	O
12	:	_	:	_	:	42	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
14	intervals	_	interval	_	NNS	42	_	_	_	_	_	_	_	O
15	(	_	(	_	(	42	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	42	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	42	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	42	_	_	_	_	_	individual.n	People	O
19	needs	_	need	_	NNS	42	_	_	_	_	_	_	_	S-Person
20	)	_	)	_	)	42	_	_	_	_	_	_	_	O
21	,	_	,	_	,	42	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	42	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	42	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	42	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	42	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	42	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	42	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	42	_	_	_	_	_	_	_	O
32	once	_	once	_	IN	42	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	42	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	42	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	42	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	42	_	_	_	_	_	_	_	O
38	glucose	_	UNK	_	NN	42	_	_	_	_	_	_	_	O
39	lowering	_	lower	_	VBG	42	_	_	_	_	_	_	_	O
40	therapy	_	therapy	_	NN	42	_	_	_	_	_	_	_	O
41	are	_	be	_	VBP	42	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	42	_	_	_	_	_	_	_	O
43	.	_	.	_	.	42	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	42	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	42	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	42	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	42	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	42	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	42	_	_	_	_	_	_	_	O
7	,	_	,	_	,	42	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	42	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	42	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	42	_	_	_	_	_	_	_	O
12	:	_	:	_	:	42	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
14	intervals	_	interval	_	NNS	42	_	_	_	_	_	_	_	O
15	(	_	(	_	(	42	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	42	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	42	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	42	_	_	_	_	_	_	_	S-Cognizer
19	needs	_	need	_	NNS	42	_	_	_	_	_	need.n	Needing	S-Requirement
20	)	_	)	_	)	42	_	_	_	_	_	_	_	O
21	,	_	,	_	,	42	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	42	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	42	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	42	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	42	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	42	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	42	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	42	_	_	_	_	_	_	_	O
32	once	_	once	_	IN	42	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	42	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	42	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	42	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	42	_	_	_	_	_	_	_	O
38	glucose	_	UNK	_	NN	42	_	_	_	_	_	_	_	O
39	lowering	_	lower	_	VBG	42	_	_	_	_	_	_	_	O
40	therapy	_	therapy	_	NN	42	_	_	_	_	_	_	_	O
41	are	_	be	_	VBP	42	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	42	_	_	_	_	_	_	_	O
43	.	_	.	_	.	42	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	42	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	42	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	42	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	42	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	42	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	42	_	_	_	_	_	_	_	O
7	,	_	,	_	,	42	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	42	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	42	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	42	_	_	_	_	_	_	_	O
12	:	_	:	_	:	42	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
14	intervals	_	interval	_	NNS	42	_	_	_	_	_	_	_	O
15	(	_	(	_	(	42	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	42	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	42	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	42	_	_	_	_	_	_	_	O
19	needs	_	need	_	NNS	42	_	_	_	_	_	_	_	O
20	)	_	)	_	)	42	_	_	_	_	_	_	_	O
21	,	_	,	_	,	42	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	42	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	42	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	42	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	42	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	42	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	42	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
30	unk	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	42	_	_	_	_	_	_	_	O
32	once	_	once	_	IN	42	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	42	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	42	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	42	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	42	_	_	_	_	_	_	_	O
38	glucose	_	UNK	_	NN	42	_	_	_	_	_	_	_	O
39	lowering	_	lower	_	VBG	42	_	_	_	_	_	_	_	O
40	therapy	_	therapy	_	NN	42	_	_	_	_	_	_	_	O
41	are	_	be	_	VBP	42	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	42	_	_	_	_	_	_	_	O
43	.	_	.	_	.	42	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	42	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	42	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	42	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	42	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	42	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	42	_	_	_	_	_	_	_	O
7	,	_	,	_	,	42	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	42	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	42	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	42	_	_	_	_	_	_	_	O
12	:	_	:	_	:	42	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
14	intervals	_	interval	_	NNS	42	_	_	_	_	_	_	_	O
15	(	_	(	_	(	42	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	42	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	42	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	42	_	_	_	_	_	_	_	O
19	needs	_	need	_	NNS	42	_	_	_	_	_	_	_	O
20	)	_	)	_	)	42	_	_	_	_	_	_	_	O
21	,	_	,	_	,	42	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	42	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	42	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	42	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	42	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	42	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	42	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	42	_	_	_	_	_	interval.n	Frequency	S-Interval
32	once	_	once	_	IN	42	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	42	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	42	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	42	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	42	_	_	_	_	_	_	_	O
38	glucose	_	UNK	_	NN	42	_	_	_	_	_	_	_	O
39	lowering	_	lower	_	VBG	42	_	_	_	_	_	_	_	O
40	therapy	_	therapy	_	NN	42	_	_	_	_	_	_	_	O
41	are	_	be	_	VBP	42	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	42	_	_	_	_	_	_	_	O
43	.	_	.	_	.	42	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	42	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	42	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	42	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	42	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	42	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	42	_	_	_	_	_	_	_	O
7	,	_	,	_	,	42	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	42	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	42	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	42	_	_	_	_	_	_	_	O
12	:	_	:	_	:	42	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
14	intervals	_	interval	_	NNS	42	_	_	_	_	_	_	_	O
15	(	_	(	_	(	42	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	42	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	42	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	42	_	_	_	_	_	_	_	O
19	needs	_	need	_	NNS	42	_	_	_	_	_	_	_	O
20	)	_	)	_	)	42	_	_	_	_	_	_	_	O
21	,	_	,	_	,	42	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	42	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	42	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	42	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	42	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	42	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	42	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	42	_	_	_	_	_	_	_	O
32	once	_	once	_	IN	42	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	42	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	42	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	42	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	42	_	_	_	_	_	_	_	B-Item
38	glucose	_	UNK	_	NN	42	_	_	_	_	_	_	_	I-Item
39	lowering	_	lower	_	VBG	42	_	_	_	_	_	lower.v	Cause_change_of_position_on_a_scale	O
40	therapy	_	therapy	_	NN	42	_	_	_	_	_	_	_	S-Item
41	are	_	be	_	VBP	42	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	42	_	_	_	_	_	_	_	O
43	.	_	.	_	.	42	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	42	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	42	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	42	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	42	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	42	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	42	_	_	_	_	_	_	_	O
7	,	_	,	_	,	42	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	42	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	42	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	42	_	_	_	_	_	_	_	O
12	:	_	:	_	:	42	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
14	intervals	_	interval	_	NNS	42	_	_	_	_	_	_	_	O
15	(	_	(	_	(	42	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	42	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	42	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	42	_	_	_	_	_	_	_	O
19	needs	_	need	_	NNS	42	_	_	_	_	_	_	_	O
20	)	_	)	_	)	42	_	_	_	_	_	_	_	O
21	,	_	,	_	,	42	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	42	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	42	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	42	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	42	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	42	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	42	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	42	_	_	_	_	_	_	_	O
32	once	_	once	_	IN	42	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	42	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	42	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	42	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	42	_	_	_	_	_	_	_	O
38	glucose	_	UNK	_	NN	42	_	_	_	_	_	_	_	O
39	lowering	_	lower	_	VBG	42	_	_	_	_	_	_	_	O
40	therapy	_	therapy	_	NN	42	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
41	are	_	be	_	VBP	42	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	42	_	_	_	_	_	_	_	O
43	.	_	.	_	.	42	_	_	_	_	_	_	_	O

1	use	_	UNK	_	NNP	43	_	_	_	_	_	_	_	S-Purpose
2	methods	_	method	_	NNS	43	_	_	_	_	_	method.n	Means	S-Means
3	to	_	to	_	TO	43	_	_	_	_	_	_	_	O
4	measure	_	measure	_	VB	43	_	_	_	_	_	_	_	O
5	hba1c	_	UNK	_	NNP	43	_	_	_	_	_	_	_	O
6	that	_	that	_	WDT	43	_	_	_	_	_	_	_	O
7	have	_	have	_	VBP	43	_	_	_	_	_	_	_	O
8	been	_	be	_	VBN	43	_	_	_	_	_	_	_	O
9	calibrated	_	UNK	_	VBN	43	_	_	_	_	_	_	_	O
10	according	_	accord	_	VBG	43	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	43	_	_	_	_	_	_	_	O

1	use	_	UNK	_	NNP	43	_	_	_	_	_	_	_	O
2	methods	_	method	_	NNS	43	_	_	_	_	_	_	_	O
3	to	_	to	_	TO	43	_	_	_	_	_	_	_	O
4	measure	_	measure	_	VB	43	_	_	_	_	_	measure.v	Dimension	S-Dimension
5	hba1c	_	UNK	_	NNP	43	_	_	_	_	_	_	_	S-Object
6	that	_	that	_	WDT	43	_	_	_	_	_	_	_	O
7	have	_	have	_	VBP	43	_	_	_	_	_	_	_	O
8	been	_	be	_	VBN	43	_	_	_	_	_	_	_	O
9	calibrated	_	UNK	_	VBN	43	_	_	_	_	_	_	_	O
10	according	_	accord	_	VBG	43	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	43	_	_	_	_	_	_	_	O

1	use	_	UNK	_	NNP	43	_	_	_	_	_	_	_	B-Obligation
2	methods	_	method	_	NNS	43	_	_	_	_	_	_	_	I-Obligation
3	to	_	to	_	TO	43	_	_	_	_	_	_	_	I-Obligation
4	measure	_	measure	_	VB	43	_	_	_	_	_	_	_	I-Obligation
5	hba1c	_	UNK	_	NNP	43	_	_	_	_	_	_	_	I-Obligation
6	that	_	that	_	WDT	43	_	_	_	_	_	_	_	S-Party_1
7	have	_	have	_	VBP	43	_	_	_	_	_	_	_	O
8	been	_	be	_	VBN	43	_	_	_	_	_	_	_	O
9	calibrated	_	UNK	_	VBN	43	_	_	_	_	_	_	_	O
10	according	_	accord	_	VBG	43	_	_	_	_	_	accord.v	Be_in_agreement_on_action	O
11	to	_	to	_	TO	43	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	44	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	44	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	44	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	44	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	44	_	_	_	_	_	_	_	O
6	:	_	:	_	:	44	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	44	_	_	_	_	_	_	_	O
8	(	_	(	_	(	44	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	44	_	_	_	_	_	_	_	O
10	)	_	)	_	)	44	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	44	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	44	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	44	_	_	_	_	_	_	_	O
14	)	_	)	_	)	44	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	44	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	44	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	44	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	44	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	44	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	44	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	44	_	_	_	_	_	_	_	O
8	(	_	(	_	(	44	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	44	_	_	_	_	_	_	_	O
10	)	_	)	_	)	44	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	44	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	44	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	44	_	_	_	_	_	_	_	O
14	)	_	)	_	)	44	_	_	_	_	_	_	_	O

1	investigate	_	UNK	_	NNP	45	_	_	_	_	_	_	_	O
2	unexplained	_	UNK	_	JJ	45	_	_	_	_	_	_	_	O
3	discrepancies	_	UNK	_	NNS	45	_	_	_	_	_	_	_	O
4	between	_	between	_	IN	45	_	_	_	_	_	_	_	O
5	hba1c	_	UNK	_	NNP	45	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	45	_	_	_	_	_	_	_	O
7	other	_	other	_	JJ	45	_	_	_	_	_	other.a	Increment	O
8	glucose	_	UNK	_	NN	45	_	_	_	_	_	_	_	B-Class
9	measurements	_	measurement	_	NNS	45	_	_	_	_	_	_	_	I-Class

1	involve	_	UNK	_	NNP	46	_	_	_	_	_	_	_	S-Descriptor
2	adults	_	adult	_	NNS	46	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	46	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	46	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	46	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	46	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	46	_	_	_	_	_	_	_	O
8	decisions	_	decision	_	NNS	46	_	_	_	_	_	_	_	O
9	about	_	about	_	IN	46	_	_	_	_	_	_	_	O
10	their	_	their	_	PRP$	46	_	_	_	_	_	_	_	O
11	individual	_	individual	_	JJ	46	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	46	_	_	_	_	_	_	_	O
13	target	_	target	_	NN	46	_	_	_	_	_	_	_	O

1	involve	_	UNK	_	NNP	46	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	46	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	46	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	46	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	46	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	46	_	_	_	_	_	_	_	I-Category
7	in	_	in	_	IN	46	_	_	_	_	_	_	_	O
8	decisions	_	decision	_	NNS	46	_	_	_	_	_	_	_	O
9	about	_	about	_	IN	46	_	_	_	_	_	_	_	O
10	their	_	their	_	PRP$	46	_	_	_	_	_	_	_	O
11	individual	_	individual	_	JJ	46	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	46	_	_	_	_	_	_	_	O
13	target	_	target	_	NN	46	_	_	_	_	_	_	_	O

1	involve	_	UNK	_	NNP	46	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	46	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	46	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	46	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	46	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	46	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	46	_	_	_	_	_	_	_	O
8	decisions	_	decision	_	NNS	46	_	_	_	_	_	decision.n	Deciding	O
9	about	_	about	_	IN	46	_	_	_	_	_	_	_	O
10	their	_	their	_	PRP$	46	_	_	_	_	_	_	_	O
11	individual	_	individual	_	JJ	46	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	46	_	_	_	_	_	_	_	O
13	target	_	target	_	NN	46	_	_	_	_	_	_	_	O

1	involve	_	UNK	_	NNP	46	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	46	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	46	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	46	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	46	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	46	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	46	_	_	_	_	_	_	_	O
8	decisions	_	decision	_	NNS	46	_	_	_	_	_	_	_	O
9	about	_	about	_	IN	46	_	_	_	_	_	_	_	O
10	their	_	their	_	PRP$	46	_	_	_	_	_	_	_	O
11	individual	_	individual	_	JJ	46	_	_	_	_	_	individual.n	People	B-Person
12	hba1c	_	UNK	_	NNP	46	_	_	_	_	_	_	_	I-Person
13	target	_	target	_	NN	46	_	_	_	_	_	_	_	I-Person

1	offer	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
2	lifestyle	_	lifestyle	_	JJ	47	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	47	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	47	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	47	_	_	_	_	_	_	_	S-Patient
6	treatment	_	treatment	_	NN	47	_	_	_	_	_	treatment.n	Cure	O
7	to	_	to	_	TO	47	_	_	_	_	_	_	_	O
8	support	_	support	_	VB	47	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	47	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	47	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	47	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	47	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	47	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	47	_	_	_	_	_	_	_	O
15	achieve	_	achieve	_	VB	47	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	47	_	_	_	_	_	_	_	O
17	maintain	_	maintain	_	VB	47	_	_	_	_	_	_	_	O
18	their	_	their	_	PRP$	47	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	47	_	_	_	_	_	_	_	O
20	target	_	target	_	NN	47	_	_	_	_	_	_	_	O
21	(	_	(	_	(	47	_	_	_	_	_	_	_	O
22	see	_	see	_	VB	47	_	_	_	_	_	_	_	O
23	section	_	section	_	NN	47	_	_	_	_	_	_	_	O
24	)	_	)	_	)	47	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
2	lifestyle	_	lifestyle	_	JJ	47	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	47	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	47	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	47	_	_	_	_	_	_	_	O
6	treatment	_	treatment	_	NN	47	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	47	_	_	_	_	_	_	_	O
8	support	_	support	_	VB	47	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	47	_	_	_	_	_	adult.n	People_by_age	S-Person
10	with	_	with	_	IN	47	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	47	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	47	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	47	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	47	_	_	_	_	_	_	_	O
15	achieve	_	achieve	_	VB	47	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	47	_	_	_	_	_	_	_	O
17	maintain	_	maintain	_	VB	47	_	_	_	_	_	_	_	O
18	their	_	their	_	PRP$	47	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	47	_	_	_	_	_	_	_	O
20	target	_	target	_	NN	47	_	_	_	_	_	_	_	O
21	(	_	(	_	(	47	_	_	_	_	_	_	_	O
22	see	_	see	_	VB	47	_	_	_	_	_	_	_	O
23	section	_	section	_	NN	47	_	_	_	_	_	_	_	O
24	)	_	)	_	)	47	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
2	lifestyle	_	lifestyle	_	JJ	47	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	47	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	47	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	47	_	_	_	_	_	_	_	O
6	treatment	_	treatment	_	NN	47	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	47	_	_	_	_	_	_	_	O
8	support	_	support	_	VB	47	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	47	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	47	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	47	_	_	_	_	_	type.n	Type	S-Subtype
12	2	_	2	_	CD	47	_	_	_	_	_	_	_	B-Category
13	diabetes	_	UNK	_	NNS	47	_	_	_	_	_	_	_	I-Category
14	to	_	to	_	TO	47	_	_	_	_	_	_	_	O
15	achieve	_	achieve	_	VB	47	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	47	_	_	_	_	_	_	_	O
17	maintain	_	maintain	_	VB	47	_	_	_	_	_	_	_	O
18	their	_	their	_	PRP$	47	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	47	_	_	_	_	_	_	_	O
20	target	_	target	_	NN	47	_	_	_	_	_	_	_	O
21	(	_	(	_	(	47	_	_	_	_	_	_	_	O
22	see	_	see	_	VB	47	_	_	_	_	_	_	_	O
23	section	_	section	_	NN	47	_	_	_	_	_	_	_	O
24	)	_	)	_	)	47	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
2	lifestyle	_	lifestyle	_	JJ	47	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	47	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	47	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	47	_	_	_	_	_	_	_	O
6	treatment	_	treatment	_	NN	47	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	47	_	_	_	_	_	_	_	O
8	support	_	support	_	VB	47	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	47	_	_	_	_	_	_	_	B-Agent
10	with	_	with	_	IN	47	_	_	_	_	_	_	_	I-Agent
11	type	_	type	_	JJ	47	_	_	_	_	_	_	_	I-Agent
12	2	_	2	_	CD	47	_	_	_	_	_	_	_	I-Agent
13	diabetes	_	UNK	_	NNS	47	_	_	_	_	_	_	_	I-Agent
14	to	_	to	_	TO	47	_	_	_	_	_	_	_	O
15	achieve	_	achieve	_	VB	47	_	_	_	_	_	achieve.v	Accomplishment	O
16	and	_	and	_	CC	47	_	_	_	_	_	_	_	O
17	maintain	_	maintain	_	VB	47	_	_	_	_	_	_	_	O
18	their	_	their	_	PRP$	47	_	_	_	_	_	_	_	B-Goal
19	hba1c	_	UNK	_	NNP	47	_	_	_	_	_	_	_	I-Goal
20	target	_	target	_	NN	47	_	_	_	_	_	_	_	I-Goal
21	(	_	(	_	(	47	_	_	_	_	_	_	_	O
22	see	_	see	_	VB	47	_	_	_	_	_	_	_	O
23	section	_	section	_	NN	47	_	_	_	_	_	_	_	O
24	)	_	)	_	)	47	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
2	lifestyle	_	lifestyle	_	JJ	47	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	47	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	47	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	47	_	_	_	_	_	_	_	O
6	treatment	_	treatment	_	NN	47	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	47	_	_	_	_	_	_	_	O
8	support	_	support	_	VB	47	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	47	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	47	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	47	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	47	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	47	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	47	_	_	_	_	_	_	_	O
15	achieve	_	achieve	_	VB	47	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	47	_	_	_	_	_	_	_	O
17	maintain	_	maintain	_	VB	47	_	_	_	_	_	maintain.v	Activity_ongoing	O
18	their	_	their	_	PRP$	47	_	_	_	_	_	_	_	B-Activity
19	hba1c	_	UNK	_	NNP	47	_	_	_	_	_	_	_	I-Activity
20	target	_	target	_	NN	47	_	_	_	_	_	_	_	I-Activity
21	(	_	(	_	(	47	_	_	_	_	_	_	_	O
22	see	_	see	_	VB	47	_	_	_	_	_	_	_	O
23	section	_	section	_	NN	47	_	_	_	_	_	_	_	O
24	)	_	)	_	)	47	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
2	lifestyle	_	lifestyle	_	JJ	47	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	47	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	47	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	47	_	_	_	_	_	_	_	O
6	treatment	_	treatment	_	NN	47	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	47	_	_	_	_	_	_	_	O
8	support	_	support	_	VB	47	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	47	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	47	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	47	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	47	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	47	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	47	_	_	_	_	_	_	_	O
15	achieve	_	achieve	_	VB	47	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	47	_	_	_	_	_	_	_	O
17	maintain	_	maintain	_	VB	47	_	_	_	_	_	_	_	O
18	their	_	their	_	PRP$	47	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	47	_	_	_	_	_	_	_	O
20	target	_	target	_	NN	47	_	_	_	_	_	_	_	O
21	(	_	(	_	(	47	_	_	_	_	_	_	_	O
22	see	_	see	_	VB	47	_	_	_	_	_	_	_	O
23	section	_	section	_	NN	47	_	_	_	_	_	section.n	Part_whole	S-Part
24	)	_	)	_	)	47	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	48	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	48	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	48	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	48	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
7	managed	_	manage	_	VBD	48	_	_	_	_	_	_	_	O
8	either	_	either	_	RB	48	_	_	_	_	_	_	_	O
9	by	_	by	_	IN	48	_	_	_	_	_	_	_	O
10	lifestyle	_	lifestyle	_	NN	48	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
12	diet	_	UNK	_	JJ	48	_	_	_	_	_	_	_	O
13	,	_	,	_	,	48	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	48	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	48	_	_	_	_	_	_	_	O
16	lifestyle	_	lifestyle	_	JJ	48	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
18	diet	_	UNK	_	JJ	48	_	_	_	_	_	_	_	O
19	combined	_	combine	_	VBN	48	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	48	_	_	_	_	_	_	_	O
22	single	_	single	_	JJ	48	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
24	not	_	not	_	RB	48	_	_	_	_	_	_	_	O
25	associated	_	associate	_	VBN	48	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
27	unk	_	UNK	_	NN	48	_	_	_	_	_	_	_	O
28	,	_	,	_	,	48	_	_	_	_	_	_	_	O
29	support	_	support	_	VB	48	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	48	_	_	_	_	_	_	_	O
31	person	_	person	_	NN	48	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
33	aim	_	aim	_	VB	48	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	48	_	_	_	_	_	_	_	O
35	an	_	an	_	DT	48	_	_	_	_	_	_	_	O
36	hba1c	_	UNK	_	NNP	48	_	_	_	_	_	_	_	O
37	level	_	level	_	NN	48	_	_	_	_	_	_	_	O
38	of	_	of	_	IN	48	_	_	_	_	_	_	_	O
39	48	_	48	_	CD	48	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
41	(	_	(	_	(	48	_	_	_	_	_	_	_	O
42	%	_	%	_	NN	48	_	_	_	_	_	_	_	O
43	)	_	)	_	)	48	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	48	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	48	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	48	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	48	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
7	managed	_	manage	_	VBD	48	_	_	_	_	_	_	_	O
8	either	_	either	_	RB	48	_	_	_	_	_	_	_	O
9	by	_	by	_	IN	48	_	_	_	_	_	_	_	O
10	lifestyle	_	lifestyle	_	NN	48	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
12	diet	_	UNK	_	JJ	48	_	_	_	_	_	_	_	O
13	,	_	,	_	,	48	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	48	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	48	_	_	_	_	_	_	_	O
16	lifestyle	_	lifestyle	_	JJ	48	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
18	diet	_	UNK	_	JJ	48	_	_	_	_	_	_	_	O
19	combined	_	combine	_	VBN	48	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	48	_	_	_	_	_	_	_	O
22	single	_	single	_	JJ	48	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
24	not	_	not	_	RB	48	_	_	_	_	_	_	_	O
25	associated	_	associate	_	VBN	48	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
27	unk	_	UNK	_	NN	48	_	_	_	_	_	_	_	O
28	,	_	,	_	,	48	_	_	_	_	_	_	_	O
29	support	_	support	_	VB	48	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	48	_	_	_	_	_	_	_	O
31	person	_	person	_	NN	48	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
33	aim	_	aim	_	VB	48	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	48	_	_	_	_	_	_	_	O
35	an	_	an	_	DT	48	_	_	_	_	_	_	_	O
36	hba1c	_	UNK	_	NNP	48	_	_	_	_	_	_	_	O
37	level	_	level	_	NN	48	_	_	_	_	_	_	_	O
38	of	_	of	_	IN	48	_	_	_	_	_	_	_	O
39	48	_	48	_	CD	48	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
41	(	_	(	_	(	48	_	_	_	_	_	_	_	O
42	%	_	%	_	NN	48	_	_	_	_	_	_	_	O
43	)	_	)	_	)	48	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	48	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	48	_	_	_	_	_	_	_	B-Agent
3	with	_	with	_	IN	48	_	_	_	_	_	_	_	I-Agent
4	type	_	type	_	JJ	48	_	_	_	_	_	_	_	I-Agent
5	2	_	2	_	CD	48	_	_	_	_	_	_	_	I-Agent
6	diabetes	_	UNK	_	NNS	48	_	_	_	_	_	_	_	I-Agent
7	managed	_	manage	_	VBD	48	_	_	_	_	_	manage.v	Success_or_failure	O
8	either	_	either	_	RB	48	_	_	_	_	_	_	_	B-Goal
9	by	_	by	_	IN	48	_	_	_	_	_	_	_	I-Goal
10	lifestyle	_	lifestyle	_	NN	48	_	_	_	_	_	_	_	I-Goal
11	and	_	and	_	CC	48	_	_	_	_	_	_	_	I-Goal
12	diet	_	UNK	_	JJ	48	_	_	_	_	_	_	_	I-Goal
13	,	_	,	_	,	48	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	48	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	48	_	_	_	_	_	_	_	O
16	lifestyle	_	lifestyle	_	JJ	48	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
18	diet	_	UNK	_	JJ	48	_	_	_	_	_	_	_	O
19	combined	_	combine	_	VBN	48	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	48	_	_	_	_	_	_	_	O
22	single	_	single	_	JJ	48	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
24	not	_	not	_	RB	48	_	_	_	_	_	_	_	O
25	associated	_	associate	_	VBN	48	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
27	unk	_	UNK	_	NN	48	_	_	_	_	_	_	_	O
28	,	_	,	_	,	48	_	_	_	_	_	_	_	O
29	support	_	support	_	VB	48	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	48	_	_	_	_	_	_	_	O
31	person	_	person	_	NN	48	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
33	aim	_	aim	_	VB	48	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	48	_	_	_	_	_	_	_	O
35	an	_	an	_	DT	48	_	_	_	_	_	_	_	O
36	hba1c	_	UNK	_	NNP	48	_	_	_	_	_	_	_	O
37	level	_	level	_	NN	48	_	_	_	_	_	_	_	O
38	of	_	of	_	IN	48	_	_	_	_	_	_	_	O
39	48	_	48	_	CD	48	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
41	(	_	(	_	(	48	_	_	_	_	_	_	_	O
42	%	_	%	_	NN	48	_	_	_	_	_	_	_	O
43	)	_	)	_	)	48	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	48	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	48	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	48	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	48	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
7	managed	_	manage	_	VBD	48	_	_	_	_	_	_	_	O
8	either	_	either	_	RB	48	_	_	_	_	_	_	_	O
9	by	_	by	_	IN	48	_	_	_	_	_	_	_	O
10	lifestyle	_	lifestyle	_	NN	48	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
12	diet	_	UNK	_	JJ	48	_	_	_	_	_	_	_	O
13	,	_	,	_	,	48	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	48	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	48	_	_	_	_	_	_	_	O
16	lifestyle	_	lifestyle	_	JJ	48	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
18	diet	_	UNK	_	JJ	48	_	_	_	_	_	_	_	S-Part_1
19	combined	_	combine	_	VBN	48	_	_	_	_	_	combine.v	Cause_to_amalgamate	O
20	with	_	with	_	IN	48	_	_	_	_	_	_	_	B-Part_2
21	a	_	a	_	DT	48	_	_	_	_	_	_	_	I-Part_2
22	single	_	single	_	JJ	48	_	_	_	_	_	_	_	I-Part_2
23	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	I-Part_2
24	not	_	not	_	RB	48	_	_	_	_	_	_	_	I-Part_2
25	associated	_	associate	_	VBN	48	_	_	_	_	_	_	_	I-Part_2
26	with	_	with	_	IN	48	_	_	_	_	_	_	_	I-Part_2
27	unk	_	UNK	_	NN	48	_	_	_	_	_	_	_	I-Part_2
28	,	_	,	_	,	48	_	_	_	_	_	_	_	O
29	support	_	support	_	VB	48	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	48	_	_	_	_	_	_	_	O
31	person	_	person	_	NN	48	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
33	aim	_	aim	_	VB	48	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	48	_	_	_	_	_	_	_	O
35	an	_	an	_	DT	48	_	_	_	_	_	_	_	O
36	hba1c	_	UNK	_	NNP	48	_	_	_	_	_	_	_	O
37	level	_	level	_	NN	48	_	_	_	_	_	_	_	O
38	of	_	of	_	IN	48	_	_	_	_	_	_	_	O
39	48	_	48	_	CD	48	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
41	(	_	(	_	(	48	_	_	_	_	_	_	_	O
42	%	_	%	_	NN	48	_	_	_	_	_	_	_	O
43	)	_	)	_	)	48	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	48	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	48	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	48	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	48	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
7	managed	_	manage	_	VBD	48	_	_	_	_	_	_	_	O
8	either	_	either	_	RB	48	_	_	_	_	_	_	_	O
9	by	_	by	_	IN	48	_	_	_	_	_	_	_	O
10	lifestyle	_	lifestyle	_	NN	48	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
12	diet	_	UNK	_	JJ	48	_	_	_	_	_	_	_	O
13	,	_	,	_	,	48	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	48	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	48	_	_	_	_	_	_	_	O
16	lifestyle	_	lifestyle	_	JJ	48	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
18	diet	_	UNK	_	JJ	48	_	_	_	_	_	_	_	O
19	combined	_	combine	_	VBN	48	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	48	_	_	_	_	_	_	_	O
22	single	_	single	_	JJ	48	_	_	_	_	_	single.a	Sole_instance	O
23	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	S-Type
24	not	_	not	_	RB	48	_	_	_	_	_	_	_	O
25	associated	_	associate	_	VBN	48	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
27	unk	_	UNK	_	NN	48	_	_	_	_	_	_	_	O
28	,	_	,	_	,	48	_	_	_	_	_	_	_	O
29	support	_	support	_	VB	48	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	48	_	_	_	_	_	_	_	O
31	person	_	person	_	NN	48	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
33	aim	_	aim	_	VB	48	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	48	_	_	_	_	_	_	_	O
35	an	_	an	_	DT	48	_	_	_	_	_	_	_	O
36	hba1c	_	UNK	_	NNP	48	_	_	_	_	_	_	_	O
37	level	_	level	_	NN	48	_	_	_	_	_	_	_	O
38	of	_	of	_	IN	48	_	_	_	_	_	_	_	O
39	48	_	48	_	CD	48	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
41	(	_	(	_	(	48	_	_	_	_	_	_	_	O
42	%	_	%	_	NN	48	_	_	_	_	_	_	_	O
43	)	_	)	_	)	48	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	48	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	48	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	48	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	48	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
7	managed	_	manage	_	VBD	48	_	_	_	_	_	_	_	O
8	either	_	either	_	RB	48	_	_	_	_	_	_	_	O
9	by	_	by	_	IN	48	_	_	_	_	_	_	_	O
10	lifestyle	_	lifestyle	_	NN	48	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
12	diet	_	UNK	_	JJ	48	_	_	_	_	_	_	_	O
13	,	_	,	_	,	48	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	48	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	48	_	_	_	_	_	_	_	O
16	lifestyle	_	lifestyle	_	JJ	48	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
18	diet	_	UNK	_	JJ	48	_	_	_	_	_	_	_	O
19	combined	_	combine	_	VBN	48	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	48	_	_	_	_	_	_	_	B-Partner_1
22	single	_	single	_	JJ	48	_	_	_	_	_	_	_	I-Partner_1
23	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	I-Partner_1
24	not	_	not	_	RB	48	_	_	_	_	_	_	_	O
25	associated	_	associate	_	VBN	48	_	_	_	_	_	associate.v	Collaboration	O
26	with	_	with	_	IN	48	_	_	_	_	_	_	_	B-Undertaking
27	unk	_	UNK	_	NN	48	_	_	_	_	_	_	_	I-Undertaking
28	,	_	,	_	,	48	_	_	_	_	_	_	_	O
29	support	_	support	_	VB	48	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	48	_	_	_	_	_	_	_	O
31	person	_	person	_	NN	48	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
33	aim	_	aim	_	VB	48	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	48	_	_	_	_	_	_	_	O
35	an	_	an	_	DT	48	_	_	_	_	_	_	_	O
36	hba1c	_	UNK	_	NNP	48	_	_	_	_	_	_	_	O
37	level	_	level	_	NN	48	_	_	_	_	_	_	_	O
38	of	_	of	_	IN	48	_	_	_	_	_	_	_	O
39	48	_	48	_	CD	48	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
41	(	_	(	_	(	48	_	_	_	_	_	_	_	O
42	%	_	%	_	NN	48	_	_	_	_	_	_	_	O
43	)	_	)	_	)	48	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	48	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	48	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	48	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	48	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
7	managed	_	manage	_	VBD	48	_	_	_	_	_	_	_	O
8	either	_	either	_	RB	48	_	_	_	_	_	_	_	O
9	by	_	by	_	IN	48	_	_	_	_	_	_	_	O
10	lifestyle	_	lifestyle	_	NN	48	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
12	diet	_	UNK	_	JJ	48	_	_	_	_	_	_	_	O
13	,	_	,	_	,	48	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	48	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	48	_	_	_	_	_	_	_	O
16	lifestyle	_	lifestyle	_	JJ	48	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
18	diet	_	UNK	_	JJ	48	_	_	_	_	_	_	_	O
19	combined	_	combine	_	VBN	48	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	48	_	_	_	_	_	_	_	O
22	single	_	single	_	JJ	48	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
24	not	_	not	_	RB	48	_	_	_	_	_	_	_	O
25	associated	_	associate	_	VBN	48	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
27	unk	_	UNK	_	NN	48	_	_	_	_	_	_	_	O
28	,	_	,	_	,	48	_	_	_	_	_	_	_	O
29	support	_	support	_	VB	48	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	48	_	_	_	_	_	_	_	O
31	person	_	person	_	NN	48	_	_	_	_	_	person.n	People	S-Person
32	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
33	aim	_	aim	_	VB	48	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	48	_	_	_	_	_	_	_	O
35	an	_	an	_	DT	48	_	_	_	_	_	_	_	O
36	hba1c	_	UNK	_	NNP	48	_	_	_	_	_	_	_	O
37	level	_	level	_	NN	48	_	_	_	_	_	_	_	O
38	of	_	of	_	IN	48	_	_	_	_	_	_	_	O
39	48	_	48	_	CD	48	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
41	(	_	(	_	(	48	_	_	_	_	_	_	_	O
42	%	_	%	_	NN	48	_	_	_	_	_	_	_	O
43	)	_	)	_	)	48	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	48	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	48	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	48	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	48	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
7	managed	_	manage	_	VBD	48	_	_	_	_	_	_	_	O
8	either	_	either	_	RB	48	_	_	_	_	_	_	_	O
9	by	_	by	_	IN	48	_	_	_	_	_	_	_	O
10	lifestyle	_	lifestyle	_	NN	48	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
12	diet	_	UNK	_	JJ	48	_	_	_	_	_	_	_	O
13	,	_	,	_	,	48	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	48	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	48	_	_	_	_	_	_	_	O
16	lifestyle	_	lifestyle	_	JJ	48	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
18	diet	_	UNK	_	JJ	48	_	_	_	_	_	_	_	O
19	combined	_	combine	_	VBN	48	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	48	_	_	_	_	_	_	_	O
22	single	_	single	_	JJ	48	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
24	not	_	not	_	RB	48	_	_	_	_	_	_	_	O
25	associated	_	associate	_	VBN	48	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
27	unk	_	UNK	_	NN	48	_	_	_	_	_	_	_	O
28	,	_	,	_	,	48	_	_	_	_	_	_	_	O
29	support	_	support	_	VB	48	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	48	_	_	_	_	_	_	_	B-Agent
31	person	_	person	_	NN	48	_	_	_	_	_	_	_	I-Agent
32	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
33	aim	_	aim	_	VB	48	_	_	_	_	_	aim.v	Purpose	O
34	for	_	for	_	IN	48	_	_	_	_	_	_	_	B-Goal
35	an	_	an	_	DT	48	_	_	_	_	_	_	_	I-Goal
36	hba1c	_	UNK	_	NNP	48	_	_	_	_	_	_	_	I-Goal
37	level	_	level	_	NN	48	_	_	_	_	_	_	_	I-Goal
38	of	_	of	_	IN	48	_	_	_	_	_	_	_	I-Goal
39	48	_	48	_	CD	48	_	_	_	_	_	_	_	I-Goal
40	unk	_	UNK	_	NNS	48	_	_	_	_	_	_	_	I-Goal
41	(	_	(	_	(	48	_	_	_	_	_	_	_	O
42	%	_	%	_	NN	48	_	_	_	_	_	_	_	O
43	)	_	)	_	)	48	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	49	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	49	_	_	_	_	_	adult.n	People_by_age	S-Person
3	on	_	on	_	IN	49	_	_	_	_	_	_	_	O
4	a	_	a	_	DT	49	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	49	_	_	_	_	_	_	_	O
6	associated	_	associate	_	VBN	49	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	49	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	NN	49	_	_	_	_	_	_	_	O
9	,	_	,	_	,	49	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	49	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	49	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	49	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	49	_	_	_	_	_	_	_	O
14	aim	_	aim	_	VB	49	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	49	_	_	_	_	_	_	_	O
16	an	_	an	_	DT	49	_	_	_	_	_	_	_	O
17	hba1c	_	UNK	_	NNP	49	_	_	_	_	_	_	_	O
18	level	_	level	_	NN	49	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	49	_	_	_	_	_	_	_	O
20	53	_	53	_	CD	49	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	NNS	49	_	_	_	_	_	_	_	O
22	(	_	(	_	(	49	_	_	_	_	_	_	_	O
23	%	_	%	_	NN	49	_	_	_	_	_	_	_	O
24	)	_	)	_	)	49	_	_	_	_	_	_	_	O
25	.	_	.	_	.	49	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	49	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	49	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	49	_	_	_	_	_	_	_	O
4	a	_	a	_	DT	49	_	_	_	_	_	_	_	B-Partner_1
5	drug	_	drug	_	NN	49	_	_	_	_	_	_	_	I-Partner_1
6	associated	_	associate	_	VBN	49	_	_	_	_	_	associate.v	Collaboration	O
7	with	_	with	_	IN	49	_	_	_	_	_	_	_	B-Undertaking
8	unk	_	UNK	_	NN	49	_	_	_	_	_	_	_	I-Undertaking
9	,	_	,	_	,	49	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	49	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	49	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	49	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	49	_	_	_	_	_	_	_	O
14	aim	_	aim	_	VB	49	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	49	_	_	_	_	_	_	_	O
16	an	_	an	_	DT	49	_	_	_	_	_	_	_	O
17	hba1c	_	UNK	_	NNP	49	_	_	_	_	_	_	_	O
18	level	_	level	_	NN	49	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	49	_	_	_	_	_	_	_	O
20	53	_	53	_	CD	49	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	NNS	49	_	_	_	_	_	_	_	O
22	(	_	(	_	(	49	_	_	_	_	_	_	_	O
23	%	_	%	_	NN	49	_	_	_	_	_	_	_	O
24	)	_	)	_	)	49	_	_	_	_	_	_	_	O
25	.	_	.	_	.	49	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	49	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	49	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	49	_	_	_	_	_	_	_	O
4	a	_	a	_	DT	49	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	49	_	_	_	_	_	_	_	O
6	associated	_	associate	_	VBN	49	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	49	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	NN	49	_	_	_	_	_	_	_	O
9	,	_	,	_	,	49	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	49	_	_	_	_	_	support.v	Supporting	O
11	the	_	the	_	DT	49	_	_	_	_	_	_	_	B-Supported
12	person	_	person	_	NN	49	_	_	_	_	_	_	_	I-Supported
13	to	_	to	_	TO	49	_	_	_	_	_	_	_	I-Supported
14	aim	_	aim	_	VB	49	_	_	_	_	_	_	_	I-Supported
15	for	_	for	_	IN	49	_	_	_	_	_	_	_	I-Supported
16	an	_	an	_	DT	49	_	_	_	_	_	_	_	I-Supported
17	hba1c	_	UNK	_	NNP	49	_	_	_	_	_	_	_	I-Supported
18	level	_	level	_	NN	49	_	_	_	_	_	_	_	I-Supported
19	of	_	of	_	IN	49	_	_	_	_	_	_	_	I-Supported
20	53	_	53	_	CD	49	_	_	_	_	_	_	_	I-Supported
21	unk	_	UNK	_	NNS	49	_	_	_	_	_	_	_	I-Supported
22	(	_	(	_	(	49	_	_	_	_	_	_	_	O
23	%	_	%	_	NN	49	_	_	_	_	_	_	_	O
24	)	_	)	_	)	49	_	_	_	_	_	_	_	O
25	.	_	.	_	.	49	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	49	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	49	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	49	_	_	_	_	_	_	_	O
4	a	_	a	_	DT	49	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	49	_	_	_	_	_	_	_	O
6	associated	_	associate	_	VBN	49	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	49	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	NN	49	_	_	_	_	_	_	_	O
9	,	_	,	_	,	49	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	49	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	49	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	49	_	_	_	_	_	person.n	People	S-Person
13	to	_	to	_	TO	49	_	_	_	_	_	_	_	O
14	aim	_	aim	_	VB	49	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	49	_	_	_	_	_	_	_	O
16	an	_	an	_	DT	49	_	_	_	_	_	_	_	O
17	hba1c	_	UNK	_	NNP	49	_	_	_	_	_	_	_	O
18	level	_	level	_	NN	49	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	49	_	_	_	_	_	_	_	O
20	53	_	53	_	CD	49	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	NNS	49	_	_	_	_	_	_	_	O
22	(	_	(	_	(	49	_	_	_	_	_	_	_	O
23	%	_	%	_	NN	49	_	_	_	_	_	_	_	O
24	)	_	)	_	)	49	_	_	_	_	_	_	_	O
25	.	_	.	_	.	49	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	49	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	49	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	49	_	_	_	_	_	_	_	O
4	a	_	a	_	DT	49	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	49	_	_	_	_	_	_	_	O
6	associated	_	associate	_	VBN	49	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	49	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	NN	49	_	_	_	_	_	_	_	O
9	,	_	,	_	,	49	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	49	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	49	_	_	_	_	_	_	_	B-Agent
12	person	_	person	_	NN	49	_	_	_	_	_	_	_	I-Agent
13	to	_	to	_	TO	49	_	_	_	_	_	_	_	O
14	aim	_	aim	_	VB	49	_	_	_	_	_	aim.v	Purpose	O
15	for	_	for	_	IN	49	_	_	_	_	_	_	_	B-Goal
16	an	_	an	_	DT	49	_	_	_	_	_	_	_	I-Goal
17	hba1c	_	UNK	_	NNP	49	_	_	_	_	_	_	_	I-Goal
18	level	_	level	_	NN	49	_	_	_	_	_	_	_	I-Goal
19	of	_	of	_	IN	49	_	_	_	_	_	_	_	I-Goal
20	53	_	53	_	CD	49	_	_	_	_	_	_	_	I-Goal
21	unk	_	UNK	_	NNS	49	_	_	_	_	_	_	_	I-Goal
22	(	_	(	_	(	49	_	_	_	_	_	_	_	O
23	%	_	%	_	NN	49	_	_	_	_	_	_	_	O
24	)	_	)	_	)	49	_	_	_	_	_	_	_	O
25	.	_	.	_	.	49	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	50	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	50	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	50	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	50	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	50	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
7	,	_	,	_	,	50	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	50	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	50	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	50	_	_	_	_	_	_	_	O
11	are	_	be	_	VBP	50	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	50	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	50	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	50	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	50	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	50	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	50	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	50	_	_	_	_	_	_	_	O
21	to	_	to	_	TO	50	_	_	_	_	_	_	_	O
22	58	_	UNK	_	CD	50	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
24	(	_	(	_	(	50	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	50	_	_	_	_	_	_	_	O
26	)	_	)	_	)	50	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	50	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	50	_	_	_	_	_	_	_	O
29	:	_	:	_	:	50	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	50	_	_	_	_	_	_	_	O
31	advice	_	advice	_	NN	50	_	_	_	_	_	_	_	O
32	about	_	about	_	IN	50	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	50	_	_	_	_	_	_	_	O
34	,	_	,	_	,	50	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	50	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	50	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	50	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	O
40	treatment	_	treatment	_	NN	50	_	_	_	_	_	_	_	O
41	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	50	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	50	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	50	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	50	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	50	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	50	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	50	_	_	_	_	_	_	_	O
49	hba1c	_	UNK	_	NNP	50	_	_	_	_	_	_	_	O
50	level	_	level	_	NN	50	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	50	_	_	_	_	_	_	_	O
52	53	_	53	_	CD	50	_	_	_	_	_	_	_	O
53	unk	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
54	(	_	(	_	(	50	_	_	_	_	_	_	_	O
55	%	_	%	_	NN	50	_	_	_	_	_	_	_	O
56	)	_	)	_	)	50	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
58	intensify	_	intensify	_	JJ	50	_	_	_	_	_	_	_	O
59	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	O
60	treatment	_	treatment	_	NN	50	_	_	_	_	_	_	_	O
61	.	_	.	_	.	50	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	50	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	50	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	50	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	50	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	50	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	50	_	_	_	_	_	_	_	I-Category
7	,	_	,	_	,	50	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	50	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	50	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	50	_	_	_	_	_	_	_	O
11	are	_	be	_	VBP	50	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	50	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	50	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	50	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	50	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	50	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	50	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	50	_	_	_	_	_	_	_	O
21	to	_	to	_	TO	50	_	_	_	_	_	_	_	O
22	58	_	UNK	_	CD	50	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
24	(	_	(	_	(	50	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	50	_	_	_	_	_	_	_	O
26	)	_	)	_	)	50	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	50	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	50	_	_	_	_	_	_	_	O
29	:	_	:	_	:	50	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	50	_	_	_	_	_	_	_	O
31	advice	_	advice	_	NN	50	_	_	_	_	_	_	_	O
32	about	_	about	_	IN	50	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	50	_	_	_	_	_	_	_	O
34	,	_	,	_	,	50	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	50	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	50	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	50	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	O
40	treatment	_	treatment	_	NN	50	_	_	_	_	_	_	_	O
41	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	50	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	50	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	50	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	50	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	50	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	50	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	50	_	_	_	_	_	_	_	O
49	hba1c	_	UNK	_	NNP	50	_	_	_	_	_	_	_	O
50	level	_	level	_	NN	50	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	50	_	_	_	_	_	_	_	O
52	53	_	53	_	CD	50	_	_	_	_	_	_	_	O
53	unk	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
54	(	_	(	_	(	50	_	_	_	_	_	_	_	O
55	%	_	%	_	NN	50	_	_	_	_	_	_	_	O
56	)	_	)	_	)	50	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
58	intensify	_	intensify	_	JJ	50	_	_	_	_	_	_	_	O
59	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	O
60	treatment	_	treatment	_	NN	50	_	_	_	_	_	_	_	O
61	.	_	.	_	.	50	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	50	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	50	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	50	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	50	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	50	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
7	,	_	,	_	,	50	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	50	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	50	_	_	_	_	_	_	_	S-Rank
10	levels	_	level	_	NNS	50	_	_	_	_	_	level.n	Rank	O
11	are	_	be	_	VBP	50	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	50	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	50	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	50	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	50	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	50	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	50	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	50	_	_	_	_	_	_	_	O
21	to	_	to	_	TO	50	_	_	_	_	_	_	_	O
22	58	_	UNK	_	CD	50	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
24	(	_	(	_	(	50	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	50	_	_	_	_	_	_	_	O
26	)	_	)	_	)	50	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	50	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	50	_	_	_	_	_	_	_	O
29	:	_	:	_	:	50	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	50	_	_	_	_	_	_	_	O
31	advice	_	advice	_	NN	50	_	_	_	_	_	_	_	O
32	about	_	about	_	IN	50	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	50	_	_	_	_	_	_	_	O
34	,	_	,	_	,	50	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	50	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	50	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	50	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	O
40	treatment	_	treatment	_	NN	50	_	_	_	_	_	_	_	O
41	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	50	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	50	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	50	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	50	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	50	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	50	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	50	_	_	_	_	_	_	_	O
49	hba1c	_	UNK	_	NNP	50	_	_	_	_	_	_	_	O
50	level	_	level	_	NN	50	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	50	_	_	_	_	_	_	_	O
52	53	_	53	_	CD	50	_	_	_	_	_	_	_	O
53	unk	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
54	(	_	(	_	(	50	_	_	_	_	_	_	_	O
55	%	_	%	_	NN	50	_	_	_	_	_	_	_	O
56	)	_	)	_	)	50	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
58	intensify	_	intensify	_	JJ	50	_	_	_	_	_	_	_	O
59	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	O
60	treatment	_	treatment	_	NN	50	_	_	_	_	_	_	_	O
61	.	_	.	_	.	50	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	50	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	50	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	50	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	50	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	50	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
7	,	_	,	_	,	50	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	50	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	50	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	50	_	_	_	_	_	_	_	O
11	are	_	be	_	VBP	50	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	50	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	50	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	50	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	50	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	50	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	50	_	_	_	_	_	single.a	Sole_instance	O
18	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	S-Type
19	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	50	_	_	_	_	_	_	_	O
21	to	_	to	_	TO	50	_	_	_	_	_	_	_	O
22	58	_	UNK	_	CD	50	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
24	(	_	(	_	(	50	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	50	_	_	_	_	_	_	_	O
26	)	_	)	_	)	50	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	50	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	50	_	_	_	_	_	_	_	O
29	:	_	:	_	:	50	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	50	_	_	_	_	_	_	_	O
31	advice	_	advice	_	NN	50	_	_	_	_	_	_	_	O
32	about	_	about	_	IN	50	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	50	_	_	_	_	_	_	_	O
34	,	_	,	_	,	50	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	50	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	50	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	50	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	O
40	treatment	_	treatment	_	NN	50	_	_	_	_	_	_	_	O
41	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	50	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	50	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	50	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	50	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	50	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	50	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	50	_	_	_	_	_	_	_	O
49	hba1c	_	UNK	_	NNP	50	_	_	_	_	_	_	_	O
50	level	_	level	_	NN	50	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	50	_	_	_	_	_	_	_	O
52	53	_	53	_	CD	50	_	_	_	_	_	_	_	O
53	unk	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
54	(	_	(	_	(	50	_	_	_	_	_	_	_	O
55	%	_	%	_	NN	50	_	_	_	_	_	_	_	O
56	)	_	)	_	)	50	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
58	intensify	_	intensify	_	JJ	50	_	_	_	_	_	_	_	O
59	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	O
60	treatment	_	treatment	_	NN	50	_	_	_	_	_	_	_	O
61	.	_	.	_	.	50	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	50	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	50	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	50	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	50	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	50	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
7	,	_	,	_	,	50	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	50	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	50	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	50	_	_	_	_	_	_	_	O
11	are	_	be	_	VBP	50	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	50	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	50	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	50	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	50	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	50	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	50	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	50	_	_	_	_	_	rise.n	Change_position_on_a_scale	O
21	to	_	to	_	TO	50	_	_	_	_	_	_	_	B-Item
22	58	_	UNK	_	CD	50	_	_	_	_	_	_	_	I-Item
23	unk	_	UNK	_	NNS	50	_	_	_	_	_	_	_	I-Item
24	(	_	(	_	(	50	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	50	_	_	_	_	_	_	_	O
26	)	_	)	_	)	50	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	50	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	50	_	_	_	_	_	_	_	O
29	:	_	:	_	:	50	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	50	_	_	_	_	_	_	_	O
31	advice	_	advice	_	NN	50	_	_	_	_	_	_	_	O
32	about	_	about	_	IN	50	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	50	_	_	_	_	_	_	_	O
34	,	_	,	_	,	50	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	50	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	50	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	50	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	O
40	treatment	_	treatment	_	NN	50	_	_	_	_	_	_	_	O
41	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	50	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	50	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	50	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	50	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	50	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	50	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	50	_	_	_	_	_	_	_	O
49	hba1c	_	UNK	_	NNP	50	_	_	_	_	_	_	_	O
50	level	_	level	_	NN	50	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	50	_	_	_	_	_	_	_	O
52	53	_	53	_	CD	50	_	_	_	_	_	_	_	O
53	unk	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
54	(	_	(	_	(	50	_	_	_	_	_	_	_	O
55	%	_	%	_	NN	50	_	_	_	_	_	_	_	O
56	)	_	)	_	)	50	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
58	intensify	_	intensify	_	JJ	50	_	_	_	_	_	_	_	O
59	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	O
60	treatment	_	treatment	_	NN	50	_	_	_	_	_	_	_	O
61	.	_	.	_	.	50	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	50	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	50	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	50	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	50	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	50	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
7	,	_	,	_	,	50	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	50	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	50	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	50	_	_	_	_	_	_	_	O
11	are	_	be	_	VBP	50	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	50	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	50	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	50	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	50	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	50	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	50	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	50	_	_	_	_	_	_	_	O
21	to	_	to	_	TO	50	_	_	_	_	_	_	_	O
22	58	_	UNK	_	CD	50	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
24	(	_	(	_	(	50	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	50	_	_	_	_	_	_	_	O
26	)	_	)	_	)	50	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	50	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	50	_	_	_	_	_	_	_	O
29	:	_	:	_	:	50	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	50	_	_	_	_	_	reinforce.v	Cause_change_of_strength	O
31	advice	_	advice	_	NN	50	_	_	_	_	_	_	_	S-Patient
32	about	_	about	_	IN	50	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	50	_	_	_	_	_	_	_	O
34	,	_	,	_	,	50	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	50	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	50	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	50	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	O
40	treatment	_	treatment	_	NN	50	_	_	_	_	_	_	_	O
41	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	50	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	50	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	50	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	50	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	50	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	50	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	50	_	_	_	_	_	_	_	O
49	hba1c	_	UNK	_	NNP	50	_	_	_	_	_	_	_	O
50	level	_	level	_	NN	50	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	50	_	_	_	_	_	_	_	O
52	53	_	53	_	CD	50	_	_	_	_	_	_	_	O
53	unk	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
54	(	_	(	_	(	50	_	_	_	_	_	_	_	O
55	%	_	%	_	NN	50	_	_	_	_	_	_	_	O
56	)	_	)	_	)	50	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
58	intensify	_	intensify	_	JJ	50	_	_	_	_	_	_	_	O
59	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	O
60	treatment	_	treatment	_	NN	50	_	_	_	_	_	_	_	O
61	.	_	.	_	.	50	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	50	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	50	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	50	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	50	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	50	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
7	,	_	,	_	,	50	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	50	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	50	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	50	_	_	_	_	_	_	_	O
11	are	_	be	_	VBP	50	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	50	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	50	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	50	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	50	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	50	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	50	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	50	_	_	_	_	_	_	_	O
21	to	_	to	_	TO	50	_	_	_	_	_	_	_	O
22	58	_	UNK	_	CD	50	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
24	(	_	(	_	(	50	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	50	_	_	_	_	_	_	_	O
26	)	_	)	_	)	50	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	50	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	50	_	_	_	_	_	_	_	O
29	:	_	:	_	:	50	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	50	_	_	_	_	_	_	_	O
31	advice	_	advice	_	NN	50	_	_	_	_	_	_	_	O
32	about	_	about	_	IN	50	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	50	_	_	_	_	_	_	_	O
34	,	_	,	_	,	50	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	50	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	50	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	50	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	S-Patient
40	treatment	_	treatment	_	NN	50	_	_	_	_	_	treatment.n	Cure	O
41	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	50	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	50	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	50	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	50	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	50	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	50	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	50	_	_	_	_	_	_	_	O
49	hba1c	_	UNK	_	NNP	50	_	_	_	_	_	_	_	O
50	level	_	level	_	NN	50	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	50	_	_	_	_	_	_	_	O
52	53	_	53	_	CD	50	_	_	_	_	_	_	_	O
53	unk	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
54	(	_	(	_	(	50	_	_	_	_	_	_	_	O
55	%	_	%	_	NN	50	_	_	_	_	_	_	_	O
56	)	_	)	_	)	50	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
58	intensify	_	intensify	_	JJ	50	_	_	_	_	_	_	_	O
59	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	O
60	treatment	_	treatment	_	NN	50	_	_	_	_	_	_	_	O
61	.	_	.	_	.	50	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	50	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	50	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	50	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	50	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	50	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
7	,	_	,	_	,	50	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	50	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	50	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	50	_	_	_	_	_	_	_	O
11	are	_	be	_	VBP	50	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	50	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	50	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	50	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	50	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	50	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	50	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	50	_	_	_	_	_	_	_	O
21	to	_	to	_	TO	50	_	_	_	_	_	_	_	O
22	58	_	UNK	_	CD	50	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
24	(	_	(	_	(	50	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	50	_	_	_	_	_	_	_	O
26	)	_	)	_	)	50	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	50	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	50	_	_	_	_	_	_	_	O
29	:	_	:	_	:	50	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	50	_	_	_	_	_	_	_	O
31	advice	_	advice	_	NN	50	_	_	_	_	_	_	_	O
32	about	_	about	_	IN	50	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	50	_	_	_	_	_	_	_	O
34	,	_	,	_	,	50	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	50	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	50	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	50	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	O
40	treatment	_	treatment	_	NN	50	_	_	_	_	_	_	_	O
41	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	50	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	50	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	50	_	_	_	_	_	person.n	People	S-Person
45	to	_	to	_	TO	50	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	50	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	50	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	50	_	_	_	_	_	_	_	O
49	hba1c	_	UNK	_	NNP	50	_	_	_	_	_	_	_	O
50	level	_	level	_	NN	50	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	50	_	_	_	_	_	_	_	O
52	53	_	53	_	CD	50	_	_	_	_	_	_	_	O
53	unk	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
54	(	_	(	_	(	50	_	_	_	_	_	_	_	O
55	%	_	%	_	NN	50	_	_	_	_	_	_	_	O
56	)	_	)	_	)	50	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
58	intensify	_	intensify	_	JJ	50	_	_	_	_	_	_	_	O
59	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	O
60	treatment	_	treatment	_	NN	50	_	_	_	_	_	_	_	O
61	.	_	.	_	.	50	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	50	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	50	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	50	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	50	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	50	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
7	,	_	,	_	,	50	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	50	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	50	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	50	_	_	_	_	_	_	_	O
11	are	_	be	_	VBP	50	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	50	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	50	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	50	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	50	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	50	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	50	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	50	_	_	_	_	_	_	_	O
21	to	_	to	_	TO	50	_	_	_	_	_	_	_	O
22	58	_	UNK	_	CD	50	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
24	(	_	(	_	(	50	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	50	_	_	_	_	_	_	_	O
26	)	_	)	_	)	50	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	50	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	50	_	_	_	_	_	_	_	O
29	:	_	:	_	:	50	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	50	_	_	_	_	_	_	_	O
31	advice	_	advice	_	NN	50	_	_	_	_	_	_	_	O
32	about	_	about	_	IN	50	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	50	_	_	_	_	_	_	_	O
34	,	_	,	_	,	50	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	50	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	50	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	50	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	O
40	treatment	_	treatment	_	NN	50	_	_	_	_	_	_	_	O
41	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	50	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	50	_	_	_	_	_	_	_	B-Agent
44	person	_	person	_	NN	50	_	_	_	_	_	_	_	I-Agent
45	to	_	to	_	TO	50	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	50	_	_	_	_	_	aim.v	Purpose	O
47	for	_	for	_	IN	50	_	_	_	_	_	_	_	B-Goal
48	an	_	an	_	DT	50	_	_	_	_	_	_	_	I-Goal
49	hba1c	_	UNK	_	NNP	50	_	_	_	_	_	_	_	I-Goal
50	level	_	level	_	NN	50	_	_	_	_	_	_	_	I-Goal
51	of	_	of	_	IN	50	_	_	_	_	_	_	_	I-Goal
52	53	_	53	_	CD	50	_	_	_	_	_	_	_	I-Goal
53	unk	_	UNK	_	NNS	50	_	_	_	_	_	_	_	I-Goal
54	(	_	(	_	(	50	_	_	_	_	_	_	_	I-Goal
55	%	_	%	_	NN	50	_	_	_	_	_	_	_	I-Goal
56	)	_	)	_	)	50	_	_	_	_	_	_	_	I-Goal
57	and	_	and	_	CC	50	_	_	_	_	_	_	_	I-Goal
58	intensify	_	intensify	_	JJ	50	_	_	_	_	_	_	_	I-Goal
59	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	I-Goal
60	treatment	_	treatment	_	NN	50	_	_	_	_	_	_	_	I-Goal
61	.	_	.	_	.	50	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	50	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	50	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	50	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	50	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	50	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
7	,	_	,	_	,	50	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	50	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	50	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	50	_	_	_	_	_	_	_	O
11	are	_	be	_	VBP	50	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	50	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	50	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	50	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	50	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	50	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	50	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	50	_	_	_	_	_	_	_	O
21	to	_	to	_	TO	50	_	_	_	_	_	_	_	O
22	58	_	UNK	_	CD	50	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
24	(	_	(	_	(	50	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	50	_	_	_	_	_	_	_	O
26	)	_	)	_	)	50	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	50	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	50	_	_	_	_	_	_	_	O
29	:	_	:	_	:	50	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	50	_	_	_	_	_	_	_	O
31	advice	_	advice	_	NN	50	_	_	_	_	_	_	_	O
32	about	_	about	_	IN	50	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	50	_	_	_	_	_	_	_	O
34	,	_	,	_	,	50	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	50	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	50	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	50	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	O
40	treatment	_	treatment	_	NN	50	_	_	_	_	_	_	_	O
41	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	50	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	50	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	50	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	50	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	50	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	50	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	50	_	_	_	_	_	_	_	O
49	hba1c	_	UNK	_	NNP	50	_	_	_	_	_	_	_	O
50	level	_	level	_	NN	50	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	50	_	_	_	_	_	_	_	O
52	53	_	53	_	CD	50	_	_	_	_	_	_	_	O
53	unk	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
54	(	_	(	_	(	50	_	_	_	_	_	_	_	O
55	%	_	%	_	NN	50	_	_	_	_	_	_	_	O
56	)	_	)	_	)	50	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	50	_	_	_	_	_	_	_	O
58	intensify	_	intensify	_	JJ	50	_	_	_	_	_	_	_	O
59	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	S-Patient
60	treatment	_	treatment	_	NN	50	_	_	_	_	_	treatment.n	Cure	O
61	.	_	.	_	.	50	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	52	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	52	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	52	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	52	_	_	_	_	_	_	_	O
6	:	_	:	_	:	52	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	52	_	_	_	_	_	_	_	O
8	(	_	(	_	(	52	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
10	)	_	)	_	)	52	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	52	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	52	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
14	)	_	)	_	)	52	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	52	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	52	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	52	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	52	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	52	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	52	_	_	_	_	_	_	_	O
8	(	_	(	_	(	52	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
10	)	_	)	_	)	52	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	52	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	52	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
14	)	_	)	_	)	52	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	53	_	_	_	_	_	last.a	Relative_time	O
2	updated	_	update	_	VBD	53	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	53	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	53	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	53	_	_	_	_	_	_	_	O
9	,	_	,	_	,	53	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	53	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	53	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	53	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	53	_	_	_	_	_	_	_	O
20	,	_	,	_	,	53	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
27	:	_	:	_	:	53	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	53	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	53	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	53	_	_	_	_	_	_	_	O
36	,	_	,	_	,	53	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
39	,	_	,	_	,	53	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	53	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	53	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	53	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	53	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	53	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	53	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
61	,	_	,	_	,	53	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
64	,	_	,	_	,	53	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	53	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	53	_	_	_	_	_	_	_	O
72	,	_	,	_	,	53	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	53	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	53	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
80	,	_	,	_	,	53	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	53	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	53	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	53	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	53	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	53	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	53	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	53	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	53	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	53	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	53	_	_	_	_	_	_	_	O
101	,	_	,	_	,	53	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
104	,	_	,	_	,	53	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	53	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
109	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	53	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	53	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	53	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	53	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	53	_	_	_	_	_	_	_	O
9	,	_	,	_	,	53	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	53	_	_	_	_	_	particular.a	Idiosyncrasy	O
12	consideration	_	consideration	_	NN	53	_	_	_	_	_	_	_	S-Idiosyncrasy
13	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	53	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	53	_	_	_	_	_	_	_	O
20	,	_	,	_	,	53	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
27	:	_	:	_	:	53	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	53	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	53	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	53	_	_	_	_	_	_	_	O
36	,	_	,	_	,	53	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
39	,	_	,	_	,	53	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	53	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	53	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	53	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	53	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	53	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	53	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
61	,	_	,	_	,	53	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
64	,	_	,	_	,	53	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	53	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	53	_	_	_	_	_	_	_	O
72	,	_	,	_	,	53	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	53	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	53	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
80	,	_	,	_	,	53	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	53	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	53	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	53	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	53	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	53	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	53	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	53	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	53	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	53	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	53	_	_	_	_	_	_	_	O
101	,	_	,	_	,	53	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
104	,	_	,	_	,	53	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	53	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
109	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	53	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	53	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	53	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	53	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	53	_	_	_	_	_	_	_	O
9	,	_	,	_	,	53	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	53	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	53	_	_	_	_	_	consideration.n	Cogitation	O
13	for	_	for	_	IN	53	_	_	_	_	_	_	_	B-Topic
14	people	_	people	_	NNS	53	_	_	_	_	_	_	_	I-Topic
15	who	_	who	_	WP	53	_	_	_	_	_	_	_	I-Topic
16	are	_	be	_	VBP	53	_	_	_	_	_	_	_	I-Topic
17	older	_	older	_	JJR	53	_	_	_	_	_	_	_	I-Topic
18	or	_	or	_	CC	53	_	_	_	_	_	_	_	I-Topic
19	frail	_	frail	_	NN	53	_	_	_	_	_	_	_	I-Topic
20	,	_	,	_	,	53	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
27	:	_	:	_	:	53	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	53	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	53	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	53	_	_	_	_	_	_	_	O
36	,	_	,	_	,	53	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
39	,	_	,	_	,	53	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	53	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	53	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	53	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	53	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	53	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	53	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
61	,	_	,	_	,	53	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
64	,	_	,	_	,	53	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	53	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	53	_	_	_	_	_	_	_	O
72	,	_	,	_	,	53	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	53	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	53	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
80	,	_	,	_	,	53	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	53	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	53	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	53	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	53	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	53	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	53	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	53	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	53	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	53	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	53	_	_	_	_	_	_	_	O
101	,	_	,	_	,	53	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
104	,	_	,	_	,	53	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	53	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
109	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	53	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	53	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	53	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	53	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	53	_	_	_	_	_	_	_	O
9	,	_	,	_	,	53	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	53	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	53	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	53	_	_	_	_	_	people.n	People	S-Person
15	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	53	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	53	_	_	_	_	_	_	_	O
20	,	_	,	_	,	53	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
27	:	_	:	_	:	53	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	53	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	53	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	53	_	_	_	_	_	_	_	O
36	,	_	,	_	,	53	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
39	,	_	,	_	,	53	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	53	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	53	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	53	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	53	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	53	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	53	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
61	,	_	,	_	,	53	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
64	,	_	,	_	,	53	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	53	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	53	_	_	_	_	_	_	_	O
72	,	_	,	_	,	53	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	53	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	53	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
80	,	_	,	_	,	53	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	53	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	53	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	53	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	53	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	53	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	53	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	53	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	53	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	53	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	53	_	_	_	_	_	_	_	O
101	,	_	,	_	,	53	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
104	,	_	,	_	,	53	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	53	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
109	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	53	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	53	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	53	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	53	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	53	_	_	_	_	_	_	_	O
9	,	_	,	_	,	53	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	53	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	53	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	53	_	_	_	_	_	_	_	S-Resisting_entity
16	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	53	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	53	_	_	_	_	_	frail.a	Level_of_force_resistance	O
20	,	_	,	_	,	53	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
27	:	_	:	_	:	53	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	53	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	53	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	53	_	_	_	_	_	_	_	O
36	,	_	,	_	,	53	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
39	,	_	,	_	,	53	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	53	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	53	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	53	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	53	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	53	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	53	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
61	,	_	,	_	,	53	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
64	,	_	,	_	,	53	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	53	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	53	_	_	_	_	_	_	_	O
72	,	_	,	_	,	53	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	53	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	53	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
80	,	_	,	_	,	53	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	53	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	53	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	53	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	53	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	53	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	53	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	53	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	53	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	53	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	53	_	_	_	_	_	_	_	O
101	,	_	,	_	,	53	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
104	,	_	,	_	,	53	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	53	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
109	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	53	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	53	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	53	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	53	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	53	_	_	_	_	_	_	_	O
9	,	_	,	_	,	53	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	53	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	53	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	53	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	53	_	_	_	_	_	_	_	O
20	,	_	,	_	,	53	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	53	_	_	_	_	_	adult.n	People_by_age	S-Person
23	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
27	:	_	:	_	:	53	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	53	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	53	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	53	_	_	_	_	_	_	_	O
36	,	_	,	_	,	53	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
39	,	_	,	_	,	53	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	53	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	53	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	53	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	53	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	53	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	53	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
61	,	_	,	_	,	53	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
64	,	_	,	_	,	53	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	53	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	53	_	_	_	_	_	_	_	O
72	,	_	,	_	,	53	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	53	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	53	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
80	,	_	,	_	,	53	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	53	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	53	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	53	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	53	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	53	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	53	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	53	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	53	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	53	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	53	_	_	_	_	_	_	_	O
101	,	_	,	_	,	53	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
104	,	_	,	_	,	53	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	53	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
109	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	53	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	53	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	53	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	53	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	53	_	_	_	_	_	_	_	O
9	,	_	,	_	,	53	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	53	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	53	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	53	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	53	_	_	_	_	_	_	_	O
20	,	_	,	_	,	53	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	53	_	_	_	_	_	type.n	Type	S-Subtype
25	2	_	2	_	CD	53	_	_	_	_	_	_	_	B-Category
26	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	I-Category
27	:	_	:	_	:	53	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	53	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	53	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	53	_	_	_	_	_	_	_	O
36	,	_	,	_	,	53	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
39	,	_	,	_	,	53	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	53	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	53	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	53	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	53	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	53	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	53	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
61	,	_	,	_	,	53	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
64	,	_	,	_	,	53	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	53	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	53	_	_	_	_	_	_	_	O
72	,	_	,	_	,	53	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	53	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	53	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
80	,	_	,	_	,	53	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	53	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	53	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	53	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	53	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	53	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	53	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	53	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	53	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	53	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	53	_	_	_	_	_	_	_	O
101	,	_	,	_	,	53	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
104	,	_	,	_	,	53	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	53	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
109	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	53	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	53	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	53	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	53	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	53	_	_	_	_	_	_	_	O
9	,	_	,	_	,	53	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	53	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	53	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	53	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	53	_	_	_	_	_	_	_	O
20	,	_	,	_	,	53	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
27	:	_	:	_	:	53	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	53	_	_	_	_	_	_	_	S-Hypothetical_event
29	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	53	_	_	_	_	_	unlikely.a	Likelihood	O
31	to	_	to	_	TO	53	_	_	_	_	_	_	_	B-Hypothetical_event
32	achieve	_	achieve	_	VB	53	_	_	_	_	_	_	_	I-Hypothetical_event
33	longer-term	_	UNK	_	JJ	53	_	_	_	_	_	_	_	I-Hypothetical_event
34	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	I-Hypothetical_event
35	benefits	_	benefit	_	NNS	53	_	_	_	_	_	_	_	I-Hypothetical_event
36	,	_	,	_	,	53	_	_	_	_	_	_	_	I-Hypothetical_event
37	for	_	for	_	IN	53	_	_	_	_	_	_	_	I-Hypothetical_event
38	example	_	example	_	NN	53	_	_	_	_	_	_	_	I-Hypothetical_event
39	,	_	,	_	,	53	_	_	_	_	_	_	_	I-Hypothetical_event
40	people	_	people	_	NNS	53	_	_	_	_	_	_	_	I-Hypothetical_event
41	with	_	with	_	IN	53	_	_	_	_	_	_	_	I-Hypothetical_event
42	a	_	a	_	DT	53	_	_	_	_	_	_	_	I-Hypothetical_event
43	reduced	_	UNK	_	JJ	53	_	_	_	_	_	_	_	I-Hypothetical_event
44	life	_	life	_	NN	53	_	_	_	_	_	_	_	I-Hypothetical_event
45	expectancy	_	UNK	_	NN	53	_	_	_	_	_	_	_	I-Hypothetical_event
46	for	_	for	_	IN	53	_	_	_	_	_	_	_	I-Hypothetical_event
47	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	I-Hypothetical_event
48	tight	_	UNK	_	JJ	53	_	_	_	_	_	_	_	I-Hypothetical_event
49	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	I-Hypothetical_event
50	glucose	_	UNK	_	VB	53	_	_	_	_	_	_	_	I-Hypothetical_event
51	control	_	control	_	NN	53	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	53	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	53	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	53	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
61	,	_	,	_	,	53	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
64	,	_	,	_	,	53	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	53	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	53	_	_	_	_	_	_	_	O
72	,	_	,	_	,	53	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	53	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	53	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
80	,	_	,	_	,	53	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	53	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	53	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	53	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	53	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	53	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	53	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	53	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	53	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	53	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	53	_	_	_	_	_	_	_	O
101	,	_	,	_	,	53	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
104	,	_	,	_	,	53	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	53	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
109	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	53	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	53	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	53	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	53	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	53	_	_	_	_	_	_	_	O
9	,	_	,	_	,	53	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	53	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	53	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	53	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	53	_	_	_	_	_	_	_	O
20	,	_	,	_	,	53	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
27	:	_	:	_	:	53	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	53	_	_	_	_	_	_	_	S-Agent
29	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	53	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	53	_	_	_	_	_	achieve.v	Accomplishment	O
33	longer-term	_	UNK	_	JJ	53	_	_	_	_	_	_	_	B-Goal
34	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	I-Goal
35	benefits	_	benefit	_	NNS	53	_	_	_	_	_	_	_	I-Goal
36	,	_	,	_	,	53	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
39	,	_	,	_	,	53	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	53	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	53	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	53	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	53	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	53	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	53	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
61	,	_	,	_	,	53	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
64	,	_	,	_	,	53	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	53	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	53	_	_	_	_	_	_	_	O
72	,	_	,	_	,	53	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	53	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	53	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
80	,	_	,	_	,	53	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	53	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	53	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	53	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	53	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	53	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	53	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	53	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	53	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	53	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	53	_	_	_	_	_	_	_	O
101	,	_	,	_	,	53	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
104	,	_	,	_	,	53	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	53	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
109	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	53	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	53	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	53	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	53	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	53	_	_	_	_	_	_	_	O
9	,	_	,	_	,	53	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	53	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	53	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	53	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	53	_	_	_	_	_	_	_	O
20	,	_	,	_	,	53	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
27	:	_	:	_	:	53	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	53	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	53	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	53	_	_	_	_	_	_	_	O
36	,	_	,	_	,	53	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	53	_	_	_	_	_	example.n	Instance	S-Instance
39	,	_	,	_	,	53	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	53	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	53	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	53	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	53	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	53	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	53	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
61	,	_	,	_	,	53	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
64	,	_	,	_	,	53	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	53	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	53	_	_	_	_	_	_	_	O
72	,	_	,	_	,	53	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	53	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	53	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
80	,	_	,	_	,	53	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	53	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	53	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	53	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	53	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	53	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	53	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	53	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	53	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	53	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	53	_	_	_	_	_	_	_	O
101	,	_	,	_	,	53	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
104	,	_	,	_	,	53	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	53	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
109	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	53	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	53	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	53	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	53	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	53	_	_	_	_	_	_	_	O
9	,	_	,	_	,	53	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	53	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	53	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	53	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	53	_	_	_	_	_	_	_	O
20	,	_	,	_	,	53	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
27	:	_	:	_	:	53	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	53	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	53	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	53	_	_	_	_	_	_	_	O
36	,	_	,	_	,	53	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
39	,	_	,	_	,	53	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	53	_	_	_	_	_	people.n	People	S-Person
41	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	53	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	53	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	53	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	53	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	53	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	53	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
61	,	_	,	_	,	53	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
64	,	_	,	_	,	53	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	53	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	53	_	_	_	_	_	_	_	O
72	,	_	,	_	,	53	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	53	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	53	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
80	,	_	,	_	,	53	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	53	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	53	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	53	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	53	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	53	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	53	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	53	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	53	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	53	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	53	_	_	_	_	_	_	_	O
101	,	_	,	_	,	53	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
104	,	_	,	_	,	53	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	53	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
109	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	53	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	53	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	53	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	53	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	53	_	_	_	_	_	_	_	O
9	,	_	,	_	,	53	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	53	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	53	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	53	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	53	_	_	_	_	_	_	_	O
20	,	_	,	_	,	53	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
27	:	_	:	_	:	53	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	53	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	53	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	53	_	_	_	_	_	_	_	O
36	,	_	,	_	,	53	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
39	,	_	,	_	,	53	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	53	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	B-Simulated_entity
50	glucose	_	UNK	_	VB	53	_	_	_	_	_	_	_	I-Simulated_entity
51	control	_	control	_	NN	53	_	_	_	_	_	_	_	I-Simulated_entity
52	poses	_	pose	_	VBZ	53	_	_	_	_	_	pose.v	Posing_as	O
53	a	_	a	_	DT	53	_	_	_	_	_	_	_	B-Simulated_entity
54	high	_	high	_	JJ	53	_	_	_	_	_	_	_	I-Simulated_entity
55	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	I-Simulated_entity
56	of	_	of	_	IN	53	_	_	_	_	_	_	_	I-Simulated_entity
57	the	_	the	_	DT	53	_	_	_	_	_	_	_	I-Simulated_entity
58	consequences	_	consequence	_	NNS	53	_	_	_	_	_	_	_	I-Simulated_entity
59	of	_	of	_	IN	53	_	_	_	_	_	_	_	I-Simulated_entity
60	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	I-Simulated_entity
61	,	_	,	_	,	53	_	_	_	_	_	_	_	I-Simulated_entity
62	for	_	for	_	IN	53	_	_	_	_	_	_	_	I-Simulated_entity
63	example	_	example	_	NN	53	_	_	_	_	_	_	_	I-Simulated_entity
64	,	_	,	_	,	53	_	_	_	_	_	_	_	I-Simulated_entity
65	people	_	people	_	NNS	53	_	_	_	_	_	_	_	I-Simulated_entity
66	who	_	who	_	WP	53	_	_	_	_	_	_	_	I-Simulated_entity
67	are	_	be	_	VBP	53	_	_	_	_	_	_	_	I-Simulated_entity
68	at	_	at	_	IN	53	_	_	_	_	_	_	_	I-Simulated_entity
69	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	I-Simulated_entity
70	of	_	of	_	IN	53	_	_	_	_	_	_	_	I-Simulated_entity
71	falling	_	fall	_	VBG	53	_	_	_	_	_	_	_	I-Simulated_entity
72	,	_	,	_	,	53	_	_	_	_	_	_	_	I-Simulated_entity
73	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	53	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	53	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
80	,	_	,	_	,	53	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	53	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	53	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	53	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	53	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	53	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	53	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	53	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	53	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	53	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	53	_	_	_	_	_	_	_	O
101	,	_	,	_	,	53	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
104	,	_	,	_	,	53	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	53	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
109	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	53	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	53	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	53	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	53	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	53	_	_	_	_	_	_	_	O
9	,	_	,	_	,	53	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	53	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	53	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	53	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	53	_	_	_	_	_	_	_	O
20	,	_	,	_	,	53	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
27	:	_	:	_	:	53	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	53	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	53	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	53	_	_	_	_	_	_	_	O
36	,	_	,	_	,	53	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
39	,	_	,	_	,	53	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	53	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	53	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	53	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	53	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	53	_	_	_	_	_	high.a	Position_on_a_scale	S-Value
55	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	S-Item
56	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	53	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
61	,	_	,	_	,	53	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
64	,	_	,	_	,	53	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	53	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	53	_	_	_	_	_	_	_	O
72	,	_	,	_	,	53	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	53	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	53	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
80	,	_	,	_	,	53	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	53	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	53	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	53	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	53	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	53	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	53	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	53	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	53	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	53	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	53	_	_	_	_	_	_	_	O
101	,	_	,	_	,	53	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
104	,	_	,	_	,	53	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	53	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
109	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	53	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	53	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	53	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	53	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	53	_	_	_	_	_	_	_	O
9	,	_	,	_	,	53	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	53	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	53	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	53	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	53	_	_	_	_	_	_	_	O
20	,	_	,	_	,	53	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
27	:	_	:	_	:	53	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	53	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	53	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	53	_	_	_	_	_	_	_	O
36	,	_	,	_	,	53	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
39	,	_	,	_	,	53	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	53	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	53	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	53	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	53	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	53	_	_	_	_	_	_	_	S-Bad_outcome
55	risk	_	risk	_	NN	53	_	_	_	_	_	risk.n	Run_risk	O
56	of	_	of	_	IN	53	_	_	_	_	_	_	_	B-Action
57	the	_	the	_	DT	53	_	_	_	_	_	_	_	I-Action
58	consequences	_	consequence	_	NNS	53	_	_	_	_	_	_	_	I-Action
59	of	_	of	_	IN	53	_	_	_	_	_	_	_	I-Action
60	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	I-Action
61	,	_	,	_	,	53	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
64	,	_	,	_	,	53	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	53	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	53	_	_	_	_	_	_	_	O
72	,	_	,	_	,	53	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	53	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	53	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
80	,	_	,	_	,	53	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	53	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	53	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	53	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	53	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	53	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	53	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	53	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	53	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	53	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	53	_	_	_	_	_	_	_	O
101	,	_	,	_	,	53	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
104	,	_	,	_	,	53	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	53	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
109	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	53	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	53	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	53	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	53	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	53	_	_	_	_	_	_	_	O
9	,	_	,	_	,	53	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	53	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	53	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	53	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	53	_	_	_	_	_	_	_	O
20	,	_	,	_	,	53	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
27	:	_	:	_	:	53	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	53	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	53	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	53	_	_	_	_	_	_	_	O
36	,	_	,	_	,	53	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
39	,	_	,	_	,	53	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	53	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	53	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	53	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	53	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	53	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	53	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
61	,	_	,	_	,	53	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	53	_	_	_	_	_	example.n	Instance	S-Instance
64	,	_	,	_	,	53	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	53	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	53	_	_	_	_	_	_	_	O
72	,	_	,	_	,	53	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	53	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	53	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
80	,	_	,	_	,	53	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	53	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	53	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	53	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	53	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	53	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	53	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	53	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	53	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	53	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	53	_	_	_	_	_	_	_	O
101	,	_	,	_	,	53	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
104	,	_	,	_	,	53	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	53	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
109	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	53	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	53	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	53	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	53	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	53	_	_	_	_	_	_	_	O
9	,	_	,	_	,	53	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	53	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	53	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	53	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	53	_	_	_	_	_	_	_	O
20	,	_	,	_	,	53	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
27	:	_	:	_	:	53	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	53	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	53	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	53	_	_	_	_	_	_	_	O
36	,	_	,	_	,	53	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
39	,	_	,	_	,	53	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	53	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	53	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	53	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	53	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	53	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	53	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
61	,	_	,	_	,	53	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
64	,	_	,	_	,	53	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	53	_	_	_	_	_	people.n	People	S-Person
66	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	53	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	53	_	_	_	_	_	_	_	O
72	,	_	,	_	,	53	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	53	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	53	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
80	,	_	,	_	,	53	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	53	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	53	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	53	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	53	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	53	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	53	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	53	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	53	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	53	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	53	_	_	_	_	_	_	_	O
101	,	_	,	_	,	53	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
104	,	_	,	_	,	53	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	53	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
109	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	53	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	53	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	53	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	53	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	53	_	_	_	_	_	_	_	O
9	,	_	,	_	,	53	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	53	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	53	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	53	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	53	_	_	_	_	_	_	_	O
20	,	_	,	_	,	53	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
27	:	_	:	_	:	53	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	53	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	53	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	53	_	_	_	_	_	_	_	O
36	,	_	,	_	,	53	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
39	,	_	,	_	,	53	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	53	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	53	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	53	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	53	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	53	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	53	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
61	,	_	,	_	,	53	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
64	,	_	,	_	,	53	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	53	_	_	_	_	_	_	_	B-Figure
66	who	_	who	_	WP	53	_	_	_	_	_	_	_	I-Figure
67	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	53	_	_	_	_	_	at.prep	Locative_relation	O
69	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	B-Ground
70	of	_	of	_	IN	53	_	_	_	_	_	_	_	I-Ground
71	falling	_	fall	_	VBG	53	_	_	_	_	_	_	_	I-Ground
72	,	_	,	_	,	53	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	53	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	53	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
80	,	_	,	_	,	53	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	53	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	53	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	53	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	53	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	53	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	53	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	53	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	53	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	53	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	53	_	_	_	_	_	_	_	O
101	,	_	,	_	,	53	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
104	,	_	,	_	,	53	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	53	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
109	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	53	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	53	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	53	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	53	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	53	_	_	_	_	_	_	_	O
9	,	_	,	_	,	53	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	53	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	53	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	53	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	53	_	_	_	_	_	_	_	O
20	,	_	,	_	,	53	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
27	:	_	:	_	:	53	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	53	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	53	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	53	_	_	_	_	_	_	_	O
36	,	_	,	_	,	53	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
39	,	_	,	_	,	53	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	53	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	53	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	53	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	53	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	53	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	53	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
61	,	_	,	_	,	53	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
64	,	_	,	_	,	53	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	53	_	_	_	_	_	_	_	B-Protagonist
66	who	_	who	_	WP	53	_	_	_	_	_	_	_	I-Protagonist
67	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	53	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	53	_	_	_	_	_	risk.n	Run_risk	O
70	of	_	of	_	IN	53	_	_	_	_	_	_	_	B-Asset
71	falling	_	fall	_	VBG	53	_	_	_	_	_	_	_	I-Asset
72	,	_	,	_	,	53	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	53	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	53	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
80	,	_	,	_	,	53	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	53	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	53	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	53	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	53	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	53	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	53	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	53	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	53	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	53	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	53	_	_	_	_	_	_	_	O
101	,	_	,	_	,	53	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
104	,	_	,	_	,	53	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	53	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
109	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	53	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	53	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	53	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	53	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	53	_	_	_	_	_	_	_	O
9	,	_	,	_	,	53	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	53	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	53	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	53	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	53	_	_	_	_	_	_	_	O
20	,	_	,	_	,	53	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
27	:	_	:	_	:	53	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	53	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	53	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	53	_	_	_	_	_	_	_	O
36	,	_	,	_	,	53	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
39	,	_	,	_	,	53	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	53	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	53	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	53	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	53	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	53	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	53	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
61	,	_	,	_	,	53	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
64	,	_	,	_	,	53	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	53	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	53	_	_	_	_	_	_	_	O
72	,	_	,	_	,	53	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	53	_	_	_	_	_	people.n	People	S-Person
74	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	53	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	53	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
80	,	_	,	_	,	53	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	53	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	53	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	53	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	53	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	53	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	53	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	53	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	53	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	53	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	53	_	_	_	_	_	_	_	O
101	,	_	,	_	,	53	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
104	,	_	,	_	,	53	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	53	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
109	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	53	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	53	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	53	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	53	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	53	_	_	_	_	_	_	_	O
9	,	_	,	_	,	53	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	53	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	53	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	53	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	53	_	_	_	_	_	_	_	O
20	,	_	,	_	,	53	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
27	:	_	:	_	:	53	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	53	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	53	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	53	_	_	_	_	_	_	_	O
36	,	_	,	_	,	53	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
39	,	_	,	_	,	53	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	53	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	53	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	53	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	53	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	53	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	53	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
61	,	_	,	_	,	53	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
64	,	_	,	_	,	53	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	53	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	53	_	_	_	_	_	_	_	O
72	,	_	,	_	,	53	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	53	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	53	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
80	,	_	,	_	,	53	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	53	_	_	_	_	_	people.n	People	S-Person
83	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	53	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	53	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	53	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	53	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	53	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	53	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	53	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	53	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	53	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	53	_	_	_	_	_	_	_	O
101	,	_	,	_	,	53	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
104	,	_	,	_	,	53	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	53	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
109	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	53	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	53	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	53	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	53	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	53	_	_	_	_	_	_	_	O
9	,	_	,	_	,	53	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	53	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	53	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	53	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	53	_	_	_	_	_	_	_	O
20	,	_	,	_	,	53	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
27	:	_	:	_	:	53	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	53	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	53	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	53	_	_	_	_	_	_	_	O
36	,	_	,	_	,	53	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
39	,	_	,	_	,	53	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	53	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	53	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	53	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	53	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	53	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	53	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
61	,	_	,	_	,	53	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
64	,	_	,	_	,	53	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	53	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	53	_	_	_	_	_	_	_	O
72	,	_	,	_	,	53	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	53	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	53	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
80	,	_	,	_	,	53	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	53	_	_	_	_	_	_	_	B-Agent
83	who	_	who	_	WP	53	_	_	_	_	_	_	_	I-Agent
84	drive	_	drive	_	VBP	53	_	_	_	_	_	drive.v	Subjective_influence	O
85	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	53	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	53	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	53	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	53	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	53	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	53	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	53	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	53	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	53	_	_	_	_	_	_	_	O
101	,	_	,	_	,	53	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
104	,	_	,	_	,	53	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	53	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
109	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	53	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	53	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	53	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	53	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	53	_	_	_	_	_	_	_	O
9	,	_	,	_	,	53	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	53	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	53	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	53	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	53	_	_	_	_	_	_	_	O
20	,	_	,	_	,	53	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
27	:	_	:	_	:	53	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	53	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	53	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	53	_	_	_	_	_	_	_	O
36	,	_	,	_	,	53	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
39	,	_	,	_	,	53	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	53	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	53	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	53	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	53	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	53	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	53	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
61	,	_	,	_	,	53	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
64	,	_	,	_	,	53	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	53	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	53	_	_	_	_	_	_	_	O
72	,	_	,	_	,	53	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	53	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	53	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
80	,	_	,	_	,	53	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	53	_	_	_	_	_	_	_	B-Operator
83	who	_	who	_	WP	53	_	_	_	_	_	_	_	I-Operator
84	drive	_	drive	_	VBP	53	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	53	_	_	_	_	_	operate.v	Operating_a_system	O
87	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	S-System
88	as	_	a	_	IN	53	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	53	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	53	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	53	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	53	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	53	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	53	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	53	_	_	_	_	_	_	_	O
101	,	_	,	_	,	53	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
104	,	_	,	_	,	53	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	53	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
109	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	53	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	53	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	53	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	53	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	53	_	_	_	_	_	_	_	O
9	,	_	,	_	,	53	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	53	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	53	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	53	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	53	_	_	_	_	_	_	_	O
20	,	_	,	_	,	53	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
27	:	_	:	_	:	53	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	53	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	53	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	53	_	_	_	_	_	_	_	O
36	,	_	,	_	,	53	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
39	,	_	,	_	,	53	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	53	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	53	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	53	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	53	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	53	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	53	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
61	,	_	,	_	,	53	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
64	,	_	,	_	,	53	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	53	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	53	_	_	_	_	_	_	_	O
72	,	_	,	_	,	53	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	53	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	53	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
80	,	_	,	_	,	53	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	53	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	53	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	53	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	53	_	_	_	_	_	part.n	Part_whole	S-Part
90	of	_	of	_	IN	53	_	_	_	_	_	_	_	B-Whole
91	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	I-Whole
92	job	_	job	_	NN	53	_	_	_	_	_	_	_	I-Whole
93	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	53	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	53	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	53	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	53	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	53	_	_	_	_	_	_	_	O
101	,	_	,	_	,	53	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
104	,	_	,	_	,	53	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	53	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
109	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	53	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	53	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	53	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	53	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	53	_	_	_	_	_	_	_	O
9	,	_	,	_	,	53	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	53	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	53	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	53	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	53	_	_	_	_	_	_	_	O
20	,	_	,	_	,	53	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
27	:	_	:	_	:	53	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	53	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	53	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	53	_	_	_	_	_	_	_	O
36	,	_	,	_	,	53	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
39	,	_	,	_	,	53	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	53	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	53	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	53	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	53	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	53	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	53	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
61	,	_	,	_	,	53	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
64	,	_	,	_	,	53	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	53	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	53	_	_	_	_	_	_	_	O
72	,	_	,	_	,	53	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	53	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	53	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
80	,	_	,	_	,	53	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	53	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	53	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	53	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	53	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	S-Employee
92	job	_	job	_	NN	53	_	_	_	_	_	job.n	Being_employed	O
93	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	53	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	53	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	53	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	53	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	53	_	_	_	_	_	_	_	O
101	,	_	,	_	,	53	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
104	,	_	,	_	,	53	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	53	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
109	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	53	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	53	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	53	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	53	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	53	_	_	_	_	_	_	_	O
9	,	_	,	_	,	53	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	53	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	53	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	53	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	53	_	_	_	_	_	_	_	O
20	,	_	,	_	,	53	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
27	:	_	:	_	:	53	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	53	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	53	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	53	_	_	_	_	_	_	_	O
36	,	_	,	_	,	53	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
39	,	_	,	_	,	53	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	53	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	53	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	53	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	53	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	53	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	53	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
61	,	_	,	_	,	53	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
64	,	_	,	_	,	53	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	53	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	53	_	_	_	_	_	_	_	O
72	,	_	,	_	,	53	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	53	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	53	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
80	,	_	,	_	,	53	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	53	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	53	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	53	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	53	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	53	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	53	_	_	_	_	_	_	_	B-Evaluee
96	management	_	management	_	NN	53	_	_	_	_	_	_	_	I-Evaluee
97	would	_	would	_	MD	53	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	53	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	53	_	_	_	_	_	appropriate.a	Suitability	O
101	,	_	,	_	,	53	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
104	,	_	,	_	,	53	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	53	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
109	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	53	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	53	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	53	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	53	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	53	_	_	_	_	_	_	_	O
9	,	_	,	_	,	53	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	53	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	53	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	53	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	53	_	_	_	_	_	_	_	O
20	,	_	,	_	,	53	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
27	:	_	:	_	:	53	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	53	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	53	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	53	_	_	_	_	_	_	_	O
36	,	_	,	_	,	53	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
39	,	_	,	_	,	53	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	53	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	53	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	53	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	53	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	53	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	53	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
61	,	_	,	_	,	53	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
64	,	_	,	_	,	53	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	53	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	53	_	_	_	_	_	_	_	O
72	,	_	,	_	,	53	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	53	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	53	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
80	,	_	,	_	,	53	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	53	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	53	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	53	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	53	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	53	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	53	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	53	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	53	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	53	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	53	_	_	_	_	_	_	_	O
101	,	_	,	_	,	53	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	53	_	_	_	_	_	example.n	Instance	S-Instance
104	,	_	,	_	,	53	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	53	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
109	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	53	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	53	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	53	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	53	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	53	_	_	_	_	_	_	_	O
9	,	_	,	_	,	53	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	53	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	53	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	53	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	53	_	_	_	_	_	_	_	O
20	,	_	,	_	,	53	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
27	:	_	:	_	:	53	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	53	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	53	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	53	_	_	_	_	_	_	_	O
36	,	_	,	_	,	53	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
39	,	_	,	_	,	53	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	53	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	53	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	53	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	53	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	53	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	53	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
61	,	_	,	_	,	53	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
64	,	_	,	_	,	53	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	53	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	53	_	_	_	_	_	_	_	O
72	,	_	,	_	,	53	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	53	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	53	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
80	,	_	,	_	,	53	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	53	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	53	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	53	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	53	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	53	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	53	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	53	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	53	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	53	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	53	_	_	_	_	_	_	_	O
101	,	_	,	_	,	53	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
104	,	_	,	_	,	53	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	53	_	_	_	_	_	people.n	People	S-Person
106	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	53	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
109	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	53	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	53	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	53	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	53	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	53	_	_	_	_	_	_	_	O
9	,	_	,	_	,	53	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	53	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	53	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	53	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	53	_	_	_	_	_	_	_	O
20	,	_	,	_	,	53	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
27	:	_	:	_	:	53	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	53	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	53	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	53	_	_	_	_	_	_	_	O
36	,	_	,	_	,	53	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
39	,	_	,	_	,	53	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	53	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	53	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	53	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	53	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	53	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	53	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
61	,	_	,	_	,	53	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
64	,	_	,	_	,	53	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	53	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	53	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	53	_	_	_	_	_	_	_	O
72	,	_	,	_	,	53	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	53	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	53	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
80	,	_	,	_	,	53	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	53	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	53	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	53	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	53	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	53	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	53	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	53	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	53	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	53	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	53	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	53	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	53	_	_	_	_	_	_	_	O
101	,	_	,	_	,	53	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	53	_	_	_	_	_	_	_	O
104	,	_	,	_	,	53	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	53	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	53	_	_	_	_	_	significant.a	Importance	O
108	comorbidities	_	UNK	_	NNS	53	_	_	_	_	_	_	_	S-Factor
109	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	54	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	54	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	54	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	54	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	54	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	54	_	_	_	_	_	_	_	O
7	achieve	_	achieve	_	VBP	54	_	_	_	_	_	_	_	O
8	an	_	an	_	DT	54	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	54	_	_	_	_	_	_	_	O
10	level	_	level	_	NN	54	_	_	_	_	_	_	_	O
11	that	_	that	_	WDT	54	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	54	_	_	_	_	_	_	_	O
13	lower	_	lower	_	JJR	54	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	54	_	_	_	_	_	_	_	O
15	their	_	their	_	PRP$	54	_	_	_	_	_	_	_	O
16	target	_	target	_	NN	54	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	54	_	_	_	_	_	_	_	O
18	they	_	they	_	PRP	54	_	_	_	_	_	_	_	O
19	are	_	be	_	VBP	54	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	54	_	_	_	_	_	_	_	O
21	experiencing	_	experience	_	VBG	54	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	54	_	_	_	_	_	_	_	O
23	,	_	,	_	,	54	_	_	_	_	_	_	_	O
24	encourage	_	encourage	_	VB	54	_	_	_	_	_	_	_	O
25	them	_	them	_	PRP	54	_	_	_	_	_	_	_	O
26	to	_	to	_	TO	54	_	_	_	_	_	_	_	O
27	maintain	_	maintain	_	VB	54	_	_	_	_	_	_	_	O
28	it	_	it	_	PRP	54	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	54	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	54	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	54	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	54	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	54	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	54	_	_	_	_	_	_	_	I-Category
7	achieve	_	achieve	_	VBP	54	_	_	_	_	_	_	_	O
8	an	_	an	_	DT	54	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	54	_	_	_	_	_	_	_	O
10	level	_	level	_	NN	54	_	_	_	_	_	_	_	O
11	that	_	that	_	WDT	54	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	54	_	_	_	_	_	_	_	O
13	lower	_	lower	_	JJR	54	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	54	_	_	_	_	_	_	_	O
15	their	_	their	_	PRP$	54	_	_	_	_	_	_	_	O
16	target	_	target	_	NN	54	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	54	_	_	_	_	_	_	_	O
18	they	_	they	_	PRP	54	_	_	_	_	_	_	_	O
19	are	_	be	_	VBP	54	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	54	_	_	_	_	_	_	_	O
21	experiencing	_	experience	_	VBG	54	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	54	_	_	_	_	_	_	_	O
23	,	_	,	_	,	54	_	_	_	_	_	_	_	O
24	encourage	_	encourage	_	VB	54	_	_	_	_	_	_	_	O
25	them	_	them	_	PRP	54	_	_	_	_	_	_	_	O
26	to	_	to	_	TO	54	_	_	_	_	_	_	_	O
27	maintain	_	maintain	_	VB	54	_	_	_	_	_	_	_	O
28	it	_	it	_	PRP	54	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	54	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	54	_	_	_	_	_	_	_	B-Agent
3	with	_	with	_	IN	54	_	_	_	_	_	_	_	I-Agent
4	type	_	type	_	JJ	54	_	_	_	_	_	_	_	I-Agent
5	2	_	2	_	CD	54	_	_	_	_	_	_	_	I-Agent
6	diabetes	_	UNK	_	NNS	54	_	_	_	_	_	_	_	I-Agent
7	achieve	_	achieve	_	VBP	54	_	_	_	_	_	achieve.v	Accomplishment	O
8	an	_	an	_	DT	54	_	_	_	_	_	_	_	B-Goal
9	hba1c	_	UNK	_	NNP	54	_	_	_	_	_	_	_	I-Goal
10	level	_	level	_	NN	54	_	_	_	_	_	_	_	I-Goal
11	that	_	that	_	WDT	54	_	_	_	_	_	_	_	I-Goal
12	is	_	be	_	VBZ	54	_	_	_	_	_	_	_	I-Goal
13	lower	_	lower	_	JJR	54	_	_	_	_	_	_	_	I-Goal
14	than	_	than	_	IN	54	_	_	_	_	_	_	_	I-Goal
15	their	_	their	_	PRP$	54	_	_	_	_	_	_	_	I-Goal
16	target	_	target	_	NN	54	_	_	_	_	_	_	_	I-Goal
17	and	_	and	_	CC	54	_	_	_	_	_	_	_	I-Goal
18	they	_	they	_	PRP	54	_	_	_	_	_	_	_	I-Goal
19	are	_	be	_	VBP	54	_	_	_	_	_	_	_	I-Goal
20	not	_	not	_	RB	54	_	_	_	_	_	_	_	I-Goal
21	experiencing	_	experience	_	VBG	54	_	_	_	_	_	_	_	I-Goal
22	unk	_	UNK	_	NN	54	_	_	_	_	_	_	_	I-Goal
23	,	_	,	_	,	54	_	_	_	_	_	_	_	O
24	encourage	_	encourage	_	VB	54	_	_	_	_	_	_	_	O
25	them	_	them	_	PRP	54	_	_	_	_	_	_	_	O
26	to	_	to	_	TO	54	_	_	_	_	_	_	_	O
27	maintain	_	maintain	_	VB	54	_	_	_	_	_	_	_	O
28	it	_	it	_	PRP	54	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	54	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	54	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	54	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	54	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	54	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	54	_	_	_	_	_	_	_	O
7	achieve	_	achieve	_	VBP	54	_	_	_	_	_	_	_	O
8	an	_	an	_	DT	54	_	_	_	_	_	_	_	B-Item
9	hba1c	_	UNK	_	NNP	54	_	_	_	_	_	_	_	I-Item
10	level	_	level	_	NN	54	_	_	_	_	_	_	_	I-Item
11	that	_	that	_	WDT	54	_	_	_	_	_	_	_	I-Item
12	is	_	be	_	VBZ	54	_	_	_	_	_	_	_	O
13	lower	_	lower	_	JJR	54	_	_	_	_	_	lower.v	Change_position_on_a_scale	O
14	than	_	than	_	IN	54	_	_	_	_	_	_	_	B-Attribute
15	their	_	their	_	PRP$	54	_	_	_	_	_	_	_	I-Attribute
16	target	_	target	_	NN	54	_	_	_	_	_	_	_	I-Attribute
17	and	_	and	_	CC	54	_	_	_	_	_	_	_	O
18	they	_	they	_	PRP	54	_	_	_	_	_	_	_	O
19	are	_	be	_	VBP	54	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	54	_	_	_	_	_	_	_	O
21	experiencing	_	experience	_	VBG	54	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	54	_	_	_	_	_	_	_	O
23	,	_	,	_	,	54	_	_	_	_	_	_	_	O
24	encourage	_	encourage	_	VB	54	_	_	_	_	_	_	_	O
25	them	_	them	_	PRP	54	_	_	_	_	_	_	_	O
26	to	_	to	_	TO	54	_	_	_	_	_	_	_	O
27	maintain	_	maintain	_	VB	54	_	_	_	_	_	_	_	O
28	it	_	it	_	PRP	54	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	54	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	54	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	54	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	54	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	54	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	54	_	_	_	_	_	_	_	O
7	achieve	_	achieve	_	VBP	54	_	_	_	_	_	_	_	O
8	an	_	an	_	DT	54	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	54	_	_	_	_	_	_	_	O
10	level	_	level	_	NN	54	_	_	_	_	_	_	_	O
11	that	_	that	_	WDT	54	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	54	_	_	_	_	_	_	_	O
13	lower	_	lower	_	JJR	54	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	54	_	_	_	_	_	_	_	O
15	their	_	their	_	PRP$	54	_	_	_	_	_	_	_	O
16	target	_	target	_	NN	54	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	54	_	_	_	_	_	_	_	O
18	they	_	they	_	PRP	54	_	_	_	_	_	_	_	S-Experiencer
19	are	_	be	_	VBP	54	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	54	_	_	_	_	_	_	_	O
21	experiencing	_	experience	_	VBG	54	_	_	_	_	_	experience.v	Feeling	O
22	unk	_	UNK	_	NN	54	_	_	_	_	_	_	_	S-Emotional_state
23	,	_	,	_	,	54	_	_	_	_	_	_	_	O
24	encourage	_	encourage	_	VB	54	_	_	_	_	_	_	_	O
25	them	_	them	_	PRP	54	_	_	_	_	_	_	_	O
26	to	_	to	_	TO	54	_	_	_	_	_	_	_	O
27	maintain	_	maintain	_	VB	54	_	_	_	_	_	_	_	O
28	it	_	it	_	PRP	54	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	54	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	54	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	54	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	54	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	54	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	54	_	_	_	_	_	_	_	O
7	achieve	_	achieve	_	VBP	54	_	_	_	_	_	_	_	O
8	an	_	an	_	DT	54	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	54	_	_	_	_	_	_	_	O
10	level	_	level	_	NN	54	_	_	_	_	_	_	_	O
11	that	_	that	_	WDT	54	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	54	_	_	_	_	_	_	_	O
13	lower	_	lower	_	JJR	54	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	54	_	_	_	_	_	_	_	O
15	their	_	their	_	PRP$	54	_	_	_	_	_	_	_	O
16	target	_	target	_	NN	54	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	54	_	_	_	_	_	_	_	O
18	they	_	they	_	PRP	54	_	_	_	_	_	_	_	S-Agent
19	are	_	be	_	VBP	54	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	54	_	_	_	_	_	_	_	O
21	experiencing	_	experience	_	VBG	54	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	54	_	_	_	_	_	_	_	O
23	,	_	,	_	,	54	_	_	_	_	_	_	_	O
24	encourage	_	encourage	_	VB	54	_	_	_	_	_	encourage.v	Subjective_influence	O
25	them	_	them	_	PRP	54	_	_	_	_	_	_	_	S-Situation
26	to	_	to	_	TO	54	_	_	_	_	_	_	_	O
27	maintain	_	maintain	_	VB	54	_	_	_	_	_	_	_	O
28	it	_	it	_	PRP	54	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	54	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	54	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	54	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	54	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	54	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	54	_	_	_	_	_	_	_	O
7	achieve	_	achieve	_	VBP	54	_	_	_	_	_	_	_	O
8	an	_	an	_	DT	54	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	54	_	_	_	_	_	_	_	O
10	level	_	level	_	NN	54	_	_	_	_	_	_	_	O
11	that	_	that	_	WDT	54	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	54	_	_	_	_	_	_	_	O
13	lower	_	lower	_	JJR	54	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	54	_	_	_	_	_	_	_	O
15	their	_	their	_	PRP$	54	_	_	_	_	_	_	_	O
16	target	_	target	_	NN	54	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	54	_	_	_	_	_	_	_	O
18	they	_	they	_	PRP	54	_	_	_	_	_	_	_	O
19	are	_	be	_	VBP	54	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	54	_	_	_	_	_	_	_	O
21	experiencing	_	experience	_	VBG	54	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	54	_	_	_	_	_	_	_	O
23	,	_	,	_	,	54	_	_	_	_	_	_	_	O
24	encourage	_	encourage	_	VB	54	_	_	_	_	_	_	_	O
25	them	_	them	_	PRP	54	_	_	_	_	_	_	_	S-Agent
26	to	_	to	_	TO	54	_	_	_	_	_	_	_	O
27	maintain	_	maintain	_	VB	54	_	_	_	_	_	maintain.v	Activity_ongoing	O
28	it	_	it	_	PRP	54	_	_	_	_	_	_	_	S-Activity

1	be	_	UNK	_	NNP	55	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	55	_	_	_	_	_	aware.a	Awareness	O
3	that	_	that	_	IN	55	_	_	_	_	_	_	_	B-Content
4	there	_	there	_	EX	55	_	_	_	_	_	_	_	I-Content
5	are	_	be	_	VBP	55	_	_	_	_	_	_	_	I-Content
6	other	_	other	_	JJ	55	_	_	_	_	_	_	_	I-Content
7	possible	_	possible	_	JJ	55	_	_	_	_	_	_	_	I-Content
8	reasons	_	reason	_	NNS	55	_	_	_	_	_	_	_	I-Content
9	for	_	for	_	IN	55	_	_	_	_	_	_	_	I-Content
10	a	_	a	_	DT	55	_	_	_	_	_	_	_	I-Content
11	low	_	low	_	JJ	55	_	_	_	_	_	_	_	I-Content
12	hba1c	_	UNK	_	NNP	55	_	_	_	_	_	_	_	I-Content
13	level	_	level	_	NN	55	_	_	_	_	_	_	_	I-Content
14	,	_	,	_	,	55	_	_	_	_	_	_	_	I-Content
15	for	_	for	_	IN	55	_	_	_	_	_	_	_	I-Content
16	example	_	example	_	NN	55	_	_	_	_	_	_	_	I-Content
17	,	_	,	_	,	55	_	_	_	_	_	_	_	I-Content
18	deteriorating	_	deteriorate	_	VBG	55	_	_	_	_	_	_	_	I-Content
19	renal	_	UNK	_	JJ	55	_	_	_	_	_	_	_	I-Content
20	function	_	function	_	NN	55	_	_	_	_	_	_	_	I-Content
21	or	_	or	_	CC	55	_	_	_	_	_	_	_	I-Content
22	sudden	_	sudden	_	JJ	55	_	_	_	_	_	_	_	I-Content
23	weight	_	weight	_	NN	55	_	_	_	_	_	_	_	O
24	loss	_	loss	_	NN	55	_	_	_	_	_	_	_	O
25	.	_	.	_	.	55	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	55	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	55	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	55	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	55	_	_	_	_	_	there.adv	Locative_relation	S-Ground
5	are	_	be	_	VBP	55	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	55	_	_	_	_	_	_	_	O
7	possible	_	possible	_	JJ	55	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	55	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	55	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	55	_	_	_	_	_	_	_	O
11	low	_	low	_	JJ	55	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	55	_	_	_	_	_	_	_	O
13	level	_	level	_	NN	55	_	_	_	_	_	_	_	O
14	,	_	,	_	,	55	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	55	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	55	_	_	_	_	_	_	_	O
17	,	_	,	_	,	55	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	55	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	55	_	_	_	_	_	_	_	O
20	function	_	function	_	NN	55	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	55	_	_	_	_	_	_	_	O
22	sudden	_	sudden	_	JJ	55	_	_	_	_	_	_	_	O
23	weight	_	weight	_	NN	55	_	_	_	_	_	_	_	O
24	loss	_	loss	_	NN	55	_	_	_	_	_	_	_	O
25	.	_	.	_	.	55	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	55	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	55	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	55	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	55	_	_	_	_	_	_	_	O
5	are	_	be	_	VBP	55	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	55	_	_	_	_	_	other.a	Increment	O
7	possible	_	possible	_	JJ	55	_	_	_	_	_	_	_	B-Class
8	reasons	_	reason	_	NNS	55	_	_	_	_	_	_	_	I-Class
9	for	_	for	_	IN	55	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	55	_	_	_	_	_	_	_	O
11	low	_	low	_	JJ	55	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	55	_	_	_	_	_	_	_	O
13	level	_	level	_	NN	55	_	_	_	_	_	_	_	O
14	,	_	,	_	,	55	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	55	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	55	_	_	_	_	_	_	_	O
17	,	_	,	_	,	55	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	55	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	55	_	_	_	_	_	_	_	O
20	function	_	function	_	NN	55	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	55	_	_	_	_	_	_	_	O
22	sudden	_	sudden	_	JJ	55	_	_	_	_	_	_	_	O
23	weight	_	weight	_	NN	55	_	_	_	_	_	_	_	O
24	loss	_	loss	_	NN	55	_	_	_	_	_	_	_	O
25	.	_	.	_	.	55	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	55	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	55	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	55	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	55	_	_	_	_	_	_	_	O
5	are	_	be	_	VBP	55	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	55	_	_	_	_	_	_	_	O
7	possible	_	possible	_	JJ	55	_	_	_	_	_	possible.a	Likelihood	O
8	reasons	_	reason	_	NNS	55	_	_	_	_	_	_	_	S-Hypothetical_event
9	for	_	for	_	IN	55	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	55	_	_	_	_	_	_	_	O
11	low	_	low	_	JJ	55	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	55	_	_	_	_	_	_	_	O
13	level	_	level	_	NN	55	_	_	_	_	_	_	_	O
14	,	_	,	_	,	55	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	55	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	55	_	_	_	_	_	_	_	O
17	,	_	,	_	,	55	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	55	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	55	_	_	_	_	_	_	_	O
20	function	_	function	_	NN	55	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	55	_	_	_	_	_	_	_	O
22	sudden	_	sudden	_	JJ	55	_	_	_	_	_	_	_	O
23	weight	_	weight	_	NN	55	_	_	_	_	_	_	_	O
24	loss	_	loss	_	NN	55	_	_	_	_	_	_	_	O
25	.	_	.	_	.	55	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	55	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	55	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	55	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	55	_	_	_	_	_	_	_	O
5	are	_	be	_	VBP	55	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	55	_	_	_	_	_	_	_	O
7	possible	_	possible	_	JJ	55	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	55	_	_	_	_	_	reason.n	Reason	S-State_of_affairs
9	for	_	for	_	IN	55	_	_	_	_	_	_	_	B-Action
10	a	_	a	_	DT	55	_	_	_	_	_	_	_	I-Action
11	low	_	low	_	JJ	55	_	_	_	_	_	_	_	I-Action
12	hba1c	_	UNK	_	NNP	55	_	_	_	_	_	_	_	I-Action
13	level	_	level	_	NN	55	_	_	_	_	_	_	_	I-Action
14	,	_	,	_	,	55	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	55	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	55	_	_	_	_	_	_	_	O
17	,	_	,	_	,	55	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	55	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	55	_	_	_	_	_	_	_	O
20	function	_	function	_	NN	55	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	55	_	_	_	_	_	_	_	O
22	sudden	_	sudden	_	JJ	55	_	_	_	_	_	_	_	O
23	weight	_	weight	_	NN	55	_	_	_	_	_	_	_	O
24	loss	_	loss	_	NN	55	_	_	_	_	_	_	_	O
25	.	_	.	_	.	55	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	55	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	55	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	55	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	55	_	_	_	_	_	_	_	O
5	are	_	be	_	VBP	55	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	55	_	_	_	_	_	_	_	O
7	possible	_	possible	_	JJ	55	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	55	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	55	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	55	_	_	_	_	_	_	_	O
11	low	_	low	_	JJ	55	_	_	_	_	_	low.a	Position_on_a_scale	S-Value
12	hba1c	_	UNK	_	NNP	55	_	_	_	_	_	_	_	B-Item
13	level	_	level	_	NN	55	_	_	_	_	_	_	_	I-Item
14	,	_	,	_	,	55	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	55	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	55	_	_	_	_	_	_	_	O
17	,	_	,	_	,	55	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	55	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	55	_	_	_	_	_	_	_	O
20	function	_	function	_	NN	55	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	55	_	_	_	_	_	_	_	O
22	sudden	_	sudden	_	JJ	55	_	_	_	_	_	_	_	O
23	weight	_	weight	_	NN	55	_	_	_	_	_	_	_	O
24	loss	_	loss	_	NN	55	_	_	_	_	_	_	_	O
25	.	_	.	_	.	55	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	55	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	55	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	55	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	55	_	_	_	_	_	_	_	O
5	are	_	be	_	VBP	55	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	55	_	_	_	_	_	_	_	O
7	possible	_	possible	_	JJ	55	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	55	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	55	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	55	_	_	_	_	_	_	_	O
11	low	_	low	_	JJ	55	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	55	_	_	_	_	_	_	_	O
13	level	_	level	_	NN	55	_	_	_	_	_	_	_	O
14	,	_	,	_	,	55	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	55	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	55	_	_	_	_	_	example.n	Instance	S-Instance
17	,	_	,	_	,	55	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	55	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	55	_	_	_	_	_	_	_	O
20	function	_	function	_	NN	55	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	55	_	_	_	_	_	_	_	O
22	sudden	_	sudden	_	JJ	55	_	_	_	_	_	_	_	O
23	weight	_	weight	_	NN	55	_	_	_	_	_	_	_	O
24	loss	_	loss	_	NN	55	_	_	_	_	_	_	_	O
25	.	_	.	_	.	55	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	55	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	55	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	55	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	55	_	_	_	_	_	_	_	O
5	are	_	be	_	VBP	55	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	55	_	_	_	_	_	_	_	O
7	possible	_	possible	_	JJ	55	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	55	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	55	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	55	_	_	_	_	_	_	_	O
11	low	_	low	_	JJ	55	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	55	_	_	_	_	_	_	_	O
13	level	_	level	_	NN	55	_	_	_	_	_	_	_	O
14	,	_	,	_	,	55	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	55	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	55	_	_	_	_	_	_	_	O
17	,	_	,	_	,	55	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	55	_	_	_	_	_	deteriorate.v	Improvement_or_decline	O
19	renal	_	UNK	_	JJ	55	_	_	_	_	_	_	_	B-Entity
20	function	_	function	_	NN	55	_	_	_	_	_	_	_	I-Entity
21	or	_	or	_	CC	55	_	_	_	_	_	_	_	I-Entity
22	sudden	_	sudden	_	JJ	55	_	_	_	_	_	_	_	I-Entity
23	weight	_	weight	_	NN	55	_	_	_	_	_	_	_	I-Entity
24	loss	_	loss	_	NN	55	_	_	_	_	_	_	_	I-Entity
25	.	_	.	_	.	55	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	55	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	55	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	55	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	55	_	_	_	_	_	_	_	O
5	are	_	be	_	VBP	55	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	55	_	_	_	_	_	_	_	O
7	possible	_	possible	_	JJ	55	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	55	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	55	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	55	_	_	_	_	_	_	_	O
11	low	_	low	_	JJ	55	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	55	_	_	_	_	_	_	_	O
13	level	_	level	_	NN	55	_	_	_	_	_	_	_	O
14	,	_	,	_	,	55	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	55	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	55	_	_	_	_	_	_	_	O
17	,	_	,	_	,	55	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	55	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	55	_	_	_	_	_	_	_	S-Determinant
20	function	_	function	_	NN	55	_	_	_	_	_	function.n	Contingency	O
21	or	_	or	_	CC	55	_	_	_	_	_	_	_	O
22	sudden	_	sudden	_	JJ	55	_	_	_	_	_	_	_	O
23	weight	_	weight	_	NN	55	_	_	_	_	_	_	_	B-Determinant
24	loss	_	loss	_	NN	55	_	_	_	_	_	_	_	I-Determinant
25	.	_	.	_	.	55	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	55	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	55	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	55	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	55	_	_	_	_	_	_	_	O
5	are	_	be	_	VBP	55	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	55	_	_	_	_	_	_	_	O
7	possible	_	possible	_	JJ	55	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	55	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	55	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	55	_	_	_	_	_	_	_	O
11	low	_	low	_	JJ	55	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	55	_	_	_	_	_	_	_	O
13	level	_	level	_	NN	55	_	_	_	_	_	_	_	O
14	,	_	,	_	,	55	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	55	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	55	_	_	_	_	_	_	_	O
17	,	_	,	_	,	55	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	55	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	55	_	_	_	_	_	_	_	O
20	function	_	function	_	NN	55	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	55	_	_	_	_	_	_	_	O
22	sudden	_	sudden	_	JJ	55	_	_	_	_	_	_	_	O
23	weight	_	weight	_	NN	55	_	_	_	_	_	weight.n	Dimension	S-Dimension
24	loss	_	loss	_	NN	55	_	_	_	_	_	_	_	O
25	.	_	.	_	.	55	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	56	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	56	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	56	_	_	_	_	_	_	_	O
4	hba1c	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
5	targets	_	target	_	NNS	56	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	56	_	_	_	_	_	_	_	O
7	women	_	woman	_	NNS	56	_	_	_	_	_	woman.n	People	S-Person
8	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
9	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
10	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
11	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
12	who	_	who	_	WP	56	_	_	_	_	_	_	_	O
13	are	_	be	_	VBP	56	_	_	_	_	_	_	_	O
14	pregnant	_	pregnant	_	JJ	56	_	_	_	_	_	_	_	O
15	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
16	planning	_	plan	_	VBG	56	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	56	_	_	_	_	_	_	_	O
18	become	_	become	_	VB	56	_	_	_	_	_	_	_	O
19	pregnant	_	pregnant	_	JJ	56	_	_	_	_	_	_	_	O
20	,	_	,	_	,	56	_	_	_	_	_	_	_	O
21	see	_	see	_	VB	56	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	56	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
24	guideline	_	guideline	_	NN	56	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	56	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
28	pregnancy	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
29	.	_	.	_	.	56	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	56	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	56	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	56	_	_	_	_	_	_	_	O
4	hba1c	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
5	targets	_	target	_	NNS	56	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	56	_	_	_	_	_	_	_	O
7	women	_	woman	_	NNS	56	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
9	type	_	type	_	JJ	56	_	_	_	_	_	type.n	Type	S-Subtype
10	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
11	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
12	who	_	who	_	WP	56	_	_	_	_	_	_	_	O
13	are	_	be	_	VBP	56	_	_	_	_	_	_	_	O
14	pregnant	_	pregnant	_	JJ	56	_	_	_	_	_	_	_	O
15	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
16	planning	_	plan	_	VBG	56	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	56	_	_	_	_	_	_	_	O
18	become	_	become	_	VB	56	_	_	_	_	_	_	_	O
19	pregnant	_	pregnant	_	JJ	56	_	_	_	_	_	_	_	O
20	,	_	,	_	,	56	_	_	_	_	_	_	_	O
21	see	_	see	_	VB	56	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	56	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
24	guideline	_	guideline	_	NN	56	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	56	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
28	pregnancy	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
29	.	_	.	_	.	56	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	56	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	56	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	56	_	_	_	_	_	_	_	O
4	hba1c	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
5	targets	_	target	_	NNS	56	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	56	_	_	_	_	_	_	_	O
7	women	_	woman	_	NNS	56	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
9	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
10	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
11	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
12	who	_	who	_	WP	56	_	_	_	_	_	_	_	S-Agent
13	are	_	be	_	VBP	56	_	_	_	_	_	_	_	O
14	pregnant	_	pregnant	_	JJ	56	_	_	_	_	_	_	_	O
15	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
16	planning	_	plan	_	VBG	56	_	_	_	_	_	plan.v	Making_arrangements	O
17	to	_	to	_	TO	56	_	_	_	_	_	_	_	B-Event
18	become	_	become	_	VB	56	_	_	_	_	_	_	_	I-Event
19	pregnant	_	pregnant	_	JJ	56	_	_	_	_	_	_	_	I-Event
20	,	_	,	_	,	56	_	_	_	_	_	_	_	O
21	see	_	see	_	VB	56	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	56	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
24	guideline	_	guideline	_	NN	56	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	56	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
28	pregnancy	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
29	.	_	.	_	.	56	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	56	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	56	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	56	_	_	_	_	_	_	_	O
4	hba1c	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
5	targets	_	target	_	NNS	56	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	56	_	_	_	_	_	_	_	O
7	women	_	woman	_	NNS	56	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
9	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
10	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
11	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
12	who	_	who	_	WP	56	_	_	_	_	_	_	_	S-Entity
13	are	_	be	_	VBP	56	_	_	_	_	_	_	_	O
14	pregnant	_	pregnant	_	JJ	56	_	_	_	_	_	_	_	O
15	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
16	planning	_	plan	_	VBG	56	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	56	_	_	_	_	_	_	_	O
18	become	_	become	_	VB	56	_	_	_	_	_	become.v	Becoming	O
19	pregnant	_	pregnant	_	JJ	56	_	_	_	_	_	_	_	S-Final_category
20	,	_	,	_	,	56	_	_	_	_	_	_	_	O
21	see	_	see	_	VB	56	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	56	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
24	guideline	_	guideline	_	NN	56	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	56	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
28	pregnancy	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
29	.	_	.	_	.	56	_	_	_	_	_	_	_	O

1	take	_	UNK	_	VB	57	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	57	_	_	_	_	_	_	_	O
3	driver	_	UNK	_	NNP	57	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	57	_	_	_	_	_	_	_	O
5	vehicle	_	Vehicle	_	NNP	57	_	_	_	_	_	vehicle.n	Vehicle	S-Vehicle
6	licensing	_	UNK	_	NNP	57	_	_	_	_	_	_	_	O
7	agency	_	Agency	_	NNP	57	_	_	_	_	_	_	_	O
8	(	_	(	_	(	57	_	_	_	_	_	_	_	O
9	dvla	_	UNK	_	NNP	57	_	_	_	_	_	_	_	O
10	)	_	)	_	)	57	_	_	_	_	_	_	_	O
11	at	_	At	_	IN	57	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	57	_	_	_	_	_	_	_	O
13	glance	_	glance	_	NN	57	_	_	_	_	_	_	_	O
14	guide	_	guide	_	NN	57	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	57	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	57	_	_	_	_	_	_	_	O
17	current	_	current	_	JJ	57	_	_	_	_	_	_	_	O
18	medical	_	medical	_	JJ	57	_	_	_	_	_	_	_	O
19	standards	_	standard	_	NNS	57	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	57	_	_	_	_	_	_	_	O
21	fitness	_	fitness	_	NN	57	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	57	_	_	_	_	_	_	_	O
23	drive	_	drive	_	VB	57	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	57	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	57	_	_	_	_	_	_	_	O
26	when	_	when	_	WRB	57	_	_	_	_	_	_	_	O
27	offering	_	offer	_	VBG	57	_	_	_	_	_	_	_	O
28	self-monitoring	_	UNK	_	NN	57	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	57	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	57	_	_	_	_	_	_	_	O
31	glucose	_	UNK	_	NN	57	_	_	_	_	_	_	_	O
32	levels	_	level	_	NNS	57	_	_	_	_	_	_	_	O
33	for	_	for	_	IN	57	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	57	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	57	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	57	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	57	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	57	_	_	_	_	_	_	_	O
39	.	_	.	_	.	57	_	_	_	_	_	_	_	O

1	take	_	UNK	_	VB	57	_	_	_	_	_	_	_	B-Figure
2	the	_	the	_	DT	57	_	_	_	_	_	_	_	I-Figure
3	driver	_	UNK	_	NNP	57	_	_	_	_	_	_	_	I-Figure
4	and	_	and	_	CC	57	_	_	_	_	_	_	_	I-Figure
5	vehicle	_	Vehicle	_	NNP	57	_	_	_	_	_	_	_	I-Figure
6	licensing	_	UNK	_	NNP	57	_	_	_	_	_	_	_	I-Figure
7	agency	_	Agency	_	NNP	57	_	_	_	_	_	_	_	I-Figure
8	(	_	(	_	(	57	_	_	_	_	_	_	_	I-Figure
9	dvla	_	UNK	_	NNP	57	_	_	_	_	_	_	_	I-Figure
10	)	_	)	_	)	57	_	_	_	_	_	_	_	I-Figure
11	at	_	At	_	IN	57	_	_	_	_	_	at.prep	Locative_relation	O
12	a	_	a	_	DT	57	_	_	_	_	_	_	_	B-Ground
13	glance	_	glance	_	NN	57	_	_	_	_	_	_	_	I-Ground
14	guide	_	guide	_	NN	57	_	_	_	_	_	_	_	I-Ground
15	to	_	to	_	TO	57	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	57	_	_	_	_	_	_	_	O
17	current	_	current	_	JJ	57	_	_	_	_	_	_	_	O
18	medical	_	medical	_	JJ	57	_	_	_	_	_	_	_	O
19	standards	_	standard	_	NNS	57	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	57	_	_	_	_	_	_	_	O
21	fitness	_	fitness	_	NN	57	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	57	_	_	_	_	_	_	_	O
23	drive	_	drive	_	VB	57	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	57	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	57	_	_	_	_	_	_	_	O
26	when	_	when	_	WRB	57	_	_	_	_	_	_	_	O
27	offering	_	offer	_	VBG	57	_	_	_	_	_	_	_	O
28	self-monitoring	_	UNK	_	NN	57	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	57	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	57	_	_	_	_	_	_	_	O
31	glucose	_	UNK	_	NN	57	_	_	_	_	_	_	_	O
32	levels	_	level	_	NNS	57	_	_	_	_	_	_	_	O
33	for	_	for	_	IN	57	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	57	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	57	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	57	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	57	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	57	_	_	_	_	_	_	_	O
39	.	_	.	_	.	57	_	_	_	_	_	_	_	O

1	take	_	UNK	_	VB	57	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	57	_	_	_	_	_	_	_	O
3	driver	_	UNK	_	NNP	57	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	57	_	_	_	_	_	_	_	O
5	vehicle	_	Vehicle	_	NNP	57	_	_	_	_	_	_	_	O
6	licensing	_	UNK	_	NNP	57	_	_	_	_	_	_	_	O
7	agency	_	Agency	_	NNP	57	_	_	_	_	_	_	_	O
8	(	_	(	_	(	57	_	_	_	_	_	_	_	O
9	dvla	_	UNK	_	NNP	57	_	_	_	_	_	_	_	O
10	)	_	)	_	)	57	_	_	_	_	_	_	_	O
11	at	_	At	_	IN	57	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	57	_	_	_	_	_	_	_	O
13	glance	_	glance	_	NN	57	_	_	_	_	_	glance.n	Perception_active	O
14	guide	_	guide	_	NN	57	_	_	_	_	_	_	_	S-Phenomenon
15	to	_	to	_	TO	57	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	57	_	_	_	_	_	_	_	O
17	current	_	current	_	JJ	57	_	_	_	_	_	_	_	O
18	medical	_	medical	_	JJ	57	_	_	_	_	_	_	_	O
19	standards	_	standard	_	NNS	57	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	57	_	_	_	_	_	_	_	O
21	fitness	_	fitness	_	NN	57	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	57	_	_	_	_	_	_	_	O
23	drive	_	drive	_	VB	57	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	57	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	57	_	_	_	_	_	_	_	O
26	when	_	when	_	WRB	57	_	_	_	_	_	_	_	O
27	offering	_	offer	_	VBG	57	_	_	_	_	_	_	_	O
28	self-monitoring	_	UNK	_	NN	57	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	57	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	57	_	_	_	_	_	_	_	O
31	glucose	_	UNK	_	NN	57	_	_	_	_	_	_	_	O
32	levels	_	level	_	NNS	57	_	_	_	_	_	_	_	O
33	for	_	for	_	IN	57	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	57	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	57	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	57	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	57	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	57	_	_	_	_	_	_	_	O
39	.	_	.	_	.	57	_	_	_	_	_	_	_	O

1	take	_	UNK	_	VB	57	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	57	_	_	_	_	_	_	_	O
3	driver	_	UNK	_	NNP	57	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	57	_	_	_	_	_	_	_	O
5	vehicle	_	Vehicle	_	NNP	57	_	_	_	_	_	_	_	O
6	licensing	_	UNK	_	NNP	57	_	_	_	_	_	_	_	O
7	agency	_	Agency	_	NNP	57	_	_	_	_	_	_	_	O
8	(	_	(	_	(	57	_	_	_	_	_	_	_	O
9	dvla	_	UNK	_	NNP	57	_	_	_	_	_	_	_	O
10	)	_	)	_	)	57	_	_	_	_	_	_	_	O
11	at	_	At	_	IN	57	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	57	_	_	_	_	_	_	_	O
13	glance	_	glance	_	NN	57	_	_	_	_	_	_	_	O
14	guide	_	guide	_	NN	57	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	57	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	57	_	_	_	_	_	_	_	O
17	current	_	current	_	JJ	57	_	_	_	_	_	current.a	Temporal_collocation	O
18	medical	_	medical	_	JJ	57	_	_	_	_	_	_	_	B-Trajector_entity
19	standards	_	standard	_	NNS	57	_	_	_	_	_	_	_	I-Trajector_entity
20	of	_	of	_	IN	57	_	_	_	_	_	_	_	O
21	fitness	_	fitness	_	NN	57	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	57	_	_	_	_	_	_	_	O
23	drive	_	drive	_	VB	57	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	57	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	57	_	_	_	_	_	_	_	O
26	when	_	when	_	WRB	57	_	_	_	_	_	_	_	O
27	offering	_	offer	_	VBG	57	_	_	_	_	_	_	_	O
28	self-monitoring	_	UNK	_	NN	57	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	57	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	57	_	_	_	_	_	_	_	O
31	glucose	_	UNK	_	NN	57	_	_	_	_	_	_	_	O
32	levels	_	level	_	NNS	57	_	_	_	_	_	_	_	O
33	for	_	for	_	IN	57	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	57	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	57	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	57	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	57	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	57	_	_	_	_	_	_	_	O
39	.	_	.	_	.	57	_	_	_	_	_	_	_	O

1	take	_	UNK	_	VB	57	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	57	_	_	_	_	_	_	_	O
3	driver	_	UNK	_	NNP	57	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	57	_	_	_	_	_	_	_	O
5	vehicle	_	Vehicle	_	NNP	57	_	_	_	_	_	_	_	O
6	licensing	_	UNK	_	NNP	57	_	_	_	_	_	_	_	O
7	agency	_	Agency	_	NNP	57	_	_	_	_	_	_	_	O
8	(	_	(	_	(	57	_	_	_	_	_	_	_	O
9	dvla	_	UNK	_	NNP	57	_	_	_	_	_	_	_	O
10	)	_	)	_	)	57	_	_	_	_	_	_	_	O
11	at	_	At	_	IN	57	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	57	_	_	_	_	_	_	_	O
13	glance	_	glance	_	NN	57	_	_	_	_	_	_	_	O
14	guide	_	guide	_	NN	57	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	57	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	57	_	_	_	_	_	_	_	O
17	current	_	current	_	JJ	57	_	_	_	_	_	_	_	O
18	medical	_	medical	_	JJ	57	_	_	_	_	_	_	_	O
19	standards	_	standard	_	NNS	57	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	57	_	_	_	_	_	_	_	O
21	fitness	_	fitness	_	NN	57	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	57	_	_	_	_	_	_	_	O
23	drive	_	drive	_	VB	57	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	57	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	57	_	_	_	_	_	account.n	Text	O
26	when	_	when	_	WRB	57	_	_	_	_	_	_	_	O
27	offering	_	offer	_	VBG	57	_	_	_	_	_	_	_	O
28	self-monitoring	_	UNK	_	NN	57	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	57	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	57	_	_	_	_	_	_	_	O
31	glucose	_	UNK	_	NN	57	_	_	_	_	_	_	_	O
32	levels	_	level	_	NNS	57	_	_	_	_	_	_	_	O
33	for	_	for	_	IN	57	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	57	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	57	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	57	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	57	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	57	_	_	_	_	_	_	_	O
39	.	_	.	_	.	57	_	_	_	_	_	_	_	O

1	take	_	UNK	_	VB	57	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	57	_	_	_	_	_	_	_	O
3	driver	_	UNK	_	NNP	57	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	57	_	_	_	_	_	_	_	O
5	vehicle	_	Vehicle	_	NNP	57	_	_	_	_	_	_	_	O
6	licensing	_	UNK	_	NNP	57	_	_	_	_	_	_	_	O
7	agency	_	Agency	_	NNP	57	_	_	_	_	_	_	_	O
8	(	_	(	_	(	57	_	_	_	_	_	_	_	O
9	dvla	_	UNK	_	NNP	57	_	_	_	_	_	_	_	O
10	)	_	)	_	)	57	_	_	_	_	_	_	_	O
11	at	_	At	_	IN	57	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	57	_	_	_	_	_	_	_	O
13	glance	_	glance	_	NN	57	_	_	_	_	_	_	_	O
14	guide	_	guide	_	NN	57	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	57	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	57	_	_	_	_	_	_	_	O
17	current	_	current	_	JJ	57	_	_	_	_	_	_	_	O
18	medical	_	medical	_	JJ	57	_	_	_	_	_	_	_	O
19	standards	_	standard	_	NNS	57	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	57	_	_	_	_	_	_	_	O
21	fitness	_	fitness	_	NN	57	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	57	_	_	_	_	_	_	_	O
23	drive	_	drive	_	VB	57	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	57	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	57	_	_	_	_	_	_	_	O
26	when	_	when	_	WRB	57	_	_	_	_	_	_	_	O
27	offering	_	offer	_	VBG	57	_	_	_	_	_	_	_	O
28	self-monitoring	_	UNK	_	NN	57	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	57	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	57	_	_	_	_	_	_	_	O
31	glucose	_	UNK	_	NN	57	_	_	_	_	_	_	_	O
32	levels	_	level	_	NNS	57	_	_	_	_	_	_	_	O
33	for	_	for	_	IN	57	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	57	_	_	_	_	_	adult.n	People_by_age	S-Person
35	with	_	with	_	IN	57	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	57	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	57	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	57	_	_	_	_	_	_	_	O
39	.	_	.	_	.	57	_	_	_	_	_	_	_	O

1	take	_	UNK	_	VB	57	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	57	_	_	_	_	_	_	_	O
3	driver	_	UNK	_	NNP	57	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	57	_	_	_	_	_	_	_	O
5	vehicle	_	Vehicle	_	NNP	57	_	_	_	_	_	_	_	O
6	licensing	_	UNK	_	NNP	57	_	_	_	_	_	_	_	O
7	agency	_	Agency	_	NNP	57	_	_	_	_	_	_	_	O
8	(	_	(	_	(	57	_	_	_	_	_	_	_	O
9	dvla	_	UNK	_	NNP	57	_	_	_	_	_	_	_	O
10	)	_	)	_	)	57	_	_	_	_	_	_	_	O
11	at	_	At	_	IN	57	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	57	_	_	_	_	_	_	_	O
13	glance	_	glance	_	NN	57	_	_	_	_	_	_	_	O
14	guide	_	guide	_	NN	57	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	57	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	57	_	_	_	_	_	_	_	O
17	current	_	current	_	JJ	57	_	_	_	_	_	_	_	O
18	medical	_	medical	_	JJ	57	_	_	_	_	_	_	_	O
19	standards	_	standard	_	NNS	57	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	57	_	_	_	_	_	_	_	O
21	fitness	_	fitness	_	NN	57	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	57	_	_	_	_	_	_	_	O
23	drive	_	drive	_	VB	57	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	57	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	57	_	_	_	_	_	_	_	O
26	when	_	when	_	WRB	57	_	_	_	_	_	_	_	O
27	offering	_	offer	_	VBG	57	_	_	_	_	_	_	_	O
28	self-monitoring	_	UNK	_	NN	57	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	57	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	57	_	_	_	_	_	_	_	O
31	glucose	_	UNK	_	NN	57	_	_	_	_	_	_	_	O
32	levels	_	level	_	NNS	57	_	_	_	_	_	_	_	O
33	for	_	for	_	IN	57	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	57	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	57	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	57	_	_	_	_	_	type.n	Type	S-Subtype
37	2	_	2	_	CD	57	_	_	_	_	_	_	_	B-Category
38	diabetes	_	UNK	_	NNS	57	_	_	_	_	_	_	_	I-Category
39	.	_	.	_	.	57	_	_	_	_	_	_	_	O

1	do	_	Do	_	NNP	58	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	58	_	_	_	_	_	_	_	O
3	routinely	_	routinely	_	RB	58	_	_	_	_	_	_	_	O
4	offer	_	offer	_	VBP	58	_	_	_	_	_	_	_	O
5	self-monitoring	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	58	_	_	_	_	_	_	_	O
8	glucose	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
9	levels	_	level	_	NNS	58	_	_	_	_	_	_	_	O
10	for	_	for	_	IN	58	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	58	_	_	_	_	_	adult.n	People_by_age	S-Person
12	with	_	with	_	IN	58	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	58	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	58	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	58	_	_	_	_	_	_	_	O
16	unless	_	unless	_	IN	58	_	_	_	_	_	_	_	O
17	:	_	:	_	:	58	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
21	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
22	insulin	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
23	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
24	there	_	there	_	EX	58	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
26	evidence	_	evidence	_	NN	58	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
29	episodes	_	episode	_	NNS	58	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
32	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
33	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
34	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
35	oral	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
36	medication	_	medication	_	NN	58	_	_	_	_	_	_	_	O
37	that	_	that	_	WDT	58	_	_	_	_	_	_	_	O
38	may	_	may	_	MD	58	_	_	_	_	_	_	_	O
39	increase	_	increase	_	VB	58	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	58	_	_	_	_	_	_	_	O
41	risk	_	risk	_	NN	58	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
43	unk	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
44	while	_	while	_	IN	58	_	_	_	_	_	_	_	O
45	driving	_	drive	_	VBG	58	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
47	operating	_	operate	_	VBG	58	_	_	_	_	_	_	_	O
48	machinery	_	machinery	_	NN	58	_	_	_	_	_	_	_	O
49	or	_	or	_	CC	58	_	_	_	_	_	_	_	O

1	do	_	Do	_	NNP	58	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	58	_	_	_	_	_	_	_	O
3	routinely	_	routinely	_	RB	58	_	_	_	_	_	_	_	O
4	offer	_	offer	_	VBP	58	_	_	_	_	_	_	_	O
5	self-monitoring	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	58	_	_	_	_	_	_	_	O
8	glucose	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
9	levels	_	level	_	NNS	58	_	_	_	_	_	_	_	O
10	for	_	for	_	IN	58	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	58	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	58	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	58	_	_	_	_	_	type.n	Type	S-Subtype
14	2	_	2	_	CD	58	_	_	_	_	_	_	_	B-Category
15	diabetes	_	UNK	_	NNS	58	_	_	_	_	_	_	_	I-Category
16	unless	_	unless	_	IN	58	_	_	_	_	_	_	_	O
17	:	_	:	_	:	58	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
21	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
22	insulin	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
23	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
24	there	_	there	_	EX	58	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
26	evidence	_	evidence	_	NN	58	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
29	episodes	_	episode	_	NNS	58	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
32	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
33	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
34	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
35	oral	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
36	medication	_	medication	_	NN	58	_	_	_	_	_	_	_	O
37	that	_	that	_	WDT	58	_	_	_	_	_	_	_	O
38	may	_	may	_	MD	58	_	_	_	_	_	_	_	O
39	increase	_	increase	_	VB	58	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	58	_	_	_	_	_	_	_	O
41	risk	_	risk	_	NN	58	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
43	unk	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
44	while	_	while	_	IN	58	_	_	_	_	_	_	_	O
45	driving	_	drive	_	VBG	58	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
47	operating	_	operate	_	VBG	58	_	_	_	_	_	_	_	O
48	machinery	_	machinery	_	NN	58	_	_	_	_	_	_	_	O
49	or	_	or	_	CC	58	_	_	_	_	_	_	_	O

1	do	_	Do	_	NNP	58	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	58	_	_	_	_	_	_	_	O
3	routinely	_	routinely	_	RB	58	_	_	_	_	_	_	_	O
4	offer	_	offer	_	VBP	58	_	_	_	_	_	_	_	O
5	self-monitoring	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	58	_	_	_	_	_	_	_	O
8	glucose	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
9	levels	_	level	_	NNS	58	_	_	_	_	_	_	_	O
10	for	_	for	_	IN	58	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	58	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	58	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	58	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	58	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	58	_	_	_	_	_	_	_	O
16	unless	_	unless	_	IN	58	_	_	_	_	_	_	_	O
17	:	_	:	_	:	58	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	58	_	_	_	_	_	person.n	People	S-Person
20	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
21	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
22	insulin	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
23	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
24	there	_	there	_	EX	58	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
26	evidence	_	evidence	_	NN	58	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
29	episodes	_	episode	_	NNS	58	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
32	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
33	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
34	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
35	oral	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
36	medication	_	medication	_	NN	58	_	_	_	_	_	_	_	O
37	that	_	that	_	WDT	58	_	_	_	_	_	_	_	O
38	may	_	may	_	MD	58	_	_	_	_	_	_	_	O
39	increase	_	increase	_	VB	58	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	58	_	_	_	_	_	_	_	O
41	risk	_	risk	_	NN	58	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
43	unk	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
44	while	_	while	_	IN	58	_	_	_	_	_	_	_	O
45	driving	_	drive	_	VBG	58	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
47	operating	_	operate	_	VBG	58	_	_	_	_	_	_	_	O
48	machinery	_	machinery	_	NN	58	_	_	_	_	_	_	_	O
49	or	_	or	_	CC	58	_	_	_	_	_	_	_	O

1	do	_	Do	_	NNP	58	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	58	_	_	_	_	_	_	_	O
3	routinely	_	routinely	_	RB	58	_	_	_	_	_	_	_	O
4	offer	_	offer	_	VBP	58	_	_	_	_	_	_	_	O
5	self-monitoring	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	58	_	_	_	_	_	_	_	O
8	glucose	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
9	levels	_	level	_	NNS	58	_	_	_	_	_	_	_	O
10	for	_	for	_	IN	58	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	58	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	58	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	58	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	58	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	58	_	_	_	_	_	_	_	O
16	unless	_	unless	_	IN	58	_	_	_	_	_	_	_	O
17	:	_	:	_	:	58	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
21	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
22	insulin	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
23	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
24	there	_	there	_	EX	58	_	_	_	_	_	there.adv	Locative_relation	S-Ground
25	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
26	evidence	_	evidence	_	NN	58	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
29	episodes	_	episode	_	NNS	58	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
32	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
33	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
34	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
35	oral	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
36	medication	_	medication	_	NN	58	_	_	_	_	_	_	_	O
37	that	_	that	_	WDT	58	_	_	_	_	_	_	_	O
38	may	_	may	_	MD	58	_	_	_	_	_	_	_	O
39	increase	_	increase	_	VB	58	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	58	_	_	_	_	_	_	_	O
41	risk	_	risk	_	NN	58	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
43	unk	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
44	while	_	while	_	IN	58	_	_	_	_	_	_	_	O
45	driving	_	drive	_	VBG	58	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
47	operating	_	operate	_	VBG	58	_	_	_	_	_	_	_	O
48	machinery	_	machinery	_	NN	58	_	_	_	_	_	_	_	O
49	or	_	or	_	CC	58	_	_	_	_	_	_	_	O

1	do	_	Do	_	NNP	58	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	58	_	_	_	_	_	_	_	O
3	routinely	_	routinely	_	RB	58	_	_	_	_	_	_	_	O
4	offer	_	offer	_	VBP	58	_	_	_	_	_	_	_	O
5	self-monitoring	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	58	_	_	_	_	_	_	_	O
8	glucose	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
9	levels	_	level	_	NNS	58	_	_	_	_	_	_	_	O
10	for	_	for	_	IN	58	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	58	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	58	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	58	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	58	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	58	_	_	_	_	_	_	_	O
16	unless	_	unless	_	IN	58	_	_	_	_	_	_	_	O
17	:	_	:	_	:	58	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
21	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
22	insulin	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
23	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
24	there	_	there	_	EX	58	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
26	evidence	_	evidence	_	NN	58	_	_	_	_	_	evidence.n	Evidence	O
27	of	_	of	_	IN	58	_	_	_	_	_	_	_	B-Proposition
28	unk	_	UNK	_	JJ	58	_	_	_	_	_	_	_	I-Proposition
29	episodes	_	episode	_	NNS	58	_	_	_	_	_	_	_	I-Proposition
30	or	_	or	_	CC	58	_	_	_	_	_	_	_	I-Proposition
31	the	_	the	_	DT	58	_	_	_	_	_	_	_	I-Proposition
32	person	_	person	_	NN	58	_	_	_	_	_	_	_	I-Proposition
33	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	I-Proposition
34	on	_	on	_	IN	58	_	_	_	_	_	_	_	I-Proposition
35	oral	_	UNK	_	JJ	58	_	_	_	_	_	_	_	I-Proposition
36	medication	_	medication	_	NN	58	_	_	_	_	_	_	_	I-Proposition
37	that	_	that	_	WDT	58	_	_	_	_	_	_	_	I-Proposition
38	may	_	may	_	MD	58	_	_	_	_	_	_	_	I-Proposition
39	increase	_	increase	_	VB	58	_	_	_	_	_	_	_	I-Proposition
40	their	_	their	_	PRP$	58	_	_	_	_	_	_	_	I-Proposition
41	risk	_	risk	_	NN	58	_	_	_	_	_	_	_	I-Proposition
42	of	_	of	_	IN	58	_	_	_	_	_	_	_	I-Proposition
43	unk	_	UNK	_	NN	58	_	_	_	_	_	_	_	I-Proposition
44	while	_	while	_	IN	58	_	_	_	_	_	_	_	I-Proposition
45	driving	_	drive	_	VBG	58	_	_	_	_	_	_	_	I-Proposition
46	or	_	or	_	CC	58	_	_	_	_	_	_	_	I-Proposition
47	operating	_	operate	_	VBG	58	_	_	_	_	_	_	_	O
48	machinery	_	machinery	_	NN	58	_	_	_	_	_	_	_	O
49	or	_	or	_	CC	58	_	_	_	_	_	_	_	O

1	do	_	Do	_	NNP	58	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	58	_	_	_	_	_	_	_	O
3	routinely	_	routinely	_	RB	58	_	_	_	_	_	_	_	O
4	offer	_	offer	_	VBP	58	_	_	_	_	_	_	_	O
5	self-monitoring	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	58	_	_	_	_	_	_	_	O
8	glucose	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
9	levels	_	level	_	NNS	58	_	_	_	_	_	_	_	O
10	for	_	for	_	IN	58	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	58	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	58	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	58	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	58	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	58	_	_	_	_	_	_	_	O
16	unless	_	unless	_	IN	58	_	_	_	_	_	_	_	O
17	:	_	:	_	:	58	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
21	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
22	insulin	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
23	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
24	there	_	there	_	EX	58	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
26	evidence	_	evidence	_	NN	58	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	JJ	58	_	_	_	_	_	_	_	S-Place
29	episodes	_	episode	_	NNS	58	_	_	_	_	_	episode.n	Event	S-Event
30	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
32	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
33	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
34	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
35	oral	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
36	medication	_	medication	_	NN	58	_	_	_	_	_	_	_	O
37	that	_	that	_	WDT	58	_	_	_	_	_	_	_	O
38	may	_	may	_	MD	58	_	_	_	_	_	_	_	O
39	increase	_	increase	_	VB	58	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	58	_	_	_	_	_	_	_	O
41	risk	_	risk	_	NN	58	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
43	unk	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
44	while	_	while	_	IN	58	_	_	_	_	_	_	_	O
45	driving	_	drive	_	VBG	58	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
47	operating	_	operate	_	VBG	58	_	_	_	_	_	_	_	O
48	machinery	_	machinery	_	NN	58	_	_	_	_	_	_	_	O
49	or	_	or	_	CC	58	_	_	_	_	_	_	_	O

1	do	_	Do	_	NNP	58	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	58	_	_	_	_	_	_	_	O
3	routinely	_	routinely	_	RB	58	_	_	_	_	_	_	_	O
4	offer	_	offer	_	VBP	58	_	_	_	_	_	_	_	O
5	self-monitoring	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	58	_	_	_	_	_	_	_	O
8	glucose	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
9	levels	_	level	_	NNS	58	_	_	_	_	_	_	_	O
10	for	_	for	_	IN	58	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	58	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	58	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	58	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	58	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	58	_	_	_	_	_	_	_	O
16	unless	_	unless	_	IN	58	_	_	_	_	_	_	_	O
17	:	_	:	_	:	58	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
21	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
22	insulin	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
23	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
24	there	_	there	_	EX	58	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
26	evidence	_	evidence	_	NN	58	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
29	episodes	_	episode	_	NNS	58	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
32	person	_	person	_	NN	58	_	_	_	_	_	person.n	People	S-Person
33	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
34	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
35	oral	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
36	medication	_	medication	_	NN	58	_	_	_	_	_	_	_	O
37	that	_	that	_	WDT	58	_	_	_	_	_	_	_	O
38	may	_	may	_	MD	58	_	_	_	_	_	_	_	O
39	increase	_	increase	_	VB	58	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	58	_	_	_	_	_	_	_	O
41	risk	_	risk	_	NN	58	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
43	unk	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
44	while	_	while	_	IN	58	_	_	_	_	_	_	_	O
45	driving	_	drive	_	VBG	58	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
47	operating	_	operate	_	VBG	58	_	_	_	_	_	_	_	O
48	machinery	_	machinery	_	NN	58	_	_	_	_	_	_	_	O
49	or	_	or	_	CC	58	_	_	_	_	_	_	_	O

1	do	_	Do	_	NNP	58	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	58	_	_	_	_	_	_	_	O
3	routinely	_	routinely	_	RB	58	_	_	_	_	_	_	_	O
4	offer	_	offer	_	VBP	58	_	_	_	_	_	_	_	O
5	self-monitoring	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	58	_	_	_	_	_	_	_	O
8	glucose	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
9	levels	_	level	_	NNS	58	_	_	_	_	_	_	_	O
10	for	_	for	_	IN	58	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	58	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	58	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	58	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	58	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	58	_	_	_	_	_	_	_	O
16	unless	_	unless	_	IN	58	_	_	_	_	_	_	_	O
17	:	_	:	_	:	58	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
21	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
22	insulin	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
23	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
24	there	_	there	_	EX	58	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
26	evidence	_	evidence	_	NN	58	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
29	episodes	_	episode	_	NNS	58	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
32	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
33	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
34	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
35	oral	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
36	medication	_	medication	_	NN	58	_	_	_	_	_	_	_	O
37	that	_	that	_	WDT	58	_	_	_	_	_	_	_	O
38	may	_	may	_	MD	58	_	_	_	_	_	_	_	O
39	increase	_	increase	_	VB	58	_	_	_	_	_	increase.v	Change_position_on_a_scale	O
40	their	_	their	_	PRP$	58	_	_	_	_	_	_	_	B-Item
41	risk	_	risk	_	NN	58	_	_	_	_	_	_	_	I-Item
42	of	_	of	_	IN	58	_	_	_	_	_	_	_	I-Item
43	unk	_	UNK	_	NN	58	_	_	_	_	_	_	_	I-Item
44	while	_	while	_	IN	58	_	_	_	_	_	_	_	O
45	driving	_	drive	_	VBG	58	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
47	operating	_	operate	_	VBG	58	_	_	_	_	_	_	_	O
48	machinery	_	machinery	_	NN	58	_	_	_	_	_	_	_	O
49	or	_	or	_	CC	58	_	_	_	_	_	_	_	O

1	do	_	Do	_	NNP	58	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	58	_	_	_	_	_	_	_	O
3	routinely	_	routinely	_	RB	58	_	_	_	_	_	_	_	O
4	offer	_	offer	_	VBP	58	_	_	_	_	_	_	_	O
5	self-monitoring	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	58	_	_	_	_	_	_	_	O
8	glucose	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
9	levels	_	level	_	NNS	58	_	_	_	_	_	_	_	O
10	for	_	for	_	IN	58	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	58	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	58	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	58	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	58	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	58	_	_	_	_	_	_	_	O
16	unless	_	unless	_	IN	58	_	_	_	_	_	_	_	O
17	:	_	:	_	:	58	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
21	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
22	insulin	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
23	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
24	there	_	there	_	EX	58	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
26	evidence	_	evidence	_	NN	58	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
29	episodes	_	episode	_	NNS	58	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
32	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
33	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
34	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
35	oral	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
36	medication	_	medication	_	NN	58	_	_	_	_	_	_	_	O
37	that	_	that	_	WDT	58	_	_	_	_	_	_	_	O
38	may	_	may	_	MD	58	_	_	_	_	_	_	_	O
39	increase	_	increase	_	VB	58	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	58	_	_	_	_	_	_	_	S-Protagonist
41	risk	_	risk	_	NN	58	_	_	_	_	_	risk.n	Run_risk	O
42	of	_	of	_	IN	58	_	_	_	_	_	_	_	B-Action
43	unk	_	UNK	_	NN	58	_	_	_	_	_	_	_	I-Action
44	while	_	while	_	IN	58	_	_	_	_	_	_	_	O
45	driving	_	drive	_	VBG	58	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
47	operating	_	operate	_	VBG	58	_	_	_	_	_	_	_	O
48	machinery	_	machinery	_	NN	58	_	_	_	_	_	_	_	O
49	or	_	or	_	CC	58	_	_	_	_	_	_	_	O

1	do	_	Do	_	NNP	58	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	58	_	_	_	_	_	_	_	O
3	routinely	_	routinely	_	RB	58	_	_	_	_	_	_	_	O
4	offer	_	offer	_	VBP	58	_	_	_	_	_	_	_	O
5	self-monitoring	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	58	_	_	_	_	_	_	_	O
8	glucose	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
9	levels	_	level	_	NNS	58	_	_	_	_	_	_	_	O
10	for	_	for	_	IN	58	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	58	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	58	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	58	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	58	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	58	_	_	_	_	_	_	_	O
16	unless	_	unless	_	IN	58	_	_	_	_	_	_	_	O
17	:	_	:	_	:	58	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
21	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
22	insulin	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
23	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
24	there	_	there	_	EX	58	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
26	evidence	_	evidence	_	NN	58	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
29	episodes	_	episode	_	NNS	58	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
32	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
33	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
34	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
35	oral	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
36	medication	_	medication	_	NN	58	_	_	_	_	_	_	_	O
37	that	_	that	_	WDT	58	_	_	_	_	_	_	_	O
38	may	_	may	_	MD	58	_	_	_	_	_	_	_	O
39	increase	_	increase	_	VB	58	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	58	_	_	_	_	_	_	_	O
41	risk	_	risk	_	NN	58	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
43	unk	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
44	while	_	while	_	IN	58	_	_	_	_	_	_	_	O
45	driving	_	drive	_	VBG	58	_	_	_	_	_	drive.v	Operate_vehicle	O
46	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
47	operating	_	operate	_	VBG	58	_	_	_	_	_	_	_	O
48	machinery	_	machinery	_	NN	58	_	_	_	_	_	_	_	S-Vehicle
49	or	_	or	_	CC	58	_	_	_	_	_	_	_	O

1	do	_	Do	_	NNP	58	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	58	_	_	_	_	_	_	_	O
3	routinely	_	routinely	_	RB	58	_	_	_	_	_	_	_	O
4	offer	_	offer	_	VBP	58	_	_	_	_	_	_	_	O
5	self-monitoring	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	58	_	_	_	_	_	_	_	O
8	glucose	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
9	levels	_	level	_	NNS	58	_	_	_	_	_	_	_	O
10	for	_	for	_	IN	58	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	58	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	58	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	58	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	58	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	58	_	_	_	_	_	_	_	O
16	unless	_	unless	_	IN	58	_	_	_	_	_	_	_	O
17	:	_	:	_	:	58	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
21	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
22	insulin	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
23	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
24	there	_	there	_	EX	58	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
26	evidence	_	evidence	_	NN	58	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
29	episodes	_	episode	_	NNS	58	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
32	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
33	is	_	be	_	VBZ	58	_	_	_	_	_	_	_	O
34	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
35	oral	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
36	medication	_	medication	_	NN	58	_	_	_	_	_	_	_	O
37	that	_	that	_	WDT	58	_	_	_	_	_	_	_	O
38	may	_	may	_	MD	58	_	_	_	_	_	_	_	O
39	increase	_	increase	_	VB	58	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	58	_	_	_	_	_	_	_	O
41	risk	_	risk	_	NN	58	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
43	unk	_	UNK	_	NN	58	_	_	_	_	_	_	_	O
44	while	_	while	_	IN	58	_	_	_	_	_	_	_	O
45	driving	_	drive	_	VBG	58	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	58	_	_	_	_	_	_	_	O
47	operating	_	operate	_	VBG	58	_	_	_	_	_	operate.v	Operating_a_system	O
48	machinery	_	machinery	_	NN	58	_	_	_	_	_	_	_	S-System
49	or	_	or	_	CC	58	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	59	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	59	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	59	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	59	_	_	_	_	_	_	_	O
6	:	_	:	_	:	59	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	59	_	_	_	_	_	_	_	O
8	(	_	(	_	(	59	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	59	_	_	_	_	_	_	_	O
10	)	_	)	_	)	59	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	59	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	59	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
14	)	_	)	_	)	59	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	59	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	59	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	59	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	59	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	59	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	59	_	_	_	_	_	_	_	O
8	(	_	(	_	(	59	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	59	_	_	_	_	_	_	_	O
10	)	_	)	_	)	59	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	59	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	59	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
14	)	_	)	_	)	59	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	60	_	_	_	_	_	last.a	Relative_time	O
2	updated	_	update	_	VBD	60	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	60	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	60	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	60	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	60	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	60	_	_	_	_	_	_	_	O
8	pregnant	_	pregnant	_	JJ	60	_	_	_	_	_	_	_	O
9	,	_	,	_	,	60	_	_	_	_	_	_	_	O
10	or	_	or	_	CC	60	_	_	_	_	_	_	_	O
11	is	_	be	_	VBZ	60	_	_	_	_	_	_	_	O
12	planning	_	plan	_	VBG	60	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	60	_	_	_	_	_	_	_	O
14	become	_	become	_	VB	60	_	_	_	_	_	_	_	O
15	pregnant	_	pregnant	_	JJ	60	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	60	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	60	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	60	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	60	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	60	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	60	_	_	_	_	_	person.n	People	S-Person
7	is	_	be	_	VBZ	60	_	_	_	_	_	_	_	O
8	pregnant	_	pregnant	_	JJ	60	_	_	_	_	_	_	_	O
9	,	_	,	_	,	60	_	_	_	_	_	_	_	O
10	or	_	or	_	CC	60	_	_	_	_	_	_	_	O
11	is	_	be	_	VBZ	60	_	_	_	_	_	_	_	O
12	planning	_	plan	_	VBG	60	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	60	_	_	_	_	_	_	_	O
14	become	_	become	_	VB	60	_	_	_	_	_	_	_	O
15	pregnant	_	pregnant	_	JJ	60	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	60	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	60	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	60	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	60	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	60	_	_	_	_	_	_	_	B-Agent
6	person	_	person	_	NN	60	_	_	_	_	_	_	_	I-Agent
7	is	_	be	_	VBZ	60	_	_	_	_	_	_	_	O
8	pregnant	_	pregnant	_	JJ	60	_	_	_	_	_	_	_	O
9	,	_	,	_	,	60	_	_	_	_	_	_	_	O
10	or	_	or	_	CC	60	_	_	_	_	_	_	_	O
11	is	_	be	_	VBZ	60	_	_	_	_	_	_	_	O
12	planning	_	plan	_	VBG	60	_	_	_	_	_	plan.v	Purpose	O
13	to	_	to	_	TO	60	_	_	_	_	_	_	_	O
14	become	_	become	_	VB	60	_	_	_	_	_	_	_	O
15	pregnant	_	pregnant	_	JJ	60	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	60	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	60	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	60	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	60	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	60	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	60	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	60	_	_	_	_	_	_	_	O
8	pregnant	_	pregnant	_	JJ	60	_	_	_	_	_	_	_	O
9	,	_	,	_	,	60	_	_	_	_	_	_	_	O
10	or	_	or	_	CC	60	_	_	_	_	_	_	_	O
11	is	_	be	_	VBZ	60	_	_	_	_	_	_	_	O
12	planning	_	plan	_	VBG	60	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	60	_	_	_	_	_	_	_	O
14	become	_	become	_	VB	60	_	_	_	_	_	become.v	Becoming	O
15	pregnant	_	pregnant	_	JJ	60	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	61	_	_	_	_	_	_	_	O
2	more	_	more	_	JJR	61	_	_	_	_	_	more.a	Increment	O
3	information	_	information	_	NN	61	_	_	_	_	_	_	_	S-Class
4	,	_	,	_	,	61	_	_	_	_	_	_	_	O
5	see	_	see	_	VBP	61	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
7	nice	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
8	guideline	_	guideline	_	NN	61	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	61	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	61	_	_	_	_	_	_	_	O
12	pregnancy	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
13	.	_	.	_	.	61	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	61	_	_	_	_	_	_	_	O
2	more	_	more	_	JJR	61	_	_	_	_	_	_	_	O
3	information	_	information	_	NN	61	_	_	_	_	_	information.n	Information	S-Information
4	,	_	,	_	,	61	_	_	_	_	_	_	_	O
5	see	_	see	_	VBP	61	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
7	nice	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
8	guideline	_	guideline	_	NN	61	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	61	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	61	_	_	_	_	_	_	_	O
12	pregnancy	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
13	.	_	.	_	.	61	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	62	_	_	_	_	_	_	_	O
2	short-term	_	short-term	_	JJ	62	_	_	_	_	_	_	_	O
3	self-monitoring	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	62	_	_	_	_	_	_	_	O
5	blood	_	blood	_	NN	62	_	_	_	_	_	_	_	O
6	glucose	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
7	levels	_	level	_	NNS	62	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	62	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	62	_	_	_	_	_	adult.n	People_by_age	S-Person
10	with	_	with	_	IN	62	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	62	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	62	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	62	_	_	_	_	_	_	_	O
14	(	_	(	_	(	62	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	62	_	_	_	_	_	_	_	O
16	review	_	review	_	VB	62	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	62	_	_	_	_	_	_	_	O
18	as	_	a	_	IN	62	_	_	_	_	_	_	_	O
19	necessary	_	necessary	_	JJ	62	_	_	_	_	_	_	_	O
20	)	_	)	_	)	62	_	_	_	_	_	_	_	O
21	:	_	:	_	:	62	_	_	_	_	_	_	_	O
22	when	_	when	_	WRB	62	_	_	_	_	_	_	_	O
23	starting	_	start	_	VBG	62	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	62	_	_	_	_	_	_	_	O
25	with	_	with	_	IN	62	_	_	_	_	_	_	_	O
26	oral	_	UNK	_	JJ	62	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	62	_	_	_	_	_	_	_	O
28	intravenous	_	UNK	_	JJ	62	_	_	_	_	_	_	_	O
29	corticosteroids	_	UNK	_	NNS	62	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	62	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	62	_	_	_	_	_	_	_	O
32	confirm	_	confirm	_	VB	62	_	_	_	_	_	_	_	O
33	suspected	_	suspected	_	JJ	62	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
35	.	_	.	_	.	62	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	62	_	_	_	_	_	_	_	O
2	short-term	_	short-term	_	JJ	62	_	_	_	_	_	_	_	O
3	self-monitoring	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	62	_	_	_	_	_	_	_	O
5	blood	_	blood	_	NN	62	_	_	_	_	_	_	_	O
6	glucose	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
7	levels	_	level	_	NNS	62	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	62	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	62	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	62	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	62	_	_	_	_	_	type.n	Type	S-Subtype
12	2	_	2	_	CD	62	_	_	_	_	_	_	_	B-Category
13	diabetes	_	UNK	_	NNS	62	_	_	_	_	_	_	_	I-Category
14	(	_	(	_	(	62	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	62	_	_	_	_	_	_	_	O
16	review	_	review	_	VB	62	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	62	_	_	_	_	_	_	_	O
18	as	_	a	_	IN	62	_	_	_	_	_	_	_	O
19	necessary	_	necessary	_	JJ	62	_	_	_	_	_	_	_	O
20	)	_	)	_	)	62	_	_	_	_	_	_	_	O
21	:	_	:	_	:	62	_	_	_	_	_	_	_	O
22	when	_	when	_	WRB	62	_	_	_	_	_	_	_	O
23	starting	_	start	_	VBG	62	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	62	_	_	_	_	_	_	_	O
25	with	_	with	_	IN	62	_	_	_	_	_	_	_	O
26	oral	_	UNK	_	JJ	62	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	62	_	_	_	_	_	_	_	O
28	intravenous	_	UNK	_	JJ	62	_	_	_	_	_	_	_	O
29	corticosteroids	_	UNK	_	NNS	62	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	62	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	62	_	_	_	_	_	_	_	O
32	confirm	_	confirm	_	VB	62	_	_	_	_	_	_	_	O
33	suspected	_	suspected	_	JJ	62	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
35	.	_	.	_	.	62	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	62	_	_	_	_	_	_	_	O
2	short-term	_	short-term	_	JJ	62	_	_	_	_	_	_	_	O
3	self-monitoring	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	62	_	_	_	_	_	_	_	O
5	blood	_	blood	_	NN	62	_	_	_	_	_	_	_	O
6	glucose	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
7	levels	_	level	_	NNS	62	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	62	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	62	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	62	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	62	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	62	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	62	_	_	_	_	_	_	_	O
14	(	_	(	_	(	62	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	62	_	_	_	_	_	_	_	O
16	review	_	review	_	VB	62	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	62	_	_	_	_	_	_	_	O
18	as	_	a	_	IN	62	_	_	_	_	_	_	_	O
19	necessary	_	necessary	_	JJ	62	_	_	_	_	_	necessary.a	Being_necessary	O
20	)	_	)	_	)	62	_	_	_	_	_	_	_	O
21	:	_	:	_	:	62	_	_	_	_	_	_	_	O
22	when	_	when	_	WRB	62	_	_	_	_	_	_	_	O
23	starting	_	start	_	VBG	62	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	62	_	_	_	_	_	_	_	O
25	with	_	with	_	IN	62	_	_	_	_	_	_	_	O
26	oral	_	UNK	_	JJ	62	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	62	_	_	_	_	_	_	_	O
28	intravenous	_	UNK	_	JJ	62	_	_	_	_	_	_	_	O
29	corticosteroids	_	UNK	_	NNS	62	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	62	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	62	_	_	_	_	_	_	_	O
32	confirm	_	confirm	_	VB	62	_	_	_	_	_	_	_	O
33	suspected	_	suspected	_	JJ	62	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
35	.	_	.	_	.	62	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	62	_	_	_	_	_	_	_	O
2	short-term	_	short-term	_	JJ	62	_	_	_	_	_	_	_	O
3	self-monitoring	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	62	_	_	_	_	_	_	_	O
5	blood	_	blood	_	NN	62	_	_	_	_	_	_	_	O
6	glucose	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
7	levels	_	level	_	NNS	62	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	62	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	62	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	62	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	62	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	62	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	62	_	_	_	_	_	_	_	O
14	(	_	(	_	(	62	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	62	_	_	_	_	_	_	_	O
16	review	_	review	_	VB	62	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	62	_	_	_	_	_	_	_	O
18	as	_	a	_	IN	62	_	_	_	_	_	_	_	O
19	necessary	_	necessary	_	JJ	62	_	_	_	_	_	_	_	O
20	)	_	)	_	)	62	_	_	_	_	_	_	_	O
21	:	_	:	_	:	62	_	_	_	_	_	_	_	O
22	when	_	when	_	WRB	62	_	_	_	_	_	_	_	O
23	starting	_	start	_	VBG	62	_	_	_	_	_	start.v	Process_start	O
24	treatment	_	treatment	_	NN	62	_	_	_	_	_	_	_	B-Event
25	with	_	with	_	IN	62	_	_	_	_	_	_	_	I-Event
26	oral	_	UNK	_	JJ	62	_	_	_	_	_	_	_	I-Event
27	or	_	or	_	CC	62	_	_	_	_	_	_	_	I-Event
28	intravenous	_	UNK	_	JJ	62	_	_	_	_	_	_	_	I-Event
29	corticosteroids	_	UNK	_	NNS	62	_	_	_	_	_	_	_	I-Event
30	or	_	or	_	CC	62	_	_	_	_	_	_	_	I-Event
31	to	_	to	_	TO	62	_	_	_	_	_	_	_	I-Event
32	confirm	_	confirm	_	VB	62	_	_	_	_	_	_	_	I-Event
33	suspected	_	suspected	_	JJ	62	_	_	_	_	_	_	_	I-Event
34	unk	_	UNK	_	NN	62	_	_	_	_	_	_	_	I-Event
35	.	_	.	_	.	62	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	62	_	_	_	_	_	_	_	O
2	short-term	_	short-term	_	JJ	62	_	_	_	_	_	_	_	O
3	self-monitoring	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	62	_	_	_	_	_	_	_	O
5	blood	_	blood	_	NN	62	_	_	_	_	_	_	_	O
6	glucose	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
7	levels	_	level	_	NNS	62	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	62	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	62	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	62	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	62	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	62	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	62	_	_	_	_	_	_	_	O
14	(	_	(	_	(	62	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	62	_	_	_	_	_	_	_	O
16	review	_	review	_	VB	62	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	62	_	_	_	_	_	_	_	O
18	as	_	a	_	IN	62	_	_	_	_	_	_	_	O
19	necessary	_	necessary	_	JJ	62	_	_	_	_	_	_	_	O
20	)	_	)	_	)	62	_	_	_	_	_	_	_	O
21	:	_	:	_	:	62	_	_	_	_	_	_	_	O
22	when	_	when	_	WRB	62	_	_	_	_	_	_	_	O
23	starting	_	start	_	VBG	62	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	62	_	_	_	_	_	treatment.n	Cure	O
25	with	_	with	_	IN	62	_	_	_	_	_	_	_	O
26	oral	_	UNK	_	JJ	62	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	62	_	_	_	_	_	_	_	O
28	intravenous	_	UNK	_	JJ	62	_	_	_	_	_	_	_	O
29	corticosteroids	_	UNK	_	NNS	62	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	62	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	62	_	_	_	_	_	_	_	O
32	confirm	_	confirm	_	VB	62	_	_	_	_	_	_	_	O
33	suspected	_	suspected	_	JJ	62	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
35	.	_	.	_	.	62	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	62	_	_	_	_	_	_	_	O
2	short-term	_	short-term	_	JJ	62	_	_	_	_	_	_	_	O
3	self-monitoring	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	62	_	_	_	_	_	_	_	O
5	blood	_	blood	_	NN	62	_	_	_	_	_	_	_	O
6	glucose	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
7	levels	_	level	_	NNS	62	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	62	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	62	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	62	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	62	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	62	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	62	_	_	_	_	_	_	_	O
14	(	_	(	_	(	62	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	62	_	_	_	_	_	_	_	O
16	review	_	review	_	VB	62	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	62	_	_	_	_	_	_	_	O
18	as	_	a	_	IN	62	_	_	_	_	_	_	_	O
19	necessary	_	necessary	_	JJ	62	_	_	_	_	_	_	_	O
20	)	_	)	_	)	62	_	_	_	_	_	_	_	O
21	:	_	:	_	:	62	_	_	_	_	_	_	_	O
22	when	_	when	_	WRB	62	_	_	_	_	_	_	_	O
23	starting	_	start	_	VBG	62	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	62	_	_	_	_	_	_	_	O
25	with	_	with	_	IN	62	_	_	_	_	_	_	_	O
26	oral	_	UNK	_	JJ	62	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	62	_	_	_	_	_	_	_	O
28	intravenous	_	UNK	_	JJ	62	_	_	_	_	_	_	_	O
29	corticosteroids	_	UNK	_	NNS	62	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	62	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	62	_	_	_	_	_	_	_	O
32	confirm	_	confirm	_	VB	62	_	_	_	_	_	confirm.v	Evidence	O
33	suspected	_	suspected	_	JJ	62	_	_	_	_	_	_	_	B-Proposition
34	unk	_	UNK	_	NN	62	_	_	_	_	_	_	_	I-Proposition
35	.	_	.	_	.	62	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	62	_	_	_	_	_	_	_	O
2	short-term	_	short-term	_	JJ	62	_	_	_	_	_	_	_	O
3	self-monitoring	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	62	_	_	_	_	_	_	_	O
5	blood	_	blood	_	NN	62	_	_	_	_	_	_	_	O
6	glucose	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
7	levels	_	level	_	NNS	62	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	62	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	62	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	62	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	62	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	62	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	62	_	_	_	_	_	_	_	O
14	(	_	(	_	(	62	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	62	_	_	_	_	_	_	_	O
16	review	_	review	_	VB	62	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	62	_	_	_	_	_	_	_	O
18	as	_	a	_	IN	62	_	_	_	_	_	_	_	O
19	necessary	_	necessary	_	JJ	62	_	_	_	_	_	_	_	O
20	)	_	)	_	)	62	_	_	_	_	_	_	_	O
21	:	_	:	_	:	62	_	_	_	_	_	_	_	O
22	when	_	when	_	WRB	62	_	_	_	_	_	_	_	O
23	starting	_	start	_	VBG	62	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	62	_	_	_	_	_	_	_	O
25	with	_	with	_	IN	62	_	_	_	_	_	_	_	O
26	oral	_	UNK	_	JJ	62	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	62	_	_	_	_	_	_	_	O
28	intravenous	_	UNK	_	JJ	62	_	_	_	_	_	_	_	O
29	corticosteroids	_	UNK	_	NNS	62	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	62	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	62	_	_	_	_	_	_	_	O
32	confirm	_	confirm	_	VB	62	_	_	_	_	_	_	_	O
33	suspected	_	suspected	_	JJ	62	_	_	_	_	_	suspected.a	Awareness_status	O
34	unk	_	UNK	_	NN	62	_	_	_	_	_	_	_	S-Content
35	.	_	.	_	.	62	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	63	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	63	_	_	_	_	_	aware.a	Awareness	O
3	that	_	that	_	IN	63	_	_	_	_	_	_	_	O
4	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
5	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
6	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
8	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
9	who	_	who	_	WP	63	_	_	_	_	_	_	_	O
10	have	_	have	_	VBP	63	_	_	_	_	_	_	_	O
11	acute	_	acute	_	VBN	63	_	_	_	_	_	_	_	O
12	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
13	illness	_	illness	_	NN	63	_	_	_	_	_	_	_	O
14	are	_	be	_	VBP	63	_	_	_	_	_	_	_	O
15	at	_	at	_	IN	63	_	_	_	_	_	_	_	O
16	risk	_	risk	_	NN	63	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
18	worsening	_	UNK	_	VBG	63	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NN	63	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	63	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	63	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	63	_	_	_	_	_	_	_	O
4	adults	_	adult	_	NNS	63	_	_	_	_	_	adult.n	People_by_age	S-Person
5	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
6	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
8	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
9	who	_	who	_	WP	63	_	_	_	_	_	_	_	O
10	have	_	have	_	VBP	63	_	_	_	_	_	_	_	O
11	acute	_	acute	_	VBN	63	_	_	_	_	_	_	_	O
12	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
13	illness	_	illness	_	NN	63	_	_	_	_	_	_	_	O
14	are	_	be	_	VBP	63	_	_	_	_	_	_	_	O
15	at	_	at	_	IN	63	_	_	_	_	_	_	_	O
16	risk	_	risk	_	NN	63	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
18	worsening	_	UNK	_	VBG	63	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NN	63	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	63	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	63	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	63	_	_	_	_	_	_	_	O
4	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
5	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
6	type	_	type	_	JJ	63	_	_	_	_	_	type.n	Type	S-Subtype
7	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
8	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
9	who	_	who	_	WP	63	_	_	_	_	_	_	_	O
10	have	_	have	_	VBP	63	_	_	_	_	_	_	_	O
11	acute	_	acute	_	VBN	63	_	_	_	_	_	_	_	O
12	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
13	illness	_	illness	_	NN	63	_	_	_	_	_	_	_	O
14	are	_	be	_	VBP	63	_	_	_	_	_	_	_	O
15	at	_	at	_	IN	63	_	_	_	_	_	_	_	O
16	risk	_	risk	_	NN	63	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
18	worsening	_	UNK	_	VBG	63	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NN	63	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	63	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	63	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	63	_	_	_	_	_	_	_	O
4	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
5	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
6	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
8	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
9	who	_	who	_	WP	63	_	_	_	_	_	_	_	O
10	have	_	have	_	VBP	63	_	_	_	_	_	_	_	O
11	acute	_	acute	_	VBN	63	_	_	_	_	_	acute.a	Importance	O
12	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	B-Factor
13	illness	_	illness	_	NN	63	_	_	_	_	_	_	_	I-Factor
14	are	_	be	_	VBP	63	_	_	_	_	_	_	_	O
15	at	_	at	_	IN	63	_	_	_	_	_	_	_	O
16	risk	_	risk	_	NN	63	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
18	worsening	_	UNK	_	VBG	63	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NN	63	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	63	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	63	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	63	_	_	_	_	_	_	_	O
4	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
5	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
6	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
8	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
9	who	_	who	_	WP	63	_	_	_	_	_	_	_	O
10	have	_	have	_	VBP	63	_	_	_	_	_	_	_	O
11	acute	_	acute	_	VBN	63	_	_	_	_	_	_	_	O
12	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	S-Cause
13	illness	_	illness	_	NN	63	_	_	_	_	_	illness.n	Medical_conditions	S-Ailment
14	are	_	be	_	VBP	63	_	_	_	_	_	_	_	O
15	at	_	at	_	IN	63	_	_	_	_	_	_	_	O
16	risk	_	risk	_	NN	63	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
18	worsening	_	UNK	_	VBG	63	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NN	63	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	63	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	63	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	63	_	_	_	_	_	_	_	O
4	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
5	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
6	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
8	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
9	who	_	who	_	WP	63	_	_	_	_	_	_	_	O
10	have	_	have	_	VBP	63	_	_	_	_	_	_	_	O
11	acute	_	acute	_	VBN	63	_	_	_	_	_	_	_	B-Protagonist
12	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	I-Protagonist
13	illness	_	illness	_	NN	63	_	_	_	_	_	_	_	I-Protagonist
14	are	_	be	_	VBP	63	_	_	_	_	_	_	_	O
15	at	_	at	_	IN	63	_	_	_	_	_	_	_	O
16	risk	_	risk	_	NN	63	_	_	_	_	_	risk.n	Run_risk	O
17	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
18	worsening	_	UNK	_	VBG	63	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NN	63	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	64	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	64	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	64	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	64	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	64	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	64	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	64	_	_	_	_	_	_	_	O
8	self-monitoring	_	UNK	_	VBG	64	_	_	_	_	_	_	_	O
9	their	_	their	_	PRP$	64	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	64	_	_	_	_	_	_	_	O
11	glucose	_	UNK	_	NN	64	_	_	_	_	_	_	_	O
12	levels	_	level	_	NNS	64	_	_	_	_	_	_	_	O
13	,	_	,	_	,	64	_	_	_	_	_	_	_	O
14	carry	_	carry	_	VBP	64	_	_	_	_	_	_	_	O
15	out	_	out	_	RP	64	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	64	_	_	_	_	_	_	_	O
17	structured	_	UNK	_	JJ	64	_	_	_	_	_	_	_	O
18	assessment	_	assessment	_	NN	64	_	_	_	_	_	_	_	O
19	at	_	at	_	IN	64	_	_	_	_	_	_	_	O
20	least	_	least	_	JJS	64	_	_	_	_	_	_	_	O
21	annually	_	annually	_	RB	64	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	64	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	64	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	64	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	64	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	64	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	64	_	_	_	_	_	_	_	I-Category
7	are	_	be	_	VBP	64	_	_	_	_	_	_	_	O
8	self-monitoring	_	UNK	_	VBG	64	_	_	_	_	_	_	_	O
9	their	_	their	_	PRP$	64	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	64	_	_	_	_	_	_	_	O
11	glucose	_	UNK	_	NN	64	_	_	_	_	_	_	_	O
12	levels	_	level	_	NNS	64	_	_	_	_	_	_	_	O
13	,	_	,	_	,	64	_	_	_	_	_	_	_	O
14	carry	_	carry	_	VBP	64	_	_	_	_	_	_	_	O
15	out	_	out	_	RP	64	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	64	_	_	_	_	_	_	_	O
17	structured	_	UNK	_	JJ	64	_	_	_	_	_	_	_	O
18	assessment	_	assessment	_	NN	64	_	_	_	_	_	_	_	O
19	at	_	at	_	IN	64	_	_	_	_	_	_	_	O
20	least	_	least	_	JJS	64	_	_	_	_	_	_	_	O
21	annually	_	annually	_	RB	64	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	64	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	64	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	64	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	64	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	64	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	64	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	64	_	_	_	_	_	_	_	O
8	self-monitoring	_	UNK	_	VBG	64	_	_	_	_	_	_	_	O
9	their	_	their	_	PRP$	64	_	_	_	_	_	_	_	B-Theme
10	blood	_	blood	_	NN	64	_	_	_	_	_	_	_	I-Theme
11	glucose	_	UNK	_	NN	64	_	_	_	_	_	_	_	I-Theme
12	levels	_	level	_	NNS	64	_	_	_	_	_	_	_	I-Theme
13	,	_	,	_	,	64	_	_	_	_	_	_	_	O
14	carry	_	carry	_	VBP	64	_	_	_	_	_	carry.v	Bringing	O
15	out	_	out	_	RP	64	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	64	_	_	_	_	_	_	_	B-Goal
17	structured	_	UNK	_	JJ	64	_	_	_	_	_	_	_	I-Goal
18	assessment	_	assessment	_	NN	64	_	_	_	_	_	_	_	I-Goal
19	at	_	at	_	IN	64	_	_	_	_	_	_	_	O
20	least	_	least	_	JJS	64	_	_	_	_	_	_	_	O
21	annually	_	annually	_	RB	64	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	64	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	64	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	64	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	64	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	64	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	64	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	64	_	_	_	_	_	_	_	O
8	self-monitoring	_	UNK	_	VBG	64	_	_	_	_	_	_	_	O
9	their	_	their	_	PRP$	64	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	64	_	_	_	_	_	_	_	O
11	glucose	_	UNK	_	NN	64	_	_	_	_	_	_	_	O
12	levels	_	level	_	NNS	64	_	_	_	_	_	_	_	O
13	,	_	,	_	,	64	_	_	_	_	_	_	_	O
14	carry	_	carry	_	VBP	64	_	_	_	_	_	_	_	O
15	out	_	out	_	RP	64	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	64	_	_	_	_	_	_	_	O
17	structured	_	UNK	_	JJ	64	_	_	_	_	_	_	_	O
18	assessment	_	assessment	_	NN	64	_	_	_	_	_	assessment.n	Assessing	S-Assessor
19	at	_	at	_	IN	64	_	_	_	_	_	_	_	O
20	least	_	least	_	JJS	64	_	_	_	_	_	_	_	O
21	annually	_	annually	_	RB	64	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	65	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	65	_	_	_	_	_	assessment.n	Assessing	S-Assessor
3	should	_	should	_	MD	65	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	65	_	_	_	_	_	_	_	O
5	:	_	:	_	:	65	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	65	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	65	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	65	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	65	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	65	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	65	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	65	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	65	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	65	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	65	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	65	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	65	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	65	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	65	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	65	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	65	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	65	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	65	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	65	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	65	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	65	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	65	_	_	_	_	_	_	_	O
52	.	_	.	_	.	65	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	65	_	_	_	_	_	_	_	B-Total
2	assessment	_	assessment	_	NN	65	_	_	_	_	_	_	_	I-Total
3	should	_	should	_	MD	65	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	65	_	_	_	_	_	include.v	Inclusion	O
5	:	_	:	_	:	65	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	65	_	_	_	_	_	_	_	B-Part
7	person	_	person	_	NN	65	_	_	_	_	_	_	_	I-Part
8	's	_	's	_	POS	65	_	_	_	_	_	_	_	I-Part
9	self-monitoring	_	UNK	_	JJ	65	_	_	_	_	_	_	_	I-Part
10	skills	_	skill	_	NNS	65	_	_	_	_	_	_	_	I-Part
11	the	_	the	_	DT	65	_	_	_	_	_	_	_	I-Part
12	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	I-Part
13	and	_	and	_	CC	65	_	_	_	_	_	_	_	I-Part
14	frequency	_	frequency	_	NN	65	_	_	_	_	_	_	_	I-Part
15	of	_	of	_	IN	65	_	_	_	_	_	_	_	I-Part
16	testing	_	test	_	VBG	65	_	_	_	_	_	_	_	I-Part
17	checking	_	check	_	VBG	65	_	_	_	_	_	_	_	I-Part
18	that	_	that	_	IN	65	_	_	_	_	_	_	_	I-Part
19	the	_	the	_	DT	65	_	_	_	_	_	_	_	I-Part
20	person	_	person	_	NN	65	_	_	_	_	_	_	_	I-Part
21	knows	_	know	_	VBZ	65	_	_	_	_	_	_	_	I-Part
22	how	_	how	_	WRB	65	_	_	_	_	_	_	_	I-Part
23	to	_	to	_	TO	65	_	_	_	_	_	_	_	I-Part
24	interpret	_	UNK	_	VB	65	_	_	_	_	_	_	_	I-Part
25	the	_	the	_	DT	65	_	_	_	_	_	_	_	I-Part
26	blood	_	blood	_	NN	65	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	65	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	65	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	65	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	65	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	65	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	65	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	65	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	65	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	65	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	65	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	65	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	65	_	_	_	_	_	_	_	O
52	.	_	.	_	.	65	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	65	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	65	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	65	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	65	_	_	_	_	_	_	_	O
5	:	_	:	_	:	65	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	65	_	_	_	_	_	person.n	People	S-Person
8	's	_	's	_	POS	65	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	65	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	65	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	65	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	65	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	65	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	65	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	65	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	65	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	65	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	65	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	65	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	65	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	65	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	65	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	65	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	65	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	65	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	65	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	65	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	65	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	65	_	_	_	_	_	_	_	O
52	.	_	.	_	.	65	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	65	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	65	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	65	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	65	_	_	_	_	_	_	_	O
5	:	_	:	_	:	65	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	65	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	65	_	_	_	_	_	_	_	S-Knowledge
10	skills	_	skill	_	NNS	65	_	_	_	_	_	skill.n	Expertise	O
11	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	65	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	65	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	65	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	65	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	65	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	65	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	65	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	65	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	65	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	65	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	65	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	65	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	65	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	65	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	65	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	65	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	65	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	65	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	65	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	65	_	_	_	_	_	_	_	O
52	.	_	.	_	.	65	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	65	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	65	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	65	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	65	_	_	_	_	_	_	_	O
5	:	_	:	_	:	65	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	65	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	65	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	65	_	_	_	_	_	frequency.n	Frequency	O
15	of	_	of	_	IN	65	_	_	_	_	_	_	_	B-Event
16	testing	_	test	_	VBG	65	_	_	_	_	_	_	_	I-Event
17	checking	_	check	_	VBG	65	_	_	_	_	_	_	_	I-Event
18	that	_	that	_	IN	65	_	_	_	_	_	_	_	I-Event
19	the	_	the	_	DT	65	_	_	_	_	_	_	_	I-Event
20	person	_	person	_	NN	65	_	_	_	_	_	_	_	I-Event
21	knows	_	know	_	VBZ	65	_	_	_	_	_	_	_	I-Event
22	how	_	how	_	WRB	65	_	_	_	_	_	_	_	I-Event
23	to	_	to	_	TO	65	_	_	_	_	_	_	_	I-Event
24	interpret	_	UNK	_	VB	65	_	_	_	_	_	_	_	I-Event
25	the	_	the	_	DT	65	_	_	_	_	_	_	_	I-Event
26	blood	_	blood	_	NN	65	_	_	_	_	_	_	_	I-Event
27	glucose	_	UNK	_	JJ	65	_	_	_	_	_	_	_	I-Event
28	results	_	result	_	NNS	65	_	_	_	_	_	_	_	I-Event
29	and	_	and	_	CC	65	_	_	_	_	_	_	_	I-Event
30	what	_	what	_	WP	65	_	_	_	_	_	_	_	I-Event
31	action	_	action	_	NN	65	_	_	_	_	_	_	_	I-Event
32	to	_	to	_	TO	65	_	_	_	_	_	_	_	I-Event
33	take	_	take	_	VB	65	_	_	_	_	_	_	_	I-Event
34	the	_	the	_	DT	65	_	_	_	_	_	_	_	I-Event
35	impact	_	impact	_	NN	65	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	65	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	65	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	65	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	65	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	65	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	65	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	65	_	_	_	_	_	_	_	O
52	.	_	.	_	.	65	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	65	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	65	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	65	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	65	_	_	_	_	_	_	_	O
5	:	_	:	_	:	65	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	65	_	_	_	_	_	_	_	B-Tester
7	person	_	person	_	NN	65	_	_	_	_	_	_	_	I-Tester
8	's	_	's	_	POS	65	_	_	_	_	_	_	_	I-Tester
9	self-monitoring	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	65	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	65	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	65	_	_	_	_	_	test.v	Operational_testing	O
17	checking	_	check	_	VBG	65	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	65	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	65	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	65	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	65	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	65	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	65	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	65	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	65	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	65	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	65	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	65	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	65	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	65	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	65	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	65	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	65	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	65	_	_	_	_	_	_	_	O
52	.	_	.	_	.	65	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	65	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	65	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	65	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	65	_	_	_	_	_	_	_	O
5	:	_	:	_	:	65	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	65	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	65	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	65	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	65	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	65	_	_	_	_	_	check.v	Inspecting	O
18	that	_	that	_	IN	65	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	65	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	65	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	65	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	65	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	65	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	65	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	65	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	65	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	65	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	65	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	65	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	65	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	65	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	65	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	65	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	65	_	_	_	_	_	_	_	O
52	.	_	.	_	.	65	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	65	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	65	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	65	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	65	_	_	_	_	_	_	_	O
5	:	_	:	_	:	65	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	65	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	65	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	65	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	65	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	65	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	65	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	65	_	_	_	_	_	person.n	People	S-Person
21	knows	_	know	_	VBZ	65	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	65	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	65	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	65	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	65	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	65	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	65	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	65	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	65	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	65	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	65	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	65	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	65	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	65	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	65	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	65	_	_	_	_	_	_	_	O
52	.	_	.	_	.	65	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	65	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	65	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	65	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	65	_	_	_	_	_	_	_	O
5	:	_	:	_	:	65	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	65	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	65	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	65	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	65	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	65	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	65	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	65	_	_	_	_	_	_	_	B-Cognizer
20	person	_	person	_	NN	65	_	_	_	_	_	_	_	I-Cognizer
21	knows	_	know	_	VBZ	65	_	_	_	_	_	know.v	Awareness	O
22	how	_	how	_	WRB	65	_	_	_	_	_	_	_	B-Content
23	to	_	to	_	TO	65	_	_	_	_	_	_	_	I-Content
24	interpret	_	UNK	_	VB	65	_	_	_	_	_	_	_	I-Content
25	the	_	the	_	DT	65	_	_	_	_	_	_	_	I-Content
26	blood	_	blood	_	NN	65	_	_	_	_	_	_	_	I-Content
27	glucose	_	UNK	_	JJ	65	_	_	_	_	_	_	_	I-Content
28	results	_	result	_	NNS	65	_	_	_	_	_	_	_	I-Content
29	and	_	and	_	CC	65	_	_	_	_	_	_	_	I-Content
30	what	_	what	_	WP	65	_	_	_	_	_	_	_	I-Content
31	action	_	action	_	NN	65	_	_	_	_	_	_	_	I-Content
32	to	_	to	_	TO	65	_	_	_	_	_	_	_	I-Content
33	take	_	take	_	VB	65	_	_	_	_	_	_	_	I-Content
34	the	_	the	_	DT	65	_	_	_	_	_	_	_	I-Content
35	impact	_	impact	_	NN	65	_	_	_	_	_	_	_	I-Content
36	on	_	on	_	IN	65	_	_	_	_	_	_	_	I-Content
37	the	_	the	_	DT	65	_	_	_	_	_	_	_	I-Content
38	person	_	person	_	NN	65	_	_	_	_	_	_	_	I-Content
39	's	_	's	_	POS	65	_	_	_	_	_	_	_	I-Content
40	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	I-Content
41	of	_	of	_	IN	65	_	_	_	_	_	_	_	I-Content
42	life	_	life	_	NN	65	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	65	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	65	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	65	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	65	_	_	_	_	_	_	_	O
52	.	_	.	_	.	65	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	65	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	65	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	65	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	65	_	_	_	_	_	_	_	O
5	:	_	:	_	:	65	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	65	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	65	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	65	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	65	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	65	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	65	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	65	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	65	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	65	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	65	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	65	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	65	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	65	_	_	_	_	_	action.n	Intentionally_act	O
32	to	_	to	_	TO	65	_	_	_	_	_	_	_	B-Act
33	take	_	take	_	VB	65	_	_	_	_	_	_	_	I-Act
34	the	_	the	_	DT	65	_	_	_	_	_	_	_	I-Act
35	impact	_	impact	_	NN	65	_	_	_	_	_	_	_	I-Act
36	on	_	on	_	IN	65	_	_	_	_	_	_	_	I-Act
37	the	_	the	_	DT	65	_	_	_	_	_	_	_	I-Act
38	person	_	person	_	NN	65	_	_	_	_	_	_	_	I-Act
39	's	_	's	_	POS	65	_	_	_	_	_	_	_	I-Act
40	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	I-Act
41	of	_	of	_	IN	65	_	_	_	_	_	_	_	I-Act
42	life	_	life	_	NN	65	_	_	_	_	_	_	_	I-Act
43	the	_	the	_	DT	65	_	_	_	_	_	_	_	I-Act
44	continued	_	continued	_	JJ	65	_	_	_	_	_	_	_	I-Act
45	benefit	_	benefit	_	NN	65	_	_	_	_	_	_	_	I-Act
46	to	_	to	_	TO	65	_	_	_	_	_	_	_	I-Act
47	the	_	the	_	DT	65	_	_	_	_	_	_	_	I-Act
48	person	_	person	_	NN	65	_	_	_	_	_	_	_	I-Act
49	the	_	the	_	DT	65	_	_	_	_	_	_	_	I-Act
50	equipment	_	equipment	_	NN	65	_	_	_	_	_	_	_	I-Act
51	used	_	use	_	VBN	65	_	_	_	_	_	_	_	I-Act
52	.	_	.	_	.	65	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	65	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	65	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	65	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	65	_	_	_	_	_	_	_	O
5	:	_	:	_	:	65	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	65	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	65	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	65	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	65	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	65	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	65	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	65	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	65	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	65	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	65	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	65	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	65	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	65	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	65	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	65	_	_	_	_	_	impact.n	Objective_influence	O
36	on	_	on	_	IN	65	_	_	_	_	_	_	_	B-Dependent_entity
37	the	_	the	_	DT	65	_	_	_	_	_	_	_	I-Dependent_entity
38	person	_	person	_	NN	65	_	_	_	_	_	_	_	I-Dependent_entity
39	's	_	's	_	POS	65	_	_	_	_	_	_	_	I-Dependent_entity
40	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	I-Dependent_entity
41	of	_	of	_	IN	65	_	_	_	_	_	_	_	I-Dependent_entity
42	life	_	life	_	NN	65	_	_	_	_	_	_	_	I-Dependent_entity
43	the	_	the	_	DT	65	_	_	_	_	_	_	_	I-Dependent_entity
44	continued	_	continued	_	JJ	65	_	_	_	_	_	_	_	I-Dependent_entity
45	benefit	_	benefit	_	NN	65	_	_	_	_	_	_	_	I-Dependent_entity
46	to	_	to	_	TO	65	_	_	_	_	_	_	_	I-Dependent_entity
47	the	_	the	_	DT	65	_	_	_	_	_	_	_	I-Dependent_entity
48	person	_	person	_	NN	65	_	_	_	_	_	_	_	I-Dependent_entity
49	the	_	the	_	DT	65	_	_	_	_	_	_	_	I-Dependent_entity
50	equipment	_	equipment	_	NN	65	_	_	_	_	_	_	_	I-Dependent_entity
51	used	_	use	_	VBN	65	_	_	_	_	_	_	_	I-Dependent_entity
52	.	_	.	_	.	65	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	65	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	65	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	65	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	65	_	_	_	_	_	_	_	O
5	:	_	:	_	:	65	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	65	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	65	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	65	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	65	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	65	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	65	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	65	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	65	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	65	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	65	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	65	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	65	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	65	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	65	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	65	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	65	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	65	_	_	_	_	_	person.n	People	S-Person
39	's	_	's	_	POS	65	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	65	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	65	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	65	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	65	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	65	_	_	_	_	_	_	_	O
52	.	_	.	_	.	65	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	65	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	65	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	65	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	65	_	_	_	_	_	_	_	O
5	:	_	:	_	:	65	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	65	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	65	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	65	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	65	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	65	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	65	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	65	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	65	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	65	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	65	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	65	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	65	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	65	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	65	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	65	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	65	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	65	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	65	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	65	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	65	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	65	_	_	_	_	_	person.n	People	S-Person
49	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	65	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	65	_	_	_	_	_	_	_	O
52	.	_	.	_	.	65	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	65	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	65	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	65	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	65	_	_	_	_	_	_	_	O
5	:	_	:	_	:	65	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	65	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	65	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	65	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	65	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	65	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	65	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	65	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	65	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	65	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	65	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	65	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	65	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	65	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	65	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	65	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	65	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	65	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	65	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	65	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	65	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	65	_	_	_	_	_	equipment.n	Gizmo	S-Gizmo
51	used	_	use	_	VBN	65	_	_	_	_	_	_	_	O
52	.	_	.	_	.	65	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	65	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	65	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	65	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	65	_	_	_	_	_	_	_	O
5	:	_	:	_	:	65	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	65	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	65	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	65	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	65	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	65	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	65	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	65	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	65	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	65	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	65	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	65	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	65	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	65	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	65	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	65	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	65	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	65	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	65	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	65	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	65	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	65	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	65	_	_	_	_	_	_	_	S-Instrument
51	used	_	use	_	VBN	65	_	_	_	_	_	use.v	Using	O
52	.	_	.	_	.	65	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	66	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	66	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	66	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	66	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	66	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	66	_	_	_	_	_	_	_	O
7	,	_	,	_	,	66	_	_	_	_	_	_	_	O
8	discuss	_	discuss	_	VBP	66	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	66	_	_	_	_	_	_	_	O
10	benefits	_	benefit	_	NNS	66	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	66	_	_	_	_	_	_	_	O
12	risks	_	risk	_	NNS	66	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	66	_	_	_	_	_	_	_	O
14	drug	_	drug	_	NN	66	_	_	_	_	_	_	_	O
15	treatment	_	treatment	_	NN	66	_	_	_	_	_	_	_	O
16	,	_	,	_	,	66	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	66	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	66	_	_	_	_	_	_	_	O
19	options	_	option	_	NNS	66	_	_	_	_	_	_	_	O
20	available	_	available	_	JJ	66	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	66	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	66	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	66	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	66	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	66	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	66	_	_	_	_	_	_	_	I-Category
7	,	_	,	_	,	66	_	_	_	_	_	_	_	O
8	discuss	_	discuss	_	VBP	66	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	66	_	_	_	_	_	_	_	O
10	benefits	_	benefit	_	NNS	66	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	66	_	_	_	_	_	_	_	O
12	risks	_	risk	_	NNS	66	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	66	_	_	_	_	_	_	_	O
14	drug	_	drug	_	NN	66	_	_	_	_	_	_	_	O
15	treatment	_	treatment	_	NN	66	_	_	_	_	_	_	_	O
16	,	_	,	_	,	66	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	66	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	66	_	_	_	_	_	_	_	O
19	options	_	option	_	NNS	66	_	_	_	_	_	_	_	O
20	available	_	available	_	JJ	66	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	66	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	66	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	66	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	66	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	66	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	66	_	_	_	_	_	_	_	O
7	,	_	,	_	,	66	_	_	_	_	_	_	_	O
8	discuss	_	discuss	_	VBP	66	_	_	_	_	_	discuss.v	Discussion	O
9	the	_	the	_	DT	66	_	_	_	_	_	_	_	B-Topic
10	benefits	_	benefit	_	NNS	66	_	_	_	_	_	_	_	I-Topic
11	and	_	and	_	CC	66	_	_	_	_	_	_	_	I-Topic
12	risks	_	risk	_	NNS	66	_	_	_	_	_	_	_	I-Topic
13	of	_	of	_	IN	66	_	_	_	_	_	_	_	I-Topic
14	drug	_	drug	_	NN	66	_	_	_	_	_	_	_	I-Topic
15	treatment	_	treatment	_	NN	66	_	_	_	_	_	_	_	I-Topic
16	,	_	,	_	,	66	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	66	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	66	_	_	_	_	_	_	_	O
19	options	_	option	_	NNS	66	_	_	_	_	_	_	_	O
20	available	_	available	_	JJ	66	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	66	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	66	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	66	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	66	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	66	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	66	_	_	_	_	_	_	_	O
7	,	_	,	_	,	66	_	_	_	_	_	_	_	O
8	discuss	_	discuss	_	VBP	66	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	66	_	_	_	_	_	_	_	O
10	benefits	_	benefit	_	NNS	66	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	66	_	_	_	_	_	_	_	O
12	risks	_	risk	_	NNS	66	_	_	_	_	_	risk.n	Run_risk	O
13	of	_	of	_	IN	66	_	_	_	_	_	_	_	B-Asset
14	drug	_	drug	_	NN	66	_	_	_	_	_	_	_	I-Asset
15	treatment	_	treatment	_	NN	66	_	_	_	_	_	_	_	I-Asset
16	,	_	,	_	,	66	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	66	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	66	_	_	_	_	_	_	_	O
19	options	_	option	_	NNS	66	_	_	_	_	_	_	_	O
20	available	_	available	_	JJ	66	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	66	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	66	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	66	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	66	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	66	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	66	_	_	_	_	_	_	_	O
7	,	_	,	_	,	66	_	_	_	_	_	_	_	O
8	discuss	_	discuss	_	VBP	66	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	66	_	_	_	_	_	_	_	O
10	benefits	_	benefit	_	NNS	66	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	66	_	_	_	_	_	_	_	O
12	risks	_	risk	_	NNS	66	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	66	_	_	_	_	_	_	_	O
14	drug	_	drug	_	NN	66	_	_	_	_	_	_	_	S-Patient
15	treatment	_	treatment	_	NN	66	_	_	_	_	_	treatment.n	Cure	O
16	,	_	,	_	,	66	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	66	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	66	_	_	_	_	_	_	_	O
19	options	_	option	_	NNS	66	_	_	_	_	_	_	_	O
20	available	_	available	_	JJ	66	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	66	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	66	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	66	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	66	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	66	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	66	_	_	_	_	_	_	_	O
7	,	_	,	_	,	66	_	_	_	_	_	_	_	O
8	discuss	_	discuss	_	VBP	66	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	66	_	_	_	_	_	_	_	O
10	benefits	_	benefit	_	NNS	66	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	66	_	_	_	_	_	_	_	O
12	risks	_	risk	_	NNS	66	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	66	_	_	_	_	_	_	_	O
14	drug	_	drug	_	NN	66	_	_	_	_	_	_	_	O
15	treatment	_	treatment	_	NN	66	_	_	_	_	_	_	_	O
16	,	_	,	_	,	66	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	66	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	66	_	_	_	_	_	_	_	O
19	options	_	option	_	NNS	66	_	_	_	_	_	option.n	Alternatives	O
20	available	_	available	_	JJ	66	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	67	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	67	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
6	:	_	:	_	:	67	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	67	_	_	_	_	_	_	_	O
8	(	_	(	_	(	67	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
10	)	_	)	_	)	67	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	67	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	67	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
14	)	_	)	_	)	67	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	67	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	67	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	67	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	67	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	67	_	_	_	_	_	_	_	O
8	(	_	(	_	(	67	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
10	)	_	)	_	)	67	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	67	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	67	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
14	)	_	)	_	)	67	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	68	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	68	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	68	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	68	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	68	_	_	_	_	_	_	_	O
6	(	_	(	_	(	68	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	68	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	68	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	68	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	68	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	68	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	68	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	68	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	68	_	_	_	_	_	_	_	O
18	)	_	)	_	)	68	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	68	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	68	_	_	_	_	_	_	_	S-Patient
24	treatment	_	treatment	_	NN	68	_	_	_	_	_	treatment.n	Cure	O
25	(	_	(	_	(	68	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	68	_	_	_	_	_	_	_	O
27	)	_	)	_	)	68	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	68	_	_	_	_	_	_	_	O
34	,	_	,	_	,	68	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	68	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	68	_	_	_	_	_	_	_	O
37	,	_	,	_	,	68	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
39	,	_	,	_	,	68	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	68	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	68	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	68	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	68	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	68	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	68	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	68	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	O
57	(	_	(	_	(	68	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	68	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	68	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	68	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	68	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	68	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	68	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	68	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	68	_	_	_	_	_	_	_	O
67	,	_	,	_	,	68	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	68	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	68	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	68	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	68	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	68	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	O
76	)	_	)	_	)	68	_	_	_	_	_	_	_	O
77	.	_	.	_	.	68	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	68	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	68	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	68	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	68	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	68	_	_	_	_	_	_	_	O
6	(	_	(	_	(	68	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	68	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	68	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	68	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	68	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	68	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	68	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	68	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	68	_	_	_	_	_	_	_	O
18	)	_	)	_	)	68	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	68	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	68	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	68	_	_	_	_	_	_	_	O
25	(	_	(	_	(	68	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	68	_	_	_	_	_	_	_	O
27	)	_	)	_	)	68	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	68	_	_	_	_	_	person.n	People	S-Person
30	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	68	_	_	_	_	_	_	_	O
34	,	_	,	_	,	68	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	68	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	68	_	_	_	_	_	_	_	O
37	,	_	,	_	,	68	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
39	,	_	,	_	,	68	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	68	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	68	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	68	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	68	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	68	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	68	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	68	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	O
57	(	_	(	_	(	68	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	68	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	68	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	68	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	68	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	68	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	68	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	68	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	68	_	_	_	_	_	_	_	O
67	,	_	,	_	,	68	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	68	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	68	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	68	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	68	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	68	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	O
76	)	_	)	_	)	68	_	_	_	_	_	_	_	O
77	.	_	.	_	.	68	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	68	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	68	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	68	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	68	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	68	_	_	_	_	_	_	_	O
6	(	_	(	_	(	68	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	68	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	68	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	68	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	68	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	68	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	68	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	68	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	68	_	_	_	_	_	_	_	O
18	)	_	)	_	)	68	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	68	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	68	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	68	_	_	_	_	_	_	_	O
25	(	_	(	_	(	68	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	68	_	_	_	_	_	_	_	O
27	)	_	)	_	)	68	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	68	_	_	_	_	_	individual.n	People	B-Person
32	clinical	_	UNK	_	JJ	68	_	_	_	_	_	_	_	I-Person
33	circumstances	_	circumstance	_	NNS	68	_	_	_	_	_	_	_	I-Person
34	,	_	,	_	,	68	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	68	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	68	_	_	_	_	_	_	_	O
37	,	_	,	_	,	68	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
39	,	_	,	_	,	68	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	68	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	68	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	68	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	68	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	68	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	68	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	68	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	O
57	(	_	(	_	(	68	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	68	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	68	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	68	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	68	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	68	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	68	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	68	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	68	_	_	_	_	_	_	_	O
67	,	_	,	_	,	68	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	68	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	68	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	68	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	68	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	68	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	O
76	)	_	)	_	)	68	_	_	_	_	_	_	_	O
77	.	_	.	_	.	68	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	68	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	68	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	68	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	68	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	68	_	_	_	_	_	_	_	O
6	(	_	(	_	(	68	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	68	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	68	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	68	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	68	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	68	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	68	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	68	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	68	_	_	_	_	_	_	_	O
18	)	_	)	_	)	68	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	68	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	68	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	68	_	_	_	_	_	_	_	O
25	(	_	(	_	(	68	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	68	_	_	_	_	_	_	_	O
27	)	_	)	_	)	68	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	68	_	_	_	_	_	_	_	O
34	,	_	,	_	,	68	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	68	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	68	_	_	_	_	_	example.n	Instance	S-Instance
37	,	_	,	_	,	68	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
39	,	_	,	_	,	68	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	68	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	68	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	68	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	68	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	68	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	68	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	68	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	O
57	(	_	(	_	(	68	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	68	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	68	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	68	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	68	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	68	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	68	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	68	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	68	_	_	_	_	_	_	_	O
67	,	_	,	_	,	68	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	68	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	68	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	68	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	68	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	68	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	O
76	)	_	)	_	)	68	_	_	_	_	_	_	_	O
77	.	_	.	_	.	68	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	68	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	68	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	68	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	68	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	68	_	_	_	_	_	_	_	O
6	(	_	(	_	(	68	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	68	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	68	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	68	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	68	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	68	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	68	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	68	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	68	_	_	_	_	_	_	_	O
18	)	_	)	_	)	68	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	68	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	68	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	68	_	_	_	_	_	_	_	O
25	(	_	(	_	(	68	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	68	_	_	_	_	_	_	_	O
27	)	_	)	_	)	68	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	68	_	_	_	_	_	_	_	O
34	,	_	,	_	,	68	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	68	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	68	_	_	_	_	_	_	_	O
37	,	_	,	_	,	68	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
39	,	_	,	_	,	68	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	68	_	_	_	_	_	risk.n	Run_risk	O
41	from	_	from	_	IN	68	_	_	_	_	_	_	_	B-Action
42	polypharmacy	_	UNK	_	NN	68	_	_	_	_	_	_	_	I-Action
43	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	68	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	68	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	68	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	68	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	68	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	O
57	(	_	(	_	(	68	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	68	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	68	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	68	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	68	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	68	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	68	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	68	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	68	_	_	_	_	_	_	_	O
67	,	_	,	_	,	68	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	68	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	68	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	68	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	68	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	68	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	O
76	)	_	)	_	)	68	_	_	_	_	_	_	_	O
77	.	_	.	_	.	68	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	68	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	68	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	68	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	68	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	68	_	_	_	_	_	_	_	O
6	(	_	(	_	(	68	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	68	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	68	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	68	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	68	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	68	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	68	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	68	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	68	_	_	_	_	_	_	_	O
18	)	_	)	_	)	68	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	68	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	68	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	68	_	_	_	_	_	_	_	O
25	(	_	(	_	(	68	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	68	_	_	_	_	_	_	_	O
27	)	_	)	_	)	68	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	68	_	_	_	_	_	_	_	O
34	,	_	,	_	,	68	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	68	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	68	_	_	_	_	_	_	_	O
37	,	_	,	_	,	68	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
39	,	_	,	_	,	68	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	68	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	68	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	68	_	_	_	_	_	person.n	People	S-Person
45	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	68	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	68	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	68	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	68	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	68	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	O
57	(	_	(	_	(	68	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	68	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	68	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	68	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	68	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	68	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	68	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	68	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	68	_	_	_	_	_	_	_	O
67	,	_	,	_	,	68	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	68	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	68	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	68	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	68	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	68	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	O
76	)	_	)	_	)	68	_	_	_	_	_	_	_	O
77	.	_	.	_	.	68	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	68	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	68	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	68	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	68	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	68	_	_	_	_	_	_	_	O
6	(	_	(	_	(	68	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	68	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	68	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	68	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	68	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	68	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	68	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	68	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	68	_	_	_	_	_	_	_	O
18	)	_	)	_	)	68	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	68	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	68	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	68	_	_	_	_	_	_	_	O
25	(	_	(	_	(	68	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	68	_	_	_	_	_	_	_	O
27	)	_	)	_	)	68	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	68	_	_	_	_	_	_	_	O
34	,	_	,	_	,	68	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	68	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	68	_	_	_	_	_	_	_	O
37	,	_	,	_	,	68	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
39	,	_	,	_	,	68	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	68	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	68	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	68	_	_	_	_	_	individual.n	People	S-Person
47	preferences	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	68	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	68	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	68	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	68	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	68	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	O
57	(	_	(	_	(	68	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	68	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	68	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	68	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	68	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	68	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	68	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	68	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	68	_	_	_	_	_	_	_	O
67	,	_	,	_	,	68	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	68	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	68	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	68	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	68	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	68	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	O
76	)	_	)	_	)	68	_	_	_	_	_	_	_	O
77	.	_	.	_	.	68	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	68	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	68	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	68	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	68	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	68	_	_	_	_	_	_	_	O
6	(	_	(	_	(	68	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	68	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	68	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	68	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	68	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	68	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	68	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	68	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	68	_	_	_	_	_	_	_	O
18	)	_	)	_	)	68	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	68	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	68	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	68	_	_	_	_	_	_	_	O
25	(	_	(	_	(	68	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	68	_	_	_	_	_	_	_	O
27	)	_	)	_	)	68	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	68	_	_	_	_	_	_	_	O
34	,	_	,	_	,	68	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	68	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	68	_	_	_	_	_	_	_	O
37	,	_	,	_	,	68	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
39	,	_	,	_	,	68	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	68	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	68	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	68	_	_	_	_	_	need.v	Needing	O
50	the	_	the	_	DT	68	_	_	_	_	_	_	_	B-Requirement
51	licensed	_	UNK	_	JJ	68	_	_	_	_	_	_	_	I-Requirement
52	indications	_	indication	_	NNS	68	_	_	_	_	_	_	_	I-Requirement
53	or	_	or	_	CC	68	_	_	_	_	_	_	_	I-Requirement
54	combinations	_	combination	_	NNS	68	_	_	_	_	_	_	_	I-Requirement
55	available	_	available	_	JJ	68	_	_	_	_	_	_	_	I-Requirement
56	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	I-Requirement
57	(	_	(	_	(	68	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	68	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	68	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	68	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	68	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	68	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	68	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	68	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	68	_	_	_	_	_	_	_	O
67	,	_	,	_	,	68	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	68	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	68	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	68	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	68	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	68	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	O
76	)	_	)	_	)	68	_	_	_	_	_	_	_	O
77	.	_	.	_	.	68	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	68	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	68	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	68	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	68	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	68	_	_	_	_	_	_	_	O
6	(	_	(	_	(	68	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	68	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	68	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	68	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	68	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	68	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	68	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	68	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	68	_	_	_	_	_	_	_	O
18	)	_	)	_	)	68	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	68	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	68	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	68	_	_	_	_	_	_	_	O
25	(	_	(	_	(	68	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	68	_	_	_	_	_	_	_	O
27	)	_	)	_	)	68	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	68	_	_	_	_	_	_	_	O
34	,	_	,	_	,	68	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	68	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	68	_	_	_	_	_	_	_	O
37	,	_	,	_	,	68	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
39	,	_	,	_	,	68	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	68	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	68	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	68	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	68	_	_	_	_	_	_	_	S-Descriptor
52	indications	_	indication	_	NNS	68	_	_	_	_	_	indication.n	Sign	S-Indicator
53	or	_	or	_	CC	68	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	68	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	68	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	O
57	(	_	(	_	(	68	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	68	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	68	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	68	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	68	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	68	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	68	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	68	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	68	_	_	_	_	_	_	_	O
67	,	_	,	_	,	68	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	68	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	68	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	68	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	68	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	68	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	O
76	)	_	)	_	)	68	_	_	_	_	_	_	_	O
77	.	_	.	_	.	68	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	68	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	68	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	68	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	68	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	68	_	_	_	_	_	_	_	O
6	(	_	(	_	(	68	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	68	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	68	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	68	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	68	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	68	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	68	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	68	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	68	_	_	_	_	_	_	_	O
18	)	_	)	_	)	68	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	68	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	68	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	68	_	_	_	_	_	_	_	O
25	(	_	(	_	(	68	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	68	_	_	_	_	_	_	_	O
27	)	_	)	_	)	68	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	68	_	_	_	_	_	_	_	O
34	,	_	,	_	,	68	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	68	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	68	_	_	_	_	_	_	_	O
37	,	_	,	_	,	68	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
39	,	_	,	_	,	68	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	68	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	68	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	68	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	68	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	68	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	68	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	68	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	68	_	_	_	_	_	cost.n	Expensiveness	O
57	(	_	(	_	(	68	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	68	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	68	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	68	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	68	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	68	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	68	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	68	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	68	_	_	_	_	_	_	_	O
67	,	_	,	_	,	68	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	68	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	68	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	68	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	68	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	68	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	O
76	)	_	)	_	)	68	_	_	_	_	_	_	_	O
77	.	_	.	_	.	68	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	68	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	68	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	68	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	68	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	68	_	_	_	_	_	_	_	O
6	(	_	(	_	(	68	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	68	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	68	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	68	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	68	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	68	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	68	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	68	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	68	_	_	_	_	_	_	_	O
18	)	_	)	_	)	68	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	68	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	68	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	68	_	_	_	_	_	_	_	O
25	(	_	(	_	(	68	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	68	_	_	_	_	_	_	_	O
27	)	_	)	_	)	68	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	68	_	_	_	_	_	_	_	O
34	,	_	,	_	,	68	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	68	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	68	_	_	_	_	_	_	_	O
37	,	_	,	_	,	68	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
39	,	_	,	_	,	68	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	68	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	68	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	68	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	68	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	68	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	68	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	68	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	O
57	(	_	(	_	(	68	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	68	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	68	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	68	_	_	_	_	_	drug.n	Intoxicants	S-Intoxicant
61	in	_	in	_	IN	68	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	68	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	68	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	68	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	68	_	_	_	_	_	_	_	O
67	,	_	,	_	,	68	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	68	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	68	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	68	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	68	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	68	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	O
76	)	_	)	_	)	68	_	_	_	_	_	_	_	O
77	.	_	.	_	.	68	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	68	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	68	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	68	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	68	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	68	_	_	_	_	_	_	_	O
6	(	_	(	_	(	68	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	68	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	68	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	68	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	68	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	68	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	68	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	68	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	68	_	_	_	_	_	_	_	O
18	)	_	)	_	)	68	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	68	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	68	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	68	_	_	_	_	_	_	_	O
25	(	_	(	_	(	68	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	68	_	_	_	_	_	_	_	O
27	)	_	)	_	)	68	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	68	_	_	_	_	_	_	_	O
34	,	_	,	_	,	68	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	68	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	68	_	_	_	_	_	_	_	O
37	,	_	,	_	,	68	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
39	,	_	,	_	,	68	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	68	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	68	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	68	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	68	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	68	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	68	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	68	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	O
57	(	_	(	_	(	68	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	68	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	68	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	68	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	68	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	68	_	_	_	_	_	same.a	Identicality	O
64	class	_	class	_	NN	68	_	_	_	_	_	_	_	S-Type
65	are	_	be	_	VBP	68	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	68	_	_	_	_	_	_	_	O
67	,	_	,	_	,	68	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	68	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	68	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	68	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	68	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	68	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	O
76	)	_	)	_	)	68	_	_	_	_	_	_	_	O
77	.	_	.	_	.	68	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	68	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	68	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	68	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	68	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	68	_	_	_	_	_	_	_	O
6	(	_	(	_	(	68	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	68	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	68	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	68	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	68	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	68	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	68	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	68	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	68	_	_	_	_	_	_	_	O
18	)	_	)	_	)	68	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	68	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	68	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	68	_	_	_	_	_	_	_	O
25	(	_	(	_	(	68	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	68	_	_	_	_	_	_	_	O
27	)	_	)	_	)	68	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	68	_	_	_	_	_	_	_	O
34	,	_	,	_	,	68	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	68	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	68	_	_	_	_	_	_	_	O
37	,	_	,	_	,	68	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
39	,	_	,	_	,	68	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	68	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	68	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	68	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	68	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	68	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	68	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	68	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	O
57	(	_	(	_	(	68	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	68	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	68	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	68	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	68	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	68	_	_	_	_	_	_	_	S-Type_property
64	class	_	class	_	NN	68	_	_	_	_	_	class.n	Type	S-Subtype
65	are	_	be	_	VBP	68	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	68	_	_	_	_	_	_	_	O
67	,	_	,	_	,	68	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	68	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	68	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	68	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	68	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	68	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	O
76	)	_	)	_	)	68	_	_	_	_	_	_	_	O
77	.	_	.	_	.	68	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	68	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	68	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	68	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	68	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	68	_	_	_	_	_	_	_	O
6	(	_	(	_	(	68	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	68	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	68	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	68	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	68	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	68	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	68	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	68	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	68	_	_	_	_	_	_	_	O
18	)	_	)	_	)	68	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	68	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	68	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	68	_	_	_	_	_	_	_	O
25	(	_	(	_	(	68	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	68	_	_	_	_	_	_	_	O
27	)	_	)	_	)	68	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	68	_	_	_	_	_	_	_	O
34	,	_	,	_	,	68	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	68	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	68	_	_	_	_	_	_	_	O
37	,	_	,	_	,	68	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
39	,	_	,	_	,	68	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	68	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	68	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	68	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	68	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	68	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	68	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	68	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	O
57	(	_	(	_	(	68	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	68	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	68	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	68	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	68	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	68	_	_	_	_	_	_	_	B-Evaluee
63	same	_	same	_	JJ	68	_	_	_	_	_	_	_	I-Evaluee
64	class	_	class	_	NN	68	_	_	_	_	_	_	_	I-Evaluee
65	are	_	be	_	VBP	68	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	68	_	_	_	_	_	appropriate.a	Suitability	O
67	,	_	,	_	,	68	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	68	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	68	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	68	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	68	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	68	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	O
76	)	_	)	_	)	68	_	_	_	_	_	_	_	O
77	.	_	.	_	.	68	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	68	_	_	_	_	_	_	_	B-Chosen
2	updated	_	update	_	VBD	68	_	_	_	_	_	_	_	I-Chosen
3	may	_	May	_	NNP	68	_	_	_	_	_	_	_	I-Chosen
4	2017	_	UNK	_	CD	68	_	_	_	_	_	_	_	I-Chosen
5	safety	_	safety	_	NN	68	_	_	_	_	_	_	_	I-Chosen
6	(	_	(	_	(	68	_	_	_	_	_	_	_	I-Chosen
7	see	_	see	_	VB	68	_	_	_	_	_	_	_	I-Chosen
8	medicines	_	UNK	_	NNPS	68	_	_	_	_	_	_	_	I-Chosen
9	and	_	and	_	CC	68	_	_	_	_	_	_	_	I-Chosen
10	healthcare	_	UNK	_	NNP	68	_	_	_	_	_	_	_	I-Chosen
11	products	_	product	_	NNS	68	_	_	_	_	_	_	_	I-Chosen
12	regulatory	_	Regulatory	_	NNP	68	_	_	_	_	_	_	_	I-Chosen
13	agency	_	Agency	_	NNP	68	_	_	_	_	_	_	_	I-Chosen
14	[	_	[	_	NNP	68	_	_	_	_	_	_	_	I-Chosen
15	mhra	_	UNK	_	NNP	68	_	_	_	_	_	_	_	I-Chosen
16	]	_	]	_	NNP	68	_	_	_	_	_	_	_	I-Chosen
17	guidance	_	guidance	_	NN	68	_	_	_	_	_	_	_	I-Chosen
18	)	_	)	_	)	68	_	_	_	_	_	_	_	I-Chosen
19	and	_	and	_	CC	68	_	_	_	_	_	_	_	I-Chosen
20	tolerability	_	UNK	_	NN	68	_	_	_	_	_	_	_	I-Chosen
21	of	_	of	_	IN	68	_	_	_	_	_	_	_	I-Chosen
22	the	_	the	_	DT	68	_	_	_	_	_	_	_	I-Chosen
23	drug	_	drug	_	NN	68	_	_	_	_	_	_	_	I-Chosen
24	treatment	_	treatment	_	NN	68	_	_	_	_	_	_	_	I-Chosen
25	(	_	(	_	(	68	_	_	_	_	_	_	_	I-Chosen
26	s	_	s	_	PRP	68	_	_	_	_	_	_	_	I-Chosen
27	)	_	)	_	)	68	_	_	_	_	_	_	_	I-Chosen
28	the	_	the	_	DT	68	_	_	_	_	_	_	_	I-Chosen
29	person	_	person	_	NN	68	_	_	_	_	_	_	_	I-Chosen
30	's	_	's	_	POS	68	_	_	_	_	_	_	_	I-Chosen
31	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	I-Chosen
32	clinical	_	UNK	_	JJ	68	_	_	_	_	_	_	_	I-Chosen
33	circumstances	_	circumstance	_	NNS	68	_	_	_	_	_	_	_	I-Chosen
34	,	_	,	_	,	68	_	_	_	_	_	_	_	I-Chosen
35	for	_	for	_	IN	68	_	_	_	_	_	_	_	I-Chosen
36	example	_	example	_	NN	68	_	_	_	_	_	_	_	I-Chosen
37	,	_	,	_	,	68	_	_	_	_	_	_	_	I-Chosen
38	comorbidities	_	UNK	_	NNS	68	_	_	_	_	_	_	_	I-Chosen
39	,	_	,	_	,	68	_	_	_	_	_	_	_	I-Chosen
40	risks	_	risk	_	NNS	68	_	_	_	_	_	_	_	I-Chosen
41	from	_	from	_	IN	68	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	68	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	68	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	68	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	68	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	68	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	O
57	(	_	(	_	(	68	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	68	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	68	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	68	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	68	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	68	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	68	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	68	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	68	_	_	_	_	_	_	_	O
67	,	_	,	_	,	68	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	68	_	_	_	_	_	choose.v	Choosing	O
69	the	_	the	_	DT	68	_	_	_	_	_	_	_	B-Chosen
70	option	_	option	_	NN	68	_	_	_	_	_	_	_	I-Chosen
71	with	_	with	_	IN	68	_	_	_	_	_	_	_	I-Chosen
72	the	_	the	_	DT	68	_	_	_	_	_	_	_	I-Chosen
73	lowest	_	lowest	_	JJS	68	_	_	_	_	_	_	_	I-Chosen
74	acquisition	_	acquisition	_	NN	68	_	_	_	_	_	_	_	I-Chosen
75	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	I-Chosen
76	)	_	)	_	)	68	_	_	_	_	_	_	_	O
77	.	_	.	_	.	68	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	68	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	68	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	68	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	68	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	68	_	_	_	_	_	_	_	O
6	(	_	(	_	(	68	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	68	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	68	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	68	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	68	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	68	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	68	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	68	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	68	_	_	_	_	_	_	_	O
18	)	_	)	_	)	68	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	68	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	68	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	68	_	_	_	_	_	_	_	O
25	(	_	(	_	(	68	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	68	_	_	_	_	_	_	_	O
27	)	_	)	_	)	68	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	68	_	_	_	_	_	_	_	O
34	,	_	,	_	,	68	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	68	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	68	_	_	_	_	_	_	_	O
37	,	_	,	_	,	68	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
39	,	_	,	_	,	68	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	68	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	68	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	68	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	68	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	68	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	68	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	68	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	O
57	(	_	(	_	(	68	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	68	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	68	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	68	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	68	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	68	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	68	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	68	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	68	_	_	_	_	_	_	_	O
67	,	_	,	_	,	68	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	68	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	68	_	_	_	_	_	option.n	Alternatives	O
71	with	_	with	_	IN	68	_	_	_	_	_	_	_	B-Situation
72	the	_	the	_	DT	68	_	_	_	_	_	_	_	I-Situation
73	lowest	_	lowest	_	JJS	68	_	_	_	_	_	_	_	I-Situation
74	acquisition	_	acquisition	_	NN	68	_	_	_	_	_	_	_	I-Situation
75	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	I-Situation
76	)	_	)	_	)	68	_	_	_	_	_	_	_	O
77	.	_	.	_	.	68	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	68	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	68	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	68	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	68	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	68	_	_	_	_	_	_	_	O
6	(	_	(	_	(	68	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	68	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	68	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	68	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	68	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	68	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	68	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	68	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	68	_	_	_	_	_	_	_	O
18	)	_	)	_	)	68	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	68	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	68	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	68	_	_	_	_	_	_	_	O
25	(	_	(	_	(	68	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	68	_	_	_	_	_	_	_	O
27	)	_	)	_	)	68	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	68	_	_	_	_	_	_	_	O
34	,	_	,	_	,	68	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	68	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	68	_	_	_	_	_	_	_	O
37	,	_	,	_	,	68	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
39	,	_	,	_	,	68	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	68	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	68	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	68	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	68	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	68	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	68	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	68	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	68	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	68	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	68	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	68	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	68	_	_	_	_	_	_	_	O
57	(	_	(	_	(	68	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	68	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	68	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	68	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	68	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	68	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	68	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	68	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	68	_	_	_	_	_	_	_	O
67	,	_	,	_	,	68	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	68	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	68	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	68	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	68	_	_	_	_	_	_	_	B-Asset
74	acquisition	_	acquisition	_	NN	68	_	_	_	_	_	_	_	I-Asset
75	cost	_	cost	_	NN	68	_	_	_	_	_	cost.n	Expensiveness	O
76	)	_	)	_	)	68	_	_	_	_	_	_	_	O
77	.	_	.	_	.	68	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	69	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	69	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	69	_	_	_	_	_	adult.n	People_by_age	S-Person
4	with	_	with	_	IN	69	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	69	_	_	_	_	_	_	_	O
6	2	_	2	_	CD	69	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
8	is	_	be	_	VBZ	69	_	_	_	_	_	_	_	O
9	symptomatically	_	UNK	_	RB	69	_	_	_	_	_	_	_	O
10	unk	_	UNK	_	JJ	69	_	_	_	_	_	_	_	O
11	,	_	,	_	,	69	_	_	_	_	_	_	_	O
12	consider	_	consider	_	VB	69	_	_	_	_	_	_	_	O
13	insulin	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
14	(	_	(	_	(	69	_	_	_	_	_	_	_	O
15	see	_	see	_	VB	69	_	_	_	_	_	_	_	O
16	recommendations	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	VB	69	_	_	_	_	_	_	_	O
18	)	_	)	_	)	69	_	_	_	_	_	_	_	O
19	or	_	or	_	CC	69	_	_	_	_	_	_	_	O
20	a	_	a	_	DT	69	_	_	_	_	_	_	_	O
21	sulfonylurea	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
22	,	_	,	_	,	69	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
24	review	_	review	_	VB	69	_	_	_	_	_	_	_	O
25	treatment	_	treatment	_	NN	69	_	_	_	_	_	_	_	O
26	when	_	when	_	WRB	69	_	_	_	_	_	_	_	O
27	blood	_	blood	_	NN	69	_	_	_	_	_	_	_	O
28	glucose	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
29	control	_	control	_	NN	69	_	_	_	_	_	_	_	O
30	has	_	have	_	VBZ	69	_	_	_	_	_	_	_	O
31	been	_	be	_	VBN	69	_	_	_	_	_	_	_	O
32	achieved	_	achieve	_	VBN	69	_	_	_	_	_	_	_	O
33	.	_	.	_	.	69	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	69	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	69	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	69	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	69	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	69	_	_	_	_	_	type.n	Type	S-Subtype
6	2	_	2	_	CD	69	_	_	_	_	_	_	_	B-Category
7	diabetes	_	UNK	_	NNS	69	_	_	_	_	_	_	_	I-Category
8	is	_	be	_	VBZ	69	_	_	_	_	_	_	_	O
9	symptomatically	_	UNK	_	RB	69	_	_	_	_	_	_	_	O
10	unk	_	UNK	_	JJ	69	_	_	_	_	_	_	_	O
11	,	_	,	_	,	69	_	_	_	_	_	_	_	O
12	consider	_	consider	_	VB	69	_	_	_	_	_	_	_	O
13	insulin	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
14	(	_	(	_	(	69	_	_	_	_	_	_	_	O
15	see	_	see	_	VB	69	_	_	_	_	_	_	_	O
16	recommendations	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	VB	69	_	_	_	_	_	_	_	O
18	)	_	)	_	)	69	_	_	_	_	_	_	_	O
19	or	_	or	_	CC	69	_	_	_	_	_	_	_	O
20	a	_	a	_	DT	69	_	_	_	_	_	_	_	O
21	sulfonylurea	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
22	,	_	,	_	,	69	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
24	review	_	review	_	VB	69	_	_	_	_	_	_	_	O
25	treatment	_	treatment	_	NN	69	_	_	_	_	_	_	_	O
26	when	_	when	_	WRB	69	_	_	_	_	_	_	_	O
27	blood	_	blood	_	NN	69	_	_	_	_	_	_	_	O
28	glucose	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
29	control	_	control	_	NN	69	_	_	_	_	_	_	_	O
30	has	_	have	_	VBZ	69	_	_	_	_	_	_	_	O
31	been	_	be	_	VBN	69	_	_	_	_	_	_	_	O
32	achieved	_	achieve	_	VBN	69	_	_	_	_	_	_	_	O
33	.	_	.	_	.	69	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	69	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	69	_	_	_	_	_	_	_	B-Cognizer
3	adult	_	adult	_	NN	69	_	_	_	_	_	_	_	I-Cognizer
4	with	_	with	_	IN	69	_	_	_	_	_	_	_	I-Cognizer
5	type	_	type	_	JJ	69	_	_	_	_	_	_	_	I-Cognizer
6	2	_	2	_	CD	69	_	_	_	_	_	_	_	I-Cognizer
7	diabetes	_	UNK	_	NNS	69	_	_	_	_	_	_	_	I-Cognizer
8	is	_	be	_	VBZ	69	_	_	_	_	_	_	_	O
9	symptomatically	_	UNK	_	RB	69	_	_	_	_	_	_	_	O
10	unk	_	UNK	_	JJ	69	_	_	_	_	_	_	_	O
11	,	_	,	_	,	69	_	_	_	_	_	_	_	O
12	consider	_	consider	_	VB	69	_	_	_	_	_	consider.v	Categorization	O
13	insulin	_	UNK	_	NN	69	_	_	_	_	_	_	_	S-Item
14	(	_	(	_	(	69	_	_	_	_	_	_	_	O
15	see	_	see	_	VB	69	_	_	_	_	_	_	_	O
16	recommendations	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	VB	69	_	_	_	_	_	_	_	O
18	)	_	)	_	)	69	_	_	_	_	_	_	_	O
19	or	_	or	_	CC	69	_	_	_	_	_	_	_	O
20	a	_	a	_	DT	69	_	_	_	_	_	_	_	O
21	sulfonylurea	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
22	,	_	,	_	,	69	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
24	review	_	review	_	VB	69	_	_	_	_	_	_	_	O
25	treatment	_	treatment	_	NN	69	_	_	_	_	_	_	_	O
26	when	_	when	_	WRB	69	_	_	_	_	_	_	_	O
27	blood	_	blood	_	NN	69	_	_	_	_	_	_	_	O
28	glucose	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
29	control	_	control	_	NN	69	_	_	_	_	_	_	_	O
30	has	_	have	_	VBZ	69	_	_	_	_	_	_	_	O
31	been	_	be	_	VBN	69	_	_	_	_	_	_	_	O
32	achieved	_	achieve	_	VBN	69	_	_	_	_	_	_	_	O
33	.	_	.	_	.	69	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	69	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	69	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	69	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	69	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	69	_	_	_	_	_	_	_	O
6	2	_	2	_	CD	69	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
8	is	_	be	_	VBZ	69	_	_	_	_	_	_	_	O
9	symptomatically	_	UNK	_	RB	69	_	_	_	_	_	_	_	O
10	unk	_	UNK	_	JJ	69	_	_	_	_	_	_	_	O
11	,	_	,	_	,	69	_	_	_	_	_	_	_	O
12	consider	_	consider	_	VB	69	_	_	_	_	_	_	_	O
13	insulin	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
14	(	_	(	_	(	69	_	_	_	_	_	_	_	O
15	see	_	see	_	VB	69	_	_	_	_	_	_	_	O
16	recommendations	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	VB	69	_	_	_	_	_	_	_	O
18	)	_	)	_	)	69	_	_	_	_	_	_	_	O
19	or	_	or	_	CC	69	_	_	_	_	_	_	_	O
20	a	_	a	_	DT	69	_	_	_	_	_	_	_	O
21	sulfonylurea	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
22	,	_	,	_	,	69	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
24	review	_	review	_	VB	69	_	_	_	_	_	_	_	O
25	treatment	_	treatment	_	NN	69	_	_	_	_	_	_	_	O
26	when	_	when	_	WRB	69	_	_	_	_	_	_	_	O
27	blood	_	blood	_	NN	69	_	_	_	_	_	_	_	B-Goal
28	glucose	_	UNK	_	NN	69	_	_	_	_	_	_	_	I-Goal
29	control	_	control	_	NN	69	_	_	_	_	_	_	_	I-Goal
30	has	_	have	_	VBZ	69	_	_	_	_	_	_	_	O
31	been	_	be	_	VBN	69	_	_	_	_	_	_	_	O
32	achieved	_	achieve	_	VBN	69	_	_	_	_	_	achieve.v	Accomplishment	O
33	.	_	.	_	.	69	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
3	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
4	as	_	a	_	IN	70	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
6	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
7	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	S-Patient
8	treatment	_	treatment	_	NN	70	_	_	_	_	_	treatment.n	Cure	O
9	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
13	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
15	.	_	.	_	.	70	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
3	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
4	as	_	a	_	IN	70	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
6	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
7	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
8	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	70	_	_	_	_	_	adult.n	People_by_age	S-Person
11	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
13	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
15	.	_	.	_	.	70	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
3	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
4	as	_	a	_	IN	70	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
6	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
7	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
8	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	70	_	_	_	_	_	type.n	Type	S-Subtype
13	2	_	2	_	CD	70	_	_	_	_	_	_	_	B-Category
14	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	I-Category
15	.	_	.	_	.	70	_	_	_	_	_	_	_	O

1	gradually	_	Gradually	_	RB	71	_	_	_	_	_	_	_	O
2	increase	_	increase	_	VB	71	_	_	_	_	_	increase.v	Cause_change_of_position_on_a_scale	O
3	the	_	the	_	DT	71	_	_	_	_	_	_	_	O
4	dose	_	dose	_	NN	71	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	71	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	71	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	71	_	_	_	_	_	_	_	O
8	over	_	over	_	IN	71	_	_	_	_	_	_	_	O
9	several	_	several	_	JJ	71	_	_	_	_	_	_	_	O
10	weeks	_	week	_	NNS	71	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	71	_	_	_	_	_	_	_	O
12	minimise	_	UNK	_	VB	71	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	71	_	_	_	_	_	_	_	O
14	risk	_	risk	_	NN	71	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	71	_	_	_	_	_	_	_	O
16	gastrointestinal	_	UNK	_	JJ	71	_	_	_	_	_	_	_	O
17	side	_	side	_	NN	71	_	_	_	_	_	_	_	O
18	effects	_	effect	_	NNS	71	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	71	_	_	_	_	_	_	_	O
20	adults	_	adult	_	NNS	71	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	71	_	_	_	_	_	_	_	O
22	type	_	type	_	JJ	71	_	_	_	_	_	_	_	O
23	2	_	2	_	CD	71	_	_	_	_	_	_	_	O
24	diabetes	_	UNK	_	NNS	71	_	_	_	_	_	_	_	O
25	.	_	.	_	.	71	_	_	_	_	_	_	_	O

1	gradually	_	Gradually	_	RB	71	_	_	_	_	_	_	_	O
2	increase	_	increase	_	VB	71	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	71	_	_	_	_	_	_	_	O
4	dose	_	dose	_	NN	71	_	_	_	_	_	dose.n	Quantified_mass	S-Quantity
5	of	_	of	_	IN	71	_	_	_	_	_	_	_	B-Individuals
6	unk	_	UNK	_	JJ	71	_	_	_	_	_	_	_	I-Individuals
7	metformin	_	UNK	_	NN	71	_	_	_	_	_	_	_	I-Individuals
8	over	_	over	_	IN	71	_	_	_	_	_	_	_	O
9	several	_	several	_	JJ	71	_	_	_	_	_	_	_	O
10	weeks	_	week	_	NNS	71	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	71	_	_	_	_	_	_	_	O
12	minimise	_	UNK	_	VB	71	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	71	_	_	_	_	_	_	_	O
14	risk	_	risk	_	NN	71	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	71	_	_	_	_	_	_	_	O
16	gastrointestinal	_	UNK	_	JJ	71	_	_	_	_	_	_	_	O
17	side	_	side	_	NN	71	_	_	_	_	_	_	_	O
18	effects	_	effect	_	NNS	71	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	71	_	_	_	_	_	_	_	O
20	adults	_	adult	_	NNS	71	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	71	_	_	_	_	_	_	_	O
22	type	_	type	_	JJ	71	_	_	_	_	_	_	_	O
23	2	_	2	_	CD	71	_	_	_	_	_	_	_	O
24	diabetes	_	UNK	_	NNS	71	_	_	_	_	_	_	_	O
25	.	_	.	_	.	71	_	_	_	_	_	_	_	O

1	gradually	_	Gradually	_	RB	71	_	_	_	_	_	_	_	O
2	increase	_	increase	_	VB	71	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	71	_	_	_	_	_	_	_	O
4	dose	_	dose	_	NN	71	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	71	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	71	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	71	_	_	_	_	_	_	_	O
8	over	_	over	_	IN	71	_	_	_	_	_	_	_	O
9	several	_	several	_	JJ	71	_	_	_	_	_	several.a	Quantified_mass	S-Quantity
10	weeks	_	week	_	NNS	71	_	_	_	_	_	_	_	S-Individuals
11	to	_	to	_	TO	71	_	_	_	_	_	_	_	O
12	minimise	_	UNK	_	VB	71	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	71	_	_	_	_	_	_	_	O
14	risk	_	risk	_	NN	71	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	71	_	_	_	_	_	_	_	O
16	gastrointestinal	_	UNK	_	JJ	71	_	_	_	_	_	_	_	O
17	side	_	side	_	NN	71	_	_	_	_	_	_	_	O
18	effects	_	effect	_	NNS	71	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	71	_	_	_	_	_	_	_	O
20	adults	_	adult	_	NNS	71	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	71	_	_	_	_	_	_	_	O
22	type	_	type	_	JJ	71	_	_	_	_	_	_	_	O
23	2	_	2	_	CD	71	_	_	_	_	_	_	_	O
24	diabetes	_	UNK	_	NNS	71	_	_	_	_	_	_	_	O
25	.	_	.	_	.	71	_	_	_	_	_	_	_	O

1	gradually	_	Gradually	_	RB	71	_	_	_	_	_	_	_	O
2	increase	_	increase	_	VB	71	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	71	_	_	_	_	_	_	_	O
4	dose	_	dose	_	NN	71	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	71	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	71	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	71	_	_	_	_	_	_	_	O
8	over	_	over	_	IN	71	_	_	_	_	_	_	_	O
9	several	_	several	_	JJ	71	_	_	_	_	_	_	_	S-Count
10	weeks	_	week	_	NNS	71	_	_	_	_	_	week.n	Calendric_unit	S-Unit
11	to	_	to	_	TO	71	_	_	_	_	_	_	_	O
12	minimise	_	UNK	_	VB	71	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	71	_	_	_	_	_	_	_	O
14	risk	_	risk	_	NN	71	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	71	_	_	_	_	_	_	_	O
16	gastrointestinal	_	UNK	_	JJ	71	_	_	_	_	_	_	_	O
17	side	_	side	_	NN	71	_	_	_	_	_	_	_	O
18	effects	_	effect	_	NNS	71	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	71	_	_	_	_	_	_	_	O
20	adults	_	adult	_	NNS	71	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	71	_	_	_	_	_	_	_	O
22	type	_	type	_	JJ	71	_	_	_	_	_	_	_	O
23	2	_	2	_	CD	71	_	_	_	_	_	_	_	O
24	diabetes	_	UNK	_	NNS	71	_	_	_	_	_	_	_	O
25	.	_	.	_	.	71	_	_	_	_	_	_	_	O

1	gradually	_	Gradually	_	RB	71	_	_	_	_	_	_	_	O
2	increase	_	increase	_	VB	71	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	71	_	_	_	_	_	_	_	O
4	dose	_	dose	_	NN	71	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	71	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	71	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	71	_	_	_	_	_	_	_	O
8	over	_	over	_	IN	71	_	_	_	_	_	_	_	O
9	several	_	several	_	JJ	71	_	_	_	_	_	_	_	O
10	weeks	_	week	_	NNS	71	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	71	_	_	_	_	_	_	_	O
12	minimise	_	UNK	_	VB	71	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	71	_	_	_	_	_	_	_	O
14	risk	_	risk	_	NN	71	_	_	_	_	_	risk.n	Run_risk	O
15	of	_	of	_	IN	71	_	_	_	_	_	_	_	B-Asset
16	gastrointestinal	_	UNK	_	JJ	71	_	_	_	_	_	_	_	I-Asset
17	side	_	side	_	NN	71	_	_	_	_	_	_	_	I-Asset
18	effects	_	effect	_	NNS	71	_	_	_	_	_	_	_	I-Asset
19	in	_	in	_	IN	71	_	_	_	_	_	_	_	I-Asset
20	adults	_	adult	_	NNS	71	_	_	_	_	_	_	_	I-Asset
21	with	_	with	_	IN	71	_	_	_	_	_	_	_	I-Asset
22	type	_	type	_	JJ	71	_	_	_	_	_	_	_	I-Asset
23	2	_	2	_	CD	71	_	_	_	_	_	_	_	I-Asset
24	diabetes	_	UNK	_	NNS	71	_	_	_	_	_	_	_	I-Asset
25	.	_	.	_	.	71	_	_	_	_	_	_	_	O

1	gradually	_	Gradually	_	RB	71	_	_	_	_	_	_	_	O
2	increase	_	increase	_	VB	71	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	71	_	_	_	_	_	_	_	O
4	dose	_	dose	_	NN	71	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	71	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	71	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	71	_	_	_	_	_	_	_	O
8	over	_	over	_	IN	71	_	_	_	_	_	_	_	O
9	several	_	several	_	JJ	71	_	_	_	_	_	_	_	O
10	weeks	_	week	_	NNS	71	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	71	_	_	_	_	_	_	_	O
12	minimise	_	UNK	_	VB	71	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	71	_	_	_	_	_	_	_	O
14	risk	_	risk	_	NN	71	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	71	_	_	_	_	_	_	_	O
16	gastrointestinal	_	UNK	_	JJ	71	_	_	_	_	_	_	_	B-Dependent_entity
17	side	_	side	_	NN	71	_	_	_	_	_	_	_	I-Dependent_entity
18	effects	_	effect	_	NNS	71	_	_	_	_	_	effect.n	Objective_influence	O
19	in	_	in	_	IN	71	_	_	_	_	_	_	_	O
20	adults	_	adult	_	NNS	71	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	71	_	_	_	_	_	_	_	O
22	type	_	type	_	JJ	71	_	_	_	_	_	_	_	O
23	2	_	2	_	CD	71	_	_	_	_	_	_	_	O
24	diabetes	_	UNK	_	NNS	71	_	_	_	_	_	_	_	O
25	.	_	.	_	.	71	_	_	_	_	_	_	_	O

1	gradually	_	Gradually	_	RB	71	_	_	_	_	_	_	_	O
2	increase	_	increase	_	VB	71	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	71	_	_	_	_	_	_	_	O
4	dose	_	dose	_	NN	71	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	71	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	71	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	71	_	_	_	_	_	_	_	O
8	over	_	over	_	IN	71	_	_	_	_	_	_	_	O
9	several	_	several	_	JJ	71	_	_	_	_	_	_	_	O
10	weeks	_	week	_	NNS	71	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	71	_	_	_	_	_	_	_	O
12	minimise	_	UNK	_	VB	71	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	71	_	_	_	_	_	_	_	O
14	risk	_	risk	_	NN	71	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	71	_	_	_	_	_	_	_	O
16	gastrointestinal	_	UNK	_	JJ	71	_	_	_	_	_	_	_	O
17	side	_	side	_	NN	71	_	_	_	_	_	_	_	O
18	effects	_	effect	_	NNS	71	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	71	_	_	_	_	_	_	_	O
20	adults	_	adult	_	NNS	71	_	_	_	_	_	adult.n	People_by_age	S-Person
21	with	_	with	_	IN	71	_	_	_	_	_	_	_	O
22	type	_	type	_	JJ	71	_	_	_	_	_	_	_	O
23	2	_	2	_	CD	71	_	_	_	_	_	_	_	O
24	diabetes	_	UNK	_	NNS	71	_	_	_	_	_	_	_	O
25	.	_	.	_	.	71	_	_	_	_	_	_	_	O

1	gradually	_	Gradually	_	RB	71	_	_	_	_	_	_	_	O
2	increase	_	increase	_	VB	71	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	71	_	_	_	_	_	_	_	O
4	dose	_	dose	_	NN	71	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	71	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	71	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	71	_	_	_	_	_	_	_	O
8	over	_	over	_	IN	71	_	_	_	_	_	_	_	O
9	several	_	several	_	JJ	71	_	_	_	_	_	_	_	O
10	weeks	_	week	_	NNS	71	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	71	_	_	_	_	_	_	_	O
12	minimise	_	UNK	_	VB	71	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	71	_	_	_	_	_	_	_	O
14	risk	_	risk	_	NN	71	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	71	_	_	_	_	_	_	_	O
16	gastrointestinal	_	UNK	_	JJ	71	_	_	_	_	_	_	_	O
17	side	_	side	_	NN	71	_	_	_	_	_	_	_	O
18	effects	_	effect	_	NNS	71	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	71	_	_	_	_	_	_	_	O
20	adults	_	adult	_	NNS	71	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	71	_	_	_	_	_	_	_	O
22	type	_	type	_	JJ	71	_	_	_	_	_	type.n	Type	S-Subtype
23	2	_	2	_	CD	71	_	_	_	_	_	_	_	B-Category
24	diabetes	_	UNK	_	NNS	71	_	_	_	_	_	_	_	I-Category
25	.	_	.	_	.	71	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	72	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	72	_	_	_	_	_	adult.n	People_by_age	S-Person
4	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
6	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
8	experiences	_	experience	_	NNS	72	_	_	_	_	_	_	_	O
9	gastrointestinal	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
10	side	_	side	_	NN	72	_	_	_	_	_	_	_	O
11	effects	_	effect	_	NNS	72	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
14	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
15	,	_	,	_	,	72	_	_	_	_	_	_	_	O
16	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
18	trial	_	trial	_	NN	72	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
21	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
22	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	72	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	72	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	72	_	_	_	_	_	type.n	Type	S-Subtype
6	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
8	experiences	_	experience	_	NNS	72	_	_	_	_	_	_	_	O
9	gastrointestinal	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
10	side	_	side	_	NN	72	_	_	_	_	_	_	_	O
11	effects	_	effect	_	NNS	72	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
14	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
15	,	_	,	_	,	72	_	_	_	_	_	_	_	O
16	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
18	trial	_	trial	_	NN	72	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
21	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
22	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	72	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	72	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
6	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	S-Protagonist
8	experiences	_	experience	_	NNS	72	_	_	_	_	_	experience.n	Expertise	O
9	gastrointestinal	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
10	side	_	side	_	NN	72	_	_	_	_	_	_	_	O
11	effects	_	effect	_	NNS	72	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
14	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
15	,	_	,	_	,	72	_	_	_	_	_	_	_	O
16	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
18	trial	_	trial	_	NN	72	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
21	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
22	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	72	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	72	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
6	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
8	experiences	_	experience	_	NNS	72	_	_	_	_	_	_	_	O
9	gastrointestinal	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
10	side	_	side	_	NN	72	_	_	_	_	_	side.n	Taking_sides	O
11	effects	_	effect	_	NNS	72	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
14	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
15	,	_	,	_	,	72	_	_	_	_	_	_	_	O
16	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
18	trial	_	trial	_	NN	72	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
21	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
22	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	72	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	72	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
6	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
8	experiences	_	experience	_	NNS	72	_	_	_	_	_	_	_	O
9	gastrointestinal	_	UNK	_	JJ	72	_	_	_	_	_	_	_	B-Dependent_entity
10	side	_	side	_	NN	72	_	_	_	_	_	_	_	I-Dependent_entity
11	effects	_	effect	_	NNS	72	_	_	_	_	_	effect.n	Objective_influence	O
12	with	_	with	_	IN	72	_	_	_	_	_	_	_	B-Dependent_entity
13	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	I-Dependent_entity
14	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	I-Dependent_entity
15	,	_	,	_	,	72	_	_	_	_	_	_	_	O
16	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
18	trial	_	trial	_	NN	72	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
21	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
22	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	72	_	_	_	_	_	_	_	B-Item
3	adult	_	adult	_	NN	72	_	_	_	_	_	_	_	I-Item
4	with	_	with	_	IN	72	_	_	_	_	_	_	_	I-Item
5	type	_	type	_	JJ	72	_	_	_	_	_	_	_	I-Item
6	2	_	2	_	CD	72	_	_	_	_	_	_	_	I-Item
7	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	I-Item
8	experiences	_	experience	_	NNS	72	_	_	_	_	_	_	_	I-Item
9	gastrointestinal	_	UNK	_	JJ	72	_	_	_	_	_	_	_	I-Item
10	side	_	side	_	NN	72	_	_	_	_	_	_	_	I-Item
11	effects	_	effect	_	NNS	72	_	_	_	_	_	_	_	I-Item
12	with	_	with	_	IN	72	_	_	_	_	_	_	_	I-Item
13	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	I-Item
14	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	I-Item
15	,	_	,	_	,	72	_	_	_	_	_	_	_	O
16	consider	_	consider	_	VB	72	_	_	_	_	_	consider.v	Categorization	O
17	a	_	a	_	DT	72	_	_	_	_	_	_	_	B-Category
18	trial	_	trial	_	NN	72	_	_	_	_	_	_	_	I-Category
19	of	_	of	_	IN	72	_	_	_	_	_	_	_	I-Category
20	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	I-Category
21	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	I-Category
22	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	72	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	72	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
6	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
8	experiences	_	experience	_	NNS	72	_	_	_	_	_	_	_	O
9	gastrointestinal	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
10	side	_	side	_	NN	72	_	_	_	_	_	_	_	O
11	effects	_	effect	_	NNS	72	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
14	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
15	,	_	,	_	,	72	_	_	_	_	_	_	_	O
16	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
18	trial	_	trial	_	NN	72	_	_	_	_	_	trial.n	Trial	S-Case
19	of	_	of	_	IN	72	_	_	_	_	_	_	_	B-Defendant
20	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	I-Defendant
21	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	I-Defendant
22	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	algorithm	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
2	for	_	for	_	IN	73	_	_	_	_	_	_	_	O
3	blood	_	blood	_	NN	73	_	_	_	_	_	_	_	B-Item
4	glucose	_	UNK	_	NN	73	_	_	_	_	_	_	_	I-Item
5	lowering	_	lower	_	VBG	73	_	_	_	_	_	lower.v	Cause_change_of_position_on_a_scale	O
6	therapy	_	therapy	_	NN	73	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	73	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	73	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	73	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O

1	algorithm	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
2	for	_	for	_	IN	73	_	_	_	_	_	_	_	O
3	blood	_	blood	_	NN	73	_	_	_	_	_	_	_	O
4	glucose	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
5	lowering	_	lower	_	VBG	73	_	_	_	_	_	_	_	O
6	therapy	_	therapy	_	NN	73	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	73	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	73	_	_	_	_	_	adult.n	People_by_age	S-Person
9	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	73	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O

1	algorithm	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
2	for	_	for	_	IN	73	_	_	_	_	_	_	_	O
3	blood	_	blood	_	NN	73	_	_	_	_	_	_	_	O
4	glucose	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
5	lowering	_	lower	_	VBG	73	_	_	_	_	_	_	_	O
6	therapy	_	therapy	_	NN	73	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	73	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	73	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	73	_	_	_	_	_	type.n	Type	S-Subtype
11	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	74	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	74	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	74	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	74	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	74	_	_	_	_	_	_	_	O
6	:	_	:	_	:	74	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	74	_	_	_	_	_	_	_	O
8	(	_	(	_	(	74	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	74	_	_	_	_	_	_	_	O
10	)	_	)	_	)	74	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	74	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	74	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	74	_	_	_	_	_	_	_	O
14	)	_	)	_	)	74	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	74	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	74	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	74	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	74	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	74	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	74	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	74	_	_	_	_	_	_	_	O
8	(	_	(	_	(	74	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	74	_	_	_	_	_	_	_	O
10	)	_	)	_	)	74	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	74	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	74	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	74	_	_	_	_	_	_	_	O
14	)	_	)	_	)	74	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	75	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	75	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	75	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	75	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	75	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	75	_	_	_	_	_	_	_	O
7	,	_	,	_	,	75	_	_	_	_	_	_	_	O
8	review	_	review	_	VBP	75	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	75	_	_	_	_	_	_	_	O
10	dose	_	dose	_	NN	75	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	75	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	75	_	_	_	_	_	_	_	O
13	if	_	if	_	IN	75	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	75	_	_	_	_	_	_	_	O
15	estimated	_	estimate	_	VBN	75	_	_	_	_	_	_	_	O
16	glomerular	_	UNK	_	JJ	75	_	_	_	_	_	_	_	O
17	filtration	_	filtration	_	NN	75	_	_	_	_	_	_	_	O
18	rate	_	rate	_	NN	75	_	_	_	_	_	_	_	O
19	(	_	(	_	(	75	_	_	_	_	_	_	_	O
20	egfr	_	UNK	_	NN	75	_	_	_	_	_	_	_	O
21	)	_	)	_	)	75	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	75	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	75	_	_	_	_	_	_	_	O
24	45	_	45	_	CD	75	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	NNS	75	_	_	_	_	_	_	_	O
26	m2	_	UNK	_	NN	75	_	_	_	_	_	_	_	O
27	:	_	:	_	:	75	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	75	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	75	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	75	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	75	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	75	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	75	_	_	_	_	_	_	_	I-Category
7	,	_	,	_	,	75	_	_	_	_	_	_	_	O
8	review	_	review	_	VBP	75	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	75	_	_	_	_	_	_	_	O
10	dose	_	dose	_	NN	75	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	75	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	75	_	_	_	_	_	_	_	O
13	if	_	if	_	IN	75	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	75	_	_	_	_	_	_	_	O
15	estimated	_	estimate	_	VBN	75	_	_	_	_	_	_	_	O
16	glomerular	_	UNK	_	JJ	75	_	_	_	_	_	_	_	O
17	filtration	_	filtration	_	NN	75	_	_	_	_	_	_	_	O
18	rate	_	rate	_	NN	75	_	_	_	_	_	_	_	O
19	(	_	(	_	(	75	_	_	_	_	_	_	_	O
20	egfr	_	UNK	_	NN	75	_	_	_	_	_	_	_	O
21	)	_	)	_	)	75	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	75	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	75	_	_	_	_	_	_	_	O
24	45	_	45	_	CD	75	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	NNS	75	_	_	_	_	_	_	_	O
26	m2	_	UNK	_	NN	75	_	_	_	_	_	_	_	O
27	:	_	:	_	:	75	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	75	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	75	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	75	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	75	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	75	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	75	_	_	_	_	_	_	_	O
7	,	_	,	_	,	75	_	_	_	_	_	_	_	O
8	review	_	review	_	VBP	75	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	75	_	_	_	_	_	_	_	O
10	dose	_	dose	_	NN	75	_	_	_	_	_	dose.n	Quantified_mass	S-Quantity
11	of	_	of	_	IN	75	_	_	_	_	_	_	_	B-Individuals
12	metformin	_	UNK	_	NN	75	_	_	_	_	_	_	_	I-Individuals
13	if	_	if	_	IN	75	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	75	_	_	_	_	_	_	_	O
15	estimated	_	estimate	_	VBN	75	_	_	_	_	_	_	_	O
16	glomerular	_	UNK	_	JJ	75	_	_	_	_	_	_	_	O
17	filtration	_	filtration	_	NN	75	_	_	_	_	_	_	_	O
18	rate	_	rate	_	NN	75	_	_	_	_	_	_	_	O
19	(	_	(	_	(	75	_	_	_	_	_	_	_	O
20	egfr	_	UNK	_	NN	75	_	_	_	_	_	_	_	O
21	)	_	)	_	)	75	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	75	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	75	_	_	_	_	_	_	_	O
24	45	_	45	_	CD	75	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	NNS	75	_	_	_	_	_	_	_	O
26	m2	_	UNK	_	NN	75	_	_	_	_	_	_	_	O
27	:	_	:	_	:	75	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	75	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	75	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	75	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	75	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	75	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	75	_	_	_	_	_	_	_	O
7	,	_	,	_	,	75	_	_	_	_	_	_	_	O
8	review	_	review	_	VBP	75	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	75	_	_	_	_	_	_	_	O
10	dose	_	dose	_	NN	75	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	75	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	75	_	_	_	_	_	_	_	O
13	if	_	if	_	IN	75	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	75	_	_	_	_	_	_	_	O
15	estimated	_	estimate	_	VBN	75	_	_	_	_	_	estimate.v	Estimating	O
16	glomerular	_	UNK	_	JJ	75	_	_	_	_	_	_	_	B-Estimation
17	filtration	_	filtration	_	NN	75	_	_	_	_	_	_	_	I-Estimation
18	rate	_	rate	_	NN	75	_	_	_	_	_	_	_	I-Estimation
19	(	_	(	_	(	75	_	_	_	_	_	_	_	O
20	egfr	_	UNK	_	NN	75	_	_	_	_	_	_	_	O
21	)	_	)	_	)	75	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	75	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	75	_	_	_	_	_	_	_	O
24	45	_	45	_	CD	75	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	NNS	75	_	_	_	_	_	_	_	O
26	m2	_	UNK	_	NN	75	_	_	_	_	_	_	_	O
27	:	_	:	_	:	75	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	75	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	75	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	75	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	75	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	75	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	75	_	_	_	_	_	_	_	O
7	,	_	,	_	,	75	_	_	_	_	_	_	_	O
8	review	_	review	_	VBP	75	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	75	_	_	_	_	_	_	_	O
10	dose	_	dose	_	NN	75	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	75	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	75	_	_	_	_	_	_	_	O
13	if	_	if	_	IN	75	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	75	_	_	_	_	_	_	_	O
15	estimated	_	estimate	_	VBN	75	_	_	_	_	_	_	_	O
16	glomerular	_	UNK	_	JJ	75	_	_	_	_	_	_	_	B-Entity
17	filtration	_	filtration	_	NN	75	_	_	_	_	_	_	_	I-Entity
18	rate	_	rate	_	NN	75	_	_	_	_	_	rate.n	Speed_description	S-Attribute
19	(	_	(	_	(	75	_	_	_	_	_	_	_	O
20	egfr	_	UNK	_	NN	75	_	_	_	_	_	_	_	O
21	)	_	)	_	)	75	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	75	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	75	_	_	_	_	_	_	_	O
24	45	_	45	_	CD	75	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	NNS	75	_	_	_	_	_	_	_	O
26	m2	_	UNK	_	NN	75	_	_	_	_	_	_	_	O
27	:	_	:	_	:	75	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	75	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	75	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	75	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	75	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	75	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	75	_	_	_	_	_	_	_	O
7	,	_	,	_	,	75	_	_	_	_	_	_	_	O
8	review	_	review	_	VBP	75	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	75	_	_	_	_	_	_	_	O
10	dose	_	dose	_	NN	75	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	75	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	75	_	_	_	_	_	_	_	O
13	if	_	if	_	IN	75	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	75	_	_	_	_	_	_	_	B-Figure
15	estimated	_	estimate	_	VBN	75	_	_	_	_	_	_	_	I-Figure
16	glomerular	_	UNK	_	JJ	75	_	_	_	_	_	_	_	I-Figure
17	filtration	_	filtration	_	NN	75	_	_	_	_	_	_	_	I-Figure
18	rate	_	rate	_	NN	75	_	_	_	_	_	_	_	I-Figure
19	(	_	(	_	(	75	_	_	_	_	_	_	_	I-Figure
20	egfr	_	UNK	_	NN	75	_	_	_	_	_	_	_	I-Figure
21	)	_	)	_	)	75	_	_	_	_	_	_	_	I-Figure
22	is	_	be	_	VBZ	75	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	75	_	_	_	_	_	below.prep	Directional_locative_relation	O
24	45	_	45	_	CD	75	_	_	_	_	_	_	_	B-Ground
25	unk	_	UNK	_	NNS	75	_	_	_	_	_	_	_	I-Ground
26	m2	_	UNK	_	NN	75	_	_	_	_	_	_	_	I-Ground
27	:	_	:	_	:	75	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	76	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	76	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	76	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	76	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	76	_	_	_	_	_	_	_	O
7	,	_	,	_	,	76	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	76	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	76	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	76	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	76	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	76	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	76	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	76	_	_	_	_	_	_	_	O
15	,	_	,	_	,	76	_	_	_	_	_	_	_	O
16	consider	_	consider	_	VB	76	_	_	_	_	_	_	_	O
17	initial	_	initial	_	JJ	76	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	76	_	_	_	_	_	_	_	O
19	treatment	_	treatment	_	NN	76	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	76	_	_	_	_	_	_	_	O
21	:	_	:	_	:	76	_	_	_	_	_	_	_	O
22	a	_	a	_	DT	76	_	_	_	_	_	_	_	O
23	dipeptidyl	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
24	unk	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
25	(	_	(	_	(	76	_	_	_	_	_	_	_	O
26	dpp-4	_	UNK	_	NNP	76	_	_	_	_	_	_	_	O
27	)	_	)	_	)	76	_	_	_	_	_	_	_	O
28	inhibitor	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
29	or	_	or	_	CC	76	_	_	_	_	_	_	_	O
30	pioglitazone	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
31	or	_	or	_	CC	76	_	_	_	_	_	_	_	O
32	a	_	a	_	DT	76	_	_	_	_	_	_	_	O
33	sulfonylurea	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
34	.	_	.	_	.	76	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	76	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	76	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	76	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	76	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	76	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	76	_	_	_	_	_	_	_	I-Category
7	,	_	,	_	,	76	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	76	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	76	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	76	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	76	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	76	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	76	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	76	_	_	_	_	_	_	_	O
15	,	_	,	_	,	76	_	_	_	_	_	_	_	O
16	consider	_	consider	_	VB	76	_	_	_	_	_	_	_	O
17	initial	_	initial	_	JJ	76	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	76	_	_	_	_	_	_	_	O
19	treatment	_	treatment	_	NN	76	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	76	_	_	_	_	_	_	_	O
21	:	_	:	_	:	76	_	_	_	_	_	_	_	O
22	a	_	a	_	DT	76	_	_	_	_	_	_	_	O
23	dipeptidyl	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
24	unk	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
25	(	_	(	_	(	76	_	_	_	_	_	_	_	O
26	dpp-4	_	UNK	_	NNP	76	_	_	_	_	_	_	_	O
27	)	_	)	_	)	76	_	_	_	_	_	_	_	O
28	inhibitor	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
29	or	_	or	_	CC	76	_	_	_	_	_	_	_	O
30	pioglitazone	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
31	or	_	or	_	CC	76	_	_	_	_	_	_	_	O
32	a	_	a	_	DT	76	_	_	_	_	_	_	_	O
33	sulfonylurea	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
34	.	_	.	_	.	76	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	76	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	76	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	76	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	76	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	76	_	_	_	_	_	_	_	O
7	,	_	,	_	,	76	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	76	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	76	_	_	_	_	_	_	_	S-Item
10	is	_	be	_	VBZ	76	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	76	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	76	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	76	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	76	_	_	_	_	_	_	_	O
15	,	_	,	_	,	76	_	_	_	_	_	_	_	O
16	consider	_	consider	_	VB	76	_	_	_	_	_	consider.v	Categorization	O
17	initial	_	initial	_	JJ	76	_	_	_	_	_	_	_	B-Category
18	drug	_	drug	_	NN	76	_	_	_	_	_	_	_	I-Category
19	treatment	_	treatment	_	NN	76	_	_	_	_	_	_	_	I-Category
20	with	_	with	_	IN	76	_	_	_	_	_	_	_	I-Category
21	:	_	:	_	:	76	_	_	_	_	_	_	_	I-Category
22	a	_	a	_	DT	76	_	_	_	_	_	_	_	I-Category
23	dipeptidyl	_	UNK	_	JJ	76	_	_	_	_	_	_	_	I-Category
24	unk	_	UNK	_	NN	76	_	_	_	_	_	_	_	I-Category
25	(	_	(	_	(	76	_	_	_	_	_	_	_	I-Category
26	dpp-4	_	UNK	_	NNP	76	_	_	_	_	_	_	_	I-Category
27	)	_	)	_	)	76	_	_	_	_	_	_	_	I-Category
28	inhibitor	_	UNK	_	NN	76	_	_	_	_	_	_	_	I-Category
29	or	_	or	_	CC	76	_	_	_	_	_	_	_	I-Category
30	pioglitazone	_	UNK	_	NN	76	_	_	_	_	_	_	_	I-Category
31	or	_	or	_	CC	76	_	_	_	_	_	_	_	I-Category
32	a	_	a	_	DT	76	_	_	_	_	_	_	_	I-Category
33	sulfonylurea	_	UNK	_	NN	76	_	_	_	_	_	_	_	I-Category
34	.	_	.	_	.	76	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	76	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	76	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	76	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	76	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	76	_	_	_	_	_	_	_	O
7	,	_	,	_	,	76	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	76	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	76	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	76	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	76	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	76	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	76	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	76	_	_	_	_	_	_	_	O
15	,	_	,	_	,	76	_	_	_	_	_	_	_	O
16	consider	_	consider	_	VB	76	_	_	_	_	_	_	_	O
17	initial	_	initial	_	JJ	76	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	76	_	_	_	_	_	_	_	S-Patient
19	treatment	_	treatment	_	NN	76	_	_	_	_	_	treatment.n	Cure	O
20	with	_	with	_	IN	76	_	_	_	_	_	_	_	O
21	:	_	:	_	:	76	_	_	_	_	_	_	_	O
22	a	_	a	_	DT	76	_	_	_	_	_	_	_	O
23	dipeptidyl	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
24	unk	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
25	(	_	(	_	(	76	_	_	_	_	_	_	_	O
26	dpp-4	_	UNK	_	NNP	76	_	_	_	_	_	_	_	O
27	)	_	)	_	)	76	_	_	_	_	_	_	_	O
28	inhibitor	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
29	or	_	or	_	CC	76	_	_	_	_	_	_	_	O
30	pioglitazone	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
31	or	_	or	_	CC	76	_	_	_	_	_	_	_	O
32	a	_	a	_	DT	76	_	_	_	_	_	_	_	O
33	sulfonylurea	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
34	.	_	.	_	.	76	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	77	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	77	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	77	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	77	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	77	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	77	_	_	_	_	_	_	_	O
7	,	_	,	_	,	77	_	_	_	_	_	_	_	O
8	do	_	do	_	VBP	77	_	_	_	_	_	_	_	O
9	not	_	not	_	RB	77	_	_	_	_	_	_	_	O
10	offer	_	offer	_	VB	77	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	77	_	_	_	_	_	_	_	O
12	continue	_	continue	_	VB	77	_	_	_	_	_	_	_	O
13	pioglitazone	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	77	_	_	_	_	_	_	_	O
15	they	_	they	_	PRP	77	_	_	_	_	_	_	_	O
16	have	_	have	_	VBP	77	_	_	_	_	_	_	_	O
17	any	_	any	_	DT	77	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	77	_	_	_	_	_	_	_	O
20	following	_	following	_	NN	77	_	_	_	_	_	_	_	O
21	:	_	:	_	:	77	_	_	_	_	_	_	_	O
22	heart	_	heart	_	NN	77	_	_	_	_	_	_	_	O
23	failure	_	failure	_	NN	77	_	_	_	_	_	_	_	O
24	or	_	or	_	CC	77	_	_	_	_	_	_	_	O
25	history	_	history	_	NN	77	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
27	heart	_	heart	_	NN	77	_	_	_	_	_	_	_	O
28	failure	_	failure	_	NN	77	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	77	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	77	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	77	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	77	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	77	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	77	_	_	_	_	_	_	_	I-Category
7	,	_	,	_	,	77	_	_	_	_	_	_	_	O
8	do	_	do	_	VBP	77	_	_	_	_	_	_	_	O
9	not	_	not	_	RB	77	_	_	_	_	_	_	_	O
10	offer	_	offer	_	VB	77	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	77	_	_	_	_	_	_	_	O
12	continue	_	continue	_	VB	77	_	_	_	_	_	_	_	O
13	pioglitazone	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	77	_	_	_	_	_	_	_	O
15	they	_	they	_	PRP	77	_	_	_	_	_	_	_	O
16	have	_	have	_	VBP	77	_	_	_	_	_	_	_	O
17	any	_	any	_	DT	77	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	77	_	_	_	_	_	_	_	O
20	following	_	following	_	NN	77	_	_	_	_	_	_	_	O
21	:	_	:	_	:	77	_	_	_	_	_	_	_	O
22	heart	_	heart	_	NN	77	_	_	_	_	_	_	_	O
23	failure	_	failure	_	NN	77	_	_	_	_	_	_	_	O
24	or	_	or	_	CC	77	_	_	_	_	_	_	_	O
25	history	_	history	_	NN	77	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
27	heart	_	heart	_	NN	77	_	_	_	_	_	_	_	O
28	failure	_	failure	_	NN	77	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	77	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	77	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	77	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	77	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	77	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	77	_	_	_	_	_	_	_	O
7	,	_	,	_	,	77	_	_	_	_	_	_	_	O
8	do	_	do	_	VBP	77	_	_	_	_	_	_	_	O
9	not	_	not	_	RB	77	_	_	_	_	_	_	_	O
10	offer	_	offer	_	VB	77	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	77	_	_	_	_	_	_	_	O
12	continue	_	continue	_	VB	77	_	_	_	_	_	continue.v	Process_continue	O
13	pioglitazone	_	UNK	_	NN	77	_	_	_	_	_	_	_	S-Event
14	if	_	if	_	IN	77	_	_	_	_	_	_	_	O
15	they	_	they	_	PRP	77	_	_	_	_	_	_	_	O
16	have	_	have	_	VBP	77	_	_	_	_	_	_	_	O
17	any	_	any	_	DT	77	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	77	_	_	_	_	_	_	_	O
20	following	_	following	_	NN	77	_	_	_	_	_	_	_	O
21	:	_	:	_	:	77	_	_	_	_	_	_	_	O
22	heart	_	heart	_	NN	77	_	_	_	_	_	_	_	O
23	failure	_	failure	_	NN	77	_	_	_	_	_	_	_	O
24	or	_	or	_	CC	77	_	_	_	_	_	_	_	O
25	history	_	history	_	NN	77	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
27	heart	_	heart	_	NN	77	_	_	_	_	_	_	_	O
28	failure	_	failure	_	NN	77	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	77	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	77	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	77	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	77	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	77	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	77	_	_	_	_	_	_	_	O
7	,	_	,	_	,	77	_	_	_	_	_	_	_	O
8	do	_	do	_	VBP	77	_	_	_	_	_	_	_	O
9	not	_	not	_	RB	77	_	_	_	_	_	_	_	O
10	offer	_	offer	_	VB	77	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	77	_	_	_	_	_	_	_	O
12	continue	_	continue	_	VB	77	_	_	_	_	_	_	_	O
13	pioglitazone	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	77	_	_	_	_	_	_	_	O
15	they	_	they	_	PRP	77	_	_	_	_	_	_	_	O
16	have	_	have	_	VBP	77	_	_	_	_	_	_	_	O
17	any	_	any	_	DT	77	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	77	_	_	_	_	_	_	_	O
20	following	_	following	_	NN	77	_	_	_	_	_	_	_	O
21	:	_	:	_	:	77	_	_	_	_	_	_	_	O
22	heart	_	heart	_	NN	77	_	_	_	_	_	_	_	S-Agent
23	failure	_	failure	_	NN	77	_	_	_	_	_	failure.n	Success_or_failure	O
24	or	_	or	_	CC	77	_	_	_	_	_	_	_	O
25	history	_	history	_	NN	77	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
27	heart	_	heart	_	NN	77	_	_	_	_	_	_	_	O
28	failure	_	failure	_	NN	77	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	77	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	77	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	77	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	77	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	77	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	77	_	_	_	_	_	_	_	O
7	,	_	,	_	,	77	_	_	_	_	_	_	_	O
8	do	_	do	_	VBP	77	_	_	_	_	_	_	_	O
9	not	_	not	_	RB	77	_	_	_	_	_	_	_	O
10	offer	_	offer	_	VB	77	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	77	_	_	_	_	_	_	_	O
12	continue	_	continue	_	VB	77	_	_	_	_	_	_	_	O
13	pioglitazone	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	77	_	_	_	_	_	_	_	O
15	they	_	they	_	PRP	77	_	_	_	_	_	_	_	O
16	have	_	have	_	VBP	77	_	_	_	_	_	_	_	O
17	any	_	any	_	DT	77	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	77	_	_	_	_	_	_	_	O
20	following	_	following	_	NN	77	_	_	_	_	_	_	_	O
21	:	_	:	_	:	77	_	_	_	_	_	_	_	O
22	heart	_	heart	_	NN	77	_	_	_	_	_	_	_	O
23	failure	_	failure	_	NN	77	_	_	_	_	_	_	_	O
24	or	_	or	_	CC	77	_	_	_	_	_	_	_	O
25	history	_	history	_	NN	77	_	_	_	_	_	history.n	History	O
26	of	_	of	_	IN	77	_	_	_	_	_	_	_	B-Topic
27	heart	_	heart	_	NN	77	_	_	_	_	_	_	_	I-Topic
28	failure	_	failure	_	NN	77	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	77	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	77	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	77	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	77	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	77	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	77	_	_	_	_	_	_	_	O
7	,	_	,	_	,	77	_	_	_	_	_	_	_	O
8	do	_	do	_	VBP	77	_	_	_	_	_	_	_	O
9	not	_	not	_	RB	77	_	_	_	_	_	_	_	O
10	offer	_	offer	_	VB	77	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	77	_	_	_	_	_	_	_	O
12	continue	_	continue	_	VB	77	_	_	_	_	_	_	_	O
13	pioglitazone	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	77	_	_	_	_	_	_	_	O
15	they	_	they	_	PRP	77	_	_	_	_	_	_	_	O
16	have	_	have	_	VBP	77	_	_	_	_	_	_	_	O
17	any	_	any	_	DT	77	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	77	_	_	_	_	_	_	_	O
20	following	_	following	_	NN	77	_	_	_	_	_	_	_	O
21	:	_	:	_	:	77	_	_	_	_	_	_	_	O
22	heart	_	heart	_	NN	77	_	_	_	_	_	_	_	O
23	failure	_	failure	_	NN	77	_	_	_	_	_	_	_	O
24	or	_	or	_	CC	77	_	_	_	_	_	_	_	O
25	history	_	history	_	NN	77	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
27	heart	_	heart	_	NN	77	_	_	_	_	_	_	_	S-Agent
28	failure	_	failure	_	NN	77	_	_	_	_	_	failure.n	Success_or_failure	O

1	type	_	Type	_	$	78	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	78	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	78	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	78	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	78	_	_	_	_	_	_	_	O
6	:	_	:	_	:	78	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	78	_	_	_	_	_	_	_	O
8	(	_	(	_	(	78	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	78	_	_	_	_	_	_	_	O
10	)	_	)	_	)	78	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	78	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	78	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	78	_	_	_	_	_	_	_	O
14	)	_	)	_	)	78	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	78	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	78	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	78	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	78	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	78	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	78	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	78	_	_	_	_	_	_	_	O
8	(	_	(	_	(	78	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	78	_	_	_	_	_	_	_	O
10	)	_	)	_	)	78	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	78	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	78	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	78	_	_	_	_	_	_	_	O
14	)	_	)	_	)	78	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	79	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	79	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	JJ	79	_	_	_	_	_	_	_	O
4	cotransporter	_	UNK	_	NN	79	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	79	_	_	_	_	_	_	_	O
6	(	_	(	_	(	79	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	NNP	79	_	_	_	_	_	_	_	O
8	)	_	)	_	)	79	_	_	_	_	_	_	_	O
9	inhibitors	_	UNK	_	NNS	79	_	_	_	_	_	_	_	O
10	,	_	,	_	,	79	_	_	_	_	_	_	_	O
11	may	_	may	_	MD	79	_	_	_	_	_	_	_	O
12	be	_	be	_	VB	79	_	_	_	_	_	_	_	O
13	appropriate	_	appropriate	_	JJ	79	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	79	_	_	_	_	_	_	_	O
15	some	_	some	_	DT	79	_	_	_	_	_	_	_	O
16	adults	_	adult	_	NNS	79	_	_	_	_	_	adult.n	People_by_age	S-Person
17	with	_	with	_	IN	79	_	_	_	_	_	_	_	O
18	type	_	type	_	JJ	79	_	_	_	_	_	_	_	O
19	2	_	2	_	CD	79	_	_	_	_	_	_	_	O
20	diabetes	_	UNK	_	NNS	79	_	_	_	_	_	_	_	O
21	if	_	if	_	IN	79	_	_	_	_	_	_	_	O
22	metformin	_	UNK	_	NN	79	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	79	_	_	_	_	_	_	_	O
24	contraindicated	_	UNK	_	VBN	79	_	_	_	_	_	_	_	O
25	or	_	or	_	CC	79	_	_	_	_	_	_	_	O
26	not	_	not	_	RB	79	_	_	_	_	_	_	_	O
27	tolerated	_	UNK	_	VBN	79	_	_	_	_	_	_	_	O
28	(	_	(	_	(	79	_	_	_	_	_	_	_	O
29	see	_	see	_	VB	79	_	_	_	_	_	_	_	O
30	nice	_	UNK	_	NNP	79	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	79	_	_	_	_	_	_	_	O
32	guidance	_	guidance	_	NN	79	_	_	_	_	_	_	_	O
33	on	_	on	_	IN	79	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	79	_	_	_	_	_	_	_	O
35	,	_	,	_	,	79	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	79	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	79	_	_	_	_	_	_	_	O
38	unk	_	UNK	_	NN	79	_	_	_	_	_	_	_	O
39	as	_	a	_	IN	79	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	79	_	_	_	_	_	_	_	O
41	for	_	for	_	IN	79	_	_	_	_	_	_	_	O
42	treating	_	treat	_	VBG	79	_	_	_	_	_	_	_	O
43	type	_	type	_	NN	79	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	79	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	79	_	_	_	_	_	_	_	O
46	)	_	)	_	)	79	_	_	_	_	_	_	_	O
47	.	_	.	_	.	79	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	79	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	79	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	JJ	79	_	_	_	_	_	_	_	O
4	cotransporter	_	UNK	_	NN	79	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	79	_	_	_	_	_	_	_	O
6	(	_	(	_	(	79	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	NNP	79	_	_	_	_	_	_	_	O
8	)	_	)	_	)	79	_	_	_	_	_	_	_	O
9	inhibitors	_	UNK	_	NNS	79	_	_	_	_	_	_	_	O
10	,	_	,	_	,	79	_	_	_	_	_	_	_	O
11	may	_	may	_	MD	79	_	_	_	_	_	_	_	O
12	be	_	be	_	VB	79	_	_	_	_	_	_	_	O
13	appropriate	_	appropriate	_	JJ	79	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	79	_	_	_	_	_	_	_	O
15	some	_	some	_	DT	79	_	_	_	_	_	_	_	O
16	adults	_	adult	_	NNS	79	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	79	_	_	_	_	_	_	_	O
18	type	_	type	_	JJ	79	_	_	_	_	_	type.n	Type	S-Subtype
19	2	_	2	_	CD	79	_	_	_	_	_	_	_	B-Category
20	diabetes	_	UNK	_	NNS	79	_	_	_	_	_	_	_	I-Category
21	if	_	if	_	IN	79	_	_	_	_	_	_	_	O
22	metformin	_	UNK	_	NN	79	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	79	_	_	_	_	_	_	_	O
24	contraindicated	_	UNK	_	VBN	79	_	_	_	_	_	_	_	O
25	or	_	or	_	CC	79	_	_	_	_	_	_	_	O
26	not	_	not	_	RB	79	_	_	_	_	_	_	_	O
27	tolerated	_	UNK	_	VBN	79	_	_	_	_	_	_	_	O
28	(	_	(	_	(	79	_	_	_	_	_	_	_	O
29	see	_	see	_	VB	79	_	_	_	_	_	_	_	O
30	nice	_	UNK	_	NNP	79	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	79	_	_	_	_	_	_	_	O
32	guidance	_	guidance	_	NN	79	_	_	_	_	_	_	_	O
33	on	_	on	_	IN	79	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	79	_	_	_	_	_	_	_	O
35	,	_	,	_	,	79	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	79	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	79	_	_	_	_	_	_	_	O
38	unk	_	UNK	_	NN	79	_	_	_	_	_	_	_	O
39	as	_	a	_	IN	79	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	79	_	_	_	_	_	_	_	O
41	for	_	for	_	IN	79	_	_	_	_	_	_	_	O
42	treating	_	treat	_	VBG	79	_	_	_	_	_	_	_	O
43	type	_	type	_	NN	79	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	79	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	79	_	_	_	_	_	_	_	O
46	)	_	)	_	)	79	_	_	_	_	_	_	_	O
47	.	_	.	_	.	79	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	79	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	79	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	JJ	79	_	_	_	_	_	_	_	O
4	cotransporter	_	UNK	_	NN	79	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	79	_	_	_	_	_	_	_	O
6	(	_	(	_	(	79	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	NNP	79	_	_	_	_	_	_	_	O
8	)	_	)	_	)	79	_	_	_	_	_	_	_	O
9	inhibitors	_	UNK	_	NNS	79	_	_	_	_	_	_	_	O
10	,	_	,	_	,	79	_	_	_	_	_	_	_	O
11	may	_	may	_	MD	79	_	_	_	_	_	_	_	O
12	be	_	be	_	VB	79	_	_	_	_	_	_	_	O
13	appropriate	_	appropriate	_	JJ	79	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	79	_	_	_	_	_	_	_	O
15	some	_	some	_	DT	79	_	_	_	_	_	_	_	O
16	adults	_	adult	_	NNS	79	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	79	_	_	_	_	_	_	_	O
18	type	_	type	_	JJ	79	_	_	_	_	_	_	_	O
19	2	_	2	_	CD	79	_	_	_	_	_	_	_	O
20	diabetes	_	UNK	_	NNS	79	_	_	_	_	_	_	_	O
21	if	_	if	_	IN	79	_	_	_	_	_	_	_	O
22	metformin	_	UNK	_	NN	79	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	79	_	_	_	_	_	_	_	O
24	contraindicated	_	UNK	_	VBN	79	_	_	_	_	_	_	_	O
25	or	_	or	_	CC	79	_	_	_	_	_	_	_	O
26	not	_	not	_	RB	79	_	_	_	_	_	_	_	O
27	tolerated	_	UNK	_	VBN	79	_	_	_	_	_	_	_	O
28	(	_	(	_	(	79	_	_	_	_	_	_	_	O
29	see	_	see	_	VB	79	_	_	_	_	_	_	_	O
30	nice	_	UNK	_	NNP	79	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	79	_	_	_	_	_	_	_	O
32	guidance	_	guidance	_	NN	79	_	_	_	_	_	_	_	O
33	on	_	on	_	IN	79	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	79	_	_	_	_	_	_	_	O
35	,	_	,	_	,	79	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	79	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	79	_	_	_	_	_	_	_	O
38	unk	_	UNK	_	NN	79	_	_	_	_	_	_	_	O
39	as	_	a	_	IN	79	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	79	_	_	_	_	_	_	_	O
41	for	_	for	_	IN	79	_	_	_	_	_	_	_	O
42	treating	_	treat	_	VBG	79	_	_	_	_	_	treat.v	Medical_intervention	O
43	type	_	type	_	NN	79	_	_	_	_	_	_	_	B-Patient
44	2	_	2	_	CD	79	_	_	_	_	_	_	_	I-Patient
45	diabetes	_	UNK	_	NNS	79	_	_	_	_	_	_	_	I-Patient
46	)	_	)	_	)	79	_	_	_	_	_	_	_	O
47	.	_	.	_	.	79	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	79	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	79	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	JJ	79	_	_	_	_	_	_	_	O
4	cotransporter	_	UNK	_	NN	79	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	79	_	_	_	_	_	_	_	O
6	(	_	(	_	(	79	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	NNP	79	_	_	_	_	_	_	_	O
8	)	_	)	_	)	79	_	_	_	_	_	_	_	O
9	inhibitors	_	UNK	_	NNS	79	_	_	_	_	_	_	_	O
10	,	_	,	_	,	79	_	_	_	_	_	_	_	O
11	may	_	may	_	MD	79	_	_	_	_	_	_	_	O
12	be	_	be	_	VB	79	_	_	_	_	_	_	_	O
13	appropriate	_	appropriate	_	JJ	79	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	79	_	_	_	_	_	_	_	O
15	some	_	some	_	DT	79	_	_	_	_	_	_	_	O
16	adults	_	adult	_	NNS	79	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	79	_	_	_	_	_	_	_	O
18	type	_	type	_	JJ	79	_	_	_	_	_	_	_	O
19	2	_	2	_	CD	79	_	_	_	_	_	_	_	O
20	diabetes	_	UNK	_	NNS	79	_	_	_	_	_	_	_	O
21	if	_	if	_	IN	79	_	_	_	_	_	_	_	O
22	metformin	_	UNK	_	NN	79	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	79	_	_	_	_	_	_	_	O
24	contraindicated	_	UNK	_	VBN	79	_	_	_	_	_	_	_	O
25	or	_	or	_	CC	79	_	_	_	_	_	_	_	O
26	not	_	not	_	RB	79	_	_	_	_	_	_	_	O
27	tolerated	_	UNK	_	VBN	79	_	_	_	_	_	_	_	O
28	(	_	(	_	(	79	_	_	_	_	_	_	_	O
29	see	_	see	_	VB	79	_	_	_	_	_	_	_	O
30	nice	_	UNK	_	NNP	79	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	79	_	_	_	_	_	_	_	O
32	guidance	_	guidance	_	NN	79	_	_	_	_	_	_	_	O
33	on	_	on	_	IN	79	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	79	_	_	_	_	_	_	_	O
35	,	_	,	_	,	79	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	79	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	79	_	_	_	_	_	_	_	O
38	unk	_	UNK	_	NN	79	_	_	_	_	_	_	_	O
39	as	_	a	_	IN	79	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	79	_	_	_	_	_	_	_	O
41	for	_	for	_	IN	79	_	_	_	_	_	_	_	O
42	treating	_	treat	_	VBG	79	_	_	_	_	_	_	_	O
43	type	_	type	_	NN	79	_	_	_	_	_	type.n	Type	S-Subtype
44	2	_	2	_	CD	79	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	79	_	_	_	_	_	_	_	O
46	)	_	)	_	)	79	_	_	_	_	_	_	_	O
47	.	_	.	_	.	79	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	80	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	80	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	80	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	80	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
7	,	_	,	_	,	80	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	80	_	_	_	_	_	_	_	O
9	initial	_	initial	_	JJ	80	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	80	_	_	_	_	_	_	_	O
11	treatment	_	treatment	_	NN	80	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
13	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
14	has	_	have	_	VBZ	80	_	_	_	_	_	_	_	O
15	not	_	not	_	RB	80	_	_	_	_	_	_	_	O
16	continued	_	continue	_	VBN	80	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
18	control	_	control	_	VB	80	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
21	below	_	below	_	VB	80	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	80	_	_	_	_	_	_	_	O
23	person	_	person	_	NN	80	_	_	_	_	_	_	_	O
24	's	_	's	_	POS	80	_	_	_	_	_	_	_	O
25	individually	_	UNK	_	RB	80	_	_	_	_	_	_	_	O
26	agreed	_	agree	_	VBN	80	_	_	_	_	_	_	_	O
27	threshold	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
28	for	_	for	_	IN	80	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
30	,	_	,	_	,	80	_	_	_	_	_	_	_	O
31	consider	_	consider	_	VB	80	_	_	_	_	_	_	_	O
32	dual	_	dual	_	JJ	80	_	_	_	_	_	_	_	O
33	therapy	_	therapy	_	NN	80	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
35	:	_	:	_	:	80	_	_	_	_	_	_	_	O
36	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
38	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
39	dpp-4	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
40	inhibitor	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
44	pioglitazone	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
46	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
47	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
48	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
49	sulfonylurea	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
50	.	_	.	_	.	80	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	80	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	80	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	80	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	80	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	80	_	_	_	_	_	_	_	I-Category
7	,	_	,	_	,	80	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	80	_	_	_	_	_	_	_	O
9	initial	_	initial	_	JJ	80	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	80	_	_	_	_	_	_	_	O
11	treatment	_	treatment	_	NN	80	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
13	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
14	has	_	have	_	VBZ	80	_	_	_	_	_	_	_	O
15	not	_	not	_	RB	80	_	_	_	_	_	_	_	O
16	continued	_	continue	_	VBN	80	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
18	control	_	control	_	VB	80	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
21	below	_	below	_	VB	80	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	80	_	_	_	_	_	_	_	O
23	person	_	person	_	NN	80	_	_	_	_	_	_	_	O
24	's	_	's	_	POS	80	_	_	_	_	_	_	_	O
25	individually	_	UNK	_	RB	80	_	_	_	_	_	_	_	O
26	agreed	_	agree	_	VBN	80	_	_	_	_	_	_	_	O
27	threshold	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
28	for	_	for	_	IN	80	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
30	,	_	,	_	,	80	_	_	_	_	_	_	_	O
31	consider	_	consider	_	VB	80	_	_	_	_	_	_	_	O
32	dual	_	dual	_	JJ	80	_	_	_	_	_	_	_	O
33	therapy	_	therapy	_	NN	80	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
35	:	_	:	_	:	80	_	_	_	_	_	_	_	O
36	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
38	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
39	dpp-4	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
40	inhibitor	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
44	pioglitazone	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
46	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
47	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
48	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
49	sulfonylurea	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
50	.	_	.	_	.	80	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	80	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	80	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	80	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	80	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
7	,	_	,	_	,	80	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	80	_	_	_	_	_	_	_	O
9	initial	_	initial	_	JJ	80	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	80	_	_	_	_	_	_	_	S-Patient
11	treatment	_	treatment	_	NN	80	_	_	_	_	_	treatment.n	Cure	O
12	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
13	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
14	has	_	have	_	VBZ	80	_	_	_	_	_	_	_	O
15	not	_	not	_	RB	80	_	_	_	_	_	_	_	O
16	continued	_	continue	_	VBN	80	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
18	control	_	control	_	VB	80	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
21	below	_	below	_	VB	80	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	80	_	_	_	_	_	_	_	O
23	person	_	person	_	NN	80	_	_	_	_	_	_	_	O
24	's	_	's	_	POS	80	_	_	_	_	_	_	_	O
25	individually	_	UNK	_	RB	80	_	_	_	_	_	_	_	O
26	agreed	_	agree	_	VBN	80	_	_	_	_	_	_	_	O
27	threshold	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
28	for	_	for	_	IN	80	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
30	,	_	,	_	,	80	_	_	_	_	_	_	_	O
31	consider	_	consider	_	VB	80	_	_	_	_	_	_	_	O
32	dual	_	dual	_	JJ	80	_	_	_	_	_	_	_	O
33	therapy	_	therapy	_	NN	80	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
35	:	_	:	_	:	80	_	_	_	_	_	_	_	O
36	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
38	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
39	dpp-4	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
40	inhibitor	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
44	pioglitazone	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
46	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
47	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
48	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
49	sulfonylurea	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
50	.	_	.	_	.	80	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	80	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	80	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	80	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	80	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
7	,	_	,	_	,	80	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	80	_	_	_	_	_	_	_	O
9	initial	_	initial	_	JJ	80	_	_	_	_	_	_	_	B-Event
10	drug	_	drug	_	NN	80	_	_	_	_	_	_	_	I-Event
11	treatment	_	treatment	_	NN	80	_	_	_	_	_	_	_	I-Event
12	with	_	with	_	IN	80	_	_	_	_	_	_	_	I-Event
13	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Event
14	has	_	have	_	VBZ	80	_	_	_	_	_	_	_	O
15	not	_	not	_	RB	80	_	_	_	_	_	_	_	O
16	continued	_	continue	_	VBN	80	_	_	_	_	_	continue.v	Process_continue	O
17	to	_	to	_	TO	80	_	_	_	_	_	_	_	B-Event
18	control	_	control	_	VB	80	_	_	_	_	_	_	_	I-Event
19	hba1c	_	UNK	_	NNP	80	_	_	_	_	_	_	_	I-Event
20	to	_	to	_	TO	80	_	_	_	_	_	_	_	I-Event
21	below	_	below	_	VB	80	_	_	_	_	_	_	_	I-Event
22	the	_	the	_	DT	80	_	_	_	_	_	_	_	I-Event
23	person	_	person	_	NN	80	_	_	_	_	_	_	_	I-Event
24	's	_	's	_	POS	80	_	_	_	_	_	_	_	I-Event
25	individually	_	UNK	_	RB	80	_	_	_	_	_	_	_	I-Event
26	agreed	_	agree	_	VBN	80	_	_	_	_	_	_	_	I-Event
27	threshold	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Event
28	for	_	for	_	IN	80	_	_	_	_	_	_	_	I-Event
29	intensification	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Event
30	,	_	,	_	,	80	_	_	_	_	_	_	_	O
31	consider	_	consider	_	VB	80	_	_	_	_	_	_	_	O
32	dual	_	dual	_	JJ	80	_	_	_	_	_	_	_	O
33	therapy	_	therapy	_	NN	80	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
35	:	_	:	_	:	80	_	_	_	_	_	_	_	O
36	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
38	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
39	dpp-4	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
40	inhibitor	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
44	pioglitazone	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
46	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
47	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
48	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
49	sulfonylurea	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
50	.	_	.	_	.	80	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	80	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	80	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	80	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	80	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
7	,	_	,	_	,	80	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	80	_	_	_	_	_	_	_	O
9	initial	_	initial	_	JJ	80	_	_	_	_	_	_	_	B-Controlling_entity
10	drug	_	drug	_	NN	80	_	_	_	_	_	_	_	I-Controlling_entity
11	treatment	_	treatment	_	NN	80	_	_	_	_	_	_	_	I-Controlling_entity
12	with	_	with	_	IN	80	_	_	_	_	_	_	_	I-Controlling_entity
13	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Controlling_entity
14	has	_	have	_	VBZ	80	_	_	_	_	_	_	_	O
15	not	_	not	_	RB	80	_	_	_	_	_	_	_	O
16	continued	_	continue	_	VBN	80	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
18	control	_	control	_	VB	80	_	_	_	_	_	control.v	Being_in_control	O
19	hba1c	_	UNK	_	NNP	80	_	_	_	_	_	_	_	S-Dependent_entity
20	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
21	below	_	below	_	VB	80	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	80	_	_	_	_	_	_	_	O
23	person	_	person	_	NN	80	_	_	_	_	_	_	_	O
24	's	_	's	_	POS	80	_	_	_	_	_	_	_	O
25	individually	_	UNK	_	RB	80	_	_	_	_	_	_	_	O
26	agreed	_	agree	_	VBN	80	_	_	_	_	_	_	_	O
27	threshold	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
28	for	_	for	_	IN	80	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
30	,	_	,	_	,	80	_	_	_	_	_	_	_	O
31	consider	_	consider	_	VB	80	_	_	_	_	_	_	_	O
32	dual	_	dual	_	JJ	80	_	_	_	_	_	_	_	O
33	therapy	_	therapy	_	NN	80	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
35	:	_	:	_	:	80	_	_	_	_	_	_	_	O
36	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
38	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
39	dpp-4	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
40	inhibitor	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
44	pioglitazone	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
46	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
47	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
48	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
49	sulfonylurea	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
50	.	_	.	_	.	80	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	80	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	80	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	80	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	80	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
7	,	_	,	_	,	80	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	80	_	_	_	_	_	_	_	O
9	initial	_	initial	_	JJ	80	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	80	_	_	_	_	_	_	_	O
11	treatment	_	treatment	_	NN	80	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
13	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
14	has	_	have	_	VBZ	80	_	_	_	_	_	_	_	O
15	not	_	not	_	RB	80	_	_	_	_	_	_	_	O
16	continued	_	continue	_	VBN	80	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
18	control	_	control	_	VB	80	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
21	below	_	below	_	VB	80	_	_	_	_	_	below.prep	Directional_locative_relation	O
22	the	_	the	_	DT	80	_	_	_	_	_	_	_	O
23	person	_	person	_	NN	80	_	_	_	_	_	_	_	O
24	's	_	's	_	POS	80	_	_	_	_	_	_	_	O
25	individually	_	UNK	_	RB	80	_	_	_	_	_	_	_	O
26	agreed	_	agree	_	VBN	80	_	_	_	_	_	_	_	O
27	threshold	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
28	for	_	for	_	IN	80	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
30	,	_	,	_	,	80	_	_	_	_	_	_	_	O
31	consider	_	consider	_	VB	80	_	_	_	_	_	_	_	O
32	dual	_	dual	_	JJ	80	_	_	_	_	_	_	_	O
33	therapy	_	therapy	_	NN	80	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
35	:	_	:	_	:	80	_	_	_	_	_	_	_	O
36	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
38	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
39	dpp-4	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
40	inhibitor	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
44	pioglitazone	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
46	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
47	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
48	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
49	sulfonylurea	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
50	.	_	.	_	.	80	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	80	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	80	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	80	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	80	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
7	,	_	,	_	,	80	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	80	_	_	_	_	_	_	_	O
9	initial	_	initial	_	JJ	80	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	80	_	_	_	_	_	_	_	O
11	treatment	_	treatment	_	NN	80	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
13	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
14	has	_	have	_	VBZ	80	_	_	_	_	_	_	_	O
15	not	_	not	_	RB	80	_	_	_	_	_	_	_	O
16	continued	_	continue	_	VBN	80	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
18	control	_	control	_	VB	80	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
21	below	_	below	_	VB	80	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	80	_	_	_	_	_	_	_	O
23	person	_	person	_	NN	80	_	_	_	_	_	person.n	People	S-Person
24	's	_	's	_	POS	80	_	_	_	_	_	_	_	O
25	individually	_	UNK	_	RB	80	_	_	_	_	_	_	_	O
26	agreed	_	agree	_	VBN	80	_	_	_	_	_	_	_	O
27	threshold	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
28	for	_	for	_	IN	80	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
30	,	_	,	_	,	80	_	_	_	_	_	_	_	O
31	consider	_	consider	_	VB	80	_	_	_	_	_	_	_	O
32	dual	_	dual	_	JJ	80	_	_	_	_	_	_	_	O
33	therapy	_	therapy	_	NN	80	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
35	:	_	:	_	:	80	_	_	_	_	_	_	_	O
36	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
38	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
39	dpp-4	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
40	inhibitor	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
44	pioglitazone	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
46	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
47	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
48	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
49	sulfonylurea	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
50	.	_	.	_	.	80	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	80	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	80	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	80	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	80	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
7	,	_	,	_	,	80	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	80	_	_	_	_	_	_	_	O
9	initial	_	initial	_	JJ	80	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	80	_	_	_	_	_	_	_	O
11	treatment	_	treatment	_	NN	80	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
13	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
14	has	_	have	_	VBZ	80	_	_	_	_	_	_	_	O
15	not	_	not	_	RB	80	_	_	_	_	_	_	_	O
16	continued	_	continue	_	VBN	80	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
18	control	_	control	_	VB	80	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
21	below	_	below	_	VB	80	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	80	_	_	_	_	_	_	_	B-Party_1
23	person	_	person	_	NN	80	_	_	_	_	_	_	_	I-Party_1
24	's	_	's	_	POS	80	_	_	_	_	_	_	_	I-Party_1
25	individually	_	UNK	_	RB	80	_	_	_	_	_	_	_	S-Parties
26	agreed	_	agree	_	VBN	80	_	_	_	_	_	agree.v	Make_agreement_on_action	O
27	threshold	_	UNK	_	NN	80	_	_	_	_	_	_	_	B-Obligation
28	for	_	for	_	IN	80	_	_	_	_	_	_	_	I-Obligation
29	intensification	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Obligation
30	,	_	,	_	,	80	_	_	_	_	_	_	_	O
31	consider	_	consider	_	VB	80	_	_	_	_	_	_	_	O
32	dual	_	dual	_	JJ	80	_	_	_	_	_	_	_	O
33	therapy	_	therapy	_	NN	80	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
35	:	_	:	_	:	80	_	_	_	_	_	_	_	O
36	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
38	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
39	dpp-4	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
40	inhibitor	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
44	pioglitazone	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
46	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
47	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
48	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
49	sulfonylurea	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
50	.	_	.	_	.	80	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	80	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	80	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	80	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	80	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
7	,	_	,	_	,	80	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	80	_	_	_	_	_	_	_	O
9	initial	_	initial	_	JJ	80	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	80	_	_	_	_	_	_	_	O
11	treatment	_	treatment	_	NN	80	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
13	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
14	has	_	have	_	VBZ	80	_	_	_	_	_	_	_	O
15	not	_	not	_	RB	80	_	_	_	_	_	_	_	O
16	continued	_	continue	_	VBN	80	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
18	control	_	control	_	VB	80	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
21	below	_	below	_	VB	80	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	80	_	_	_	_	_	_	_	O
23	person	_	person	_	NN	80	_	_	_	_	_	_	_	O
24	's	_	's	_	POS	80	_	_	_	_	_	_	_	O
25	individually	_	UNK	_	RB	80	_	_	_	_	_	_	_	O
26	agreed	_	agree	_	VBN	80	_	_	_	_	_	_	_	O
27	threshold	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
28	for	_	for	_	IN	80	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
30	,	_	,	_	,	80	_	_	_	_	_	_	_	O
31	consider	_	consider	_	VB	80	_	_	_	_	_	consider.v	Categorization	O
32	dual	_	dual	_	JJ	80	_	_	_	_	_	_	_	B-Item
33	therapy	_	therapy	_	NN	80	_	_	_	_	_	_	_	I-Item
34	with	_	with	_	IN	80	_	_	_	_	_	_	_	S-Category
35	:	_	:	_	:	80	_	_	_	_	_	_	_	O
36	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	B-Category
37	and	_	and	_	CC	80	_	_	_	_	_	_	_	I-Category
38	a	_	a	_	DT	80	_	_	_	_	_	_	_	I-Category
39	dpp-4	_	UNK	_	JJ	80	_	_	_	_	_	_	_	I-Category
40	inhibitor	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Category
41	or	_	or	_	CC	80	_	_	_	_	_	_	_	I-Category
42	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Category
43	and	_	and	_	CC	80	_	_	_	_	_	_	_	I-Category
44	pioglitazone	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Category
45	or	_	or	_	CC	80	_	_	_	_	_	_	_	I-Category
46	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Category
47	and	_	and	_	CC	80	_	_	_	_	_	_	_	I-Category
48	a	_	a	_	DT	80	_	_	_	_	_	_	_	I-Category
49	sulfonylurea	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Category
50	.	_	.	_	.	80	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	80	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	80	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	80	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	80	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
7	,	_	,	_	,	80	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	80	_	_	_	_	_	_	_	O
9	initial	_	initial	_	JJ	80	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	80	_	_	_	_	_	_	_	O
11	treatment	_	treatment	_	NN	80	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
13	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
14	has	_	have	_	VBZ	80	_	_	_	_	_	_	_	O
15	not	_	not	_	RB	80	_	_	_	_	_	_	_	O
16	continued	_	continue	_	VBN	80	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
18	control	_	control	_	VB	80	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
21	below	_	below	_	VB	80	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	80	_	_	_	_	_	_	_	O
23	person	_	person	_	NN	80	_	_	_	_	_	_	_	O
24	's	_	's	_	POS	80	_	_	_	_	_	_	_	O
25	individually	_	UNK	_	RB	80	_	_	_	_	_	_	_	O
26	agreed	_	agree	_	VBN	80	_	_	_	_	_	_	_	O
27	threshold	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
28	for	_	for	_	IN	80	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
30	,	_	,	_	,	80	_	_	_	_	_	_	_	O
31	consider	_	consider	_	VB	80	_	_	_	_	_	_	_	O
32	dual	_	dual	_	JJ	80	_	_	_	_	_	dual.a	Cardinal_numbers	S-Number
33	therapy	_	therapy	_	NN	80	_	_	_	_	_	_	_	S-Entity
34	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
35	:	_	:	_	:	80	_	_	_	_	_	_	_	O
36	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
38	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
39	dpp-4	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
40	inhibitor	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
44	pioglitazone	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
46	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
47	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
48	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
49	sulfonylurea	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
50	.	_	.	_	.	80	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	80	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	80	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	80	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	80	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
7	,	_	,	_	,	80	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	80	_	_	_	_	_	_	_	O
9	initial	_	initial	_	JJ	80	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	80	_	_	_	_	_	_	_	O
11	treatment	_	treatment	_	NN	80	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
13	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
14	has	_	have	_	VBZ	80	_	_	_	_	_	_	_	O
15	not	_	not	_	RB	80	_	_	_	_	_	_	_	O
16	continued	_	continue	_	VBN	80	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
18	control	_	control	_	VB	80	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
21	below	_	below	_	VB	80	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	80	_	_	_	_	_	_	_	O
23	person	_	person	_	NN	80	_	_	_	_	_	_	_	O
24	's	_	's	_	POS	80	_	_	_	_	_	_	_	O
25	individually	_	UNK	_	RB	80	_	_	_	_	_	_	_	O
26	agreed	_	agree	_	VBN	80	_	_	_	_	_	_	_	O
27	threshold	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
28	for	_	for	_	IN	80	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
30	,	_	,	_	,	80	_	_	_	_	_	_	_	O
31	consider	_	consider	_	VB	80	_	_	_	_	_	_	_	O
32	dual	_	dual	_	JJ	80	_	_	_	_	_	_	_	O
33	therapy	_	therapy	_	NN	80	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
34	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
35	:	_	:	_	:	80	_	_	_	_	_	_	_	O
36	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
38	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
39	dpp-4	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
40	inhibitor	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
44	pioglitazone	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
46	metformin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
47	and	_	and	_	CC	80	_	_	_	_	_	_	_	O
48	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
49	sulfonylurea	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
50	.	_	.	_	.	80	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	81	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	81	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	81	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	81	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	81	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	81	_	_	_	_	_	_	_	O
7	,	_	,	_	,	81	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	81	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	81	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	81	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	81	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	81	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	81	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	81	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
16	initial	_	initial	_	JJ	81	_	_	_	_	_	_	_	O
17	drug	_	drug	_	NN	81	_	_	_	_	_	_	_	O
18	treatment	_	treatment	_	NN	81	_	_	_	_	_	_	_	O
19	has	_	have	_	VBZ	81	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	81	_	_	_	_	_	_	_	O
21	continued	_	continue	_	VBN	81	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	81	_	_	_	_	_	_	_	O
23	control	_	control	_	VB	81	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	81	_	_	_	_	_	_	_	O
25	to	_	to	_	TO	81	_	_	_	_	_	_	_	O
26	below	_	below	_	VB	81	_	_	_	_	_	_	_	O
27	the	_	the	_	DT	81	_	_	_	_	_	_	_	O
28	person	_	person	_	NN	81	_	_	_	_	_	_	_	O
29	's	_	's	_	POS	81	_	_	_	_	_	_	_	O
30	individually	_	UNK	_	RB	81	_	_	_	_	_	_	_	O
31	agreed	_	agree	_	VBN	81	_	_	_	_	_	_	_	O
32	threshold	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
33	for	_	for	_	IN	81	_	_	_	_	_	_	_	O
34	intensification	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
35	,	_	,	_	,	81	_	_	_	_	_	_	_	O
36	consider	_	consider	_	VB	81	_	_	_	_	_	_	_	O
37	dual	_	dual	_	JJ	81	_	_	_	_	_	_	_	O
38	therapy	_	therapy	_	NN	81	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	81	_	_	_	_	_	_	_	O
40	:	_	:	_	:	81	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
42	dpp-4	_	UNK	_	NNP	81	_	_	_	_	_	_	_	O
43	inhibitor	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
44	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
45	pioglitazone	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	81	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	JJ	81	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	81	_	_	_	_	_	_	_	O
54	pioglitazone	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
55	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
57	sulfonylurea	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
58	.	_	.	_	.	81	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	81	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	81	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	81	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	81	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	81	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	81	_	_	_	_	_	_	_	I-Category
7	,	_	,	_	,	81	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	81	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	81	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	81	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	81	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	81	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	81	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	81	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
16	initial	_	initial	_	JJ	81	_	_	_	_	_	_	_	O
17	drug	_	drug	_	NN	81	_	_	_	_	_	_	_	O
18	treatment	_	treatment	_	NN	81	_	_	_	_	_	_	_	O
19	has	_	have	_	VBZ	81	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	81	_	_	_	_	_	_	_	O
21	continued	_	continue	_	VBN	81	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	81	_	_	_	_	_	_	_	O
23	control	_	control	_	VB	81	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	81	_	_	_	_	_	_	_	O
25	to	_	to	_	TO	81	_	_	_	_	_	_	_	O
26	below	_	below	_	VB	81	_	_	_	_	_	_	_	O
27	the	_	the	_	DT	81	_	_	_	_	_	_	_	O
28	person	_	person	_	NN	81	_	_	_	_	_	_	_	O
29	's	_	's	_	POS	81	_	_	_	_	_	_	_	O
30	individually	_	UNK	_	RB	81	_	_	_	_	_	_	_	O
31	agreed	_	agree	_	VBN	81	_	_	_	_	_	_	_	O
32	threshold	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
33	for	_	for	_	IN	81	_	_	_	_	_	_	_	O
34	intensification	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
35	,	_	,	_	,	81	_	_	_	_	_	_	_	O
36	consider	_	consider	_	VB	81	_	_	_	_	_	_	_	O
37	dual	_	dual	_	JJ	81	_	_	_	_	_	_	_	O
38	therapy	_	therapy	_	NN	81	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	81	_	_	_	_	_	_	_	O
40	:	_	:	_	:	81	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
42	dpp-4	_	UNK	_	NNP	81	_	_	_	_	_	_	_	O
43	inhibitor	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
44	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
45	pioglitazone	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	81	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	JJ	81	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	81	_	_	_	_	_	_	_	O
54	pioglitazone	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
55	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
57	sulfonylurea	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
58	.	_	.	_	.	81	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	81	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	81	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	81	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	81	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	81	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	81	_	_	_	_	_	_	_	O
7	,	_	,	_	,	81	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	81	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	81	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	81	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	81	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	81	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	81	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	81	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
16	initial	_	initial	_	JJ	81	_	_	_	_	_	_	_	B-Activity
17	drug	_	drug	_	NN	81	_	_	_	_	_	_	_	I-Activity
18	treatment	_	treatment	_	NN	81	_	_	_	_	_	_	_	I-Activity
19	has	_	have	_	VBZ	81	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	81	_	_	_	_	_	_	_	O
21	continued	_	continue	_	VBN	81	_	_	_	_	_	continue.v	Activity_ongoing	O
22	to	_	to	_	TO	81	_	_	_	_	_	_	_	B-Activity
23	control	_	control	_	VB	81	_	_	_	_	_	_	_	I-Activity
24	hba1c	_	UNK	_	NNP	81	_	_	_	_	_	_	_	I-Activity
25	to	_	to	_	TO	81	_	_	_	_	_	_	_	I-Activity
26	below	_	below	_	VB	81	_	_	_	_	_	_	_	I-Activity
27	the	_	the	_	DT	81	_	_	_	_	_	_	_	I-Activity
28	person	_	person	_	NN	81	_	_	_	_	_	_	_	I-Activity
29	's	_	's	_	POS	81	_	_	_	_	_	_	_	I-Activity
30	individually	_	UNK	_	RB	81	_	_	_	_	_	_	_	I-Activity
31	agreed	_	agree	_	VBN	81	_	_	_	_	_	_	_	I-Activity
32	threshold	_	UNK	_	NN	81	_	_	_	_	_	_	_	I-Activity
33	for	_	for	_	IN	81	_	_	_	_	_	_	_	I-Activity
34	intensification	_	UNK	_	NN	81	_	_	_	_	_	_	_	I-Activity
35	,	_	,	_	,	81	_	_	_	_	_	_	_	O
36	consider	_	consider	_	VB	81	_	_	_	_	_	_	_	O
37	dual	_	dual	_	JJ	81	_	_	_	_	_	_	_	O
38	therapy	_	therapy	_	NN	81	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	81	_	_	_	_	_	_	_	O
40	:	_	:	_	:	81	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
42	dpp-4	_	UNK	_	NNP	81	_	_	_	_	_	_	_	O
43	inhibitor	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
44	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
45	pioglitazone	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	81	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	JJ	81	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	81	_	_	_	_	_	_	_	O
54	pioglitazone	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
55	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
57	sulfonylurea	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
58	.	_	.	_	.	81	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	81	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	81	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	81	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	81	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	81	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	81	_	_	_	_	_	_	_	O
7	,	_	,	_	,	81	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	81	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	81	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	81	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	81	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	81	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	81	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	81	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
16	initial	_	initial	_	JJ	81	_	_	_	_	_	_	_	O
17	drug	_	drug	_	NN	81	_	_	_	_	_	_	_	O
18	treatment	_	treatment	_	NN	81	_	_	_	_	_	_	_	O
19	has	_	have	_	VBZ	81	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	81	_	_	_	_	_	_	_	O
21	continued	_	continue	_	VBN	81	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	81	_	_	_	_	_	_	_	O
23	control	_	control	_	VB	81	_	_	_	_	_	control.v	Being_in_control	O
24	hba1c	_	UNK	_	NNP	81	_	_	_	_	_	_	_	B-Dependent_entity
25	to	_	to	_	TO	81	_	_	_	_	_	_	_	I-Dependent_entity
26	below	_	below	_	VB	81	_	_	_	_	_	_	_	I-Dependent_entity
27	the	_	the	_	DT	81	_	_	_	_	_	_	_	I-Dependent_entity
28	person	_	person	_	NN	81	_	_	_	_	_	_	_	I-Dependent_entity
29	's	_	's	_	POS	81	_	_	_	_	_	_	_	I-Dependent_entity
30	individually	_	UNK	_	RB	81	_	_	_	_	_	_	_	I-Dependent_entity
31	agreed	_	agree	_	VBN	81	_	_	_	_	_	_	_	I-Dependent_entity
32	threshold	_	UNK	_	NN	81	_	_	_	_	_	_	_	I-Dependent_entity
33	for	_	for	_	IN	81	_	_	_	_	_	_	_	I-Dependent_entity
34	intensification	_	UNK	_	NN	81	_	_	_	_	_	_	_	I-Dependent_entity
35	,	_	,	_	,	81	_	_	_	_	_	_	_	O
36	consider	_	consider	_	VB	81	_	_	_	_	_	_	_	O
37	dual	_	dual	_	JJ	81	_	_	_	_	_	_	_	O
38	therapy	_	therapy	_	NN	81	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	81	_	_	_	_	_	_	_	O
40	:	_	:	_	:	81	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
42	dpp-4	_	UNK	_	NNP	81	_	_	_	_	_	_	_	O
43	inhibitor	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
44	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
45	pioglitazone	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	81	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	JJ	81	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	81	_	_	_	_	_	_	_	O
54	pioglitazone	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
55	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
57	sulfonylurea	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
58	.	_	.	_	.	81	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	81	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	81	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	81	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	81	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	81	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	81	_	_	_	_	_	_	_	O
7	,	_	,	_	,	81	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	81	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	81	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	81	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	81	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	81	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	81	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	81	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
16	initial	_	initial	_	JJ	81	_	_	_	_	_	_	_	O
17	drug	_	drug	_	NN	81	_	_	_	_	_	_	_	O
18	treatment	_	treatment	_	NN	81	_	_	_	_	_	_	_	O
19	has	_	have	_	VBZ	81	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	81	_	_	_	_	_	_	_	O
21	continued	_	continue	_	VBN	81	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	81	_	_	_	_	_	_	_	O
23	control	_	control	_	VB	81	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	81	_	_	_	_	_	_	_	O
25	to	_	to	_	TO	81	_	_	_	_	_	_	_	O
26	below	_	below	_	VB	81	_	_	_	_	_	_	_	O
27	the	_	the	_	DT	81	_	_	_	_	_	_	_	O
28	person	_	person	_	NN	81	_	_	_	_	_	person.n	People	S-Person
29	's	_	's	_	POS	81	_	_	_	_	_	_	_	O
30	individually	_	UNK	_	RB	81	_	_	_	_	_	_	_	O
31	agreed	_	agree	_	VBN	81	_	_	_	_	_	_	_	O
32	threshold	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
33	for	_	for	_	IN	81	_	_	_	_	_	_	_	O
34	intensification	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
35	,	_	,	_	,	81	_	_	_	_	_	_	_	O
36	consider	_	consider	_	VB	81	_	_	_	_	_	_	_	O
37	dual	_	dual	_	JJ	81	_	_	_	_	_	_	_	O
38	therapy	_	therapy	_	NN	81	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	81	_	_	_	_	_	_	_	O
40	:	_	:	_	:	81	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
42	dpp-4	_	UNK	_	NNP	81	_	_	_	_	_	_	_	O
43	inhibitor	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
44	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
45	pioglitazone	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	81	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	JJ	81	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	81	_	_	_	_	_	_	_	O
54	pioglitazone	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
55	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
57	sulfonylurea	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
58	.	_	.	_	.	81	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	81	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	81	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	81	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	81	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	81	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	81	_	_	_	_	_	_	_	O
7	,	_	,	_	,	81	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	81	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	81	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	81	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	81	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	81	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	81	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	81	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
16	initial	_	initial	_	JJ	81	_	_	_	_	_	_	_	O
17	drug	_	drug	_	NN	81	_	_	_	_	_	_	_	O
18	treatment	_	treatment	_	NN	81	_	_	_	_	_	_	_	O
19	has	_	have	_	VBZ	81	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	81	_	_	_	_	_	_	_	O
21	continued	_	continue	_	VBN	81	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	81	_	_	_	_	_	_	_	O
23	control	_	control	_	VB	81	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	81	_	_	_	_	_	_	_	O
25	to	_	to	_	TO	81	_	_	_	_	_	_	_	O
26	below	_	below	_	VB	81	_	_	_	_	_	_	_	O
27	the	_	the	_	DT	81	_	_	_	_	_	_	_	B-Party_1
28	person	_	person	_	NN	81	_	_	_	_	_	_	_	I-Party_1
29	's	_	's	_	POS	81	_	_	_	_	_	_	_	I-Party_1
30	individually	_	UNK	_	RB	81	_	_	_	_	_	_	_	S-Parties
31	agreed	_	agree	_	VBN	81	_	_	_	_	_	agree.v	Make_agreement_on_action	O
32	threshold	_	UNK	_	NN	81	_	_	_	_	_	_	_	B-Obligation
33	for	_	for	_	IN	81	_	_	_	_	_	_	_	I-Obligation
34	intensification	_	UNK	_	NN	81	_	_	_	_	_	_	_	I-Obligation
35	,	_	,	_	,	81	_	_	_	_	_	_	_	O
36	consider	_	consider	_	VB	81	_	_	_	_	_	_	_	O
37	dual	_	dual	_	JJ	81	_	_	_	_	_	_	_	O
38	therapy	_	therapy	_	NN	81	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	81	_	_	_	_	_	_	_	O
40	:	_	:	_	:	81	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
42	dpp-4	_	UNK	_	NNP	81	_	_	_	_	_	_	_	O
43	inhibitor	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
44	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
45	pioglitazone	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	81	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	JJ	81	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	81	_	_	_	_	_	_	_	O
54	pioglitazone	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
55	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
57	sulfonylurea	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
58	.	_	.	_	.	81	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	81	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	81	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	81	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	81	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	81	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	81	_	_	_	_	_	_	_	O
7	,	_	,	_	,	81	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	81	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	81	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	81	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	81	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	81	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	81	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	81	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
16	initial	_	initial	_	JJ	81	_	_	_	_	_	_	_	O
17	drug	_	drug	_	NN	81	_	_	_	_	_	_	_	O
18	treatment	_	treatment	_	NN	81	_	_	_	_	_	_	_	O
19	has	_	have	_	VBZ	81	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	81	_	_	_	_	_	_	_	O
21	continued	_	continue	_	VBN	81	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	81	_	_	_	_	_	_	_	O
23	control	_	control	_	VB	81	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	81	_	_	_	_	_	_	_	O
25	to	_	to	_	TO	81	_	_	_	_	_	_	_	O
26	below	_	below	_	VB	81	_	_	_	_	_	_	_	O
27	the	_	the	_	DT	81	_	_	_	_	_	_	_	O
28	person	_	person	_	NN	81	_	_	_	_	_	_	_	O
29	's	_	's	_	POS	81	_	_	_	_	_	_	_	O
30	individually	_	UNK	_	RB	81	_	_	_	_	_	_	_	O
31	agreed	_	agree	_	VBN	81	_	_	_	_	_	_	_	O
32	threshold	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
33	for	_	for	_	IN	81	_	_	_	_	_	_	_	O
34	intensification	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
35	,	_	,	_	,	81	_	_	_	_	_	_	_	O
36	consider	_	consider	_	VB	81	_	_	_	_	_	consider.v	Categorization	O
37	dual	_	dual	_	JJ	81	_	_	_	_	_	_	_	B-Item
38	therapy	_	therapy	_	NN	81	_	_	_	_	_	_	_	I-Item
39	with	_	with	_	IN	81	_	_	_	_	_	_	_	S-Category
40	:	_	:	_	:	81	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	81	_	_	_	_	_	_	_	B-Category
42	dpp-4	_	UNK	_	NNP	81	_	_	_	_	_	_	_	I-Category
43	inhibitor	_	UNK	_	NN	81	_	_	_	_	_	_	_	I-Category
44	and	_	and	_	CC	81	_	_	_	_	_	_	_	I-Category
45	pioglitazone	_	UNK	_	NN	81	_	_	_	_	_	_	_	I-Category
46	or	_	or	_	CC	81	_	_	_	_	_	_	_	I-Category
47	a	_	a	_	DT	81	_	_	_	_	_	_	_	I-Category
48	dpp-4	_	UNK	_	JJ	81	_	_	_	_	_	_	_	I-Category
49	inhibitor	_	UNK	_	NN	81	_	_	_	_	_	_	_	I-Category
50	and	_	and	_	CC	81	_	_	_	_	_	_	_	I-Category
51	a	_	a	_	DT	81	_	_	_	_	_	_	_	I-Category
52	sulfonylurea	_	UNK	_	NN	81	_	_	_	_	_	_	_	I-Category
53	or	_	or	_	CC	81	_	_	_	_	_	_	_	I-Category
54	pioglitazone	_	UNK	_	NN	81	_	_	_	_	_	_	_	I-Category
55	and	_	and	_	CC	81	_	_	_	_	_	_	_	I-Category
56	a	_	a	_	DT	81	_	_	_	_	_	_	_	I-Category
57	sulfonylurea	_	UNK	_	NN	81	_	_	_	_	_	_	_	I-Category
58	.	_	.	_	.	81	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	81	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	81	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	81	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	81	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	81	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	81	_	_	_	_	_	_	_	O
7	,	_	,	_	,	81	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	81	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	81	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	81	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	81	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	81	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	81	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	81	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
16	initial	_	initial	_	JJ	81	_	_	_	_	_	_	_	O
17	drug	_	drug	_	NN	81	_	_	_	_	_	_	_	O
18	treatment	_	treatment	_	NN	81	_	_	_	_	_	_	_	O
19	has	_	have	_	VBZ	81	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	81	_	_	_	_	_	_	_	O
21	continued	_	continue	_	VBN	81	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	81	_	_	_	_	_	_	_	O
23	control	_	control	_	VB	81	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	81	_	_	_	_	_	_	_	O
25	to	_	to	_	TO	81	_	_	_	_	_	_	_	O
26	below	_	below	_	VB	81	_	_	_	_	_	_	_	O
27	the	_	the	_	DT	81	_	_	_	_	_	_	_	O
28	person	_	person	_	NN	81	_	_	_	_	_	_	_	O
29	's	_	's	_	POS	81	_	_	_	_	_	_	_	O
30	individually	_	UNK	_	RB	81	_	_	_	_	_	_	_	O
31	agreed	_	agree	_	VBN	81	_	_	_	_	_	_	_	O
32	threshold	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
33	for	_	for	_	IN	81	_	_	_	_	_	_	_	O
34	intensification	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
35	,	_	,	_	,	81	_	_	_	_	_	_	_	O
36	consider	_	consider	_	VB	81	_	_	_	_	_	_	_	O
37	dual	_	dual	_	JJ	81	_	_	_	_	_	dual.a	Cardinal_numbers	S-Number
38	therapy	_	therapy	_	NN	81	_	_	_	_	_	_	_	S-Entity
39	with	_	with	_	IN	81	_	_	_	_	_	_	_	O
40	:	_	:	_	:	81	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
42	dpp-4	_	UNK	_	NNP	81	_	_	_	_	_	_	_	O
43	inhibitor	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
44	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
45	pioglitazone	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	81	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	JJ	81	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	81	_	_	_	_	_	_	_	O
54	pioglitazone	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
55	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
57	sulfonylurea	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
58	.	_	.	_	.	81	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	81	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	81	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	81	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	81	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	81	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	81	_	_	_	_	_	_	_	O
7	,	_	,	_	,	81	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	81	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	81	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	81	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	81	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	81	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	81	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	81	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
16	initial	_	initial	_	JJ	81	_	_	_	_	_	_	_	O
17	drug	_	drug	_	NN	81	_	_	_	_	_	_	_	O
18	treatment	_	treatment	_	NN	81	_	_	_	_	_	_	_	O
19	has	_	have	_	VBZ	81	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	81	_	_	_	_	_	_	_	O
21	continued	_	continue	_	VBN	81	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	81	_	_	_	_	_	_	_	O
23	control	_	control	_	VB	81	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	81	_	_	_	_	_	_	_	O
25	to	_	to	_	TO	81	_	_	_	_	_	_	_	O
26	below	_	below	_	VB	81	_	_	_	_	_	_	_	O
27	the	_	the	_	DT	81	_	_	_	_	_	_	_	O
28	person	_	person	_	NN	81	_	_	_	_	_	_	_	O
29	's	_	's	_	POS	81	_	_	_	_	_	_	_	O
30	individually	_	UNK	_	RB	81	_	_	_	_	_	_	_	O
31	agreed	_	agree	_	VBN	81	_	_	_	_	_	_	_	O
32	threshold	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
33	for	_	for	_	IN	81	_	_	_	_	_	_	_	O
34	intensification	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
35	,	_	,	_	,	81	_	_	_	_	_	_	_	O
36	consider	_	consider	_	VB	81	_	_	_	_	_	_	_	O
37	dual	_	dual	_	JJ	81	_	_	_	_	_	_	_	O
38	therapy	_	therapy	_	NN	81	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
39	with	_	with	_	IN	81	_	_	_	_	_	_	_	O
40	:	_	:	_	:	81	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
42	dpp-4	_	UNK	_	NNP	81	_	_	_	_	_	_	_	O
43	inhibitor	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
44	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
45	pioglitazone	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	81	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	JJ	81	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	81	_	_	_	_	_	_	_	O
54	pioglitazone	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
55	and	_	and	_	CC	81	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	81	_	_	_	_	_	_	_	O
57	sulfonylurea	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
58	.	_	.	_	.	81	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	82	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	82	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
6	:	_	:	_	:	82	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	82	_	_	_	_	_	_	_	O
8	(	_	(	_	(	82	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
10	)	_	)	_	)	82	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	82	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	82	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
14	)	_	)	_	)	82	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	82	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	82	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	82	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	82	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	82	_	_	_	_	_	_	_	O
8	(	_	(	_	(	82	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
10	)	_	)	_	)	82	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	82	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	82	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
14	)	_	)	_	)	82	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	83	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	83	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	83	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	83	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
7	,	_	,	_	,	83	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	83	_	_	_	_	_	_	_	O
9	dual	_	dual	_	JJ	83	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	83	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
14	another	_	another	_	DT	83	_	_	_	_	_	_	_	O
15	oral	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	83	_	_	_	_	_	_	_	O
17	(	_	(	_	(	83	_	_	_	_	_	_	_	O
18	see	_	see	_	VB	83	_	_	_	_	_	_	_	O
19	recommendation	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
20	)	_	)	_	)	83	_	_	_	_	_	_	_	O
21	has	_	have	_	VBZ	83	_	_	_	_	_	_	_	O
22	not	_	not	_	RB	83	_	_	_	_	_	_	_	O
23	continued	_	continue	_	VBN	83	_	_	_	_	_	_	_	O
24	to	_	to	_	TO	83	_	_	_	_	_	_	_	O
25	control	_	control	_	VB	83	_	_	_	_	_	_	_	O
26	hba1c	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	83	_	_	_	_	_	_	_	O
28	below	_	below	_	VB	83	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	83	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	83	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	83	_	_	_	_	_	_	_	O
32	individually	_	UNK	_	RB	83	_	_	_	_	_	_	_	O
33	agreed	_	agree	_	VBN	83	_	_	_	_	_	_	_	O
34	threshold	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	83	_	_	_	_	_	_	_	O
36	intensification	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
37	,	_	,	_	,	83	_	_	_	_	_	_	_	O
38	consider	_	consider	_	VB	83	_	_	_	_	_	_	_	O
39	either	_	either	_	DT	83	_	_	_	_	_	_	_	O
40	:	_	:	_	:	83	_	_	_	_	_	_	_	O
41	triple	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
42	therapy	_	therapy	_	NN	83	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
44	:	_	:	_	:	83	_	_	_	_	_	_	_	O
45	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
46	,	_	,	_	,	83	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	83	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
55	,	_	,	_	,	83	_	_	_	_	_	_	_	O
56	pioglitazone	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	83	_	_	_	_	_	_	_	O
61	starting	_	start	_	VBG	83	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
63	treatment	_	treatment	_	NN	83	_	_	_	_	_	_	_	O
64	(	_	(	_	(	83	_	_	_	_	_	_	_	O
65	see	_	see	_	VB	83	_	_	_	_	_	_	_	O
66	recommendations	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
68	)	_	)	_	)	83	_	_	_	_	_	_	_	O
69	.	_	.	_	.	83	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	83	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	83	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	83	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	83	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	83	_	_	_	_	_	_	_	I-Category
7	,	_	,	_	,	83	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	83	_	_	_	_	_	_	_	O
9	dual	_	dual	_	JJ	83	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	83	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
14	another	_	another	_	DT	83	_	_	_	_	_	_	_	O
15	oral	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	83	_	_	_	_	_	_	_	O
17	(	_	(	_	(	83	_	_	_	_	_	_	_	O
18	see	_	see	_	VB	83	_	_	_	_	_	_	_	O
19	recommendation	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
20	)	_	)	_	)	83	_	_	_	_	_	_	_	O
21	has	_	have	_	VBZ	83	_	_	_	_	_	_	_	O
22	not	_	not	_	RB	83	_	_	_	_	_	_	_	O
23	continued	_	continue	_	VBN	83	_	_	_	_	_	_	_	O
24	to	_	to	_	TO	83	_	_	_	_	_	_	_	O
25	control	_	control	_	VB	83	_	_	_	_	_	_	_	O
26	hba1c	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	83	_	_	_	_	_	_	_	O
28	below	_	below	_	VB	83	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	83	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	83	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	83	_	_	_	_	_	_	_	O
32	individually	_	UNK	_	RB	83	_	_	_	_	_	_	_	O
33	agreed	_	agree	_	VBN	83	_	_	_	_	_	_	_	O
34	threshold	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	83	_	_	_	_	_	_	_	O
36	intensification	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
37	,	_	,	_	,	83	_	_	_	_	_	_	_	O
38	consider	_	consider	_	VB	83	_	_	_	_	_	_	_	O
39	either	_	either	_	DT	83	_	_	_	_	_	_	_	O
40	:	_	:	_	:	83	_	_	_	_	_	_	_	O
41	triple	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
42	therapy	_	therapy	_	NN	83	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
44	:	_	:	_	:	83	_	_	_	_	_	_	_	O
45	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
46	,	_	,	_	,	83	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	83	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
55	,	_	,	_	,	83	_	_	_	_	_	_	_	O
56	pioglitazone	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	83	_	_	_	_	_	_	_	O
61	starting	_	start	_	VBG	83	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
63	treatment	_	treatment	_	NN	83	_	_	_	_	_	_	_	O
64	(	_	(	_	(	83	_	_	_	_	_	_	_	O
65	see	_	see	_	VB	83	_	_	_	_	_	_	_	O
66	recommendations	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
68	)	_	)	_	)	83	_	_	_	_	_	_	_	O
69	.	_	.	_	.	83	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	83	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	83	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	83	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	83	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
7	,	_	,	_	,	83	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	83	_	_	_	_	_	_	_	O
9	dual	_	dual	_	JJ	83	_	_	_	_	_	dual.a	Cardinal_numbers	S-Number
10	therapy	_	therapy	_	NN	83	_	_	_	_	_	_	_	S-Entity
11	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
14	another	_	another	_	DT	83	_	_	_	_	_	_	_	O
15	oral	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	83	_	_	_	_	_	_	_	O
17	(	_	(	_	(	83	_	_	_	_	_	_	_	O
18	see	_	see	_	VB	83	_	_	_	_	_	_	_	O
19	recommendation	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
20	)	_	)	_	)	83	_	_	_	_	_	_	_	O
21	has	_	have	_	VBZ	83	_	_	_	_	_	_	_	O
22	not	_	not	_	RB	83	_	_	_	_	_	_	_	O
23	continued	_	continue	_	VBN	83	_	_	_	_	_	_	_	O
24	to	_	to	_	TO	83	_	_	_	_	_	_	_	O
25	control	_	control	_	VB	83	_	_	_	_	_	_	_	O
26	hba1c	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	83	_	_	_	_	_	_	_	O
28	below	_	below	_	VB	83	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	83	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	83	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	83	_	_	_	_	_	_	_	O
32	individually	_	UNK	_	RB	83	_	_	_	_	_	_	_	O
33	agreed	_	agree	_	VBN	83	_	_	_	_	_	_	_	O
34	threshold	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	83	_	_	_	_	_	_	_	O
36	intensification	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
37	,	_	,	_	,	83	_	_	_	_	_	_	_	O
38	consider	_	consider	_	VB	83	_	_	_	_	_	_	_	O
39	either	_	either	_	DT	83	_	_	_	_	_	_	_	O
40	:	_	:	_	:	83	_	_	_	_	_	_	_	O
41	triple	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
42	therapy	_	therapy	_	NN	83	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
44	:	_	:	_	:	83	_	_	_	_	_	_	_	O
45	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
46	,	_	,	_	,	83	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	83	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
55	,	_	,	_	,	83	_	_	_	_	_	_	_	O
56	pioglitazone	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	83	_	_	_	_	_	_	_	O
61	starting	_	start	_	VBG	83	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
63	treatment	_	treatment	_	NN	83	_	_	_	_	_	_	_	O
64	(	_	(	_	(	83	_	_	_	_	_	_	_	O
65	see	_	see	_	VB	83	_	_	_	_	_	_	_	O
66	recommendations	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
68	)	_	)	_	)	83	_	_	_	_	_	_	_	O
69	.	_	.	_	.	83	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	83	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	83	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	83	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	83	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
7	,	_	,	_	,	83	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	83	_	_	_	_	_	_	_	O
9	dual	_	dual	_	JJ	83	_	_	_	_	_	_	_	S-Type
10	therapy	_	therapy	_	NN	83	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
11	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
14	another	_	another	_	DT	83	_	_	_	_	_	_	_	O
15	oral	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	83	_	_	_	_	_	_	_	O
17	(	_	(	_	(	83	_	_	_	_	_	_	_	O
18	see	_	see	_	VB	83	_	_	_	_	_	_	_	O
19	recommendation	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
20	)	_	)	_	)	83	_	_	_	_	_	_	_	O
21	has	_	have	_	VBZ	83	_	_	_	_	_	_	_	O
22	not	_	not	_	RB	83	_	_	_	_	_	_	_	O
23	continued	_	continue	_	VBN	83	_	_	_	_	_	_	_	O
24	to	_	to	_	TO	83	_	_	_	_	_	_	_	O
25	control	_	control	_	VB	83	_	_	_	_	_	_	_	O
26	hba1c	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	83	_	_	_	_	_	_	_	O
28	below	_	below	_	VB	83	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	83	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	83	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	83	_	_	_	_	_	_	_	O
32	individually	_	UNK	_	RB	83	_	_	_	_	_	_	_	O
33	agreed	_	agree	_	VBN	83	_	_	_	_	_	_	_	O
34	threshold	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	83	_	_	_	_	_	_	_	O
36	intensification	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
37	,	_	,	_	,	83	_	_	_	_	_	_	_	O
38	consider	_	consider	_	VB	83	_	_	_	_	_	_	_	O
39	either	_	either	_	DT	83	_	_	_	_	_	_	_	O
40	:	_	:	_	:	83	_	_	_	_	_	_	_	O
41	triple	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
42	therapy	_	therapy	_	NN	83	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
44	:	_	:	_	:	83	_	_	_	_	_	_	_	O
45	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
46	,	_	,	_	,	83	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	83	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
55	,	_	,	_	,	83	_	_	_	_	_	_	_	O
56	pioglitazone	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	83	_	_	_	_	_	_	_	O
61	starting	_	start	_	VBG	83	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
63	treatment	_	treatment	_	NN	83	_	_	_	_	_	_	_	O
64	(	_	(	_	(	83	_	_	_	_	_	_	_	O
65	see	_	see	_	VB	83	_	_	_	_	_	_	_	O
66	recommendations	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
68	)	_	)	_	)	83	_	_	_	_	_	_	_	O
69	.	_	.	_	.	83	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	83	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	83	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	83	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	83	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
7	,	_	,	_	,	83	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	83	_	_	_	_	_	_	_	O
9	dual	_	dual	_	JJ	83	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	83	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
14	another	_	another	_	DT	83	_	_	_	_	_	another.n	Increment	O
15	oral	_	UNK	_	JJ	83	_	_	_	_	_	_	_	B-Class
16	drug	_	drug	_	NN	83	_	_	_	_	_	_	_	I-Class
17	(	_	(	_	(	83	_	_	_	_	_	_	_	O
18	see	_	see	_	VB	83	_	_	_	_	_	_	_	O
19	recommendation	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
20	)	_	)	_	)	83	_	_	_	_	_	_	_	O
21	has	_	have	_	VBZ	83	_	_	_	_	_	_	_	O
22	not	_	not	_	RB	83	_	_	_	_	_	_	_	O
23	continued	_	continue	_	VBN	83	_	_	_	_	_	_	_	O
24	to	_	to	_	TO	83	_	_	_	_	_	_	_	O
25	control	_	control	_	VB	83	_	_	_	_	_	_	_	O
26	hba1c	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	83	_	_	_	_	_	_	_	O
28	below	_	below	_	VB	83	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	83	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	83	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	83	_	_	_	_	_	_	_	O
32	individually	_	UNK	_	RB	83	_	_	_	_	_	_	_	O
33	agreed	_	agree	_	VBN	83	_	_	_	_	_	_	_	O
34	threshold	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	83	_	_	_	_	_	_	_	O
36	intensification	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
37	,	_	,	_	,	83	_	_	_	_	_	_	_	O
38	consider	_	consider	_	VB	83	_	_	_	_	_	_	_	O
39	either	_	either	_	DT	83	_	_	_	_	_	_	_	O
40	:	_	:	_	:	83	_	_	_	_	_	_	_	O
41	triple	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
42	therapy	_	therapy	_	NN	83	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
44	:	_	:	_	:	83	_	_	_	_	_	_	_	O
45	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
46	,	_	,	_	,	83	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	83	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
55	,	_	,	_	,	83	_	_	_	_	_	_	_	O
56	pioglitazone	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	83	_	_	_	_	_	_	_	O
61	starting	_	start	_	VBG	83	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
63	treatment	_	treatment	_	NN	83	_	_	_	_	_	_	_	O
64	(	_	(	_	(	83	_	_	_	_	_	_	_	O
65	see	_	see	_	VB	83	_	_	_	_	_	_	_	O
66	recommendations	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
68	)	_	)	_	)	83	_	_	_	_	_	_	_	O
69	.	_	.	_	.	83	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	83	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	83	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	83	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	83	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
7	,	_	,	_	,	83	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	83	_	_	_	_	_	_	_	O
9	dual	_	dual	_	JJ	83	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	83	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
14	another	_	another	_	DT	83	_	_	_	_	_	_	_	O
15	oral	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	83	_	_	_	_	_	_	_	O
17	(	_	(	_	(	83	_	_	_	_	_	_	_	O
18	see	_	see	_	VB	83	_	_	_	_	_	_	_	O
19	recommendation	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
20	)	_	)	_	)	83	_	_	_	_	_	_	_	O
21	has	_	have	_	VBZ	83	_	_	_	_	_	_	_	O
22	not	_	not	_	RB	83	_	_	_	_	_	_	_	O
23	continued	_	continue	_	VBN	83	_	_	_	_	_	continue.v	Activity_ongoing	O
24	to	_	to	_	TO	83	_	_	_	_	_	_	_	B-Activity
25	control	_	control	_	VB	83	_	_	_	_	_	_	_	I-Activity
26	hba1c	_	UNK	_	NNP	83	_	_	_	_	_	_	_	I-Activity
27	to	_	to	_	TO	83	_	_	_	_	_	_	_	I-Activity
28	below	_	below	_	VB	83	_	_	_	_	_	_	_	I-Activity
29	the	_	the	_	DT	83	_	_	_	_	_	_	_	I-Activity
30	person	_	person	_	NN	83	_	_	_	_	_	_	_	I-Activity
31	's	_	's	_	POS	83	_	_	_	_	_	_	_	I-Activity
32	individually	_	UNK	_	RB	83	_	_	_	_	_	_	_	I-Activity
33	agreed	_	agree	_	VBN	83	_	_	_	_	_	_	_	I-Activity
34	threshold	_	UNK	_	NN	83	_	_	_	_	_	_	_	I-Activity
35	for	_	for	_	IN	83	_	_	_	_	_	_	_	I-Activity
36	intensification	_	UNK	_	NN	83	_	_	_	_	_	_	_	I-Activity
37	,	_	,	_	,	83	_	_	_	_	_	_	_	O
38	consider	_	consider	_	VB	83	_	_	_	_	_	_	_	O
39	either	_	either	_	DT	83	_	_	_	_	_	_	_	O
40	:	_	:	_	:	83	_	_	_	_	_	_	_	O
41	triple	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
42	therapy	_	therapy	_	NN	83	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
44	:	_	:	_	:	83	_	_	_	_	_	_	_	O
45	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
46	,	_	,	_	,	83	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	83	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
55	,	_	,	_	,	83	_	_	_	_	_	_	_	O
56	pioglitazone	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	83	_	_	_	_	_	_	_	O
61	starting	_	start	_	VBG	83	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
63	treatment	_	treatment	_	NN	83	_	_	_	_	_	_	_	O
64	(	_	(	_	(	83	_	_	_	_	_	_	_	O
65	see	_	see	_	VB	83	_	_	_	_	_	_	_	O
66	recommendations	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
68	)	_	)	_	)	83	_	_	_	_	_	_	_	O
69	.	_	.	_	.	83	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	83	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	83	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	83	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	83	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
7	,	_	,	_	,	83	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	83	_	_	_	_	_	_	_	O
9	dual	_	dual	_	JJ	83	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	83	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
14	another	_	another	_	DT	83	_	_	_	_	_	_	_	O
15	oral	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	83	_	_	_	_	_	_	_	O
17	(	_	(	_	(	83	_	_	_	_	_	_	_	O
18	see	_	see	_	VB	83	_	_	_	_	_	_	_	O
19	recommendation	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
20	)	_	)	_	)	83	_	_	_	_	_	_	_	O
21	has	_	have	_	VBZ	83	_	_	_	_	_	_	_	O
22	not	_	not	_	RB	83	_	_	_	_	_	_	_	O
23	continued	_	continue	_	VBN	83	_	_	_	_	_	_	_	O
24	to	_	to	_	TO	83	_	_	_	_	_	_	_	O
25	control	_	control	_	VB	83	_	_	_	_	_	control.v	Being_in_control	O
26	hba1c	_	UNK	_	NNP	83	_	_	_	_	_	_	_	S-Dependent_entity
27	to	_	to	_	TO	83	_	_	_	_	_	_	_	O
28	below	_	below	_	VB	83	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	83	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	83	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	83	_	_	_	_	_	_	_	O
32	individually	_	UNK	_	RB	83	_	_	_	_	_	_	_	O
33	agreed	_	agree	_	VBN	83	_	_	_	_	_	_	_	O
34	threshold	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	83	_	_	_	_	_	_	_	O
36	intensification	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
37	,	_	,	_	,	83	_	_	_	_	_	_	_	O
38	consider	_	consider	_	VB	83	_	_	_	_	_	_	_	O
39	either	_	either	_	DT	83	_	_	_	_	_	_	_	O
40	:	_	:	_	:	83	_	_	_	_	_	_	_	O
41	triple	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
42	therapy	_	therapy	_	NN	83	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
44	:	_	:	_	:	83	_	_	_	_	_	_	_	O
45	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
46	,	_	,	_	,	83	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	83	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
55	,	_	,	_	,	83	_	_	_	_	_	_	_	O
56	pioglitazone	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	83	_	_	_	_	_	_	_	O
61	starting	_	start	_	VBG	83	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
63	treatment	_	treatment	_	NN	83	_	_	_	_	_	_	_	O
64	(	_	(	_	(	83	_	_	_	_	_	_	_	O
65	see	_	see	_	VB	83	_	_	_	_	_	_	_	O
66	recommendations	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
68	)	_	)	_	)	83	_	_	_	_	_	_	_	O
69	.	_	.	_	.	83	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	83	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	83	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	83	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	83	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
7	,	_	,	_	,	83	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	83	_	_	_	_	_	_	_	O
9	dual	_	dual	_	JJ	83	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	83	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
14	another	_	another	_	DT	83	_	_	_	_	_	_	_	O
15	oral	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	83	_	_	_	_	_	_	_	O
17	(	_	(	_	(	83	_	_	_	_	_	_	_	O
18	see	_	see	_	VB	83	_	_	_	_	_	_	_	O
19	recommendation	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
20	)	_	)	_	)	83	_	_	_	_	_	_	_	O
21	has	_	have	_	VBZ	83	_	_	_	_	_	_	_	O
22	not	_	not	_	RB	83	_	_	_	_	_	_	_	O
23	continued	_	continue	_	VBN	83	_	_	_	_	_	_	_	O
24	to	_	to	_	TO	83	_	_	_	_	_	_	_	O
25	control	_	control	_	VB	83	_	_	_	_	_	_	_	O
26	hba1c	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	83	_	_	_	_	_	_	_	O
28	below	_	below	_	VB	83	_	_	_	_	_	below.prep	Directional_locative_relation	O
29	the	_	the	_	DT	83	_	_	_	_	_	_	_	B-Ground
30	person	_	person	_	NN	83	_	_	_	_	_	_	_	I-Ground
31	's	_	's	_	POS	83	_	_	_	_	_	_	_	I-Ground
32	individually	_	UNK	_	RB	83	_	_	_	_	_	_	_	I-Ground
33	agreed	_	agree	_	VBN	83	_	_	_	_	_	_	_	I-Ground
34	threshold	_	UNK	_	NN	83	_	_	_	_	_	_	_	I-Ground
35	for	_	for	_	IN	83	_	_	_	_	_	_	_	I-Ground
36	intensification	_	UNK	_	NN	83	_	_	_	_	_	_	_	I-Ground
37	,	_	,	_	,	83	_	_	_	_	_	_	_	O
38	consider	_	consider	_	VB	83	_	_	_	_	_	_	_	O
39	either	_	either	_	DT	83	_	_	_	_	_	_	_	O
40	:	_	:	_	:	83	_	_	_	_	_	_	_	O
41	triple	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
42	therapy	_	therapy	_	NN	83	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
44	:	_	:	_	:	83	_	_	_	_	_	_	_	O
45	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
46	,	_	,	_	,	83	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	83	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
55	,	_	,	_	,	83	_	_	_	_	_	_	_	O
56	pioglitazone	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	83	_	_	_	_	_	_	_	O
61	starting	_	start	_	VBG	83	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
63	treatment	_	treatment	_	NN	83	_	_	_	_	_	_	_	O
64	(	_	(	_	(	83	_	_	_	_	_	_	_	O
65	see	_	see	_	VB	83	_	_	_	_	_	_	_	O
66	recommendations	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
68	)	_	)	_	)	83	_	_	_	_	_	_	_	O
69	.	_	.	_	.	83	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	83	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	83	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	83	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	83	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
7	,	_	,	_	,	83	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	83	_	_	_	_	_	_	_	O
9	dual	_	dual	_	JJ	83	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	83	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
14	another	_	another	_	DT	83	_	_	_	_	_	_	_	O
15	oral	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	83	_	_	_	_	_	_	_	O
17	(	_	(	_	(	83	_	_	_	_	_	_	_	O
18	see	_	see	_	VB	83	_	_	_	_	_	_	_	O
19	recommendation	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
20	)	_	)	_	)	83	_	_	_	_	_	_	_	O
21	has	_	have	_	VBZ	83	_	_	_	_	_	_	_	O
22	not	_	not	_	RB	83	_	_	_	_	_	_	_	O
23	continued	_	continue	_	VBN	83	_	_	_	_	_	_	_	O
24	to	_	to	_	TO	83	_	_	_	_	_	_	_	O
25	control	_	control	_	VB	83	_	_	_	_	_	_	_	O
26	hba1c	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	83	_	_	_	_	_	_	_	O
28	below	_	below	_	VB	83	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	83	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	83	_	_	_	_	_	person.n	People	S-Person
31	's	_	's	_	POS	83	_	_	_	_	_	_	_	O
32	individually	_	UNK	_	RB	83	_	_	_	_	_	_	_	O
33	agreed	_	agree	_	VBN	83	_	_	_	_	_	_	_	O
34	threshold	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	83	_	_	_	_	_	_	_	O
36	intensification	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
37	,	_	,	_	,	83	_	_	_	_	_	_	_	O
38	consider	_	consider	_	VB	83	_	_	_	_	_	_	_	O
39	either	_	either	_	DT	83	_	_	_	_	_	_	_	O
40	:	_	:	_	:	83	_	_	_	_	_	_	_	O
41	triple	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
42	therapy	_	therapy	_	NN	83	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
44	:	_	:	_	:	83	_	_	_	_	_	_	_	O
45	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
46	,	_	,	_	,	83	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	83	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
55	,	_	,	_	,	83	_	_	_	_	_	_	_	O
56	pioglitazone	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	83	_	_	_	_	_	_	_	O
61	starting	_	start	_	VBG	83	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
63	treatment	_	treatment	_	NN	83	_	_	_	_	_	_	_	O
64	(	_	(	_	(	83	_	_	_	_	_	_	_	O
65	see	_	see	_	VB	83	_	_	_	_	_	_	_	O
66	recommendations	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
68	)	_	)	_	)	83	_	_	_	_	_	_	_	O
69	.	_	.	_	.	83	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	83	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	83	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	83	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	83	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
7	,	_	,	_	,	83	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	83	_	_	_	_	_	_	_	O
9	dual	_	dual	_	JJ	83	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	83	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
14	another	_	another	_	DT	83	_	_	_	_	_	_	_	O
15	oral	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	83	_	_	_	_	_	_	_	O
17	(	_	(	_	(	83	_	_	_	_	_	_	_	O
18	see	_	see	_	VB	83	_	_	_	_	_	_	_	O
19	recommendation	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
20	)	_	)	_	)	83	_	_	_	_	_	_	_	O
21	has	_	have	_	VBZ	83	_	_	_	_	_	_	_	O
22	not	_	not	_	RB	83	_	_	_	_	_	_	_	O
23	continued	_	continue	_	VBN	83	_	_	_	_	_	_	_	O
24	to	_	to	_	TO	83	_	_	_	_	_	_	_	O
25	control	_	control	_	VB	83	_	_	_	_	_	_	_	O
26	hba1c	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	83	_	_	_	_	_	_	_	O
28	below	_	below	_	VB	83	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	83	_	_	_	_	_	_	_	B-Party_1
30	person	_	person	_	NN	83	_	_	_	_	_	_	_	I-Party_1
31	's	_	's	_	POS	83	_	_	_	_	_	_	_	I-Party_1
32	individually	_	UNK	_	RB	83	_	_	_	_	_	_	_	S-Parties
33	agreed	_	agree	_	VBN	83	_	_	_	_	_	agree.v	Make_agreement_on_action	O
34	threshold	_	UNK	_	NN	83	_	_	_	_	_	_	_	B-Obligation
35	for	_	for	_	IN	83	_	_	_	_	_	_	_	I-Obligation
36	intensification	_	UNK	_	NN	83	_	_	_	_	_	_	_	I-Obligation
37	,	_	,	_	,	83	_	_	_	_	_	_	_	O
38	consider	_	consider	_	VB	83	_	_	_	_	_	_	_	O
39	either	_	either	_	DT	83	_	_	_	_	_	_	_	O
40	:	_	:	_	:	83	_	_	_	_	_	_	_	O
41	triple	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
42	therapy	_	therapy	_	NN	83	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
44	:	_	:	_	:	83	_	_	_	_	_	_	_	O
45	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
46	,	_	,	_	,	83	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	83	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
55	,	_	,	_	,	83	_	_	_	_	_	_	_	O
56	pioglitazone	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	83	_	_	_	_	_	_	_	O
61	starting	_	start	_	VBG	83	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
63	treatment	_	treatment	_	NN	83	_	_	_	_	_	_	_	O
64	(	_	(	_	(	83	_	_	_	_	_	_	_	O
65	see	_	see	_	VB	83	_	_	_	_	_	_	_	O
66	recommendations	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
68	)	_	)	_	)	83	_	_	_	_	_	_	_	O
69	.	_	.	_	.	83	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	83	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	83	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	83	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	83	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
7	,	_	,	_	,	83	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	83	_	_	_	_	_	_	_	O
9	dual	_	dual	_	JJ	83	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	83	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
14	another	_	another	_	DT	83	_	_	_	_	_	_	_	O
15	oral	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	83	_	_	_	_	_	_	_	O
17	(	_	(	_	(	83	_	_	_	_	_	_	_	O
18	see	_	see	_	VB	83	_	_	_	_	_	_	_	O
19	recommendation	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
20	)	_	)	_	)	83	_	_	_	_	_	_	_	O
21	has	_	have	_	VBZ	83	_	_	_	_	_	_	_	O
22	not	_	not	_	RB	83	_	_	_	_	_	_	_	O
23	continued	_	continue	_	VBN	83	_	_	_	_	_	_	_	O
24	to	_	to	_	TO	83	_	_	_	_	_	_	_	O
25	control	_	control	_	VB	83	_	_	_	_	_	_	_	O
26	hba1c	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	83	_	_	_	_	_	_	_	O
28	below	_	below	_	VB	83	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	83	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	83	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	83	_	_	_	_	_	_	_	O
32	individually	_	UNK	_	RB	83	_	_	_	_	_	_	_	O
33	agreed	_	agree	_	VBN	83	_	_	_	_	_	_	_	O
34	threshold	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	83	_	_	_	_	_	_	_	O
36	intensification	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
37	,	_	,	_	,	83	_	_	_	_	_	_	_	O
38	consider	_	consider	_	VB	83	_	_	_	_	_	consider.v	Categorization	O
39	either	_	either	_	DT	83	_	_	_	_	_	_	_	S-Category
40	:	_	:	_	:	83	_	_	_	_	_	_	_	O
41	triple	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
42	therapy	_	therapy	_	NN	83	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
44	:	_	:	_	:	83	_	_	_	_	_	_	_	O
45	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
46	,	_	,	_	,	83	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	83	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
55	,	_	,	_	,	83	_	_	_	_	_	_	_	O
56	pioglitazone	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	83	_	_	_	_	_	_	_	O
61	starting	_	start	_	VBG	83	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
63	treatment	_	treatment	_	NN	83	_	_	_	_	_	_	_	O
64	(	_	(	_	(	83	_	_	_	_	_	_	_	O
65	see	_	see	_	VB	83	_	_	_	_	_	_	_	O
66	recommendations	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
68	)	_	)	_	)	83	_	_	_	_	_	_	_	O
69	.	_	.	_	.	83	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	83	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	83	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	83	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	83	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
7	,	_	,	_	,	83	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	83	_	_	_	_	_	_	_	O
9	dual	_	dual	_	JJ	83	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	83	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
14	another	_	another	_	DT	83	_	_	_	_	_	_	_	O
15	oral	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	83	_	_	_	_	_	_	_	O
17	(	_	(	_	(	83	_	_	_	_	_	_	_	O
18	see	_	see	_	VB	83	_	_	_	_	_	_	_	O
19	recommendation	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
20	)	_	)	_	)	83	_	_	_	_	_	_	_	O
21	has	_	have	_	VBZ	83	_	_	_	_	_	_	_	O
22	not	_	not	_	RB	83	_	_	_	_	_	_	_	O
23	continued	_	continue	_	VBN	83	_	_	_	_	_	_	_	O
24	to	_	to	_	TO	83	_	_	_	_	_	_	_	O
25	control	_	control	_	VB	83	_	_	_	_	_	_	_	O
26	hba1c	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	83	_	_	_	_	_	_	_	O
28	below	_	below	_	VB	83	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	83	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	83	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	83	_	_	_	_	_	_	_	O
32	individually	_	UNK	_	RB	83	_	_	_	_	_	_	_	O
33	agreed	_	agree	_	VBN	83	_	_	_	_	_	_	_	O
34	threshold	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	83	_	_	_	_	_	_	_	O
36	intensification	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
37	,	_	,	_	,	83	_	_	_	_	_	_	_	O
38	consider	_	consider	_	VB	83	_	_	_	_	_	_	_	O
39	either	_	either	_	DT	83	_	_	_	_	_	_	_	O
40	:	_	:	_	:	83	_	_	_	_	_	_	_	O
41	triple	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
42	therapy	_	therapy	_	NN	83	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
43	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
44	:	_	:	_	:	83	_	_	_	_	_	_	_	O
45	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
46	,	_	,	_	,	83	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	83	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
55	,	_	,	_	,	83	_	_	_	_	_	_	_	O
56	pioglitazone	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	83	_	_	_	_	_	_	_	O
61	starting	_	start	_	VBG	83	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
63	treatment	_	treatment	_	NN	83	_	_	_	_	_	_	_	O
64	(	_	(	_	(	83	_	_	_	_	_	_	_	O
65	see	_	see	_	VB	83	_	_	_	_	_	_	_	O
66	recommendations	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
68	)	_	)	_	)	83	_	_	_	_	_	_	_	O
69	.	_	.	_	.	83	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	83	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	83	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	83	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	83	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
7	,	_	,	_	,	83	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	83	_	_	_	_	_	_	_	O
9	dual	_	dual	_	JJ	83	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	83	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
14	another	_	another	_	DT	83	_	_	_	_	_	_	_	O
15	oral	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	83	_	_	_	_	_	_	_	O
17	(	_	(	_	(	83	_	_	_	_	_	_	_	O
18	see	_	see	_	VB	83	_	_	_	_	_	_	_	O
19	recommendation	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
20	)	_	)	_	)	83	_	_	_	_	_	_	_	O
21	has	_	have	_	VBZ	83	_	_	_	_	_	_	_	O
22	not	_	not	_	RB	83	_	_	_	_	_	_	_	O
23	continued	_	continue	_	VBN	83	_	_	_	_	_	_	_	O
24	to	_	to	_	TO	83	_	_	_	_	_	_	_	O
25	control	_	control	_	VB	83	_	_	_	_	_	_	_	O
26	hba1c	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	83	_	_	_	_	_	_	_	O
28	below	_	below	_	VB	83	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	83	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	83	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	83	_	_	_	_	_	_	_	O
32	individually	_	UNK	_	RB	83	_	_	_	_	_	_	_	O
33	agreed	_	agree	_	VBN	83	_	_	_	_	_	_	_	O
34	threshold	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	83	_	_	_	_	_	_	_	O
36	intensification	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
37	,	_	,	_	,	83	_	_	_	_	_	_	_	O
38	consider	_	consider	_	VB	83	_	_	_	_	_	_	_	O
39	either	_	either	_	DT	83	_	_	_	_	_	_	_	O
40	:	_	:	_	:	83	_	_	_	_	_	_	_	O
41	triple	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
42	therapy	_	therapy	_	NN	83	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
44	:	_	:	_	:	83	_	_	_	_	_	_	_	O
45	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
46	,	_	,	_	,	83	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	83	_	_	_	_	_	_	_	B-Agent
48	dpp-4	_	UNK	_	NNP	83	_	_	_	_	_	_	_	I-Agent
49	inhibitor	_	UNK	_	NN	83	_	_	_	_	_	_	_	I-Agent
50	and	_	and	_	CC	83	_	_	_	_	_	_	_	I-Agent
51	a	_	a	_	DT	83	_	_	_	_	_	_	_	I-Agent
52	sulfonylurea	_	UNK	_	NN	83	_	_	_	_	_	_	_	I-Agent
53	or	_	or	_	CC	83	_	_	_	_	_	_	_	I-Agent
54	metformin	_	UNK	_	NN	83	_	_	_	_	_	_	_	I-Agent
55	,	_	,	_	,	83	_	_	_	_	_	_	_	O
56	pioglitazone	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	83	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	83	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	83	_	_	_	_	_	_	_	O
61	starting	_	start	_	VBG	83	_	_	_	_	_	start.v	Activity_start	O
62	unk	_	UNK	_	JJ	83	_	_	_	_	_	_	_	B-Activity
63	treatment	_	treatment	_	NN	83	_	_	_	_	_	_	_	I-Activity
64	(	_	(	_	(	83	_	_	_	_	_	_	_	O
65	see	_	see	_	VB	83	_	_	_	_	_	_	_	O
66	recommendations	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
68	)	_	)	_	)	83	_	_	_	_	_	_	_	O
69	.	_	.	_	.	83	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	84	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	84	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
4	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	84	_	_	_	_	_	_	_	O
11	(	_	(	_	(	84	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	84	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
14	)	_	)	_	)	84	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	84	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	84	_	_	_	_	_	_	_	O
18	,	_	,	_	,	84	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
23	,	_	,	_	,	84	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	84	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	84	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
29	,	_	,	_	,	84	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
36	(	_	(	_	(	84	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
38	)	_	)	_	)	84	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	84	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	84	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	84	_	_	_	_	_	_	_	O
47	:	_	:	_	:	84	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	84	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	84	_	_	_	_	_	_	_	O
56	(	_	(	_	(	84	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	84	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	84	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	84	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	84	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	84	_	_	_	_	_	_	_	O
63	,	_	,	_	,	84	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	84	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	84	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	84	_	_	_	_	_	_	_	O
70	)	_	)	_	)	84	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	84	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	84	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	84	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	84	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	84	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	84	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	84	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	84	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
89	:	_	:	_	:	84	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	84	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	84	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	84	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	84	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	84	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
108	.	_	.	_	.	84	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	84	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	84	_	_	_	_	_	other.a	Increment	O
9	oral	_	UNK	_	JJ	84	_	_	_	_	_	_	_	B-Class
10	drugs	_	drug	_	NNS	84	_	_	_	_	_	_	_	I-Class
11	(	_	(	_	(	84	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	84	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
14	)	_	)	_	)	84	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	84	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	84	_	_	_	_	_	_	_	O
18	,	_	,	_	,	84	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
23	,	_	,	_	,	84	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	84	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	84	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
29	,	_	,	_	,	84	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
36	(	_	(	_	(	84	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
38	)	_	)	_	)	84	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	84	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	84	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	84	_	_	_	_	_	_	_	O
47	:	_	:	_	:	84	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	84	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	84	_	_	_	_	_	_	_	O
56	(	_	(	_	(	84	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	84	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	84	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	84	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	84	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	84	_	_	_	_	_	_	_	O
63	,	_	,	_	,	84	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	84	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	84	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	84	_	_	_	_	_	_	_	O
70	)	_	)	_	)	84	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	84	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	84	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	84	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	84	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	84	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	84	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	84	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	84	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
89	:	_	:	_	:	84	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	84	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	84	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	84	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	84	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	84	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
108	.	_	.	_	.	84	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	84	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	84	_	_	_	_	_	_	_	S-Descriptor
10	drugs	_	drug	_	NNS	84	_	_	_	_	_	drug.n	Intoxicants	S-Intoxicant
11	(	_	(	_	(	84	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	84	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
14	)	_	)	_	)	84	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	84	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	84	_	_	_	_	_	_	_	O
18	,	_	,	_	,	84	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
23	,	_	,	_	,	84	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	84	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	84	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
29	,	_	,	_	,	84	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
36	(	_	(	_	(	84	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
38	)	_	)	_	)	84	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	84	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	84	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	84	_	_	_	_	_	_	_	O
47	:	_	:	_	:	84	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	84	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	84	_	_	_	_	_	_	_	O
56	(	_	(	_	(	84	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	84	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	84	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	84	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	84	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	84	_	_	_	_	_	_	_	O
63	,	_	,	_	,	84	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	84	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	84	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	84	_	_	_	_	_	_	_	O
70	)	_	)	_	)	84	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	84	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	84	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	84	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	84	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	84	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	84	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	84	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	84	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
89	:	_	:	_	:	84	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	84	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	84	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	84	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	84	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	84	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
108	.	_	.	_	.	84	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	84	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	84	_	_	_	_	_	_	_	O
11	(	_	(	_	(	84	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	84	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	84	_	_	_	_	_	_	_	B-Entity
14	)	_	)	_	)	84	_	_	_	_	_	_	_	I-Entity
15	is	_	be	_	VBZ	84	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	84	_	_	_	_	_	effective.a	Usefulness	O
18	,	_	,	_	,	84	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
23	,	_	,	_	,	84	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	84	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	84	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
29	,	_	,	_	,	84	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
36	(	_	(	_	(	84	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
38	)	_	)	_	)	84	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	84	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	84	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	84	_	_	_	_	_	_	_	O
47	:	_	:	_	:	84	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	84	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	84	_	_	_	_	_	_	_	O
56	(	_	(	_	(	84	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	84	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	84	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	84	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	84	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	84	_	_	_	_	_	_	_	O
63	,	_	,	_	,	84	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	84	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	84	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	84	_	_	_	_	_	_	_	O
70	)	_	)	_	)	84	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	84	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	84	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	84	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	84	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	84	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	84	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	84	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	84	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
89	:	_	:	_	:	84	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	84	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	84	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	84	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	84	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	84	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
108	.	_	.	_	.	84	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	84	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	84	_	_	_	_	_	_	_	O
11	(	_	(	_	(	84	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	84	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
14	)	_	)	_	)	84	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	84	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	84	_	_	_	_	_	_	_	O
18	,	_	,	_	,	84	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
23	,	_	,	_	,	84	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	84	_	_	_	_	_	consider.v	Categorization	O
25	combination	_	combination	_	NN	84	_	_	_	_	_	_	_	B-Category
26	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	I-Category
27	with	_	with	_	IN	84	_	_	_	_	_	_	_	I-Category
28	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	I-Category
29	,	_	,	_	,	84	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
36	(	_	(	_	(	84	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
38	)	_	)	_	)	84	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	84	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	84	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	84	_	_	_	_	_	_	_	O
47	:	_	:	_	:	84	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	84	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	84	_	_	_	_	_	_	_	O
56	(	_	(	_	(	84	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	84	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	84	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	84	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	84	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	84	_	_	_	_	_	_	_	O
63	,	_	,	_	,	84	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	84	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	84	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	84	_	_	_	_	_	_	_	O
70	)	_	)	_	)	84	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	84	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	84	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	84	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	84	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	84	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	84	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	84	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	84	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
89	:	_	:	_	:	84	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	84	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	84	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	84	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	84	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	84	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
108	.	_	.	_	.	84	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	84	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	84	_	_	_	_	_	_	_	O
11	(	_	(	_	(	84	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	84	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
14	)	_	)	_	)	84	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	84	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	84	_	_	_	_	_	_	_	O
18	,	_	,	_	,	84	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
23	,	_	,	_	,	84	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	84	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	84	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	84	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
27	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
29	,	_	,	_	,	84	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
36	(	_	(	_	(	84	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
38	)	_	)	_	)	84	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	84	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	84	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	84	_	_	_	_	_	_	_	O
47	:	_	:	_	:	84	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	84	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	84	_	_	_	_	_	_	_	O
56	(	_	(	_	(	84	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	84	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	84	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	84	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	84	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	84	_	_	_	_	_	_	_	O
63	,	_	,	_	,	84	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	84	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	84	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	84	_	_	_	_	_	_	_	O
70	)	_	)	_	)	84	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	84	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	84	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	84	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	84	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	84	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	84	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	84	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	84	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
89	:	_	:	_	:	84	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	84	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	84	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	84	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	84	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	84	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
108	.	_	.	_	.	84	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	84	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	84	_	_	_	_	_	_	_	O
11	(	_	(	_	(	84	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	84	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
14	)	_	)	_	)	84	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	84	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	84	_	_	_	_	_	_	_	O
18	,	_	,	_	,	84	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
23	,	_	,	_	,	84	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	84	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	84	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
29	,	_	,	_	,	84	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
36	(	_	(	_	(	84	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
38	)	_	)	_	)	84	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	84	_	_	_	_	_	adult.n	People_by_age	S-Person
42	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	84	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	84	_	_	_	_	_	_	_	O
47	:	_	:	_	:	84	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	84	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	84	_	_	_	_	_	_	_	O
56	(	_	(	_	(	84	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	84	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	84	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	84	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	84	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	84	_	_	_	_	_	_	_	O
63	,	_	,	_	,	84	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	84	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	84	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	84	_	_	_	_	_	_	_	O
70	)	_	)	_	)	84	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	84	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	84	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	84	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	84	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	84	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	84	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	84	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	84	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
89	:	_	:	_	:	84	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	84	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	84	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	84	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	84	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	84	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
108	.	_	.	_	.	84	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	84	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	84	_	_	_	_	_	_	_	O
11	(	_	(	_	(	84	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	84	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
14	)	_	)	_	)	84	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	84	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	84	_	_	_	_	_	_	_	O
18	,	_	,	_	,	84	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
23	,	_	,	_	,	84	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	84	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	84	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
29	,	_	,	_	,	84	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
36	(	_	(	_	(	84	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
38	)	_	)	_	)	84	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	84	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	84	_	_	_	_	_	type.n	Type	S-Subtype
44	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	84	_	_	_	_	_	_	_	O
47	:	_	:	_	:	84	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	84	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	84	_	_	_	_	_	_	_	O
56	(	_	(	_	(	84	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	84	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	84	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	84	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	84	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	84	_	_	_	_	_	_	_	O
63	,	_	,	_	,	84	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	84	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	84	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	84	_	_	_	_	_	_	_	O
70	)	_	)	_	)	84	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	84	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	84	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	84	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	84	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	84	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	84	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	84	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	84	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
89	:	_	:	_	:	84	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	84	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	84	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	84	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	84	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	84	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
108	.	_	.	_	.	84	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	84	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	84	_	_	_	_	_	_	_	O
11	(	_	(	_	(	84	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	84	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
14	)	_	)	_	)	84	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	84	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	84	_	_	_	_	_	_	_	O
18	,	_	,	_	,	84	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
23	,	_	,	_	,	84	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	84	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	84	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
29	,	_	,	_	,	84	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
36	(	_	(	_	(	84	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
38	)	_	)	_	)	84	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	84	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	84	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	84	_	_	_	_	_	_	_	O
47	:	_	:	_	:	84	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	84	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	84	_	_	_	_	_	_	_	O
56	(	_	(	_	(	84	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	84	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	84	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	84	_	_	_	_	_	people.n	People	S-Person
61	from	_	from	_	IN	84	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	84	_	_	_	_	_	_	_	O
63	,	_	,	_	,	84	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	84	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	84	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	84	_	_	_	_	_	_	_	O
70	)	_	)	_	)	84	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	84	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	84	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	84	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	84	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	84	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	84	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	84	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	84	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
89	:	_	:	_	:	84	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	84	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	84	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	84	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	84	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	84	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
108	.	_	.	_	.	84	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	84	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	84	_	_	_	_	_	_	_	O
11	(	_	(	_	(	84	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	84	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
14	)	_	)	_	)	84	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	84	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	84	_	_	_	_	_	_	_	O
18	,	_	,	_	,	84	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
23	,	_	,	_	,	84	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	84	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	84	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
29	,	_	,	_	,	84	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
36	(	_	(	_	(	84	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
38	)	_	)	_	)	84	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	84	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	84	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	84	_	_	_	_	_	_	_	O
47	:	_	:	_	:	84	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	84	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	84	_	_	_	_	_	_	_	O
56	(	_	(	_	(	84	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	84	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	84	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	84	_	_	_	_	_	_	_	S-Entity
61	from	_	from	_	IN	84	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	84	_	_	_	_	_	black.a	Color	S-Color
63	,	_	,	_	,	84	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	84	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	84	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	84	_	_	_	_	_	_	_	O
70	)	_	)	_	)	84	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	84	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	84	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	84	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	84	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	84	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	84	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	84	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	84	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
89	:	_	:	_	:	84	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	84	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	84	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	84	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	84	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	84	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
108	.	_	.	_	.	84	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	84	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	84	_	_	_	_	_	_	_	O
11	(	_	(	_	(	84	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	84	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
14	)	_	)	_	)	84	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	84	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	84	_	_	_	_	_	_	_	O
18	,	_	,	_	,	84	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
23	,	_	,	_	,	84	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	84	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	84	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
29	,	_	,	_	,	84	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
36	(	_	(	_	(	84	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
38	)	_	)	_	)	84	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	84	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	84	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	84	_	_	_	_	_	_	_	O
47	:	_	:	_	:	84	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	84	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	84	_	_	_	_	_	_	_	O
56	(	_	(	_	(	84	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	84	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	84	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	84	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	84	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	84	_	_	_	_	_	_	_	O
63	,	_	,	_	,	84	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	84	_	_	_	_	_	other.a	Increment	O
67	minority	_	minority	_	NN	84	_	_	_	_	_	_	_	B-Class
68	ethnic	_	ethnic	_	JJ	84	_	_	_	_	_	_	_	I-Class
69	groups	_	group	_	NNS	84	_	_	_	_	_	_	_	I-Class
70	)	_	)	_	)	84	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	84	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	84	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	84	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	84	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	84	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	84	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	84	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	84	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
89	:	_	:	_	:	84	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	84	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	84	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	84	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	84	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	84	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
108	.	_	.	_	.	84	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	84	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	84	_	_	_	_	_	_	_	O
11	(	_	(	_	(	84	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	84	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
14	)	_	)	_	)	84	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	84	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	84	_	_	_	_	_	_	_	O
18	,	_	,	_	,	84	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
23	,	_	,	_	,	84	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	84	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	84	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
29	,	_	,	_	,	84	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
36	(	_	(	_	(	84	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
38	)	_	)	_	)	84	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	84	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	84	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	84	_	_	_	_	_	_	_	O
47	:	_	:	_	:	84	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	84	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	84	_	_	_	_	_	_	_	O
56	(	_	(	_	(	84	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	84	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	84	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	84	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	84	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	84	_	_	_	_	_	_	_	O
63	,	_	,	_	,	84	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	84	_	_	_	_	_	_	_	B-Aggregate_property
68	ethnic	_	ethnic	_	JJ	84	_	_	_	_	_	_	_	I-Aggregate_property
69	groups	_	group	_	NNS	84	_	_	_	_	_	group.n	Aggregate	S-Aggregate
70	)	_	)	_	)	84	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	84	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	84	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	84	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	84	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	84	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	84	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	84	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	84	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
89	:	_	:	_	:	84	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	84	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	84	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	84	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	84	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	84	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
108	.	_	.	_	.	84	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	84	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	84	_	_	_	_	_	_	_	O
11	(	_	(	_	(	84	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	84	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
14	)	_	)	_	)	84	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	84	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	84	_	_	_	_	_	_	_	O
18	,	_	,	_	,	84	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
23	,	_	,	_	,	84	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	84	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	84	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
29	,	_	,	_	,	84	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
36	(	_	(	_	(	84	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
38	)	_	)	_	)	84	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	84	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	84	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	84	_	_	_	_	_	_	_	O
47	:	_	:	_	:	84	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	84	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	84	_	_	_	_	_	_	_	O
56	(	_	(	_	(	84	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	84	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	84	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	84	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	84	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	84	_	_	_	_	_	_	_	O
63	,	_	,	_	,	84	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	84	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	84	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	84	_	_	_	_	_	_	_	O
70	)	_	)	_	)	84	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	84	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	84	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	84	_	_	_	_	_	other.a	Increment	O
76	medical	_	medical	_	JJ	84	_	_	_	_	_	_	_	B-Class
77	problems	_	problem	_	NNS	84	_	_	_	_	_	_	_	I-Class
78	associated	_	associate	_	VBN	84	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	84	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	84	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	84	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
89	:	_	:	_	:	84	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	84	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	84	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	84	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	84	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	84	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
108	.	_	.	_	.	84	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	84	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	84	_	_	_	_	_	_	_	O
11	(	_	(	_	(	84	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	84	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
14	)	_	)	_	)	84	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	84	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	84	_	_	_	_	_	_	_	O
18	,	_	,	_	,	84	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
23	,	_	,	_	,	84	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	84	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	84	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
29	,	_	,	_	,	84	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
36	(	_	(	_	(	84	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
38	)	_	)	_	)	84	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	84	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	84	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	84	_	_	_	_	_	_	_	O
47	:	_	:	_	:	84	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	84	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	84	_	_	_	_	_	_	_	O
56	(	_	(	_	(	84	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	84	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	84	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	84	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	84	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	84	_	_	_	_	_	_	_	O
63	,	_	,	_	,	84	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	84	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	84	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	84	_	_	_	_	_	_	_	O
70	)	_	)	_	)	84	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	84	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	84	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	84	_	_	_	_	_	_	_	S-Experiencer
77	problems	_	problem	_	NNS	84	_	_	_	_	_	problem.n	Predicament	S-Situation
78	associated	_	associate	_	VBN	84	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	84	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	84	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	84	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
89	:	_	:	_	:	84	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	84	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	84	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	84	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	84	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	84	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
108	.	_	.	_	.	84	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	84	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	84	_	_	_	_	_	_	_	O
11	(	_	(	_	(	84	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	84	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
14	)	_	)	_	)	84	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	84	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	84	_	_	_	_	_	_	_	O
18	,	_	,	_	,	84	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
23	,	_	,	_	,	84	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	84	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	84	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
29	,	_	,	_	,	84	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
36	(	_	(	_	(	84	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
38	)	_	)	_	)	84	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	84	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	84	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	84	_	_	_	_	_	_	_	O
47	:	_	:	_	:	84	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	84	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	84	_	_	_	_	_	_	_	O
56	(	_	(	_	(	84	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	84	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	84	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	84	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	84	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	84	_	_	_	_	_	_	_	O
63	,	_	,	_	,	84	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	84	_	_	_	_	_	_	_	B-Partner_1
65	and	_	and	_	CC	84	_	_	_	_	_	_	_	I-Partner_1
66	other	_	other	_	JJ	84	_	_	_	_	_	_	_	I-Partner_1
67	minority	_	minority	_	NN	84	_	_	_	_	_	_	_	I-Partner_1
68	ethnic	_	ethnic	_	JJ	84	_	_	_	_	_	_	_	I-Partner_1
69	groups	_	group	_	NNS	84	_	_	_	_	_	_	_	I-Partner_1
70	)	_	)	_	)	84	_	_	_	_	_	_	_	I-Partner_1
71	and	_	and	_	CC	84	_	_	_	_	_	_	_	I-Partner_1
72	specific	_	specific	_	JJ	84	_	_	_	_	_	_	_	I-Partner_1
73	psychological	_	psychological	_	JJ	84	_	_	_	_	_	_	_	I-Partner_1
74	or	_	or	_	CC	84	_	_	_	_	_	_	_	I-Partner_1
75	other	_	other	_	JJ	84	_	_	_	_	_	_	_	I-Partner_1
76	medical	_	medical	_	JJ	84	_	_	_	_	_	_	_	I-Partner_1
77	problems	_	problem	_	NNS	84	_	_	_	_	_	_	_	I-Partner_1
78	associated	_	associate	_	VBN	84	_	_	_	_	_	associate.v	Collaboration	O
79	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	84	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	84	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	84	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
89	:	_	:	_	:	84	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	84	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	84	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	84	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	84	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	84	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
108	.	_	.	_	.	84	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	84	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	84	_	_	_	_	_	_	_	O
11	(	_	(	_	(	84	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	84	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
14	)	_	)	_	)	84	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	84	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	84	_	_	_	_	_	_	_	O
18	,	_	,	_	,	84	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
23	,	_	,	_	,	84	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	84	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	84	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
29	,	_	,	_	,	84	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
36	(	_	(	_	(	84	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
38	)	_	)	_	)	84	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	84	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	84	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	84	_	_	_	_	_	_	_	O
47	:	_	:	_	:	84	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	84	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	84	_	_	_	_	_	_	_	O
56	(	_	(	_	(	84	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	84	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	84	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	84	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	84	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	84	_	_	_	_	_	_	_	O
63	,	_	,	_	,	84	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	84	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	84	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	84	_	_	_	_	_	_	_	O
70	)	_	)	_	)	84	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	84	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	84	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	84	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	84	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	84	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	84	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	84	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	84	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
89	:	_	:	_	:	84	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	84	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	84	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
94	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	84	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	84	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	84	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	84	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
108	.	_	.	_	.	84	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	84	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	84	_	_	_	_	_	_	_	O
11	(	_	(	_	(	84	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	84	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
14	)	_	)	_	)	84	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	84	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	84	_	_	_	_	_	_	_	O
18	,	_	,	_	,	84	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
23	,	_	,	_	,	84	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	84	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	84	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
29	,	_	,	_	,	84	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
36	(	_	(	_	(	84	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
38	)	_	)	_	)	84	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	84	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	84	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	84	_	_	_	_	_	_	_	O
47	:	_	:	_	:	84	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	84	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	84	_	_	_	_	_	_	_	O
56	(	_	(	_	(	84	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	84	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	84	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	84	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	84	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	84	_	_	_	_	_	_	_	O
63	,	_	,	_	,	84	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	84	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	84	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	84	_	_	_	_	_	_	_	O
70	)	_	)	_	)	84	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	84	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	84	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	84	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	84	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	84	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	84	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	84	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	84	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
89	:	_	:	_	:	84	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	84	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	84	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	84	_	_	_	_	_	significant.a	Importance	O
97	occupational	_	UNK	_	JJ	84	_	_	_	_	_	_	_	B-Factor
98	implications	_	UNK	_	NNS	84	_	_	_	_	_	_	_	I-Factor
99	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	84	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	84	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	84	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
108	.	_	.	_	.	84	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	84	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	84	_	_	_	_	_	_	_	O
11	(	_	(	_	(	84	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	84	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
14	)	_	)	_	)	84	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	84	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	84	_	_	_	_	_	_	_	O
18	,	_	,	_	,	84	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
23	,	_	,	_	,	84	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	84	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	84	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
29	,	_	,	_	,	84	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
36	(	_	(	_	(	84	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
38	)	_	)	_	)	84	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	84	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	84	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	84	_	_	_	_	_	_	_	O
47	:	_	:	_	:	84	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	84	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	84	_	_	_	_	_	_	_	O
56	(	_	(	_	(	84	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	84	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	84	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	84	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	84	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	84	_	_	_	_	_	_	_	O
63	,	_	,	_	,	84	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	84	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	84	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	84	_	_	_	_	_	_	_	O
70	)	_	)	_	)	84	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	84	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	84	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	84	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	84	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	84	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	84	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	84	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	84	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
89	:	_	:	_	:	84	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	84	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	84	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	84	_	_	_	_	_	weight.n	Dimension	S-Dimension
101	loss	_	loss	_	NN	84	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	84	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
108	.	_	.	_	.	84	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	84	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	84	_	_	_	_	_	_	_	O
11	(	_	(	_	(	84	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	84	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
14	)	_	)	_	)	84	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	84	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	84	_	_	_	_	_	_	_	O
18	,	_	,	_	,	84	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
23	,	_	,	_	,	84	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	84	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	84	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
29	,	_	,	_	,	84	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
36	(	_	(	_	(	84	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
38	)	_	)	_	)	84	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	84	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	84	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	84	_	_	_	_	_	_	_	O
47	:	_	:	_	:	84	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	84	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	84	_	_	_	_	_	_	_	O
56	(	_	(	_	(	84	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	84	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	84	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	84	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	84	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	84	_	_	_	_	_	_	_	O
63	,	_	,	_	,	84	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	84	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	84	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	84	_	_	_	_	_	_	_	O
70	)	_	)	_	)	84	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	84	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	84	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	84	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	84	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	84	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	84	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	84	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	84	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
89	:	_	:	_	:	84	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	84	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	84	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	84	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	84	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	84	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	84	_	_	_	_	_	other.a	Increment	O
105	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	B-Class
106	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	I-Class
107	comorbidities	_	UNK	_	NNS	84	_	_	_	_	_	_	_	I-Class
108	.	_	.	_	.	84	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	84	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	84	_	_	_	_	_	_	_	O
11	(	_	(	_	(	84	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	84	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
14	)	_	)	_	)	84	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	84	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	84	_	_	_	_	_	_	_	O
18	,	_	,	_	,	84	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	84	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	84	_	_	_	_	_	_	_	O
23	,	_	,	_	,	84	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	84	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	84	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
29	,	_	,	_	,	84	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
36	(	_	(	_	(	84	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
38	)	_	)	_	)	84	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	84	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	84	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	84	_	_	_	_	_	_	_	O
47	:	_	:	_	:	84	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	84	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	84	_	_	_	_	_	_	_	O
56	(	_	(	_	(	84	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	84	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	84	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	84	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	84	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	84	_	_	_	_	_	_	_	O
63	,	_	,	_	,	84	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	84	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	84	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	84	_	_	_	_	_	_	_	O
70	)	_	)	_	)	84	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	84	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	84	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	84	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	84	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	84	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	84	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	84	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	84	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	84	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	84	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	84	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
89	:	_	:	_	:	84	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	84	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	84	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	84	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	84	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	84	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	84	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	84	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	84	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	84	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	84	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	84	_	_	_	_	_	significant.a	Importance	O
106	unk	_	UNK	_	JJ	84	_	_	_	_	_	_	_	B-Factor
107	comorbidities	_	UNK	_	NNS	84	_	_	_	_	_	_	_	I-Factor
108	.	_	.	_	.	84	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	85	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	85	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	85	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
7	,	_	,	_	,	85	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	85	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	85	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
15	,	_	,	_	,	85	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	85	_	_	_	_	_	_	_	O
17	if	_	if	_	IN	85	_	_	_	_	_	_	_	O
18	dual	_	dual	_	JJ	85	_	_	_	_	_	_	_	O
19	therapy	_	therapy	_	NN	85	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
22	oral	_	UNK	_	JJ	85	_	_	_	_	_	_	_	O
23	drugs	_	drug	_	NNS	85	_	_	_	_	_	_	_	O
24	(	_	(	_	(	85	_	_	_	_	_	_	_	O
25	see	_	see	_	VB	85	_	_	_	_	_	_	_	O
26	recommendation	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
27	)	_	)	_	)	85	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	85	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	85	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	85	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	85	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	85	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	85	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	85	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	85	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	85	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	85	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	85	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	85	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	85	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
44	,	_	,	_	,	85	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	85	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	JJ	85	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	85	_	_	_	_	_	_	_	O
48	(	_	(	_	(	85	_	_	_	_	_	_	_	O
49	see	_	see	_	VB	85	_	_	_	_	_	_	_	O
50	recommendations	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NNP	85	_	_	_	_	_	_	_	O
52	)	_	)	_	)	85	_	_	_	_	_	_	_	O
53	.	_	.	_	.	85	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	85	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	85	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	85	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	85	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	85	_	_	_	_	_	_	_	I-Category
7	,	_	,	_	,	85	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	85	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	85	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
15	,	_	,	_	,	85	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	85	_	_	_	_	_	_	_	O
17	if	_	if	_	IN	85	_	_	_	_	_	_	_	O
18	dual	_	dual	_	JJ	85	_	_	_	_	_	_	_	O
19	therapy	_	therapy	_	NN	85	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
22	oral	_	UNK	_	JJ	85	_	_	_	_	_	_	_	O
23	drugs	_	drug	_	NNS	85	_	_	_	_	_	_	_	O
24	(	_	(	_	(	85	_	_	_	_	_	_	_	O
25	see	_	see	_	VB	85	_	_	_	_	_	_	_	O
26	recommendation	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
27	)	_	)	_	)	85	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	85	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	85	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	85	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	85	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	85	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	85	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	85	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	85	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	85	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	85	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	85	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	85	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	85	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
44	,	_	,	_	,	85	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	85	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	JJ	85	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	85	_	_	_	_	_	_	_	O
48	(	_	(	_	(	85	_	_	_	_	_	_	_	O
49	see	_	see	_	VB	85	_	_	_	_	_	_	_	O
50	recommendations	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NNP	85	_	_	_	_	_	_	_	O
52	)	_	)	_	)	85	_	_	_	_	_	_	_	O
53	.	_	.	_	.	85	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	85	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	85	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	85	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
7	,	_	,	_	,	85	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	85	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	85	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
15	,	_	,	_	,	85	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	85	_	_	_	_	_	_	_	O
17	if	_	if	_	IN	85	_	_	_	_	_	_	_	O
18	dual	_	dual	_	JJ	85	_	_	_	_	_	dual.a	Cardinal_numbers	S-Number
19	therapy	_	therapy	_	NN	85	_	_	_	_	_	_	_	S-Entity
20	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
22	oral	_	UNK	_	JJ	85	_	_	_	_	_	_	_	O
23	drugs	_	drug	_	NNS	85	_	_	_	_	_	_	_	O
24	(	_	(	_	(	85	_	_	_	_	_	_	_	O
25	see	_	see	_	VB	85	_	_	_	_	_	_	_	O
26	recommendation	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
27	)	_	)	_	)	85	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	85	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	85	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	85	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	85	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	85	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	85	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	85	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	85	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	85	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	85	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	85	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	85	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	85	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
44	,	_	,	_	,	85	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	85	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	JJ	85	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	85	_	_	_	_	_	_	_	O
48	(	_	(	_	(	85	_	_	_	_	_	_	_	O
49	see	_	see	_	VB	85	_	_	_	_	_	_	_	O
50	recommendations	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NNP	85	_	_	_	_	_	_	_	O
52	)	_	)	_	)	85	_	_	_	_	_	_	_	O
53	.	_	.	_	.	85	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	85	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	85	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	85	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
7	,	_	,	_	,	85	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	85	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	85	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
15	,	_	,	_	,	85	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	85	_	_	_	_	_	_	_	O
17	if	_	if	_	IN	85	_	_	_	_	_	_	_	O
18	dual	_	dual	_	JJ	85	_	_	_	_	_	_	_	O
19	therapy	_	therapy	_	NN	85	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
20	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
22	oral	_	UNK	_	JJ	85	_	_	_	_	_	_	_	O
23	drugs	_	drug	_	NNS	85	_	_	_	_	_	_	_	O
24	(	_	(	_	(	85	_	_	_	_	_	_	_	O
25	see	_	see	_	VB	85	_	_	_	_	_	_	_	O
26	recommendation	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
27	)	_	)	_	)	85	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	85	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	85	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	85	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	85	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	85	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	85	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	85	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	85	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	85	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	85	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	85	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	85	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	85	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
44	,	_	,	_	,	85	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	85	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	JJ	85	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	85	_	_	_	_	_	_	_	O
48	(	_	(	_	(	85	_	_	_	_	_	_	_	O
49	see	_	see	_	VB	85	_	_	_	_	_	_	_	O
50	recommendations	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NNP	85	_	_	_	_	_	_	_	O
52	)	_	)	_	)	85	_	_	_	_	_	_	_	O
53	.	_	.	_	.	85	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	85	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	85	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	85	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
7	,	_	,	_	,	85	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	85	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	85	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
15	,	_	,	_	,	85	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	85	_	_	_	_	_	_	_	O
17	if	_	if	_	IN	85	_	_	_	_	_	_	_	O
18	dual	_	dual	_	JJ	85	_	_	_	_	_	_	_	O
19	therapy	_	therapy	_	NN	85	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	85	_	_	_	_	_	_	_	B-Descriptor
22	oral	_	UNK	_	JJ	85	_	_	_	_	_	_	_	I-Descriptor
23	drugs	_	drug	_	NNS	85	_	_	_	_	_	drug.n	Intoxicants	S-Intoxicant
24	(	_	(	_	(	85	_	_	_	_	_	_	_	O
25	see	_	see	_	VB	85	_	_	_	_	_	_	_	O
26	recommendation	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
27	)	_	)	_	)	85	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	85	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	85	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	85	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	85	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	85	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	85	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	85	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	85	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	85	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	85	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	85	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	85	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	85	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
44	,	_	,	_	,	85	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	85	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	JJ	85	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	85	_	_	_	_	_	_	_	O
48	(	_	(	_	(	85	_	_	_	_	_	_	_	O
49	see	_	see	_	VB	85	_	_	_	_	_	_	_	O
50	recommendations	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NNP	85	_	_	_	_	_	_	_	O
52	)	_	)	_	)	85	_	_	_	_	_	_	_	O
53	.	_	.	_	.	85	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	85	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	85	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	85	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
7	,	_	,	_	,	85	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	85	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	85	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
15	,	_	,	_	,	85	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	85	_	_	_	_	_	_	_	O
17	if	_	if	_	IN	85	_	_	_	_	_	_	_	O
18	dual	_	dual	_	JJ	85	_	_	_	_	_	_	_	O
19	therapy	_	therapy	_	NN	85	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	85	_	_	_	_	_	_	_	B-Agent
22	oral	_	UNK	_	JJ	85	_	_	_	_	_	_	_	I-Agent
23	drugs	_	drug	_	NNS	85	_	_	_	_	_	_	_	I-Agent
24	(	_	(	_	(	85	_	_	_	_	_	_	_	I-Agent
25	see	_	see	_	VB	85	_	_	_	_	_	_	_	I-Agent
26	recommendation	_	UNK	_	NN	85	_	_	_	_	_	_	_	I-Agent
27	)	_	)	_	)	85	_	_	_	_	_	_	_	I-Agent
28	has	_	have	_	VBZ	85	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	85	_	_	_	_	_	continue.v	Activity_ongoing	O
31	to	_	to	_	TO	85	_	_	_	_	_	_	_	B-Activity
32	control	_	control	_	VB	85	_	_	_	_	_	_	_	I-Activity
33	hba1c	_	UNK	_	NNP	85	_	_	_	_	_	_	_	I-Activity
34	to	_	to	_	TO	85	_	_	_	_	_	_	_	I-Activity
35	below	_	below	_	VB	85	_	_	_	_	_	_	_	I-Activity
36	the	_	the	_	DT	85	_	_	_	_	_	_	_	I-Activity
37	person	_	person	_	NN	85	_	_	_	_	_	_	_	I-Activity
38	's	_	's	_	POS	85	_	_	_	_	_	_	_	I-Activity
39	individually	_	UNK	_	RB	85	_	_	_	_	_	_	_	I-Activity
40	agreed	_	agree	_	VBN	85	_	_	_	_	_	_	_	I-Activity
41	threshold	_	UNK	_	NN	85	_	_	_	_	_	_	_	I-Activity
42	for	_	for	_	IN	85	_	_	_	_	_	_	_	I-Activity
43	intensification	_	UNK	_	NN	85	_	_	_	_	_	_	_	I-Activity
44	,	_	,	_	,	85	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	85	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	JJ	85	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	85	_	_	_	_	_	_	_	O
48	(	_	(	_	(	85	_	_	_	_	_	_	_	O
49	see	_	see	_	VB	85	_	_	_	_	_	_	_	O
50	recommendations	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NNP	85	_	_	_	_	_	_	_	O
52	)	_	)	_	)	85	_	_	_	_	_	_	_	O
53	.	_	.	_	.	85	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	85	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	85	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	85	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
7	,	_	,	_	,	85	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	85	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	85	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
15	,	_	,	_	,	85	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	85	_	_	_	_	_	_	_	O
17	if	_	if	_	IN	85	_	_	_	_	_	_	_	O
18	dual	_	dual	_	JJ	85	_	_	_	_	_	_	_	O
19	therapy	_	therapy	_	NN	85	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
22	oral	_	UNK	_	JJ	85	_	_	_	_	_	_	_	O
23	drugs	_	drug	_	NNS	85	_	_	_	_	_	_	_	O
24	(	_	(	_	(	85	_	_	_	_	_	_	_	O
25	see	_	see	_	VB	85	_	_	_	_	_	_	_	O
26	recommendation	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
27	)	_	)	_	)	85	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	85	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	85	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	85	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	85	_	_	_	_	_	control.v	Being_in_control	O
33	hba1c	_	UNK	_	NNP	85	_	_	_	_	_	_	_	B-Dependent_entity
34	to	_	to	_	TO	85	_	_	_	_	_	_	_	I-Dependent_entity
35	below	_	below	_	VB	85	_	_	_	_	_	_	_	I-Dependent_entity
36	the	_	the	_	DT	85	_	_	_	_	_	_	_	I-Dependent_entity
37	person	_	person	_	NN	85	_	_	_	_	_	_	_	I-Dependent_entity
38	's	_	's	_	POS	85	_	_	_	_	_	_	_	I-Dependent_entity
39	individually	_	UNK	_	RB	85	_	_	_	_	_	_	_	I-Dependent_entity
40	agreed	_	agree	_	VBN	85	_	_	_	_	_	_	_	I-Dependent_entity
41	threshold	_	UNK	_	NN	85	_	_	_	_	_	_	_	I-Dependent_entity
42	for	_	for	_	IN	85	_	_	_	_	_	_	_	I-Dependent_entity
43	intensification	_	UNK	_	NN	85	_	_	_	_	_	_	_	I-Dependent_entity
44	,	_	,	_	,	85	_	_	_	_	_	_	_	I-Dependent_entity
45	consider	_	consider	_	VB	85	_	_	_	_	_	_	_	I-Dependent_entity
46	unk	_	UNK	_	JJ	85	_	_	_	_	_	_	_	I-Dependent_entity
47	treatment	_	treatment	_	NN	85	_	_	_	_	_	_	_	I-Dependent_entity
48	(	_	(	_	(	85	_	_	_	_	_	_	_	I-Dependent_entity
49	see	_	see	_	VB	85	_	_	_	_	_	_	_	I-Dependent_entity
50	recommendations	_	UNK	_	NNS	85	_	_	_	_	_	_	_	I-Dependent_entity
51	unk	_	UNK	_	NNP	85	_	_	_	_	_	_	_	I-Dependent_entity
52	)	_	)	_	)	85	_	_	_	_	_	_	_	I-Dependent_entity
53	.	_	.	_	.	85	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	85	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	85	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	85	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
7	,	_	,	_	,	85	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	85	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	85	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
15	,	_	,	_	,	85	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	85	_	_	_	_	_	_	_	O
17	if	_	if	_	IN	85	_	_	_	_	_	_	_	O
18	dual	_	dual	_	JJ	85	_	_	_	_	_	_	_	O
19	therapy	_	therapy	_	NN	85	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	85	_	_	_	_	_	_	_	B-Figure
22	oral	_	UNK	_	JJ	85	_	_	_	_	_	_	_	I-Figure
23	drugs	_	drug	_	NNS	85	_	_	_	_	_	_	_	I-Figure
24	(	_	(	_	(	85	_	_	_	_	_	_	_	I-Figure
25	see	_	see	_	VB	85	_	_	_	_	_	_	_	I-Figure
26	recommendation	_	UNK	_	NN	85	_	_	_	_	_	_	_	I-Figure
27	)	_	)	_	)	85	_	_	_	_	_	_	_	I-Figure
28	has	_	have	_	VBZ	85	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	85	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	85	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	85	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	85	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	85	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	85	_	_	_	_	_	below.prep	Directional_locative_relation	O
36	the	_	the	_	DT	85	_	_	_	_	_	_	_	B-Ground
37	person	_	person	_	NN	85	_	_	_	_	_	_	_	I-Ground
38	's	_	's	_	POS	85	_	_	_	_	_	_	_	I-Ground
39	individually	_	UNK	_	RB	85	_	_	_	_	_	_	_	I-Ground
40	agreed	_	agree	_	VBN	85	_	_	_	_	_	_	_	I-Ground
41	threshold	_	UNK	_	NN	85	_	_	_	_	_	_	_	I-Ground
42	for	_	for	_	IN	85	_	_	_	_	_	_	_	I-Ground
43	intensification	_	UNK	_	NN	85	_	_	_	_	_	_	_	I-Ground
44	,	_	,	_	,	85	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	85	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	JJ	85	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	85	_	_	_	_	_	_	_	O
48	(	_	(	_	(	85	_	_	_	_	_	_	_	O
49	see	_	see	_	VB	85	_	_	_	_	_	_	_	O
50	recommendations	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NNP	85	_	_	_	_	_	_	_	O
52	)	_	)	_	)	85	_	_	_	_	_	_	_	O
53	.	_	.	_	.	85	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	85	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	85	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	85	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
7	,	_	,	_	,	85	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	85	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	85	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
15	,	_	,	_	,	85	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	85	_	_	_	_	_	_	_	O
17	if	_	if	_	IN	85	_	_	_	_	_	_	_	O
18	dual	_	dual	_	JJ	85	_	_	_	_	_	_	_	O
19	therapy	_	therapy	_	NN	85	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
22	oral	_	UNK	_	JJ	85	_	_	_	_	_	_	_	O
23	drugs	_	drug	_	NNS	85	_	_	_	_	_	_	_	O
24	(	_	(	_	(	85	_	_	_	_	_	_	_	O
25	see	_	see	_	VB	85	_	_	_	_	_	_	_	O
26	recommendation	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
27	)	_	)	_	)	85	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	85	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	85	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	85	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	85	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	85	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	85	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	85	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	85	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	85	_	_	_	_	_	person.n	People	S-Person
38	's	_	's	_	POS	85	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	85	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	85	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	85	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
44	,	_	,	_	,	85	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	85	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	JJ	85	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	85	_	_	_	_	_	_	_	O
48	(	_	(	_	(	85	_	_	_	_	_	_	_	O
49	see	_	see	_	VB	85	_	_	_	_	_	_	_	O
50	recommendations	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NNP	85	_	_	_	_	_	_	_	O
52	)	_	)	_	)	85	_	_	_	_	_	_	_	O
53	.	_	.	_	.	85	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	85	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	85	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	85	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
7	,	_	,	_	,	85	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	85	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	85	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
15	,	_	,	_	,	85	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	85	_	_	_	_	_	_	_	O
17	if	_	if	_	IN	85	_	_	_	_	_	_	_	O
18	dual	_	dual	_	JJ	85	_	_	_	_	_	_	_	O
19	therapy	_	therapy	_	NN	85	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
22	oral	_	UNK	_	JJ	85	_	_	_	_	_	_	_	O
23	drugs	_	drug	_	NNS	85	_	_	_	_	_	_	_	O
24	(	_	(	_	(	85	_	_	_	_	_	_	_	O
25	see	_	see	_	VB	85	_	_	_	_	_	_	_	O
26	recommendation	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
27	)	_	)	_	)	85	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	85	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	85	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	85	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	85	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	85	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	85	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	85	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	85	_	_	_	_	_	_	_	B-Party_1
37	person	_	person	_	NN	85	_	_	_	_	_	_	_	I-Party_1
38	's	_	's	_	POS	85	_	_	_	_	_	_	_	I-Party_1
39	individually	_	UNK	_	RB	85	_	_	_	_	_	_	_	S-Parties
40	agreed	_	agree	_	VBN	85	_	_	_	_	_	agree.v	Make_agreement_on_action	O
41	threshold	_	UNK	_	NN	85	_	_	_	_	_	_	_	B-Obligation
42	for	_	for	_	IN	85	_	_	_	_	_	_	_	I-Obligation
43	intensification	_	UNK	_	NN	85	_	_	_	_	_	_	_	I-Obligation
44	,	_	,	_	,	85	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	85	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	JJ	85	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	85	_	_	_	_	_	_	_	O
48	(	_	(	_	(	85	_	_	_	_	_	_	_	O
49	see	_	see	_	VB	85	_	_	_	_	_	_	_	O
50	recommendations	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NNP	85	_	_	_	_	_	_	_	O
52	)	_	)	_	)	85	_	_	_	_	_	_	_	O
53	.	_	.	_	.	85	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	85	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	85	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	85	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
7	,	_	,	_	,	85	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	85	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	85	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	85	_	_	_	_	_	_	_	O
15	,	_	,	_	,	85	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	85	_	_	_	_	_	_	_	O
17	if	_	if	_	IN	85	_	_	_	_	_	_	_	O
18	dual	_	dual	_	JJ	85	_	_	_	_	_	_	_	O
19	therapy	_	therapy	_	NN	85	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
22	oral	_	UNK	_	JJ	85	_	_	_	_	_	_	_	O
23	drugs	_	drug	_	NNS	85	_	_	_	_	_	_	_	O
24	(	_	(	_	(	85	_	_	_	_	_	_	_	O
25	see	_	see	_	VB	85	_	_	_	_	_	_	_	O
26	recommendation	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
27	)	_	)	_	)	85	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	85	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	85	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	85	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	85	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	85	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	85	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	85	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	85	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	85	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	85	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	85	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	85	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	85	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
44	,	_	,	_	,	85	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	85	_	_	_	_	_	consider.v	Categorization	O
46	unk	_	UNK	_	JJ	85	_	_	_	_	_	_	_	B-Item
47	treatment	_	treatment	_	NN	85	_	_	_	_	_	_	_	I-Item
48	(	_	(	_	(	85	_	_	_	_	_	_	_	O
49	see	_	see	_	VB	85	_	_	_	_	_	_	_	O
50	recommendations	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NNP	85	_	_	_	_	_	_	_	O
52	)	_	)	_	)	85	_	_	_	_	_	_	_	O
53	.	_	.	_	.	85	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	86	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	86	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	86	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	86	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	86	_	_	_	_	_	_	_	O
6	:	_	:	_	:	86	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	86	_	_	_	_	_	_	_	O
8	(	_	(	_	(	86	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	86	_	_	_	_	_	_	_	O
10	)	_	)	_	)	86	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	86	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	86	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	86	_	_	_	_	_	_	_	O
14	)	_	)	_	)	86	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	86	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	86	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	86	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	86	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	86	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	86	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	86	_	_	_	_	_	_	_	O
8	(	_	(	_	(	86	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	86	_	_	_	_	_	_	_	O
10	)	_	)	_	)	86	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	86	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	86	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	86	_	_	_	_	_	_	_	O
14	)	_	)	_	)	86	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	87	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	87	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	87	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	87	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	87	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	87	_	_	_	_	_	_	_	O
7	,	_	,	_	,	87	_	_	_	_	_	_	_	O
8	only	_	only	_	RB	87	_	_	_	_	_	_	_	O
9	offer	_	offer	_	VBP	87	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	87	_	_	_	_	_	_	_	O
11	glp-1	_	UNK	_	NNP	87	_	_	_	_	_	_	_	O
12	mimetic	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	87	_	_	_	_	_	_	_	O
14	combination	_	combination	_	NN	87	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	87	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	87	_	_	_	_	_	_	_	O
18	specialist	_	specialist	_	NN	87	_	_	_	_	_	_	_	O
19	care	_	care	_	NN	87	_	_	_	_	_	_	_	O
20	advice	_	advice	_	NN	87	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	87	_	_	_	_	_	_	_	O
22	ongoing	_	ongoing	_	VBG	87	_	_	_	_	_	_	_	O
23	support	_	support	_	NN	87	_	_	_	_	_	_	_	O
24	from	_	from	_	IN	87	_	_	_	_	_	_	_	O
25	a	_	a	_	DT	87	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	JJ	87	_	_	_	_	_	_	_	O
27	multidisciplinary	_	UNK	_	JJ	87	_	_	_	_	_	_	_	O
28	team	_	team	_	NN	87	_	_	_	_	_	_	_	O
29	.	_	.	_	.	87	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	87	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	87	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	87	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	87	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	87	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	87	_	_	_	_	_	_	_	I-Category
7	,	_	,	_	,	87	_	_	_	_	_	_	_	O
8	only	_	only	_	RB	87	_	_	_	_	_	_	_	O
9	offer	_	offer	_	VBP	87	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	87	_	_	_	_	_	_	_	O
11	glp-1	_	UNK	_	NNP	87	_	_	_	_	_	_	_	O
12	mimetic	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	87	_	_	_	_	_	_	_	O
14	combination	_	combination	_	NN	87	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	87	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	87	_	_	_	_	_	_	_	O
18	specialist	_	specialist	_	NN	87	_	_	_	_	_	_	_	O
19	care	_	care	_	NN	87	_	_	_	_	_	_	_	O
20	advice	_	advice	_	NN	87	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	87	_	_	_	_	_	_	_	O
22	ongoing	_	ongoing	_	VBG	87	_	_	_	_	_	_	_	O
23	support	_	support	_	NN	87	_	_	_	_	_	_	_	O
24	from	_	from	_	IN	87	_	_	_	_	_	_	_	O
25	a	_	a	_	DT	87	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	JJ	87	_	_	_	_	_	_	_	O
27	multidisciplinary	_	UNK	_	JJ	87	_	_	_	_	_	_	_	O
28	team	_	team	_	NN	87	_	_	_	_	_	_	_	O
29	.	_	.	_	.	87	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	87	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	87	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	87	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	87	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	87	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	87	_	_	_	_	_	_	_	O
7	,	_	,	_	,	87	_	_	_	_	_	_	_	O
8	only	_	only	_	RB	87	_	_	_	_	_	_	_	O
9	offer	_	offer	_	VBP	87	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	87	_	_	_	_	_	_	_	O
11	glp-1	_	UNK	_	NNP	87	_	_	_	_	_	_	_	O
12	mimetic	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	87	_	_	_	_	_	_	_	O
14	combination	_	combination	_	NN	87	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	87	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	87	_	_	_	_	_	_	_	O
18	specialist	_	specialist	_	NN	87	_	_	_	_	_	_	_	O
19	care	_	care	_	NN	87	_	_	_	_	_	_	_	O
20	advice	_	advice	_	NN	87	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	87	_	_	_	_	_	_	_	O
22	ongoing	_	ongoing	_	VBG	87	_	_	_	_	_	ongoing.a	Process_continue	O
23	support	_	support	_	NN	87	_	_	_	_	_	_	_	S-Event
24	from	_	from	_	IN	87	_	_	_	_	_	_	_	O
25	a	_	a	_	DT	87	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	JJ	87	_	_	_	_	_	_	_	O
27	multidisciplinary	_	UNK	_	JJ	87	_	_	_	_	_	_	_	O
28	team	_	team	_	NN	87	_	_	_	_	_	_	_	O
29	.	_	.	_	.	87	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	87	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	87	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	87	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	87	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	87	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	87	_	_	_	_	_	_	_	O
7	,	_	,	_	,	87	_	_	_	_	_	_	_	O
8	only	_	only	_	RB	87	_	_	_	_	_	_	_	O
9	offer	_	offer	_	VBP	87	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	87	_	_	_	_	_	_	_	O
11	glp-1	_	UNK	_	NNP	87	_	_	_	_	_	_	_	O
12	mimetic	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	87	_	_	_	_	_	_	_	O
14	combination	_	combination	_	NN	87	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	87	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	87	_	_	_	_	_	_	_	O
18	specialist	_	specialist	_	NN	87	_	_	_	_	_	_	_	O
19	care	_	care	_	NN	87	_	_	_	_	_	_	_	O
20	advice	_	advice	_	NN	87	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	87	_	_	_	_	_	_	_	O
22	ongoing	_	ongoing	_	VBG	87	_	_	_	_	_	_	_	O
23	support	_	support	_	NN	87	_	_	_	_	_	_	_	O
24	from	_	from	_	IN	87	_	_	_	_	_	_	_	O
25	a	_	a	_	DT	87	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	JJ	87	_	_	_	_	_	_	_	B-Aggregate_property
27	multidisciplinary	_	UNK	_	JJ	87	_	_	_	_	_	_	_	I-Aggregate_property
28	team	_	team	_	NN	87	_	_	_	_	_	team.n	Aggregate	S-Aggregate
29	.	_	.	_	.	87	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	88	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	88	_	_	_	_	_	start.v	Activity_start	O
3	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	B-Activity
4	therapy	_	therapy	_	NN	88	_	_	_	_	_	_	_	I-Activity
5	in	_	in	_	IN	88	_	_	_	_	_	_	_	I-Activity
6	adults	_	adult	_	NNS	88	_	_	_	_	_	_	_	I-Activity
7	with	_	with	_	IN	88	_	_	_	_	_	_	_	I-Activity
8	type	_	type	_	JJ	88	_	_	_	_	_	_	_	I-Activity
9	2	_	2	_	CD	88	_	_	_	_	_	_	_	I-Activity
10	diabetes	_	UNK	_	NNS	88	_	_	_	_	_	_	_	I-Activity
11	,	_	,	_	,	88	_	_	_	_	_	_	_	I-Activity
12	use	_	use	_	VBP	88	_	_	_	_	_	_	_	I-Activity
13	a	_	a	_	DT	88	_	_	_	_	_	_	_	I-Activity
14	structured	_	UNK	_	JJ	88	_	_	_	_	_	_	_	I-Activity
15	programme	_	UNK	_	NN	88	_	_	_	_	_	_	_	I-Activity
16	employing	_	employ	_	VBG	88	_	_	_	_	_	_	_	I-Activity
17	active	_	active	_	JJ	88	_	_	_	_	_	_	_	I-Activity
18	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	I-Activity
19	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	I-Activity
20	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	I-Activity
21	that	_	that	_	WDT	88	_	_	_	_	_	_	_	I-Activity
22	encompasses	_	encompass	_	VBZ	88	_	_	_	_	_	_	_	I-Activity
23	:	_	:	_	:	88	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	O
25	technique	_	technique	_	NN	88	_	_	_	_	_	_	_	O
26	,	_	,	_	,	88	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	88	_	_	_	_	_	_	_	O
28	rotating	_	UNK	_	VBG	88	_	_	_	_	_	_	_	O
29	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	O
30	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	88	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	88	_	_	_	_	_	_	_	O
33	repeated	_	repeat	_	VBN	88	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	88	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	88	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	88	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	88	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	88	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	88	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	O
41	continuing	_	continue	_	VBG	88	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	88	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	88	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	88	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	88	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	88	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	88	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	88	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	88	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	88	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	88	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	88	_	_	_	_	_	adult.n	People_by_age	S-Person
7	with	_	with	_	IN	88	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	88	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	88	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
11	,	_	,	_	,	88	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	88	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	88	_	_	_	_	_	_	_	O
14	structured	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
16	employing	_	employ	_	VBG	88	_	_	_	_	_	_	_	O
17	active	_	active	_	JJ	88	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
19	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	O
20	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	88	_	_	_	_	_	_	_	O
22	encompasses	_	encompass	_	VBZ	88	_	_	_	_	_	_	_	O
23	:	_	:	_	:	88	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	O
25	technique	_	technique	_	NN	88	_	_	_	_	_	_	_	O
26	,	_	,	_	,	88	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	88	_	_	_	_	_	_	_	O
28	rotating	_	UNK	_	VBG	88	_	_	_	_	_	_	_	O
29	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	O
30	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	88	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	88	_	_	_	_	_	_	_	O
33	repeated	_	repeat	_	VBN	88	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	88	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	88	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	88	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	88	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	88	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	88	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	O
41	continuing	_	continue	_	VBG	88	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	88	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	88	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	88	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	88	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	88	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	88	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	88	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	88	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	88	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	88	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	88	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	88	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	88	_	_	_	_	_	type.n	Type	S-Subtype
9	2	_	2	_	CD	88	_	_	_	_	_	_	_	B-Category
10	diabetes	_	UNK	_	NNS	88	_	_	_	_	_	_	_	I-Category
11	,	_	,	_	,	88	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	88	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	88	_	_	_	_	_	_	_	O
14	structured	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
16	employing	_	employ	_	VBG	88	_	_	_	_	_	_	_	O
17	active	_	active	_	JJ	88	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
19	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	O
20	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	88	_	_	_	_	_	_	_	O
22	encompasses	_	encompass	_	VBZ	88	_	_	_	_	_	_	_	O
23	:	_	:	_	:	88	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	O
25	technique	_	technique	_	NN	88	_	_	_	_	_	_	_	O
26	,	_	,	_	,	88	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	88	_	_	_	_	_	_	_	O
28	rotating	_	UNK	_	VBG	88	_	_	_	_	_	_	_	O
29	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	O
30	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	88	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	88	_	_	_	_	_	_	_	O
33	repeated	_	repeat	_	VBN	88	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	88	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	88	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	88	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	88	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	88	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	88	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	O
41	continuing	_	continue	_	VBG	88	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	88	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	88	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	88	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	88	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	88	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	88	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	88	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	88	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	88	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	88	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	88	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	88	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	88	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	88	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
11	,	_	,	_	,	88	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	88	_	_	_	_	_	use.v	Using	O
13	a	_	a	_	DT	88	_	_	_	_	_	_	_	B-Instrument
14	structured	_	UNK	_	JJ	88	_	_	_	_	_	_	_	I-Instrument
15	programme	_	UNK	_	NN	88	_	_	_	_	_	_	_	I-Instrument
16	employing	_	employ	_	VBG	88	_	_	_	_	_	_	_	I-Instrument
17	active	_	active	_	JJ	88	_	_	_	_	_	_	_	I-Instrument
18	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	I-Instrument
19	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	I-Instrument
20	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	I-Instrument
21	that	_	that	_	WDT	88	_	_	_	_	_	_	_	I-Instrument
22	encompasses	_	encompass	_	VBZ	88	_	_	_	_	_	_	_	I-Instrument
23	:	_	:	_	:	88	_	_	_	_	_	_	_	I-Instrument
24	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	I-Instrument
25	technique	_	technique	_	NN	88	_	_	_	_	_	_	_	I-Instrument
26	,	_	,	_	,	88	_	_	_	_	_	_	_	I-Instrument
27	including	_	include	_	VBG	88	_	_	_	_	_	_	_	I-Instrument
28	rotating	_	UNK	_	VBG	88	_	_	_	_	_	_	_	I-Instrument
29	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	I-Instrument
30	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	I-Instrument
31	and	_	and	_	CC	88	_	_	_	_	_	_	_	I-Instrument
32	avoiding	_	avoid	_	VBG	88	_	_	_	_	_	_	_	I-Instrument
33	repeated	_	repeat	_	VBN	88	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	88	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	88	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	88	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	88	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	88	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	88	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	O
41	continuing	_	continue	_	VBG	88	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	88	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	88	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	88	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	88	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	88	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	88	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	88	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	88	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	88	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	88	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	88	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	88	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	88	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	88	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
11	,	_	,	_	,	88	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	88	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	88	_	_	_	_	_	_	_	B-Agent
14	structured	_	UNK	_	JJ	88	_	_	_	_	_	_	_	I-Agent
15	programme	_	UNK	_	NN	88	_	_	_	_	_	_	_	I-Agent
16	employing	_	employ	_	VBG	88	_	_	_	_	_	employ.v	Using	O
17	active	_	active	_	JJ	88	_	_	_	_	_	_	_	B-Instrument
18	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	I-Instrument
19	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	I-Instrument
20	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	I-Instrument
21	that	_	that	_	WDT	88	_	_	_	_	_	_	_	I-Instrument
22	encompasses	_	encompass	_	VBZ	88	_	_	_	_	_	_	_	I-Instrument
23	:	_	:	_	:	88	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	O
25	technique	_	technique	_	NN	88	_	_	_	_	_	_	_	O
26	,	_	,	_	,	88	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	88	_	_	_	_	_	_	_	O
28	rotating	_	UNK	_	VBG	88	_	_	_	_	_	_	_	O
29	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	O
30	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	88	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	88	_	_	_	_	_	_	_	O
33	repeated	_	repeat	_	VBN	88	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	88	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	88	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	88	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	88	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	88	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	88	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	O
41	continuing	_	continue	_	VBG	88	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	88	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	88	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	88	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	88	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	88	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	88	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	88	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	88	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	88	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	88	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	88	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	88	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	88	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	88	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
11	,	_	,	_	,	88	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	88	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	88	_	_	_	_	_	_	_	O
14	structured	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
16	employing	_	employ	_	VBG	88	_	_	_	_	_	_	_	O
17	active	_	active	_	JJ	88	_	_	_	_	_	active.a	Being_active	O
18	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
19	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	O
20	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	88	_	_	_	_	_	_	_	O
22	encompasses	_	encompass	_	VBZ	88	_	_	_	_	_	_	_	O
23	:	_	:	_	:	88	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	O
25	technique	_	technique	_	NN	88	_	_	_	_	_	_	_	O
26	,	_	,	_	,	88	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	88	_	_	_	_	_	_	_	O
28	rotating	_	UNK	_	VBG	88	_	_	_	_	_	_	_	O
29	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	O
30	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	88	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	88	_	_	_	_	_	_	_	O
33	repeated	_	repeat	_	VBN	88	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	88	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	88	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	88	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	88	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	88	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	88	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	O
41	continuing	_	continue	_	VBG	88	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	88	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	88	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	88	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	88	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	88	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	88	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	88	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	88	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	88	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	88	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	88	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	88	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	88	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	88	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
11	,	_	,	_	,	88	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	88	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	88	_	_	_	_	_	_	_	O
14	structured	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
16	employing	_	employ	_	VBG	88	_	_	_	_	_	_	_	O
17	active	_	active	_	JJ	88	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	S-Mass
19	dose	_	dose	_	JJ	88	_	_	_	_	_	dose.n	Quantified_mass	S-Quantity
20	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	88	_	_	_	_	_	_	_	O
22	encompasses	_	encompass	_	VBZ	88	_	_	_	_	_	_	_	O
23	:	_	:	_	:	88	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	O
25	technique	_	technique	_	NN	88	_	_	_	_	_	_	_	O
26	,	_	,	_	,	88	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	88	_	_	_	_	_	_	_	O
28	rotating	_	UNK	_	VBG	88	_	_	_	_	_	_	_	O
29	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	O
30	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	88	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	88	_	_	_	_	_	_	_	O
33	repeated	_	repeat	_	VBN	88	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	88	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	88	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	88	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	88	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	88	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	88	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	O
41	continuing	_	continue	_	VBG	88	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	88	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	88	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	88	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	88	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	88	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	88	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	88	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	88	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	88	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	88	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	88	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	88	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	88	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	88	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
11	,	_	,	_	,	88	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	88	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	88	_	_	_	_	_	_	_	O
14	structured	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
16	employing	_	employ	_	VBG	88	_	_	_	_	_	_	_	O
17	active	_	active	_	JJ	88	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
19	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	O
20	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	88	_	_	_	_	_	_	_	O
22	encompasses	_	encompass	_	VBZ	88	_	_	_	_	_	_	_	O
23	:	_	:	_	:	88	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	S-Purpose
25	technique	_	technique	_	NN	88	_	_	_	_	_	technique.n	Means	O
26	,	_	,	_	,	88	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	88	_	_	_	_	_	_	_	O
28	rotating	_	UNK	_	VBG	88	_	_	_	_	_	_	_	O
29	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	O
30	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	88	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	88	_	_	_	_	_	_	_	O
33	repeated	_	repeat	_	VBN	88	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	88	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	88	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	88	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	88	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	88	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	88	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	O
41	continuing	_	continue	_	VBG	88	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	88	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	88	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	88	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	88	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	88	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	88	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	88	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	88	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	88	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	88	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	88	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	88	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	88	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	88	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
11	,	_	,	_	,	88	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	88	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	88	_	_	_	_	_	_	_	O
14	structured	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
16	employing	_	employ	_	VBG	88	_	_	_	_	_	_	_	O
17	active	_	active	_	JJ	88	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
19	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	O
20	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	88	_	_	_	_	_	_	_	O
22	encompasses	_	encompass	_	VBZ	88	_	_	_	_	_	_	_	O
23	:	_	:	_	:	88	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	B-Total
25	technique	_	technique	_	NN	88	_	_	_	_	_	_	_	I-Total
26	,	_	,	_	,	88	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	88	_	_	_	_	_	include.v	Inclusion	O
28	rotating	_	UNK	_	VBG	88	_	_	_	_	_	_	_	B-Part
29	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	I-Part
30	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	I-Part
31	and	_	and	_	CC	88	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	88	_	_	_	_	_	_	_	O
33	repeated	_	repeat	_	VBN	88	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	88	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	88	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	88	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	88	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	88	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	88	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	O
41	continuing	_	continue	_	VBG	88	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	88	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	88	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	88	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	88	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	88	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	88	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	88	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	88	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	88	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	88	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	88	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	88	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	88	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	88	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
11	,	_	,	_	,	88	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	88	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	88	_	_	_	_	_	_	_	O
14	structured	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
16	employing	_	employ	_	VBG	88	_	_	_	_	_	_	_	O
17	active	_	active	_	JJ	88	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
19	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	O
20	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	88	_	_	_	_	_	_	_	O
22	encompasses	_	encompass	_	VBZ	88	_	_	_	_	_	_	_	O
23	:	_	:	_	:	88	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	O
25	technique	_	technique	_	NN	88	_	_	_	_	_	_	_	O
26	,	_	,	_	,	88	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	88	_	_	_	_	_	_	_	O
28	rotating	_	UNK	_	VBG	88	_	_	_	_	_	_	_	O
29	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	S-Use
30	sites	_	site	_	NNS	88	_	_	_	_	_	site.n	Locale_by_use	S-Locale
31	and	_	and	_	CC	88	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	88	_	_	_	_	_	_	_	O
33	repeated	_	repeat	_	VBN	88	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	88	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	88	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	88	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	88	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	88	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	88	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	O
41	continuing	_	continue	_	VBG	88	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	88	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	88	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	88	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	88	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	88	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	88	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	88	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	88	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	88	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	88	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	88	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	88	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	88	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	88	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
11	,	_	,	_	,	88	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	88	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	88	_	_	_	_	_	_	_	O
14	structured	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
16	employing	_	employ	_	VBG	88	_	_	_	_	_	_	_	O
17	active	_	active	_	JJ	88	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
19	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	O
20	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	88	_	_	_	_	_	_	_	O
22	encompasses	_	encompass	_	VBZ	88	_	_	_	_	_	_	_	O
23	:	_	:	_	:	88	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	O
25	technique	_	technique	_	NN	88	_	_	_	_	_	_	_	O
26	,	_	,	_	,	88	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	88	_	_	_	_	_	_	_	O
28	rotating	_	UNK	_	VBG	88	_	_	_	_	_	_	_	O
29	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	O
30	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	88	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	88	_	_	_	_	_	avoid.v	Avoiding	O
33	repeated	_	repeat	_	VBN	88	_	_	_	_	_	_	_	B-Undesirable_situation
34	injections	_	injection	_	NNS	88	_	_	_	_	_	_	_	I-Undesirable_situation
35	at	_	at	_	IN	88	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	88	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	88	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	88	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	88	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	O
41	continuing	_	continue	_	VBG	88	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	88	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	88	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	88	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	88	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	88	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	88	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	88	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	88	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	88	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	88	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	88	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	88	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	88	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	88	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
11	,	_	,	_	,	88	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	88	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	88	_	_	_	_	_	_	_	O
14	structured	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
16	employing	_	employ	_	VBG	88	_	_	_	_	_	_	_	O
17	active	_	active	_	JJ	88	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
19	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	O
20	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	88	_	_	_	_	_	_	_	O
22	encompasses	_	encompass	_	VBZ	88	_	_	_	_	_	_	_	O
23	:	_	:	_	:	88	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	O
25	technique	_	technique	_	NN	88	_	_	_	_	_	_	_	O
26	,	_	,	_	,	88	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	88	_	_	_	_	_	_	_	O
28	rotating	_	UNK	_	VBG	88	_	_	_	_	_	_	_	O
29	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	O
30	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	88	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	88	_	_	_	_	_	_	_	O
33	repeated	_	repeat	_	VBN	88	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	88	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	88	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	88	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	88	_	_	_	_	_	same.a	Identicality	O
38	point	_	point	_	NN	88	_	_	_	_	_	_	_	B-Type
39	within	_	within	_	IN	88	_	_	_	_	_	_	_	I-Type
40	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	I-Type
41	continuing	_	continue	_	VBG	88	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	88	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	88	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	88	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	88	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	88	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	88	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	88	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	88	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	88	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	88	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	88	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	88	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	88	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	88	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
11	,	_	,	_	,	88	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	88	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	88	_	_	_	_	_	_	_	O
14	structured	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
16	employing	_	employ	_	VBG	88	_	_	_	_	_	_	_	O
17	active	_	active	_	JJ	88	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
19	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	O
20	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	88	_	_	_	_	_	_	_	O
22	encompasses	_	encompass	_	VBZ	88	_	_	_	_	_	_	_	O
23	:	_	:	_	:	88	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	O
25	technique	_	technique	_	NN	88	_	_	_	_	_	_	_	O
26	,	_	,	_	,	88	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	88	_	_	_	_	_	_	_	O
28	rotating	_	UNK	_	VBG	88	_	_	_	_	_	_	_	O
29	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	O
30	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	88	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	88	_	_	_	_	_	_	_	O
33	repeated	_	repeat	_	VBN	88	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	88	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	88	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	88	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	88	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	88	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	88	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	88	_	_	_	_	_	site.n	Locale_by_use	S-Locale
41	continuing	_	continue	_	VBG	88	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	88	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	88	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	88	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	88	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	88	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	88	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	88	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	88	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	88	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	88	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	88	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	88	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	88	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	88	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
11	,	_	,	_	,	88	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	88	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	88	_	_	_	_	_	_	_	O
14	structured	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
16	employing	_	employ	_	VBG	88	_	_	_	_	_	_	_	O
17	active	_	active	_	JJ	88	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
19	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	O
20	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	88	_	_	_	_	_	_	_	O
22	encompasses	_	encompass	_	VBZ	88	_	_	_	_	_	_	_	O
23	:	_	:	_	:	88	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	O
25	technique	_	technique	_	NN	88	_	_	_	_	_	_	_	O
26	,	_	,	_	,	88	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	88	_	_	_	_	_	_	_	O
28	rotating	_	UNK	_	VBG	88	_	_	_	_	_	_	_	O
29	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	O
30	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	88	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	88	_	_	_	_	_	_	_	O
33	repeated	_	repeat	_	VBN	88	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	88	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	88	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	88	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	88	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	88	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	88	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	S-Activity
41	continuing	_	continue	_	VBG	88	_	_	_	_	_	continue.v	Activity_ongoing	O
42	telephone	_	telephone	_	NN	88	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	88	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	88	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	88	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	88	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	88	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	88	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	88	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	88	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	88	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	88	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	88	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	88	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	88	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
11	,	_	,	_	,	88	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	88	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	88	_	_	_	_	_	_	_	O
14	structured	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
16	employing	_	employ	_	VBG	88	_	_	_	_	_	_	_	O
17	active	_	active	_	JJ	88	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
19	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	O
20	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	88	_	_	_	_	_	_	_	O
22	encompasses	_	encompass	_	VBZ	88	_	_	_	_	_	_	_	O
23	:	_	:	_	:	88	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	O
25	technique	_	technique	_	NN	88	_	_	_	_	_	_	_	O
26	,	_	,	_	,	88	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	88	_	_	_	_	_	_	_	O
28	rotating	_	UNK	_	VBG	88	_	_	_	_	_	_	_	O
29	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	O
30	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	88	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	88	_	_	_	_	_	_	_	O
33	repeated	_	repeat	_	VBN	88	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	88	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	88	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	88	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	88	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	88	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	88	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	O
41	continuing	_	continue	_	VBG	88	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	88	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	88	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	88	_	_	_	_	_	_	_	S-Mass
45	dose	_	dose	_	JJ	88	_	_	_	_	_	dose.n	Quantified_mass	S-Quantity
46	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	88	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	88	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	88	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	88	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	88	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	88	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	88	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	88	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	88	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	88	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	88	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	88	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
11	,	_	,	_	,	88	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	88	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	88	_	_	_	_	_	_	_	O
14	structured	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
16	employing	_	employ	_	VBG	88	_	_	_	_	_	_	_	O
17	active	_	active	_	JJ	88	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
19	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	O
20	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	88	_	_	_	_	_	_	_	O
22	encompasses	_	encompass	_	VBZ	88	_	_	_	_	_	_	_	O
23	:	_	:	_	:	88	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	O
25	technique	_	technique	_	NN	88	_	_	_	_	_	_	_	O
26	,	_	,	_	,	88	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	88	_	_	_	_	_	_	_	O
28	rotating	_	UNK	_	VBG	88	_	_	_	_	_	_	_	O
29	injection	_	injection	_	NN	88	_	_	_	_	_	_	_	O
30	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	88	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	88	_	_	_	_	_	_	_	O
33	repeated	_	repeat	_	VBN	88	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	88	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	88	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	88	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	88	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	88	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	88	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	88	_	_	_	_	_	_	_	O
41	continuing	_	continue	_	VBG	88	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	88	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	88	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	88	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	88	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	88	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	88	_	_	_	_	_	_	_	B-Content
50	dietary	_	UNK	_	JJ	88	_	_	_	_	_	_	_	I-Content
51	understanding	_	understanding	_	NN	88	_	_	_	_	_	understanding.n	Awareness	O

1	when	_	When	_	WRB	89	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	89	_	_	_	_	_	start.v	Activity_start	O
3	insulin	_	UNK	_	NN	89	_	_	_	_	_	_	_	B-Activity
4	therapy	_	therapy	_	NN	89	_	_	_	_	_	_	_	I-Activity
5	in	_	in	_	IN	89	_	_	_	_	_	_	_	I-Activity
6	adults	_	adult	_	NNS	89	_	_	_	_	_	_	_	I-Activity
7	with	_	with	_	IN	89	_	_	_	_	_	_	_	I-Activity
8	type	_	type	_	JJ	89	_	_	_	_	_	_	_	I-Activity
9	2	_	2	_	CD	89	_	_	_	_	_	_	_	I-Activity
10	diabetes	_	UNK	_	NNS	89	_	_	_	_	_	_	_	I-Activity
11	,	_	,	_	,	89	_	_	_	_	_	_	_	O
12	continue	_	continue	_	VBP	89	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	89	_	_	_	_	_	_	_	O
14	offer	_	offer	_	VB	89	_	_	_	_	_	_	_	O
15	metformin	_	UNK	_	NN	89	_	_	_	_	_	_	_	O
16	for	_	for	_	IN	89	_	_	_	_	_	_	_	O
17	people	_	people	_	NNS	89	_	_	_	_	_	_	_	O
18	without	_	without	_	IN	89	_	_	_	_	_	_	_	O
19	contraindications	_	UNK	_	NNS	89	_	_	_	_	_	_	_	O
20	or	_	or	_	CC	89	_	_	_	_	_	_	_	O
21	intolerance	_	UNK	_	NN	89	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	89	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	89	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	89	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	89	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	89	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	89	_	_	_	_	_	adult.n	People_by_age	S-Person
7	with	_	with	_	IN	89	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	89	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	89	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	89	_	_	_	_	_	_	_	O
11	,	_	,	_	,	89	_	_	_	_	_	_	_	O
12	continue	_	continue	_	VBP	89	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	89	_	_	_	_	_	_	_	O
14	offer	_	offer	_	VB	89	_	_	_	_	_	_	_	O
15	metformin	_	UNK	_	NN	89	_	_	_	_	_	_	_	O
16	for	_	for	_	IN	89	_	_	_	_	_	_	_	O
17	people	_	people	_	NNS	89	_	_	_	_	_	_	_	O
18	without	_	without	_	IN	89	_	_	_	_	_	_	_	O
19	contraindications	_	UNK	_	NNS	89	_	_	_	_	_	_	_	O
20	or	_	or	_	CC	89	_	_	_	_	_	_	_	O
21	intolerance	_	UNK	_	NN	89	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	89	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	89	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	89	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	89	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	89	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	89	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	89	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	89	_	_	_	_	_	type.n	Type	S-Subtype
9	2	_	2	_	CD	89	_	_	_	_	_	_	_	B-Category
10	diabetes	_	UNK	_	NNS	89	_	_	_	_	_	_	_	I-Category
11	,	_	,	_	,	89	_	_	_	_	_	_	_	O
12	continue	_	continue	_	VBP	89	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	89	_	_	_	_	_	_	_	O
14	offer	_	offer	_	VB	89	_	_	_	_	_	_	_	O
15	metformin	_	UNK	_	NN	89	_	_	_	_	_	_	_	O
16	for	_	for	_	IN	89	_	_	_	_	_	_	_	O
17	people	_	people	_	NNS	89	_	_	_	_	_	_	_	O
18	without	_	without	_	IN	89	_	_	_	_	_	_	_	O
19	contraindications	_	UNK	_	NNS	89	_	_	_	_	_	_	_	O
20	or	_	or	_	CC	89	_	_	_	_	_	_	_	O
21	intolerance	_	UNK	_	NN	89	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	89	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	89	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	89	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	89	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	89	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	89	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	89	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	89	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	89	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	89	_	_	_	_	_	_	_	O
11	,	_	,	_	,	89	_	_	_	_	_	_	_	O
12	continue	_	continue	_	VBP	89	_	_	_	_	_	continue.v	Activity_ongoing	O
13	to	_	to	_	TO	89	_	_	_	_	_	_	_	B-Activity
14	offer	_	offer	_	VB	89	_	_	_	_	_	_	_	I-Activity
15	metformin	_	UNK	_	NN	89	_	_	_	_	_	_	_	I-Activity
16	for	_	for	_	IN	89	_	_	_	_	_	_	_	I-Activity
17	people	_	people	_	NNS	89	_	_	_	_	_	_	_	I-Activity
18	without	_	without	_	IN	89	_	_	_	_	_	_	_	I-Activity
19	contraindications	_	UNK	_	NNS	89	_	_	_	_	_	_	_	I-Activity
20	or	_	or	_	CC	89	_	_	_	_	_	_	_	I-Activity
21	intolerance	_	UNK	_	NN	89	_	_	_	_	_	_	_	I-Activity

1	when	_	When	_	WRB	89	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	89	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	89	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	89	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	89	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	89	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	89	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	89	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	89	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	89	_	_	_	_	_	_	_	O
11	,	_	,	_	,	89	_	_	_	_	_	_	_	O
12	continue	_	continue	_	VBP	89	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	89	_	_	_	_	_	_	_	O
14	offer	_	offer	_	VB	89	_	_	_	_	_	_	_	O
15	metformin	_	UNK	_	NN	89	_	_	_	_	_	_	_	O
16	for	_	for	_	IN	89	_	_	_	_	_	_	_	O
17	people	_	people	_	NNS	89	_	_	_	_	_	people.n	People	S-Person
18	without	_	without	_	IN	89	_	_	_	_	_	_	_	O
19	contraindications	_	UNK	_	NNS	89	_	_	_	_	_	_	_	O
20	or	_	or	_	CC	89	_	_	_	_	_	_	_	O
21	intolerance	_	UNK	_	NN	89	_	_	_	_	_	_	_	O

1	start	_	UNK	_	NNP	90	_	_	_	_	_	_	_	O
2	insulin	_	UNK	_	NN	90	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	90	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	90	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	90	_	_	_	_	_	adult.n	People_by_age	S-Person
6	with	_	with	_	IN	90	_	_	_	_	_	_	_	O
7	type	_	type	_	JJ	90	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	90	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	90	_	_	_	_	_	_	_	O
10	from	_	from	_	IN	90	_	_	_	_	_	_	_	O
11	a	_	a	_	DT	90	_	_	_	_	_	_	_	O
12	choice	_	choice	_	NN	90	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	90	_	_	_	_	_	_	_	O
14	a	_	a	_	DT	90	_	_	_	_	_	_	_	O
15	number	_	number	_	NN	90	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	90	_	_	_	_	_	_	_	O
17	insulin	_	UNK	_	NN	90	_	_	_	_	_	_	_	O
18	types	_	type	_	NNS	90	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	90	_	_	_	_	_	_	_	O
20	regimens	_	UNK	_	NNS	90	_	_	_	_	_	_	_	O
21	:	_	:	_	:	90	_	_	_	_	_	_	_	O

1	start	_	UNK	_	NNP	90	_	_	_	_	_	_	_	O
2	insulin	_	UNK	_	NN	90	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	90	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	90	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	90	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	90	_	_	_	_	_	_	_	O
7	type	_	type	_	JJ	90	_	_	_	_	_	type.n	Type	S-Subtype
8	2	_	2	_	CD	90	_	_	_	_	_	_	_	B-Category
9	diabetes	_	UNK	_	NNS	90	_	_	_	_	_	_	_	I-Category
10	from	_	from	_	IN	90	_	_	_	_	_	_	_	O
11	a	_	a	_	DT	90	_	_	_	_	_	_	_	O
12	choice	_	choice	_	NN	90	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	90	_	_	_	_	_	_	_	O
14	a	_	a	_	DT	90	_	_	_	_	_	_	_	O
15	number	_	number	_	NN	90	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	90	_	_	_	_	_	_	_	O
17	insulin	_	UNK	_	NN	90	_	_	_	_	_	_	_	O
18	types	_	type	_	NNS	90	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	90	_	_	_	_	_	_	_	O
20	regimens	_	UNK	_	NNS	90	_	_	_	_	_	_	_	O
21	:	_	:	_	:	90	_	_	_	_	_	_	_	O

1	start	_	UNK	_	NNP	90	_	_	_	_	_	_	_	O
2	insulin	_	UNK	_	NN	90	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	90	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	90	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	90	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	90	_	_	_	_	_	_	_	O
7	type	_	type	_	JJ	90	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	90	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	90	_	_	_	_	_	_	_	O
10	from	_	from	_	IN	90	_	_	_	_	_	_	_	O
11	a	_	a	_	DT	90	_	_	_	_	_	_	_	O
12	choice	_	choice	_	NN	90	_	_	_	_	_	choice.n	Choosing	O
13	of	_	of	_	IN	90	_	_	_	_	_	_	_	B-Topic
14	a	_	a	_	DT	90	_	_	_	_	_	_	_	I-Topic
15	number	_	number	_	NN	90	_	_	_	_	_	_	_	I-Topic
16	of	_	of	_	IN	90	_	_	_	_	_	_	_	I-Topic
17	insulin	_	UNK	_	NN	90	_	_	_	_	_	_	_	I-Topic
18	types	_	type	_	NNS	90	_	_	_	_	_	_	_	I-Topic
19	and	_	and	_	CC	90	_	_	_	_	_	_	_	I-Topic
20	regimens	_	UNK	_	NNS	90	_	_	_	_	_	_	_	I-Topic
21	:	_	:	_	:	90	_	_	_	_	_	_	_	O

1	start	_	UNK	_	NNP	90	_	_	_	_	_	_	_	O
2	insulin	_	UNK	_	NN	90	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	90	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	90	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	90	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	90	_	_	_	_	_	_	_	O
7	type	_	type	_	JJ	90	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	90	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	90	_	_	_	_	_	_	_	O
10	from	_	from	_	IN	90	_	_	_	_	_	_	_	O
11	a	_	a	_	DT	90	_	_	_	_	_	_	_	O
12	choice	_	choice	_	NN	90	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	90	_	_	_	_	_	_	_	O
14	a	_	a	_	DT	90	_	_	_	_	_	_	_	O
15	number	_	number	_	NN	90	_	_	_	_	_	number.n	Cardinal_numbers	S-Number
16	of	_	of	_	IN	90	_	_	_	_	_	_	_	B-Entity
17	insulin	_	UNK	_	NN	90	_	_	_	_	_	_	_	I-Entity
18	types	_	type	_	NNS	90	_	_	_	_	_	_	_	I-Entity
19	and	_	and	_	CC	90	_	_	_	_	_	_	_	I-Entity
20	regimens	_	UNK	_	NNS	90	_	_	_	_	_	_	_	I-Entity
21	:	_	:	_	:	90	_	_	_	_	_	_	_	O

1	start	_	UNK	_	NNP	90	_	_	_	_	_	_	_	O
2	insulin	_	UNK	_	NN	90	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	90	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	90	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	90	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	90	_	_	_	_	_	_	_	O
7	type	_	type	_	JJ	90	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	90	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	90	_	_	_	_	_	_	_	O
10	from	_	from	_	IN	90	_	_	_	_	_	_	_	O
11	a	_	a	_	DT	90	_	_	_	_	_	_	_	O
12	choice	_	choice	_	NN	90	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	90	_	_	_	_	_	_	_	O
14	a	_	a	_	DT	90	_	_	_	_	_	_	_	O
15	number	_	number	_	NN	90	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	90	_	_	_	_	_	_	_	O
17	insulin	_	UNK	_	NN	90	_	_	_	_	_	_	_	S-Category
18	types	_	type	_	NNS	90	_	_	_	_	_	type.n	Type	S-Subtype
19	and	_	and	_	CC	90	_	_	_	_	_	_	_	O
20	regimens	_	UNK	_	NNS	90	_	_	_	_	_	_	_	O
21	:	_	:	_	:	90	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	91	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	91	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	91	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	91	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	91	_	_	_	_	_	_	_	O
6	:	_	:	_	:	91	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	91	_	_	_	_	_	_	_	O
8	(	_	(	_	(	91	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	91	_	_	_	_	_	_	_	O
10	)	_	)	_	)	91	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	91	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	91	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	91	_	_	_	_	_	_	_	O
14	)	_	)	_	)	91	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	91	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	91	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	91	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	91	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	91	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	91	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	91	_	_	_	_	_	_	_	O
8	(	_	(	_	(	91	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	91	_	_	_	_	_	_	_	O
10	)	_	)	_	)	91	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	91	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	91	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	91	_	_	_	_	_	_	_	O
14	)	_	)	_	)	91	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	92	_	_	_	_	_	_	_	O
2	switching	_	switch	_	VBG	92	_	_	_	_	_	switch.v	Exchange	O
3	to	_	to	_	TO	92	_	_	_	_	_	_	_	B-Themes
4	insulin	_	UNK	_	VB	92	_	_	_	_	_	_	_	I-Themes
5	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	I-Themes
6	or	_	or	_	CC	92	_	_	_	_	_	_	_	I-Themes
7	insulin	_	UNK	_	NN	92	_	_	_	_	_	_	_	I-Themes
8	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	I-Themes
9	from	_	from	_	IN	92	_	_	_	_	_	_	_	I-Themes
10	nph	_	UNK	_	NNP	92	_	_	_	_	_	_	_	I-Themes
11	insulin	_	UNK	_	NN	92	_	_	_	_	_	_	_	I-Themes
12	in	_	in	_	IN	92	_	_	_	_	_	_	_	I-Themes
13	adults	_	adult	_	NNS	92	_	_	_	_	_	_	_	I-Themes
14	with	_	with	_	IN	92	_	_	_	_	_	_	_	I-Themes
15	type	_	type	_	JJ	92	_	_	_	_	_	_	_	I-Themes
16	2	_	2	_	CD	92	_	_	_	_	_	_	_	I-Themes
17	diabetes	_	UNK	_	NNS	92	_	_	_	_	_	_	_	I-Themes
18	:	_	:	_	:	92	_	_	_	_	_	_	_	O
19	who	_	who	_	WP	92	_	_	_	_	_	_	_	O
20	do	_	do	_	VBP	92	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	92	_	_	_	_	_	_	_	O
22	reach	_	reach	_	VB	92	_	_	_	_	_	_	_	O
23	their	_	their	_	PRP$	92	_	_	_	_	_	_	_	O
24	target	_	target	_	NN	92	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
26	because	_	because	_	IN	92	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
28	significant	_	significant	_	JJ	92	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
31	who	_	who	_	WP	92	_	_	_	_	_	_	_	O
32	experience	_	experience	_	VBP	92	_	_	_	_	_	_	_	O
33	significant	_	significant	_	JJ	92	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
35	on	_	on	_	IN	92	_	_	_	_	_	_	_	O
36	nph	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
37	insulin	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
38	irrespective	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
39	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
41	level	_	level	_	NN	92	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	92	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	92	_	_	_	_	_	_	_	O
2	switching	_	switch	_	VBG	92	_	_	_	_	_	_	_	O
3	to	_	to	_	TO	92	_	_	_	_	_	_	_	O
4	insulin	_	UNK	_	VB	92	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
6	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
7	insulin	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
9	from	_	from	_	IN	92	_	_	_	_	_	_	_	O
10	nph	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
11	insulin	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
13	adults	_	adult	_	NNS	92	_	_	_	_	_	adult.n	People_by_age	S-Person
14	with	_	with	_	IN	92	_	_	_	_	_	_	_	O
15	type	_	type	_	JJ	92	_	_	_	_	_	_	_	O
16	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
17	diabetes	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
18	:	_	:	_	:	92	_	_	_	_	_	_	_	O
19	who	_	who	_	WP	92	_	_	_	_	_	_	_	O
20	do	_	do	_	VBP	92	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	92	_	_	_	_	_	_	_	O
22	reach	_	reach	_	VB	92	_	_	_	_	_	_	_	O
23	their	_	their	_	PRP$	92	_	_	_	_	_	_	_	O
24	target	_	target	_	NN	92	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
26	because	_	because	_	IN	92	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
28	significant	_	significant	_	JJ	92	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
31	who	_	who	_	WP	92	_	_	_	_	_	_	_	O
32	experience	_	experience	_	VBP	92	_	_	_	_	_	_	_	O
33	significant	_	significant	_	JJ	92	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
35	on	_	on	_	IN	92	_	_	_	_	_	_	_	O
36	nph	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
37	insulin	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
38	irrespective	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
39	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
41	level	_	level	_	NN	92	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	92	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	92	_	_	_	_	_	_	_	O
2	switching	_	switch	_	VBG	92	_	_	_	_	_	_	_	O
3	to	_	to	_	TO	92	_	_	_	_	_	_	_	O
4	insulin	_	UNK	_	VB	92	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
6	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
7	insulin	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
9	from	_	from	_	IN	92	_	_	_	_	_	_	_	O
10	nph	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
11	insulin	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
13	adults	_	adult	_	NNS	92	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	92	_	_	_	_	_	_	_	O
15	type	_	type	_	JJ	92	_	_	_	_	_	type.n	Type	S-Subtype
16	2	_	2	_	CD	92	_	_	_	_	_	_	_	B-Category
17	diabetes	_	UNK	_	NNS	92	_	_	_	_	_	_	_	I-Category
18	:	_	:	_	:	92	_	_	_	_	_	_	_	O
19	who	_	who	_	WP	92	_	_	_	_	_	_	_	O
20	do	_	do	_	VBP	92	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	92	_	_	_	_	_	_	_	O
22	reach	_	reach	_	VB	92	_	_	_	_	_	_	_	O
23	their	_	their	_	PRP$	92	_	_	_	_	_	_	_	O
24	target	_	target	_	NN	92	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
26	because	_	because	_	IN	92	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
28	significant	_	significant	_	JJ	92	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
31	who	_	who	_	WP	92	_	_	_	_	_	_	_	O
32	experience	_	experience	_	VBP	92	_	_	_	_	_	_	_	O
33	significant	_	significant	_	JJ	92	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
35	on	_	on	_	IN	92	_	_	_	_	_	_	_	O
36	nph	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
37	insulin	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
38	irrespective	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
39	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
41	level	_	level	_	NN	92	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	92	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	92	_	_	_	_	_	_	_	O
2	switching	_	switch	_	VBG	92	_	_	_	_	_	_	_	O
3	to	_	to	_	TO	92	_	_	_	_	_	_	_	O
4	insulin	_	UNK	_	VB	92	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
6	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
7	insulin	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
9	from	_	from	_	IN	92	_	_	_	_	_	_	_	O
10	nph	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
11	insulin	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
13	adults	_	adult	_	NNS	92	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	92	_	_	_	_	_	_	_	O
15	type	_	type	_	JJ	92	_	_	_	_	_	_	_	O
16	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
17	diabetes	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
18	:	_	:	_	:	92	_	_	_	_	_	_	_	O
19	who	_	who	_	WP	92	_	_	_	_	_	_	_	S-Theme
20	do	_	do	_	VBP	92	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	92	_	_	_	_	_	_	_	O
22	reach	_	reach	_	VB	92	_	_	_	_	_	reach.v	Arriving	O
23	their	_	their	_	PRP$	92	_	_	_	_	_	_	_	B-Goal
24	target	_	target	_	NN	92	_	_	_	_	_	_	_	I-Goal
25	hba1c	_	UNK	_	NNP	92	_	_	_	_	_	_	_	I-Goal
26	because	_	because	_	IN	92	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
28	significant	_	significant	_	JJ	92	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
31	who	_	who	_	WP	92	_	_	_	_	_	_	_	O
32	experience	_	experience	_	VBP	92	_	_	_	_	_	_	_	O
33	significant	_	significant	_	JJ	92	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
35	on	_	on	_	IN	92	_	_	_	_	_	_	_	O
36	nph	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
37	insulin	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
38	irrespective	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
39	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
41	level	_	level	_	NN	92	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	92	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	92	_	_	_	_	_	_	_	O
2	switching	_	switch	_	VBG	92	_	_	_	_	_	_	_	O
3	to	_	to	_	TO	92	_	_	_	_	_	_	_	O
4	insulin	_	UNK	_	VB	92	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
6	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
7	insulin	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
9	from	_	from	_	IN	92	_	_	_	_	_	_	_	O
10	nph	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
11	insulin	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
13	adults	_	adult	_	NNS	92	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	92	_	_	_	_	_	_	_	O
15	type	_	type	_	JJ	92	_	_	_	_	_	_	_	O
16	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
17	diabetes	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
18	:	_	:	_	:	92	_	_	_	_	_	_	_	O
19	who	_	who	_	WP	92	_	_	_	_	_	_	_	B-Cause
20	do	_	do	_	VBP	92	_	_	_	_	_	_	_	I-Cause
21	not	_	not	_	RB	92	_	_	_	_	_	_	_	I-Cause
22	reach	_	reach	_	VB	92	_	_	_	_	_	_	_	I-Cause
23	their	_	their	_	PRP$	92	_	_	_	_	_	_	_	I-Cause
24	target	_	target	_	NN	92	_	_	_	_	_	_	_	I-Cause
25	hba1c	_	UNK	_	NNP	92	_	_	_	_	_	_	_	I-Cause
26	because	_	because	_	IN	92	_	_	_	_	_	because.c	Causation	O
27	of	_	of	_	IN	92	_	_	_	_	_	_	_	B-Effect
28	significant	_	significant	_	JJ	92	_	_	_	_	_	_	_	I-Effect
29	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	I-Effect
30	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
31	who	_	who	_	WP	92	_	_	_	_	_	_	_	O
32	experience	_	experience	_	VBP	92	_	_	_	_	_	_	_	O
33	significant	_	significant	_	JJ	92	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
35	on	_	on	_	IN	92	_	_	_	_	_	_	_	O
36	nph	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
37	insulin	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
38	irrespective	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
39	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
41	level	_	level	_	NN	92	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	92	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	92	_	_	_	_	_	_	_	O
2	switching	_	switch	_	VBG	92	_	_	_	_	_	_	_	O
3	to	_	to	_	TO	92	_	_	_	_	_	_	_	O
4	insulin	_	UNK	_	VB	92	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
6	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
7	insulin	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
9	from	_	from	_	IN	92	_	_	_	_	_	_	_	O
10	nph	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
11	insulin	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
13	adults	_	adult	_	NNS	92	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	92	_	_	_	_	_	_	_	O
15	type	_	type	_	JJ	92	_	_	_	_	_	_	_	O
16	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
17	diabetes	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
18	:	_	:	_	:	92	_	_	_	_	_	_	_	O
19	who	_	who	_	WP	92	_	_	_	_	_	_	_	O
20	do	_	do	_	VBP	92	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	92	_	_	_	_	_	_	_	O
22	reach	_	reach	_	VB	92	_	_	_	_	_	_	_	O
23	their	_	their	_	PRP$	92	_	_	_	_	_	_	_	O
24	target	_	target	_	NN	92	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
26	because	_	because	_	IN	92	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
28	significant	_	significant	_	JJ	92	_	_	_	_	_	significant.a	Importance	O
29	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	S-Factor
30	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
31	who	_	who	_	WP	92	_	_	_	_	_	_	_	O
32	experience	_	experience	_	VBP	92	_	_	_	_	_	_	_	O
33	significant	_	significant	_	JJ	92	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
35	on	_	on	_	IN	92	_	_	_	_	_	_	_	O
36	nph	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
37	insulin	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
38	irrespective	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
39	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
41	level	_	level	_	NN	92	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	92	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	92	_	_	_	_	_	_	_	O
2	switching	_	switch	_	VBG	92	_	_	_	_	_	_	_	O
3	to	_	to	_	TO	92	_	_	_	_	_	_	_	O
4	insulin	_	UNK	_	VB	92	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
6	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
7	insulin	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
9	from	_	from	_	IN	92	_	_	_	_	_	_	_	O
10	nph	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
11	insulin	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
13	adults	_	adult	_	NNS	92	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	92	_	_	_	_	_	_	_	O
15	type	_	type	_	JJ	92	_	_	_	_	_	_	_	O
16	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
17	diabetes	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
18	:	_	:	_	:	92	_	_	_	_	_	_	_	O
19	who	_	who	_	WP	92	_	_	_	_	_	_	_	O
20	do	_	do	_	VBP	92	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	92	_	_	_	_	_	_	_	O
22	reach	_	reach	_	VB	92	_	_	_	_	_	_	_	O
23	their	_	their	_	PRP$	92	_	_	_	_	_	_	_	O
24	target	_	target	_	NN	92	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
26	because	_	because	_	IN	92	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
28	significant	_	significant	_	JJ	92	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
31	who	_	who	_	WP	92	_	_	_	_	_	_	_	S-Experiencer
32	experience	_	experience	_	VBP	92	_	_	_	_	_	experience.v	Feeling	O
33	significant	_	significant	_	JJ	92	_	_	_	_	_	_	_	B-Emotional_state
34	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	I-Emotional_state
35	on	_	on	_	IN	92	_	_	_	_	_	_	_	O
36	nph	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
37	insulin	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
38	irrespective	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
39	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
41	level	_	level	_	NN	92	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	92	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	92	_	_	_	_	_	_	_	O
2	switching	_	switch	_	VBG	92	_	_	_	_	_	_	_	O
3	to	_	to	_	TO	92	_	_	_	_	_	_	_	O
4	insulin	_	UNK	_	VB	92	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
6	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
7	insulin	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
9	from	_	from	_	IN	92	_	_	_	_	_	_	_	O
10	nph	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
11	insulin	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
13	adults	_	adult	_	NNS	92	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	92	_	_	_	_	_	_	_	O
15	type	_	type	_	JJ	92	_	_	_	_	_	_	_	O
16	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
17	diabetes	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
18	:	_	:	_	:	92	_	_	_	_	_	_	_	O
19	who	_	who	_	WP	92	_	_	_	_	_	_	_	O
20	do	_	do	_	VBP	92	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	92	_	_	_	_	_	_	_	O
22	reach	_	reach	_	VB	92	_	_	_	_	_	_	_	O
23	their	_	their	_	PRP$	92	_	_	_	_	_	_	_	O
24	target	_	target	_	NN	92	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
26	because	_	because	_	IN	92	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
28	significant	_	significant	_	JJ	92	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
31	who	_	who	_	WP	92	_	_	_	_	_	_	_	O
32	experience	_	experience	_	VBP	92	_	_	_	_	_	_	_	O
33	significant	_	significant	_	JJ	92	_	_	_	_	_	significant.a	Importance	O
34	unk	_	UNK	_	NN	92	_	_	_	_	_	_	_	S-Factor
35	on	_	on	_	IN	92	_	_	_	_	_	_	_	O
36	nph	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
37	insulin	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
38	irrespective	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
39	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
41	level	_	level	_	NN	92	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	92	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	93	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	93	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	93	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	93	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	93	_	_	_	_	_	_	_	O
6	:	_	:	_	:	93	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	93	_	_	_	_	_	_	_	O
8	(	_	(	_	(	93	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	93	_	_	_	_	_	_	_	O
10	)	_	)	_	)	93	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	93	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	93	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	93	_	_	_	_	_	_	_	O
14	)	_	)	_	)	93	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	93	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	93	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	93	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	93	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	93	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	93	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	93	_	_	_	_	_	_	_	O
8	(	_	(	_	(	93	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	93	_	_	_	_	_	_	_	O
10	)	_	)	_	)	93	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	93	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	93	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	93	_	_	_	_	_	_	_	O
14	)	_	)	_	)	93	_	_	_	_	_	_	_	O

1	monitor	_	Monitor	_	NNP	94	_	_	_	_	_	_	_	S-Origin
2	adults	_	adult	_	NNS	94	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	94	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	94	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	94	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	94	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	94	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	94	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	94	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	94	_	_	_	_	_	_	_	O
11	basal	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
12	insulin	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
13	regimen	_	UNK	_	NNS	94	_	_	_	_	_	_	_	O
14	(	_	(	_	(	94	_	_	_	_	_	_	_	O
15	nph	_	UNK	_	NNP	94	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
17	,	_	,	_	,	94	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
20	or	_	or	_	CC	94	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
23	)	_	)	_	)	94	_	_	_	_	_	_	_	O
24	for	_	for	_	IN	94	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	94	_	_	_	_	_	_	_	O
26	need	_	need	_	NN	94	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	94	_	_	_	_	_	_	_	O
28	short-acting	_	UNK	_	JJ	94	_	_	_	_	_	_	_	O
29	insulin	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
30	before	_	before	_	IN	94	_	_	_	_	_	_	_	O
31	meals	_	meal	_	NNS	94	_	_	_	_	_	_	_	O
32	(	_	(	_	(	94	_	_	_	_	_	_	_	O
33	or	_	or	_	CC	94	_	_	_	_	_	_	_	O
34	a	_	a	_	DT	94	_	_	_	_	_	_	_	O
35	pre-mixed	_	UNK	_	JJ	94	_	_	_	_	_	_	_	O
36	[	_	[	_	NN	94	_	_	_	_	_	_	_	O
37	biphasic	_	UNK	_	JJ	94	_	_	_	_	_	_	_	O
38	]	_	]	_	NNP	94	_	_	_	_	_	_	_	O
39	insulin	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
40	preparation	_	preparation	_	NN	94	_	_	_	_	_	_	_	O
41	)	_	)	_	)	94	_	_	_	_	_	_	_	O
42	.	_	.	_	.	94	_	_	_	_	_	_	_	O

1	monitor	_	Monitor	_	NNP	94	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	94	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	94	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	94	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	94	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	94	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	94	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	94	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	94	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	94	_	_	_	_	_	_	_	O
11	basal	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
12	insulin	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
13	regimen	_	UNK	_	NNS	94	_	_	_	_	_	_	_	O
14	(	_	(	_	(	94	_	_	_	_	_	_	_	O
15	nph	_	UNK	_	NNP	94	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
17	,	_	,	_	,	94	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
20	or	_	or	_	CC	94	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
23	)	_	)	_	)	94	_	_	_	_	_	_	_	O
24	for	_	for	_	IN	94	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	94	_	_	_	_	_	_	_	O
26	need	_	need	_	NN	94	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	94	_	_	_	_	_	_	_	O
28	short-acting	_	UNK	_	JJ	94	_	_	_	_	_	_	_	O
29	insulin	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
30	before	_	before	_	IN	94	_	_	_	_	_	_	_	O
31	meals	_	meal	_	NNS	94	_	_	_	_	_	_	_	O
32	(	_	(	_	(	94	_	_	_	_	_	_	_	O
33	or	_	or	_	CC	94	_	_	_	_	_	_	_	O
34	a	_	a	_	DT	94	_	_	_	_	_	_	_	O
35	pre-mixed	_	UNK	_	JJ	94	_	_	_	_	_	_	_	O
36	[	_	[	_	NN	94	_	_	_	_	_	_	_	O
37	biphasic	_	UNK	_	JJ	94	_	_	_	_	_	_	_	O
38	]	_	]	_	NNP	94	_	_	_	_	_	_	_	O
39	insulin	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
40	preparation	_	preparation	_	NN	94	_	_	_	_	_	_	_	O
41	)	_	)	_	)	94	_	_	_	_	_	_	_	O
42	.	_	.	_	.	94	_	_	_	_	_	_	_	O

1	monitor	_	Monitor	_	NNP	94	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	94	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	94	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	94	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	94	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	94	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	94	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	94	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	94	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	94	_	_	_	_	_	_	_	O
11	basal	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
12	insulin	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
13	regimen	_	UNK	_	NNS	94	_	_	_	_	_	_	_	O
14	(	_	(	_	(	94	_	_	_	_	_	_	_	O
15	nph	_	UNK	_	NNP	94	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
17	,	_	,	_	,	94	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
20	or	_	or	_	CC	94	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
23	)	_	)	_	)	94	_	_	_	_	_	_	_	O
24	for	_	for	_	IN	94	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	94	_	_	_	_	_	_	_	O
26	need	_	need	_	NN	94	_	_	_	_	_	need.n	Needing	O
27	for	_	for	_	IN	94	_	_	_	_	_	_	_	B-Dependent
28	short-acting	_	UNK	_	JJ	94	_	_	_	_	_	_	_	I-Dependent
29	insulin	_	UNK	_	NN	94	_	_	_	_	_	_	_	I-Dependent
30	before	_	before	_	IN	94	_	_	_	_	_	_	_	O
31	meals	_	meal	_	NNS	94	_	_	_	_	_	_	_	O
32	(	_	(	_	(	94	_	_	_	_	_	_	_	O
33	or	_	or	_	CC	94	_	_	_	_	_	_	_	O
34	a	_	a	_	DT	94	_	_	_	_	_	_	_	O
35	pre-mixed	_	UNK	_	JJ	94	_	_	_	_	_	_	_	O
36	[	_	[	_	NN	94	_	_	_	_	_	_	_	O
37	biphasic	_	UNK	_	JJ	94	_	_	_	_	_	_	_	O
38	]	_	]	_	NNP	94	_	_	_	_	_	_	_	O
39	insulin	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
40	preparation	_	preparation	_	NN	94	_	_	_	_	_	_	_	O
41	)	_	)	_	)	94	_	_	_	_	_	_	_	O
42	.	_	.	_	.	94	_	_	_	_	_	_	_	O

1	monitor	_	Monitor	_	NNP	94	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	94	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	94	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	94	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	94	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	94	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	94	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	94	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	94	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	94	_	_	_	_	_	_	_	O
11	basal	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
12	insulin	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
13	regimen	_	UNK	_	NNS	94	_	_	_	_	_	_	_	O
14	(	_	(	_	(	94	_	_	_	_	_	_	_	O
15	nph	_	UNK	_	NNP	94	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
17	,	_	,	_	,	94	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
20	or	_	or	_	CC	94	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
23	)	_	)	_	)	94	_	_	_	_	_	_	_	O
24	for	_	for	_	IN	94	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	94	_	_	_	_	_	_	_	O
26	need	_	need	_	NN	94	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	94	_	_	_	_	_	_	_	O
28	short-acting	_	UNK	_	JJ	94	_	_	_	_	_	_	_	O
29	insulin	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
30	before	_	before	_	IN	94	_	_	_	_	_	_	_	O
31	meals	_	meal	_	NNS	94	_	_	_	_	_	_	_	O
32	(	_	(	_	(	94	_	_	_	_	_	_	_	O
33	or	_	or	_	CC	94	_	_	_	_	_	_	_	O
34	a	_	a	_	DT	94	_	_	_	_	_	_	_	O
35	pre-mixed	_	UNK	_	JJ	94	_	_	_	_	_	_	_	O
36	[	_	[	_	NN	94	_	_	_	_	_	_	_	O
37	biphasic	_	UNK	_	JJ	94	_	_	_	_	_	_	_	O
38	]	_	]	_	NNP	94	_	_	_	_	_	_	_	O
39	insulin	_	UNK	_	NN	94	_	_	_	_	_	_	_	S-Activity
40	preparation	_	preparation	_	NN	94	_	_	_	_	_	preparation.n	Activity_prepare	O
41	)	_	)	_	)	94	_	_	_	_	_	_	_	O
42	.	_	.	_	.	94	_	_	_	_	_	_	_	O

1	monitor	_	Monitor	_	NNP	95	_	_	_	_	_	_	_	S-Origin
2	adults	_	adult	_	NNS	95	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	95	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	95	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	95	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	95	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	95	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	95	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	95	_	_	_	_	_	_	_	O
10	pre-mixed	_	UNK	_	JJ	95	_	_	_	_	_	_	_	O
11	(	_	(	_	(	95	_	_	_	_	_	_	_	O
12	biphasic	_	UNK	_	JJ	95	_	_	_	_	_	_	_	O
13	)	_	)	_	)	95	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	95	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	95	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	95	_	_	_	_	_	_	_	O
17	need	_	need	_	NN	95	_	_	_	_	_	_	_	O
18	for	_	for	_	IN	95	_	_	_	_	_	_	_	O
19	a	_	a	_	DT	95	_	_	_	_	_	_	_	O
20	further	_	further	_	JJ	95	_	_	_	_	_	_	_	O
21	injection	_	injection	_	NN	95	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	95	_	_	_	_	_	_	_	O
23	short-acting	_	UNK	_	JJ	95	_	_	_	_	_	_	_	O
24	insulin	_	UNK	_	NN	95	_	_	_	_	_	_	_	O
25	befor	_	UNK	_	NN	95	_	_	_	_	_	_	_	O

1	monitor	_	Monitor	_	NNP	95	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	95	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	95	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	95	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	95	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	95	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	95	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	95	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	95	_	_	_	_	_	_	_	O
10	pre-mixed	_	UNK	_	JJ	95	_	_	_	_	_	_	_	O
11	(	_	(	_	(	95	_	_	_	_	_	_	_	O
12	biphasic	_	UNK	_	JJ	95	_	_	_	_	_	_	_	O
13	)	_	)	_	)	95	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	95	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	95	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	95	_	_	_	_	_	_	_	O
17	need	_	need	_	NN	95	_	_	_	_	_	_	_	O
18	for	_	for	_	IN	95	_	_	_	_	_	_	_	O
19	a	_	a	_	DT	95	_	_	_	_	_	_	_	O
20	further	_	further	_	JJ	95	_	_	_	_	_	_	_	O
21	injection	_	injection	_	NN	95	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	95	_	_	_	_	_	_	_	O
23	short-acting	_	UNK	_	JJ	95	_	_	_	_	_	_	_	O
24	insulin	_	UNK	_	NN	95	_	_	_	_	_	_	_	O
25	befor	_	UNK	_	NN	95	_	_	_	_	_	_	_	O

1	monitor	_	Monitor	_	NNP	95	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	95	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	95	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	95	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	95	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	95	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	95	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	95	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	95	_	_	_	_	_	_	_	O
10	pre-mixed	_	UNK	_	JJ	95	_	_	_	_	_	_	_	O
11	(	_	(	_	(	95	_	_	_	_	_	_	_	O
12	biphasic	_	UNK	_	JJ	95	_	_	_	_	_	_	_	O
13	)	_	)	_	)	95	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	95	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	95	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	95	_	_	_	_	_	_	_	O
17	need	_	need	_	NN	95	_	_	_	_	_	need.n	Needing	S-Requirement
18	for	_	for	_	IN	95	_	_	_	_	_	_	_	O
19	a	_	a	_	DT	95	_	_	_	_	_	_	_	O
20	further	_	further	_	JJ	95	_	_	_	_	_	_	_	O
21	injection	_	injection	_	NN	95	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	95	_	_	_	_	_	_	_	O
23	short-acting	_	UNK	_	JJ	95	_	_	_	_	_	_	_	O
24	insulin	_	UNK	_	NN	95	_	_	_	_	_	_	_	O
25	befor	_	UNK	_	NN	95	_	_	_	_	_	_	_	O

1	monitor	_	Monitor	_	NNP	95	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	95	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	95	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	95	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	95	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	95	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	95	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	95	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	95	_	_	_	_	_	_	_	O
10	pre-mixed	_	UNK	_	JJ	95	_	_	_	_	_	_	_	O
11	(	_	(	_	(	95	_	_	_	_	_	_	_	O
12	biphasic	_	UNK	_	JJ	95	_	_	_	_	_	_	_	O
13	)	_	)	_	)	95	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	95	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	95	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	95	_	_	_	_	_	_	_	O
17	need	_	need	_	NN	95	_	_	_	_	_	_	_	O
18	for	_	for	_	IN	95	_	_	_	_	_	_	_	O
19	a	_	a	_	DT	95	_	_	_	_	_	_	_	O
20	further	_	further	_	JJ	95	_	_	_	_	_	further.a	Increment	O
21	injection	_	injection	_	NN	95	_	_	_	_	_	_	_	B-Class
22	of	_	of	_	IN	95	_	_	_	_	_	_	_	I-Class
23	short-acting	_	UNK	_	JJ	95	_	_	_	_	_	_	_	I-Class
24	insulin	_	UNK	_	NN	95	_	_	_	_	_	_	_	I-Class
25	befor	_	UNK	_	NN	95	_	_	_	_	_	_	_	O

